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Abstract	  
Chlamydia	  pneumoniae	  is	  a	  ubiquitous	  human	  and	  animal	  pathogen.	  Originally	  identified	  
as	  a	  human	  respiratory	  pathogen,	  it	  is	  now	  associated	  with	  a	  number	  of	  chronic	  diseases	  
such	   atherosclerosis	   and	   Alzheimer's	   disease,	   as	   well	   as	   respiratory	   and	   systemic	  
infections	   in	   a	   number	   of	   animal	   hosts	   including	   marsupials,	   horses,	   amphibians	   and	  
reptiles.	   Previous	   targeted	   molecular	   and	   whole	   genome	   studies	   of	   human	   C.	  
pneumoniae	  strains	  have	  described	  a	  highly	  conserved	  genome	  with	  only	  a	  few	  hundred	  
nucleotide	   polymorphisms	   distinguishing	   strains,	  whilst	  whole	   genome	   comparisons	   of	  
human	   strains	  with	   the	   koala	  C.	   pneumoniae	   strain	   distinguished	   a	   number	  of	   notable	  
sequence	   polymorphisms	   as	   well	   as	   additional	   chromosomal	   coding	   capacity	   and	   an	  
extrachromosomal	   plasmid.	   Additionally,	   developmental	   and	   morphological	   variations	  
have	  been	  described	   in	   in	   vitro	   studies	   examining	  C.	   pneumoniae	   strains	   isolated	   from	  
different	   hosts	   and	   different	   human	   diseases.	   In	   spite	   of	   its	   association	   with	   a	   broad	  
range	  of	  hosts	  and	  pathologies,	  a	  genetic	  basis	  of	  host	  and	  tissue	  tropism	  has	  yet	  to	  be	  
identified.	   Until	   recently,	   whole	   genome	   sequences	   of	   human	   C.	   pneumoniae	   strains	  
were	   almost	   exclusively	   respiratory	   in	   origin,	   and	   only	   a	   single	   animal	   C.	   pneumoniae	  
strain	  had	  been	  sequenced,	  making	  inferences	  on	  the	  genetic	  basis	  of	  disease	  associated	  
with	   C.	   pneumoniae	   tenuous	   at	   best.	   In	   an	   attempt	   to	   identify	   a	   genetic	   basis	   for	   C.	  
pneumoniae	   host	   and	   tissue	   specificity,	   the	   present	   study	   utilised	   next	   generation	  
sequencing	   technologies	   and	   various	   bioinformatic	   tools	   to	   (a)	   obtain,	   compare	   and	  
characterise	  a	  number	  of	  C.	  pneumoniae	  whole	  genome	  sequences	  isolated	  from	  human	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respiratory,	   atherosclerosis	   and	   Alzheimer's	   patients,	   as	   well	   as	   a	   whole	   genome	  
sequence	  from	  the	  western	  barred	  bandicoot,	  and	  (b)	  used	  RNAseq	  to	  compare	  a	  human	  
and	   animal	   C.	   pneumoniae	   transcriptome	   in	   order	   to	   determine	   whether	   sequence	  
polymorphism	   and	   gene	   expression	   variance	   accounted	   for	   the	   difference	   in	  
development	  and	  morphology	  between	  human	  and	  animal	  C.	  pneumoniae	  strains.	  	  
Overall,	   we	   performed	   three	   genomic	   sequencing	   and	   comparative	   studies	   and	   one	  
comparative	  transcriptome	  study,	  resulting	  in	  the	  release	  of	  six	  additional	  C.	  pneumoniae	  
genomes	  and	  an	  RNAseq	  pilot	  study,	  which	  was	  the	  first	  to	  examine	  the	  transcriptome	  of	  
an	  animal	  C.	  pneumoniae	  strain.	  
For	   our	   first	   study	   (chapter	   three),	   we	   chose	   to	   sequence	   the	   B21	   western	   barred	  
bandicoot	  strain	  as	  previous	  studies	  suggested	  that	  C.	  pneumoniae	  isolated	  from	  western	  
barred	  bandicoots	  (and	  other	  Australian	  fauna)	  were	  identical	  in	  sequence	  to	  the	  LPCoLN	  
koala	  C.	  pneumoniae	  strain.	   	  We	  obtained	  full	  chromosomal	  and	  plasmid	  sequences	  for	  
the	   B21	   strain	   and	   found	   them	   to	   differ	   from	   the	   LPCoLN	   strain	   by	   only	   a	   few	  
nucleotides.	  These	   findings	   suggest	   that	  C.	  pneumoniae	   strains	   circulating	   in	  Australian	  
marsupials	  are	  highly	  conserved	  in	  their	  genetic	  content,	  supporting	  the	  existence	  of	  an	  
Australian	  animal/marsupial	  biovar.	  
Our	   second	   study	   (chapter	   four)	   sought	   to	   investigate	  whether	   human	  C.	   pneumoniae	  
strains	  isolated	  from	  different	  pathologies	  displayed	  characteristic	  polymorphisms	  which	  
may	   account	   for	   their	   adaptation	   to	   particular	   diseases.	   We	   sequenced	   strains	   A03	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(isolated	   from	   a	   patient	   undergoing	   endarterectomy	   for	   atherosclerosis)	   and	   TOR-­‐1	   (a	  
post-­‐mortem	  brain	  isolate	  from	  a	  patient	  with	  Alzheimer's	  disease)	  and	  compared	  these	  
to	   the	   C.	   pneumoniae	   whole	   genome	   sequences	   publicly	   available	   in	   GenBank.	   We	  
described	  a	  number	  of	  characteristic	  sequence	  polymorphisms	  that	  may	  account	  for	  the	  
presence	  of	  these	  strains	  in	  particular	  human	  tissues,	  as	  well	  as	  their	  distinctly	  divergent	  
phylogenetic	  groupings.	  
In	   order	   to	   expand	   on	   findings	   from	   our	   second	   study,	   and	   further	   elucidate	   the	  
phylogenetic	   and	  evolutionary	  position	  of	   various	  human	  C.	   pneumoniae	   strains	   in	   the	  
evolutionary	  timeline,	  we	  sequenced	  three	  Australian	  human	  respiratory	  C.	  pneumoniae	  
isolates	  and	  compared	  them	  to	  an	  expanded	  number	  of	  animal,	  human	  respiratory	  and	  
non-­‐respiratory	   whole	   genome	   sequences	   (chapter	   five).	   In	   this	   study	   we	   identified	   a	  
phylogenetically	   distinct	   human	   C.	   pneumoniae	   lineage	   consisting	   of	   two	   Australian	  
indigenous	  respiratory	  strains,	  supported	  by	  characteristic	  sequence	  polymorphisms	  and	  
recombination	  profiles.	  
Chapter	  six	  details	  findings	  from	  a	  pilot	  study	  where	  we	  employed	  RNAseq	  technology	  to	  
compare	   the	   transcriptomes	   of	   two	   C.	   pneumoniae	   strains.	   In	   order	   to	   investigate	  
whether	  gene	  expression	  differences	  could	  account	   for	   the	  divergence	   in	  development	  
and	   inclusion	   morphology	   between	   human	   and	   animal	   C.	   pneumoniae	   strains,	   we	  
examined	   transcriptomes	   of	   the	   human	   atherosclerosis	   strain	   A03	   and	   koala	   strain	  
LPCoLN,	  at	  the	  same	  time	  point	  propagated	  under	  identical	  conditions.	  	  We	  described	  a	  
number	  of	   genes	   and	  gene	   families	  which	  were	   similarly	   transcribed	  between	   the	   two	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strains,	  as	  well	  as	  a	  number	  of	  pseudogenes	  and	  a	   large	  number	  of	  genes	  expressed	   in	  
the	  plasticity	  zones	  of	  both	  strains	  examined.	  
Taken	   together,	   the	   findings	   from	   this	   study	   indicate	   that	   the	   genetic	   diversity	   of	   C.	  
pneumoniae	   in	  both	  human	  and	  animal	  hosts	   is	  greater	  than	  previously	  recognised	  and	  
suggests	   that	   a	   number	   of	   a	   minor	   sequence	   polymorphisms	   may	   account	   for	   the	  
biological	   fitness	   of	   particular	   strains	   to	   different	   diseases	   and	   animal	   hosts.	  
Additionally,	  this	  study	  identified	  a	  separate	  Australian	  human	  C.	  pneumoniae	  lineage	  as	  
well	   as	   a	   high	   level	   of	   whole	   genome	   nucleotide	   conservation	   in	   Australian	  marsupial	  
strains,	  suggesting	  that	  the	  evolution	  of	  C.	  pneumoniae	  may	  also	  have	  a	  biogeographical	  
basis.	  The	  outcomes	  of	  this	  study	  have	  expanded	  our	  knowledge	  of	  the	  genetic	  diversity	  
of	   this	  pathogen,	  particularly	  within	  the	  scope	  of	  human	  disease,	  and	  have	   identified	  a	  
number	   of	   molecular	   markers	   which	   could	   be	   used	   to	   further	   classify	   C.	   pneumoniae	  
strains	  isolated	  from	  various	  hosts	  and	  diseases.	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STUDY	  BACKGROUND	  
Chlamydia	  pneumoniae	   is	  an	  airborne	  obligate	   intracellular	  pathogen	  which	   is	  primarily	  
associated	  with	  atypical	  upper	  and	   lower	   respiratory	   infections	   in	  humans	  and	  animals	  
[1].	  Outbreaks	  of	  pneumonia	  caused	  by	  C.	  pneumoniae	  are	  regularly	  reported	  [2-­‐4],	  and	  
whilst	  previous	  studies	  have	  suggested	  a	  high	  serological	  prevalence	  rate	  (up	  to	  70%)	  in	  
adults	   [5,	   6],	   recent	   clinical	   observations	   suggest	   that	   the	   current	   infection	   rate	   is	   far	  
lower	  [7].	  In	  addition	  to	  its	  respiratory	  presentation,	  C.	  pneumoniae	  has	  been	  associated	  
with	   a	   range	   of	   pathologies	   including	  Alzheimer's	   [8,	   9],	   ischaemic	   stroke	   [10,	   11]	   and	  
cardiovascular	   diseases	   [12-­‐14].	   C.	   pneumoniae	   readily	   infect	   monocytes	   and	  
macrophages	  [15-­‐17]	  which	  disseminate	  from	  the	  lungs	  to	  other	  organs.	  C.	  pneumoniae	  
also	   has	   the	   widest	   host	   range	   of	   the	   Chlamydiae,	   with	   infections	   characterised	   in	   a	  
number	   of	   mammals,	   marsupials,	   reptiles	   and	   amphibians.	   Respiratory	   distress	   is	   a	  
common	  presentation	  of	  animal	  C.	  pneumoniae	   infection,	  though	  systemic	  chamydiosis	  
presenting	  as	  conjunctivitis	  and	  granulomatous	  lesions	  have	  been	  described	  [18,	  19].	  
Until	   very	   recently,	  molecular	   typing	   studies	   of	  C.	   pneumoniae	   in	   humans	   and	   animals	  
were	   limited	   to	   PCR	   sequencing	   of	   selected	   target	   genes	   [20-­‐24]	   and	   whole	   genome	  
analyses	   based	  on	   a	   single	   animal	   strain	   (koala	   -­‐	   LPCoLN)	   [25]	   and	   four	   human	   strains	  
(AR39,	   CWL029,	   J138	   and	   TW183)	   -­‐	   three	   of	   which	   were	   isolated	   from	   respiratory	  
pathologies	   [26-­‐28].	   These	   studies	   demonstrated	   highly	   conserved	   sequence	   amongst	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human	   strains	   and	   comparably	   high	   sequence	   identity	   amongst	   animal	   strains,	   but	  
notable	  polymorphisms	  were	  described	  when	  human	  and	  animal	  strains	  were	  compared.	  
HYPOTHESIS	  
Given	  that	  C.	  pneumoniae	  is	  cosmopolitan	  in	  both	  its	  infection	  of	  different	  hosts	  and	  its	  
association	   with	   different	   diseases,	   we	   hypothesised	   that	   there	   were	   genetic	  
determinants	   of	   host	   and	   tissue	   specificity	   in	  C.	   pneumoniae,	   and	   that	   strains	   isolated	  
from	   similar	   tissues	   or	   hosts	  would	   exhibit	   characteristic	   polymorphisms	   in	   nucleotide	  
sequence.	  
STUDY	  OBJECTIVES	  
The	   overall	   objective	   of	   this	   study	   was	   to	   build	   on	   molecular	   observations	   of	   C.	  
pneumoniae	   in	  human	  and	  animal	  hosts.	  More	  specifically,	  this	  study	  sought	  to	  expand	  
the	   number	   and	   range	   of	   whole	   genome	   sequences	   of	   C.	   pneumoniae	   to	   encompass	  
different	   disease	   associations	   (cardiovascular	   disease,	   Alzheimer's	   disease)	   as	   well	   as	  
different	   animal	   hosts	   (marsupial,	   reptiles	   and	   amphibians)	   and	   included	   two	   human	  
strains	  which	   appeared	   to	   be	   evolutionarily	   distinct	   from	   prior	  molecular	   studies	   [21].	  
Finally,	   this	  study	  aimed	  to	  compare	  and	  characterise	  gene	  expression	  profiles	   in	  acute	  
koala	  and	  cardiovascular	  C.	  pneumoniae	  infection	  using	  RNAseq.	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In	  order	  to	   investigate	  this	  hypothesis,	  genome	  sequencing	  of	  additional	  human	  strains	  
from	   non-­‐respiratory	   diseases,	   as	   well	   as	   animal	   strains	   from	   different	   hosts	   was	  
necessary	  and	  allowed	  us	  to	  gain	  further	  insight	  into	  host	  and	  tissue	  tropism,	  as	  well	  as	  
the	  evolutionary	  history	  of	  C.	  pneumoniae.	  Our	  group	  used	  next-­‐generation	  sequencing	  
technologies	  to	  obtain	  a	  further	  five	  human	  (A03,	  TOR-­‐1,	  WA97001,	  SH511	  and	  1979)	  [8,	  
14,	  29-­‐31]	  and	  one	  animal	  (B21)	  [32]	  C.	  pneumoniae	  whole	  genomes	  from	  isolates	  which	  
had	  been	  previously	  characterised	  by	  targeted	  PCR	  studies.	  
	  
AIMS	  OF	  THE	  STUDY	  
1.	   To	   sequence	   and	   characterise	   polymorphisms	   in	   an	   animal	   C.	   pneumoniae	  
	   strain	  isolated	  from	  the	  Western	  Barred	  Bandicoot	  (Chapter	  Three)	  
2.	   To	   sequence	   the	   genomes	   of	   two	   human	   non-­‐respiratory	   C.	   pneumoniae	  
	   isolates	   and	   compare	   these	   to	   currently	   available	   C.	   pneumoniae	   genomes	  
	   (Chapter	  Four)	  
3.	   To	   sequence	   and	   determine	   the	   evolutionary	   position	   of	   three	   Australian	  
	   human	  C.	  pneumoniae	  isolates	  by	  comparing	  them	  to	  all	  available	  human	  	  and	  
	   animal	  C.	  pneumoniae	  genomes	  (Chapter	  Five)	  
4.	   	   To	   compare	   the	   transcriptional	   profile	   of	   koala	   and	   human	   atherosclerosis	  
	   C.	   pneumoniae	   strains	   in	   an	   acute	   infection	   of	   a	   human	   lung	   epithelial	   cell	  
	   line	  (Chapter	  Six)	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SCIENTIFIC	  PROGRESS	  LINKING	  THE	  PAPERS	  AND	  CHAPTERS	  
The	   three	   papers	   presented	   as	   part	   of	   this	   thesis	   directly	   relate	   to	   the	   genomic	  
characterisation	  of	  novel	  human	  and	  animal	  C.	  pneumoniae	  strains	  that	  were	  undertaken	  
as	  part	  of	   this	   study,	  whilst	  chapter	  six	  presents	  and	  discusses	   the	  progress	   to	  date	  on	  
the	   transcriptional	   profiling	   of	   an	   animal	   and	   non-­‐respiratory	   human	   C.	   pneumoniae	  
strain	  during	  acute	  infection	  and	  finally,	  the	  Trends	  in	  Microbiology	  review	  presented	  in	  
the	  appendix	  highlights	  pertinent	  genomic	  and	  biological	  research	   in	  C.	  pneumoniae	  up	  
to	  the	  year	  2012.	  
The	  first	  results	  chapter	  (chapter	  three)	  presents	  a	  short	  communication	  examining	  the	  
whole	  genome	  and	  plasmid	  sequences	  of	  an	  animal	  C.	  pneumoniae	  strain,	  B21,	  isolated	  
from	   the	   endangered	   Australian	  marsupial,	   the	  Western	   barred	   bandicoot	   (Perameles	  
bougainville).	  In	  this	  short	  paper,	  we	  report	  that	  the	  B21	  bandicoot	  C.	  pneumoniae	  strain	  
differs	   from	   the	   LPCoLN	   koala	   C.	   pneumoniae	   strain	   by	   26	   nucleotides	   on	   the	  
chromosome	  and	  a	  single	  nucleotide	  in	  the	  plasmid.	  The	  high	  level	  of	  sequence	  identity	  
between	  the	  two	  Australian	  marsupial	  C.	  pneumoniae	  strains	  supports	  previous	  targeted	  
PCR	   observations	   of	   the	   high	   level	   of	   nucleotide	   synteny	   between	   the	   koala	   C.	  
pneumoniae	  strain	  and	  other	  isolates	  from	  Australian	  fauna	  such	  as	  the	  Great	  barred	  frog	  
and	   Gilbert's	   potoroo.	   The	   Genome	   Announcement	   manuscript	   is	   included	   in	   the	  
appendix.	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Chapter	  four	  provides	  an	  in	  depth	  comparative	  analysis	  of	  human	  C.	  pneumoniae	  strains	  
isolated	   from	   respiratory,	   brain	   and	   atherosclerotic	   tissues.	   We	   have	   shown	   that	   the	  
atherosclerotic	   and	   Alzheimer's	   strains	   are	  most	   similar	   in	   sequence	   to	   strains	   TW183	  
and	   AR39	   respectively,	   and	   that	   they	   phylogenetically	   cluster	   within	   two	   separate	  
subgroups	   of	   human	   C.	   pneumoniae	   with	   these	   strains.	   Distinct	   polymorphic	   hotspots	  
comprising	   sequence	  deletions	  and	  SNPs	  are	  described	   in	  both	   the	  atherosclerosis	  and	  
Alzheimer's	   strains,	   which	   coincide	   with	   predicted	   loci	   of	   recombination.	   The	  
phylogenetic	   and	   recombination	   profiles	   of	   the	   atherosclerotic	   and	  Alzheimer's	   strains	  
are	   further	   supported	   in	   chapter	   five.	   The	   Genomics	   manuscript	   is	   included	   in	   the	  
appendix.	  	  
	  	  
Chapter	  five	  builds	  on	  previous	  comparative	  observations	  of	  two	  phylogenetically	  distinct	  
human	   C.	   pneumoniae	   strains	   isolated	   in	   central	   Australia,	   as	   well	   as	   further	  
discriminating	   the	   genomic	   differences	   between	   animal	   and	   human	   non-­‐respiratory	  
strains	   of	   C.	   pneumoniae.	   We	   have	   shown	   that	   the	   two	   indigenous	   Australian	   C.	  
pneumoniae	  strains	  form	  a	  phylogenetically	  separate	  human	  C.	  pneumoniae	  clade	  with	  a	  
most	   recent	   common	   ancestor	   predating	   European	   exploration	   of	   the	   continent	   by	  
several	  hundred	  years.	  Whilst	  these	  strains	  are	  predominantly	  similar	   in	  nucleotide	  and	  
gene	  content	  to	  other	  C.	  pneumoniae	  strains	  isolated	  from	  various	  human	  diseases,	  they	  
exhibit	   characteristic	   polymorphisms	   at	   several	   discrete	   loci	   that	   are	   more	   similar	   in	  
sequence	   to	   Koala	   and	   Bandicoot	   strains	   of	   C.	   pneumoniae.	   	   Additionally,	   we	   further	  
describe	   sequence	   divergence	   between	   the	   DC9	   frog	   strain	   and	   koala	   and	   bandicoot	  
strains	  of	  C.	  pneumoniae.	  The	  BMC	  Genomics	  manuscript	  is	  included	  in	  the	  appendix.	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The	  final	  results	  chapter	  (chapter	  six)	  describes	  a	  pilot	  study	  using	  RNAseq	  that	  looks	  at	  
the	  transcriptional	  profile	  of	  two	  C.	  pneumoniae	  strains	  at	  mid-­‐point	  in	  the	  development	  
cycle	  under	  acute	  infection	  conditions.	  The	  study	  aimed	  to	  examine	  the	  different	  genes	  
expressed	   in	   the	   koala	   LPCoLN	   strain	   and	   the	   human	   atherosclerosis	   A03	   strain,	   and	  
compare	   these	   to	   gene	   expression	   studies	   in	   C.	   pneumoniae	   and	   other	   chlamydial	  
species.	   	  We	   found	  a	  number	  of	   commonly	  expressed	  homologous	  genes	  between	   the	  
two	  strains,	  as	  well	  as	  genes	  which	  were	  strain-­‐specific	   in	  their	  expression.	  This	  work	  is	  
the	   first	   transcriptional	   profiling	   study	   of	   an	   animal	  C.	   pneumoniae	   strain	   and	   lays	   the	  
groundwork	   for	   further	   large-­‐scale	   studies	   examining	   the	   transcriptional	   differences	  
exhibited	  by	  animal,	  human	  respiratory	  and	  human	  cardiovascular	  strains	  under	  various	  
immunomodulatory	  conditions.	  
With	   the	  exception	  of	   chapter	   six,	   the	   results	   sections	  of	   this	   thesis	   (chapters	   three	   to	  
five)	   are	   written	   as	   a	   series	   of	   manuscripts,	   which	   have	   been	   published	   in	   various	  
journals.	   The	   format	   of	   chapters	   three	   to	   five	   differs	   according	   to	   individual	   journal	  
requirements	  and	  these	  have	  been	  adjusted	  to	  fit	  the	  layout	  of	  this	  document.	  Chapter	  
two	   is	   a	   review	   of	   the	   literature.	   Chapter	   seven	   is	   an	   inclusive	   discourse	   on	   the	  main	  
elements	  of	  this	  study,	  with	  suggestions	  for	  further	  avenues	  of	  research.	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ETHICS	  APPROVAL	  FOR	  ANALYSIS	  OF	  STRAINS	  UNDERTAKEN	  IN	  THIS	  STUDY	  
The	   strains	   used	   in	   this	   study	   were	   obtained	   from	   previous	   studies	   in	   which	   written	  
consent	  and	  ethics	  approval	  was	  secured	  for	  the	  collection	  and	  analysis	  of	  the	  samples.	  
For	  strains	  B21	  and	  LPCoLN,	  ethics	  approval	  was	  obtained	  from	  Queensland	  University	  of	  
Technology.	  For	  strains	  A03	  and	  TOR-­‐1,	  ethics	  approval	  was	  obtained	  from	  Queensland	  
University	   of	   Technology,	   The	   University	   of	   Louisville	   and	  Wayne	   State	   University.	   For	  
strains	   SH511,	   1979	   and	   WA97001	   ethics	   approval	   was	   obtained	   from	   Queensland	  
University	  of	  Technology,	  Menzies	  School	  of	  Health	  Research	  and	  the	  Princess	  Margaret	  
Hospital	  for	  Children.	  (QUT	  Research	  ethics	  approval	  #1200000454)	  
	  Chapter	  One:	  Introduction	   9	  
	  
REFERENCES	  
1.	   Roulis,	   E.,	   A.	   Polkinghorne,	   and	   P.	   Timms,	   Chlamydia	   pneumoniae:	   modern	  
insights	  into	  an	  ancient	  pathogen.	  Trends	  in	  Microbiology,	  2012.	  
2.	   Kleemola,	  M.,	  et	  al.,	  Epidemics	  of	  Pneumonia	  Caused	  by	  TWAR,	  a	  New	  Chlamydia	  
Organism,	   in	  Military	   Trainees	   in	   Finland.	   Journal	   of	   Infectious	   Diseases,	   1988.	  
157(2):	  p.	  230-­‐236.	  
3.	   Saikku,	   P.,	   et	   al.,	  An	   Epidemic	   of	  Mild	   Pneumonia	   Due	   to	   an	   Unusual	   Strain	   of	  
Chlamydia	  psittaci.	  Journal	  of	  Infectious	  Diseases,	  1985.	  151(5):	  p.	  832-­‐839.	  
4.	   Conklin,	  L.,	  et	  al.,	  Investigation	  of	  a	  Chlamydia	  pneumoniae	  Outbreak	  in	  a	  Federal	  
Correctional	  Facility	  in	  Texas.	  Clinical	  Infectious	  Diseases,	  2013.	  57(5):	  p.	  639-­‐647.	  
5.	   Kauppinen,	   M.	   and	   P.	   Saikku,	   Pneumonia	   Due	   to	   Chlamydia	   pneumoniae:	  
Prevalence,	   Clinical	   Features,	   Diagnosis,	   and	   Treatment.	   Clinical	   Infectious	  
Diseases,	  1995.	  21(Supplement	  3):	  p.	  S244-­‐S252.	  
6.	   Saikku,	  P.,	  The	  epidemiology	  and	  significance	  of	  Chlamydia	  pneumoniae.	   Journal	  
of	  Infection,	  1992.	  25(Supplement	  1):	  p.	  27-­‐34.	  
7.	   Senn,	   L.,	   et	   al.,	   Does	   Respiratory	   Infection	   Due	   to	   Chlamydia	   pneumoniae	   Still	  
Exist?	  Clinical	  Infectious	  Diseases,	  2011.	  53(8):	  p.	  847-­‐848.	  
8.	   Dreses-­‐Werringloer,	   U.,	   et	   al.,	   Initial	   characterization	   of	   Chlamydophila	  
(Chlamydia)	   pneumoniae	   cultured	   from	   the	   late-­‐onset	   Alzheimer	   brain.	  
International	  Journal	  of	  Medical	  Microbiology,	  2009.	  299(3):	  p.	  187-­‐201.	  
9.	   Gerard,	   H.,	   et	   al.,	   Chlamydophila	   (Chlamydia)	   pneumoniae	   in	   the	   Alzheimer's	  
brain.	  FEMS	  Immunol	  Med	  Microbiol,	  2006.	  48(3):	  p.	  355	  -­‐	  366.	  
10.	   Bandaru,	  V.,	  et	  al.,	  Outcome	  of	  Chlamydia	  pneumoniae	  associated	  acute	  ischemic	  
stroke	   in	   elderly	   patients:	   A	   case-­‐control	   study.	   Clinical	   Neurology	   and	  
Neurosurgery,	  2012.	  114(2):	  p.	  120-­‐123.	  
11.	   Wohlschlaeger,	   J.,	   et	   al.,	   Identification	   of	   Chlamydia	   pneumoniae	   in	   intracranial	  
and	   extracranial	   arteries	   in	   patients	   with	   stroke	   and	   in	   controls:	   combined	  
immunohistochemical	  and	  polymerase	  chain	  reaction	  analyses.	  Human	  Pathology,	  
2005.	  36(4):	  p.	  395-­‐402.	  
12.	   Grayston,	   J.T.,	   et	   al.,	   Chlamydia	   pneumoniae	   (TWAR)	   in	   atherosclerosis	   of	   the	  
carotid	  artery.	  Circulation,	  1995.	  92(12):	  p.	  3397-­‐3400.	  
13.	   Benagiano,	  M.,	  et	  al.,	  Chlamydophila	  pneumoniae	  phospholipase	  D	  (CpPLD)	  drives	  
Th17	   inflammation	   in	   human	   atherosclerosis.	   Proceedings	   of	   the	   National	  
Academy	  of	  Sciences	  of	  the	  United	  States	  of	  America,	  2012.	  109(4):	  p.	  1222-­‐1227.	  
14.	   Ramirez,	  J.A.,	  et	  al.,	  Isolation	  of	  Chlamydia	  pneumoniae	  from	  the	  coronary	  artery	  
of	   a	   patient	   with	   coronary	   atherosclerosis.	   Annals	   of	   Internal	   Medicine,	   1996.	  
125(12):	  p.	  979-­‐982.	  
15.	   Rupp,	   J.,	   et	   al.,	   Chlamydia	   pneumoniae	   Hides	   inside	   Apoptotic	   Neutrophils	   to	  
Silently	  Infect	  and	  Propagate	  in	  Macrophages.	  PLoS	  One,	  2009.	  4(6).	  
16.	   Gieffers,	  J.,	  et	  al.,	  Phagocytes	  transmit	  Chlamydia	  pneumoniae	  from	  the	  lungs	  to	  
the	  vasculature.	  European	  Respiratory	  Journal,	  2004.	  23(4):	  p.	  506-­‐510.	  
	  Chapter	  One:	  Introduction	   10	  
17.	   Gaydos,	   C.A.,	   et	   al.,	   Replication	   of	   Chlamydia	   pneumoniae	   in	   vitro	   in	   human	  
macrophages,	   endothelial	   cells,	   and	   aortic	   artery	   smooth	  muscle	   cells.	   Infection	  
and	  Immunity,	  1996.	  64(5):	  p.	  1614-­‐1620.	  
18.	   Soldati,	   G.,	   et	   al.,	  Detection	   of	  mycobacteria	   and	   chlamydiae	   in	   granulomatous	  
inflammation	  of	  reptiles:	  A	  retrospective	  study.	  Veterinary	  Pathology,	  2004.	  41(4):	  
p.	  388-­‐397.	  
19.	   Bodetti,	  T.J.,	  et	  al.,	  Molecular	  evidence	  to	  support	  the	  expansion	  of	  the	  host	  range	  
of	   Chlamydophila	   pneumoniae	   to	   include	   reptiles	   as	   well	   as	   humans,	   horses,	  
koalas	  and	  amphibians.	  Systematic	  and	  Applied	  Microbiology,	  2002.	  25(1):	  p.	  146-­‐
152.	  
20.	   Wardrop,	  S.,	  et	  al.,	  Characterization	  of	  the	  koala	  biovar	  of	  Chlamydia	  pneumoniae	  
at	   four	  gene	   loci	   -­‐	  ompAVD4	  ompB,	  16S	   rRNA,	  groESL	  spacer	   region.	   Systematic	  
and	  Applied	  Microbiology,	  1999.	  22(1):	  p.	  22-­‐27.	  
21.	   Mitchell,	  C.M.,	  et	  al.,	  Chlamydia	  pneumoniae	  Is	  Genetically	  Diverse	  in	  Animals	  and	  
Appears	  to	  Have	  Crossed	  the	  Host	  Barrier	  to	  Humans	  on	  (At	  Least)	  Two	  Occasions.	  
Plos	  Pathogens,	  2010.	  6(5).	  
22.	   Mitchell,	   C.M.,	   et	   al.,	   Comparison	   of	   koala	   LPCoLN	   and	   human	   strains	   of	  
Chlamydia	  pneumoniae	  highlights	  extended	  genetic	  diversity	  in	  the	  species.	  BMC	  
Genomics,	  2010.	  11.	  
23.	   Pannekoek,	   Y.,	   et	   al.,	   Multi	   locus	   sequence	   typing	   of	   Chlamydiales:	   clonal	  
groupings	  within	  the	  obligate	   intracellular	  bacteria	  Chlamydia	  trachomatis.	  BMC	  
Microbiology,	  2008.	  8.	  
24.	   Gieffers,	  J.,	  et	  al.,	  Genotypic	  differences	  in	  the	  Chlamydia	  pneumoniae	  tyrP	  locus	  
related	   to	   vascular	   tropism	   and	   pathogenicity.	   Journal	   of	   Infectious	   Diseases,	  
2003.	  188(8):	  p.	  1085-­‐1093.	  
25.	   Myers,	   G.S.A.,	   et	   al.,	   Evidence	   that	   Human	   Chlamydia	   pneumoniae	   Was	  
Zoonotically	  Acquired.	  Journal	  of	  Bacteriology,	  2009.	  191(23):	  p.	  7225-­‐7233.	  
26.	   Shirai,	   M.,	   et	   al.,	   Comparison	   of	   whole	   genome	   sequences	   of	   Chlamydia	  
pneumoniae	   J138	   from	   Japan	   and	   CWL029	   from	   USA.	   Nucleic	   Acids	   Research,	  
2000.	  28(12):	  p.	  2311-­‐2314.	  
27.	   Kalman,	   S.,	   et	   al.,	   Comparative	   genomes	   of	   Chlamydia	   pneumoniae	   and	   C.	  
trachomatis.	  Nature	  Genetics,	  1999.	  21(4):	  p.	  385-­‐389.	  
28.	   Read,	   T.D.,	   et	   al.,	   Genome	   sequences	   of	   Chlamydia	   trachomatis	   MoPn	   and	  
Chlamydia	  pneumoniae	  AR39.	  Nucleic	  Acids	  Research,	  2000.	  28(6):	  p.	  1397-­‐1406.	  
29.	   Coles,	   K.A.,	   P.	   Timms,	   and	   D.W.	   Smith,	  Koala	   biovar	   of	   Chlamydia	   pneumoniae	  
infects	   human	   and	   koala	   monocytes	   and	   induces	   increased	   uptake	   of	   lipids	   in	  
vitro.	  Infection	  and	  Immunity,	  2001.	  69(12):	  p.	  7894-­‐7897.	  
30.	   Hutton,	   S.,	  H.	  Dodd,	   and	  V.	  Asche,	  C.	  pneumoniae	   successfully	   isolated.	   Today's	  
Life	  Science,	  1993.	  5:	  p.	  2.	  
31.	   Asche,	  L.V.,	  S.I.	  Hutton,	  and	  F.P.	  Douglas,	  Serological	  evidence	  of	  the	  3	  chlamydial	  
species	   in	  an	  Aboriginal	  community	   in	  the	  Northern	  Territory.	  Medical	  Journal	  of	  
Australia,	  1993.	  158(9):	  p.	  603-­‐604.	  
32.	   Kutlin,	   A.,	   et	   al.,	   Molecular	   characterization	   of	   Chlamydophila	   pneumoniae	  
isolates	  from	  Western	  barred	  bandicoots.	  Journal	  of	  Medical	  Microbiology,	  2007.	  
56(3):	  p.	  407-­‐417.	  	  
Chapter	  Two:	  Literature	  Review	   11	  
Chapter	  Two:	  Literature	  Review	  
	  Chapter	  Two:	  Literature	  Review	  	   	   12	  
	  
CHLAMYDIAL	  TAXONOMY	  AND	  TERMINOLOGY	  USED	  IN	  THIS	  DOCUMENT	  
	  
The	   following	   is	  a	   list	  of	   chlamydial	   taxonomy	  and	   technical	   terminology	  used	   throughout	  
the	  document	   and	  accepted	  within	   the	   chlamydial	   field.	  Chlamydia	   has	  been	  accepted	  as	  
the	   correct	   taxonomic	   name	   for	   the	   genus,	   which	   included	   species	   previously	   described	  
under	  the	  genus	  Chlamydophila.	  Chlamydiae	  is	  the	  plural	  of	  Chlamydia	  but	  also	  refers	  to	  the	  
phylum	   and	   class	   Chlamydiae.	   The	   order	   Chlamydiales	   currently	   consists	   of	   nine	   families	  
Chlamydiaceae,	   Criblamydiaceae,	   Parachlamydiaceae,	   Simkaniaceae,	   Waddliaceae,	  
Piscichlamydiaceae,	   Rhabdochlamydiaceae,	   Parilichlamydiaceae	   and	   Actinochlamydiaceae.	  
Within	   the	   Chlamydiaceae,	   there	   are	   three	   genera:	   Chlamydia,	   and	   the	   candidate	   genus	  
Amphibiichlamydia	   and	  Clavochlamydia.	   Currently,	   there	  are	  11	   recognised	   species	  within	  
the	  genus	  Chlamydia:	  C.	  abortus,	  C.	  avium,	  C.	  caviae,	  C.	  felis,	  C.	  gallinacea,	  C.	  muridarum,	  C.	  
pecorum,	   C.	   pneumoniae,	   C.	   psittaci,	   C.	   suis	   and	   C.	   trachomatis	   with	   a	   single	   candidate	  
species	   Candidatus	   C.	   ibidis	   [1].	   A	   division	   of	   the	   class	   Chlamydiia	   into	   two	   orders	   -­‐	  
Chlamydiales	   and	   Parachlamydiales	   has	   been	   proposed	   based	   on	   conserved	   signature	  
insertions/deletions	   and	   conserved	   signature	   proteins	   of	   36	  whole	   genome	   sequences	   of	  
members	  of	   the	  phylum	  Chlamydiae	   [2].	  A	   full	   list	  of	   the	  current	  members	  of	   the	  phylum	  
Chlamydiales	   are	  outlined	   in	  Table	  1.	   The	   terms	   isolate	  and	   strain	  are	  used	  extensively	   in	  
this	   document.	   An	   "isolate"	   is	   a	   population	   of	   chlamydial	   organisms	   of	   the	   same	   species	  
derived	  from	  a	  singular	  source	  that	  may	  also	  contain	  other	  microorganisms	  -­‐	   for	   instance,	  
from	  a	  clinical	  swab	  or	  paraffin	  embedded	  histological	  sample.	  A	  "strain"	  is	  a	  characterised,	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purified	   population	   of	   a	   singular	   chlamydial	   species	   that	   differs	   genetically	   from	   other	  
members	  of	  the	  species.	  Pathology	  caused	  by	  chlamydial	  infection	  is	  termed	  chlamydiosis.	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*	  denotes	  Candidatus	  designation	  
Species	   names	   as	   denoted	   from	   List	   of	   Prokaryotic	   names	  with	   Standing	   in	   Nomenclature	   [3],	   the	   All	   Species	   Living	   Tree	   Project	   [4]	   and	  National	   Centre	   for	  
Biotechnology	  Information	  [5,	  6].	  










Genus	  I:	   Genus	  I:	  	   Genus	  I:	   Genus	  I:	  	   Genus	  I:	  
Chlamydia	   Parachlamydia	   Simkania	   Criblamydia	   Rhabdochlamydia*	  
	  	  	  	  	  C.	  trachomatis	   	  	  	  	  	  P.	  acanthamoebae	   	  	  	  	  S.	  negevensis	   	  	  	  	  C.	  sequanensis	   	  	  	  	  R.	  crassificans*	  
	  	  	  	  	  C.	  psittaci	   Genus	  II:	  	   Genus	  II:	   Genus	  II:	   	  	  	  	  R.	  porcellionis*	  
	  	  	  	  	  C.	  pneumoniae	   Neochlamydia	   Fritschea*	   Estrella	   Genus	  II:	  
	  	  	  	  	  C.	  pecorum	   	  	  	  	  	  N.	  hartmannellae	   	  	  	  	  F.	  bemisiae*	   	  	  	  E.	  lausannensis	   Renichlamydia*	  
	  	  	  	  	  C.	  muridarum	   Genus	  III:	   	  	  	  	  F.	  eriococci*	   	   	  	  	  	  R.	  lutjani*	  
	  	  	  	  	  C.	  suis	   Protochlamydia	   Genus	  III:	   Family	  VI	   	  
	  	  	  	  	  C.	  felis	   	  	  	  	  	  P.	  amoebophila*	   Syngamydia*	   Pischichlamydiaceae	   Family	  VIII	  
	  	  	  	  	  C.	  abortus	   	  	  	  	  P.	  naegleriophila	   	  	  	  	  S.	  salmonis*	   Genus	  I:	   Parilichlamydiacea	  
	  	  	  	  	  C.	  caviae	   Genus	  IV:	   	   Piscichlamydia*	   Genus	  I	  
	  	  	  	  	  C.	  avium	   Metachlamydia*	   Family	  IV	   	  	  	  	  P.	  salmonis*	   Parilichlamydia*	  
	  	  	  	  	  C.	  gallinacea	   	  	  	  	  	  M.	  lacustris*	   Waddliaceae	   	   	  	  	  	  P.	  carangidicola*	  
	  	  	  	  	  C.	  ibidis*	   Genus	  V:	   Genus	  I:	   	   Genus	  II:	  
Genus	  II:	   Mesochlamydia*	   Waddlia	   	   Similichlamydia*	  
Amphibiichlamydia*	   	  	  	  	  	  M.	  elodeae*	   	  	  	  	  W.	  chondrophila	   	   	  	  	  	  S.	  latridicola*	  
	  	  	  	  	  A	  .	  ranarum*	   	   	  	  	  	  W.	  malaysiensis	   	   	  	  	  	  S.	  labri*	  
	  	  	  	  	  A.	  salamandrae*	   	   	  	  	  	  W.	  cocoyoc*	   	   	  
Genus	  III	   	   	   	   Family	  IX	  
Clavochlamydia*	   	   	   	   Actinochlamydiaceae	  
	  	  	  	  	  C.	  salmonicola*	   	   	   	   Genus	  I:	  
	   	   	   	   Actinochlamydia*	  
	   	   	   	   	  	  	  	  A.	  clariae*	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THE	  CHLAMYDIAL	  DEVELOPMENT	  CYCLE	  
	  
All	  members	  of	   the	  Chlamydiae	   are	  obligate	   intracellular	  pathogens	   characterised	  by	  a	  
bi-­‐phasic	   developmental	   cycle,	   which	   is	   unique	   within	   the	   bacterial	   kingdom.	   The	  
chlamydial	   developmental	   cycle	   involves	   the	   differentiation	   between	   two	   phases;	   the	  
infectious	   but	   metabolically	   suppressed	   elementary	   body	   (EB)	   and	   the	   non-­‐infectious,	  
metabolically	   active	   reticulate	   body	   (RB).	   Persistence	   is	   characterised	   by	   an	   atypical	  
developmental	  phenotype	  termed	  the	  aberrant	  body	  (AB)[7].	  Figure	  1	  depicts	  the	  typical	  
developmental	  cycle	  of	  the	  Chlamydiae.	  
	   	  
	   	  
	   	  
	   	  
	   	  
	   	  
	   	  
	   	  
	   	  
	   	  
	  
	  
Figure	   1	   -­‐	   Diagrammatic	   representation	   of	   life	   cycle	   of	   a	   member	   of	   the	   Chlamydiales.	   Major	  
developmental	  events	  are	  shown.	  Adapted	  from	  Roulis	  et	  al.	  2012	  [8]	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The	  infectious	  EB	  form	  is	  very	  small	  (approximately	  0.3µm)	  [9]	  with	  a	  tightly	  condensed	  
nucleoid	  resultant	  to	  aggregation	  of	  chlamydial	  DNA	  with	  histone-­‐like	  proteins	  hctA	  and	  
hctB	  [10-­‐12].	  Structural	  rigidity	  of	  the	  EB	  form	  is	  dependent	  on	  inter-­‐	  and	  intra-­‐molecular	  
bonds	   between	   cysteine	   residues	   in	   the	   outer	   membrane	   proteins	   OmpA,	   OmcA	   and	  
OmcB	   [13,	   14].	   EBs	   have	   traditionally	   been	   described	   as	   metabolically	   and	  
transcriptionally	   dormant,	   however	   studies	   have	   shown	   that	   EBs	   exhibit	   a	   low-­‐level	  
metabolic	  activity	  with	  glucose-­‐6	  phosphate	  as	  a	  preferred	  energy	   source	   [15]	  and	   the	  
presence	  of	  a	  transcription	  and	  translation	  apparatus	  ready	  for	  activation	  upon	  infection	  
of	  a	  host	  cell	  [16].	  Components	  of	  the	  Type	  3	  secretion	  (T3S)	  apparatus	  are	  found	  on	  the	  
EB	   membrane	   [17-­‐19],	   and	   the	   EB	   T3S	   injectisome	   directly	   contacts	   the	   host	   cell	  
membrane	   to	   facilitate	   host	   cell	   cytoskeletal	   reorganisation	   for	   chlamydial	  
internalisation.	  	  
	  
The	   internalised	  Chlamydia	   forms	  a	  host-­‐derived	  vacuole,	   termed	  an	  "inclusion",	  which	  
contains	  various	  biosynthetic	  precursors,	  amino	  acids	  and	   lipids	  attained	   from	  the	  host	  
cell	   [20-­‐22].	  Chlamydia	   differentiates	   from	   the	   EB	   form	   to	   the	   non-­‐infectious,	   actively	  
replicating	   RB	   form	   where	   it	   multiplies,	   predominantly	   by	   binary	   fission,	   within	   the	  
expanding	   inclusion	   [23].	   The	   size,	   shape	   and	   fusogenicity	   of	   chlamydial	   inclusions	   are	  
variable,	   often	   exhibiting	  morphological	   and	   replication	   differences	   between	   strains	   of	  
the	   same	  chlamydial	   species	   [24-­‐26].	  Persistence	  can	  be	   induced	  during	   the	   replicative	  
phase	   through	   a	   number	   of	   pathways	   such	   as	   nutrient	   starvation,	   interferon-­‐gamma	  
(IFN-­‐γ)	   stimulation,	   antibiotic	   treatment	   or	   induction	   of	   nitric	   oxide	   synthase	   [27-­‐31],	  
with	  a	  concurrent	  change	  in	  RB	  morphology	  to	  AB	  form.	  Various	  chlamydial	  species	  and	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strains	   exhibit	   startling	   differences	   in	   their	   sensitivity	   to	   tryptophan	   limitation	   and	  
response	   to	   IFN-­‐γ	   stimulation	   [27,	   31-­‐36],	   with	   induction	   and	   recovery	   from	   the	  
persistent	   state	   a	   possible	   patho-­‐adaptation	   and	   tissue	   tropic	   mechanism.	  	  
	  
RB	  to	  EB	  de-­‐differentiation	  at	  the	  late	  stage	  of	  development	  is	  an	  asynchronous	  process	  
[23,	  37]	  with	  repackaging	  of	  the	  bacterial	  chromosome,	  nutrients	  and	  T3S	  apparatus	  back	  
into	   condensed	   form	   [38].	  During	   the	  RB	   to	   EB	  process,	   intermediary	   bodies	   can	   form	  
and	   these	   can	  be	  distinguished	   from	  both	  RB	  and	  EBs	  by	   size	   and	   compactness	  of	   the	  
nucleoid	   [39].	   Release	   of	   infectious	   EBs	   from	   the	   host	   cell	   can	   proceed	   in	   two	  ways	   -­‐	  
disruption	   of	   the	   host	   cell	   membrane	   through	   a	   lytic	   pathway	   or	   extrusion	   of	   the	  
chlamydial	  inclusion	  from	  the	  host	  cell,	  releasing	  chlamydial	  EBs	  but	  leaving	  the	  host	  cell	  
intact	   [37,	   40].	   In	   particular,	   C.	   pneumoniae	   has	   been	   shown	   to	   evade	   the	   host	   cell	  
apoptotic	   response	   by	   interfacing	  with	   tumor	   necrosis	   factor-­‐α,	   nuclear	   factor-­‐kappaβ	  
(NF-­‐kβ)	  and	  mitochondrial	  signaling	  pathways	  to	  prevent	   lysis	  of	   the	  host	  cell,	  allowing	  
for	  reinfection	  after	  extrusion	  and	  release	  of	  infectious	  EBs	  [41,	  42].	  	  The	  length	  of	  time	  
taken	   to	   complete	   a	   single	   developmental	   cycle	   varies	   between	   different	   chlamydial	  
species	   and	   strains,	  with	  C.	   trachomatis	   completing	   a	   full	   cycle	   in	   36-­‐48	   hours	   [43],	  C.	  
psittaci	  in	  40-­‐48	  hours	  [44]	  and	  60-­‐96	  hours	  for	  C.	  pneumoniae	  [24].	  	  
	  
	  Chapter	  Two:	  Literature	  Review	   18	  
CHLAMYDIOSES	  IN	  HUMANS	  AND	  ANIMALS	  
	  
Chlamydia	  trachomatis	  
Trachoma	   (from	   the	   Greek	   τράχωμα	   "trākhōma"	   meaning	   "rough"),	   caused	   by	   the	  
chlamydial	  species	  C.	  trachomatis,	  was	  one	  of	  the	  earliest	  observed	  ophthalmic	  diseases,	  
with	  descriptions	  of	  the	  characteristic	  blindness	  and	  eyelid	  entropion	  caused	  by	  chronic	  
C.	   trachomatis	   infection	   recorded	   by	   Hippocrates	   as	   far	   back	   as	   420	   B.C.	   [45].	   C.	  
trachomatis	  has	  evolved	  alongside	  humans	  -­‐	  with	  divergence	  of	  ocular	  and	  genital	  strains	  
occurring	   some	   2-­‐5	   million	   years	   ago	   with	   the	   evolution	   of	   Homo	   habilis	   and	   Homo	  
erectus	  [46].	  	  
	  Today,	   C.	   trachomatis	   is	   the	   most	   frequently	   reported	   sexually	   transmitted	   infection	  
[47],	   whilst	   trachoma	   is	   considered	   a	   neglected	   infectious	   disease	   and	   still	   the	   most	  
common	  cause	  of	   infectious	  blindness	   [48,	  49].	  Disease	  associated	  with	  C.	   trachomatis	  
can	  be	  segregated	  by	  serovars	  based	  on	  the	  recognition	  of	  specific	  epitopes	  of	  variable	  
domain	   4	   of	   the	   major	   outer	   membrane	   protein	   gene	   (MOMP)	   using	   monoclonal	  
antibodies	   [50,	  51]	  and	   the	  nucleic	   acid	   sequence	  of	  ompA,	   the	  gene	  encoding	  MOMP	  
[52].	  Ocular	  infection	  is	  caused	  by	  serovars	  A	  through	  C,	  genital	  infections	  and	  sequelae	  
are	   associated	   with	   serovars	   D	   through	   K,	   whilst	   the	   considerably	   more	   virulent	   L	  
serovars	  (L1,	  2	  and	  3)	  are	  associated	  with	  lymphogranuloma	  venereum	  [53].	  
	  
Trachoma	   resulting	   in	   blindness	   is	   more	   often	   the	   result	   of	   multiple,	   untreated	   C.	  
trachomatis	   infections,	   with	   initial	   symptoms	   of	   conjunctivitis	   progressing	   to	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hypertrophic	   scarring	   of	   the	   eyelid	   and	   corneal	   tissue	   [54].	   Interestingly,	   arthritis	  
associated	  with	  C.	   trachomatis	   has	   been	   described	   and	   is	   linked	   to	   infection	  with	   the	  
trachoma	   serovars	   rather	   than	   urogenital	   strains	   [55,	   56].	   Strains	   from	   serovars	   D	  
through	  K	   are	   associated	  with	   sexually	   transmitted	  urogenital	   infections	   in	   both	  males	  
and	   females,	   with	   over	   100	   million	   cases	   reported	   annually	   worldwide	   [57,	   58].	   The	  
majority	  of	  C.	  trachomatis	   infections	  are	  asymptomatic,	  and	  some	  may	  resolve	  without	  
treatment	   [59,	   60],	   however	   severe	   complications	   resulting	   from	   chronic	   infection	  
include	  pelvic	   inflammatory	  disease	  and	   infertility	   in	   females,	  whilst	  males	  can	  develop	  
sequelae	   such	   as	   epididymitis	   [61].	  Unlike	   the	   trachoma	  and	  urogenital	  C.	   trachomatis	  
serovars,	   where	   infection	   is	   predominantly	   restricted	   to	   the	   mucosal	   epithelia,	  
lymphogranuloma	   serovars	   (L1,	   2	   and	   3)	   are	   invasive	   and	   patients	   often	   present	   with	  
systemic	   systems	   including	   lymphadenopathies,	   proctitis	   and	  ulcerative	   changes	   to	   the	  
intestinal	   tract	   [62-­‐65].	  C.	   trachomatis	   infection	  has	  also	  been	  associated	  with	   irritable	  
bowel	  syndrome,	  with	  antigens	  present	  in	  small	  bowel	  enteroendocrine	  cells	  [66,	  67].	  	  
	  
Chlamydia	  psittaci	  	  
C.	   psittaci	   is	   a	   chlamydial	   species	   common	   in	   veterinary	   settings,	   as	   well	   as	   being	   a	  
zoonotic	  pathogen	  that	  has	  caused	  human	  fatalities.	  	  The	  first	  reports	  of	  human	  infection	  
with	  psittacosis	  or	  "parrot	  fever"	  were	  documented	  as	  early	  as	  the	  1800s	  [68,	  69],	  whilst	  
the	  agent	  of	  psittacosis	  had	  been	  described	  in	  wild	  psittacine	  birds	  from	  various	  tropical	  
regions	   including	   Oceania,	   South	   and	   middle	   America,	   as	   well	   as	   its	   isolation	   from	  
domesticated	   poultry	   species	   such	   as	   chickens,	   pigeons	   and	   turkeys	   [70].	   A	  worldwide	  
	  Chapter	  Two:	  Literature	  Review	   20	  
psittacosis	   pandemic	   occurred	   in	   1929-­‐1930,	   originating	   in	   South	   America	   and	  
subsequently	  spreading	  to	  12	  countries	  as	  the	  result	  of	   importation	  of	   infected	  parrots	  
from	   various	   countries.	   The	   psittacosis	   pandemic	   of	   1929-­‐1930	   resulted	   in	   up	   to	   800	  
reported	  cases	  of	  psittacosis	  and	  resulted	  in	  a	  mortality	  rate	  of	  15%	  [71].	  	  
	  
Whilst	   recognised	   as	   a	   zoonotic	   pathogen,	   there	   have	   been	   two	   cases	   of	   human-­‐to-­‐
human	  transmission	  of	  C.	  psittaci	  in	  familial	  and	  nosocomial	  settings	  [72,	  73].	  In	  humans,	  
symptoms	  include	  coughs,	  headaches	  and	  fever	  commencing	  after	  a	  5-­‐15	  day	  incubation	  
period,	   and	   pneumonia	   is	   a	   common	   outcome	   [74-­‐76].	   C.	   psittaci	   infection	   in	   birds	   is	  
often	  asymptomatic	   though	   symptoms	  often	  become	  apparent	  when	   the	  bird	   is	  under	  
stress	  and	  infection	  tends	  to	  involve	  respiratory	  sites	  as	  well	  as	  the	  liver	  and	  spleen	  [76].	  
C.	  psittaci	  hosts	  also	  include	  a	  number	  of	  mammalian	  species,	  including	  horses,	  livestock	  
and	   rodents,	  where	   it	   can	   infect	  a	  number	  of	  organ	  systems	  and	   is	  often	   implicated	   in	  
early	   abortion	   [76-­‐78].	   As	   with	   C.	   trachomatis,	   the	   C.	   psittaci	   species	   encode	   for	   a	  
number	  of	  serovars	  which	  are	  distinguished	  based	  on	  ompA	  genotype	  [79].	  	  
	  
Chlamydia	  pneumoniae	  
C.	   pneumoniae	   first	   came	   to	   attention	   as	   an	   atypical	   C.	   psittaci	   strain	   involved	   in	   a	  
number	  of	  pneumonia	  outbreaks	  in	  the	  1980s	  [80-­‐82]	  with	  no	  links	  to	  avian	  transmission	  
vectors.	   Serological	   typing	   of	   patient	   samples	   from	   this	   outbreak	   suggested	   that	   the	  
aetiological	   agent	  was	   very	   similar	  or	   identical	   to	   an	  atypical	  C.	  psittaci	   strain,	   TW183,	  
isolated	  from	  the	  eye	  of	  a	  child	   in	  Taiwan	  as	  part	  of	  a	  trachoma	  screening	  study	   in	  the	  
Chapter	  Two:	  Literature	  Review	   21	  
1960s	   [83].	   	   Screening	   studies	   of	   respiratory	   disease	   patients	   in	   a	   Seattle	   hospital	  
between	   1983	   and	   1986	   also	   identified	   a	   strain	   serologically	   identical	   to	   the	   TW183	  
strain.	   This	   strain	   was	   designated	   TWAR	   (from	   TW183	   and	   AR39	   strains)	   [80]	   and	  
subsequently	  classified	  as	  a	  new	  chlamydial	  species	  -­‐	  C.	  pneumoniae	  -­‐	  on	  the	  basis	  of	  EB	  
morphology,	   DNA	   analysis	   and	   serology	   [83].	   C.	   pneumoniae	   is	   a	   common	   cause	   of	  
atypical	   pneumonia	   and	   respiratory	   disease	   [84-­‐86],	   and	   is	   associated	   with	  
cardiovascular	  disease	  such	  as	  atherosclerosis	  and	  myocardial	   infarction	  [87-­‐90]	  as	  well	  
as	  Alzheimer's	  disease	  [91,	  92].	  
The	   first	   descriptions	   of	   C.	   pneumoniae	   in	   veterinary	   settings	   were	   from	   chlamydial	  
screening	   studies	   in	   koalas	   [93,	   94]	   and	   horses	   [95].	   It	   was	   soon	   after	   identified	   in	   a	  
number	   of	   hosts	   including	   marsupials,	   amphibians	   and	   reptiles	   [96-­‐106]	   where	   it	  
presented	   as	   respiratory	   and	   ocular	   infection,	   as	   well	   as	   systemic	   granulomatous	  
infection	  of	  internal	  organs.	  	  Unlike	  C.	  trachomatis	  and	  C.	  psittaci,	  C.	  pneumoniae	  exhibits	  
a	  highly	  conserved	  ompA	  sequence	  and	  antigenic	  profile,	  with	  little	  difference	  between	  
human	  and	  animal	  C.	  pneumoniae	  strains	  [107-­‐109].	  C.	  pneumoniae	   is	  believed	  to	  have	  
been	  zoonotically	  transmitted	  to	  humans	  on	  at	  least	  two	  occasions	  [102,	  110],	  though	  no	  
evidence	  for	  transmission	  between	  humans	  and	  animals	  has	  been	  reported.	  
Chlamydia	  pecorum	  
First	   isolated	   from	   a	   calf	   with	   sporadic	   encephalomyelitis	   [111],	   C.	   pecorum	   has	   been	  
identified	   in	   a	   number	   of	   livestock	   and	   marsupial	   hosts,	   including	   koalas,	   bandicoots,	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sheep,	  cattle	  and	  swine	  [94,	  97,	  112-­‐116]	  where	  it	  is	  associated	  with	  a	  range	  of	  different	  
pathologies	  such	  as	  conjunctivitis,	  polyarthrtis,	   infertility	  and	  gastrointestinal	   infections.	  
C.	  pecorum	   is	  particularly	  well	  studied	  in	  the	  koala,	  where	   it	  has	  been	  suggested	  that	  a	  
number	   of	   cross-­‐species	   transmissions	   is	   responsible	   for	   the	   genotypic	   diversity	   of	   C.	  
pecorum	   strains	   in	   the	   population	   [117,	   118].	   Eight	   C.	   pecorum	   ompA	   genotypes	   are	  
recognised,	  with	   single	  and	  multi-­‐subunit	   vaccines	  based	  on	  common	  ompA	   genotypes	  
being	   developed	   in	   order	   to	   determine	   the	   efficacy	   of	   prophylactic	   and	   therapeutic	  
vaccination	  in	  koalas	  [119-­‐122].	  	  	  
	  
Chlamydia	  muridarum	  
C.	  muridarum	  was	  first	   isolated	  from	  the	  respiratory	  tracts	  of	   laboratory	  mice,	  where	  it	  
was	   initially	   believed	   to	   be	   a	   respiratory	   pathogen,	   and	   later	   found	   to	   be	   transmitted	  
through	   an	   oral	   route	   [123].	   Infection	   of	   the	   mouse	   genitourinary	   tract	   with	   mouse	  
pneumonitis	   strain	   MoPn	   demonstrated	   progression	   and	   pathology	   very	   similar	   to	  
sexually	  transmitted	  C.	  trachomatis	  infection	  in	  humans	  [124],	  paving	  the	  way	  for	  the	  use	  
of	   the	  mouse	   and	  C.	  muridarum	   as	  model	   organisms	   for	   the	   study	   of	   respiratory	   and	  
sexually	   transmitted	   chlamydial	   infections	   [125,	   126].	   Two	   C.	   muridarum	   strains	   are	  
recognised,	  Nigg	  (MoPn)	  and	  Weiss	  [125].	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Chlamydia	  felis	  
C.	  felis	  is	  restricted	  to	  a	  single	  host,	  the	  domestic	  cat,	  where	  it	  causes	  conjunctivitis	  and	  
occasional	   pneumonia	   [127].	   Cases	   of	   human	   infection	   with	   C.	   felis	   resulting	   in	  
conjunctivitis	  have	  been	  reported	  [128-­‐130]	  whilst	  the	  prevalence	  of	  C.	  felis	   is	  reported	  
to	   be	   1.7%	   in	   the	   human	   population	   [128],	   actual	   prevalence	  may	   be	  much	   higher	   as	  
human	   infection	   is	  predominantly	  asymptomatic	   [131].	  C.	   felis	   infection	   tends	   to	  affect	  
cats	   and	   kittens	   under	   the	   age	   of	   one,	   and	   is	   a	   problem	   in	   catteries	   where	   multiple	  
animals	  share	  a	  common	  space	  and	  transmission	  occurs	  through	  ocular	  secretions	  [132].	  
Chlamydia	  abortus	  
First	   identified	  as	  a	  cause	  of	  enzootic	  abortion	  in	  sheep,	  C.	  abortus	   is	  common	  in	  many	  
sheep-­‐rearing	   areas	   of	   the	  world,	  where	   it	   is	   a	   serious	   economic	   problem	   in	   terms	   of	  
reproductive	  wastage	  [133].	  Additionally,	  it	  has	  been	  described	  in	  other	  livestock	  species	  
as	  well	  as	  rodents	  [134].	   Infected	  animals	  generally	  show	  no	  clinical	  symptoms	  prior	  to	  
abortion	   [135].	  C.	   abortus	   presents	   a	   hazard	   to	   pregnant	  women,	   particularly	   those	   in	  
contact	  with	   sheep	   and	   other	   livestock,	   due	   to	   severe	   illness	   including	   impaired	   renal	  
function,	  foetal	  abortion	  and	  pelvic	  inflammatory	  disease	  caused	  by	  C.	  abortus	  infection	  
[136-­‐138].	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Chlamydia	  caviae	  
C.	   caviae	   is	   a	   natural	   pathogen	   of	   guinea	   pigs,	   and	   cause	   of	   the	   disease	   guinea	   pig	  
inclusion	   conjunctivitis	   (GPIC)[139,	   140].	   C.	   caviae	   infection	   of	   the	   guinea	   pig	  
reproductive	   tract	   is	   used	   as	   a	   model	   for	   human	   genitourinary	   infection	   with	   C.	  
trachomatis	  given	  the	  similarity	  of	  tissue	  tropism	  and	  disease	  progression	  [141].	  C.	  caviae	  
is	  particularly	  host-­‐specific,	  with	  attempts	  to	  infect	  other	  rodents	  such	  as	  mice,	  rats	  and	  
rabbits	   unsuccessful	   [142].	   Whilst	   C.	   caviae	   is	   not	   considered	   to	   be	   pathogenic	   to	  
humans,	   a	   number	   of	   C.	   caviae-­‐like	   strains	   were	   identified	   in	   both	   male	   and	   female	  
patients	  from	  STI	  screenings	  [143].	  	  
Chlamydia	  suis	  
Whilst	  a	  number	  of	   chlamydial	   species	  have	  been	   identified	   in	  pigs,	  C.	   suis	   is	   the	  most	  
prevalent	   and	   is	   associated	   with	   respiratory,	   gastrointestinal	   and	   reproductive	   tract	  
disease	   [144,	   145].	   C.	   suis	   appears	   to	   be	   endemic	   in	   both	   farmed	   and	   wild	   pig	  
populations	   worldwide,	   and	   subclinical	   infections	   are	   common	   [146,	   147].	   Whilst	   the	  
zoonotic	  potential	  of	  C.	  suis	  with	  respect	  to	  human	  infection	  has	  not	  been	  exhaustively	  
examined,	   there	   is	   some	   indication	   that	   C.	   suis	   can	   infect	   and	   cause	   conjunctivitis	   in	  
abattoir	  workers	  [146].	  Several	  strains	  of	  C.	  suis	  have	  been	  described	  with	  a	  tetracycline	  
resistance	   gene,	   tet(C),	   which	   is	   believed	   to	   have	   been	   horizontally	   acquired	   from	  
Yersiniae	  sp.	  [148].	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Chlamydia	  avium,	  Chlamydia	  gallinacea	  and	  Candidatus	  Chlamydia	  ibidis	  
Two	   species	   have	   been	   recently	   added	   to	   the	   Chlamydiaceae	   -­‐	   C.	   avium	   and	   C.	  
gallinacea.	  C.	  avium	  was	  isolated	  from	  a	  number	  of	  avian	  species,	  including	  pigeons	  and	  
parrots,	   whilst	   C.	   gallinacea	   was	   isolated	   from	   a	   number	   of	   chickens.	   Clinical	   signs	   of	  
chlamydiosis	   in	   these	   animals	   included	   respiratory	   disease,	   enteritis	   and	   hepatic	  
enlargement	   as	   well	   as	   a	   number	   of	   asymptomatic	   presentations	   [149].	   Both	   species	  
exhibit	   inclusion	   morphologies	   similar	   to	   other	   members	   of	   the	   Chlamydiae,	   with	   a	  
comparatively	  long	  development	  cycle	  of	  60-­‐72	  hours.	  	  
	  
The	   candidate	   species	  C.	   ibidis	  was	   isolated	   from	   a	   number	   of	   cloacal	   swabs	   obtained	  
from	  a	  culling	  of	  feral	  sacred	  ibis	  in	  France.	  The	  birds	  appeared	  healthy	  so	  it	  is	  likely	  that	  
C.	  ibidis	  caused	  asymptomatic	  infection	  in	  this	  particular	  ibis	  population	  [150].	  	  
	  
Chlamydioses	  caused	  by	  other	  members	  of	  the	  Chlamydiales	  
Members	   of	   the	  Waddliaceae	   have	   been	   implicated	   in	   human	   foetal	   death	   associated	  
with	  sporadic	  and	  recurrent	  miscarriage	  [151],	  as	  well	  as	  bovine	  abortion	  [152,	  153].	  Bats	  
are	  a	  possible	  reservoir	  for	  transmission	  of	  Waddlia	  species	  [154,	  155].	  	  	  
A	  number	  of	  Chlamydiales	   are	  endosymbionts	  of	   free-­‐living	  amoebae.	  Members	  of	   the	  
Parachlamydiaceae	   have	   been	   associated	  with	   pneumonia	   and	   lower	   respiratory	   tract	  
infections	   in	   humans	   [156,	   157],	   whilst	   Simkania	   negevensis	   (family	   Simkaniaceae)	   is	  
believed	  to	  be	  ubiquitous	  in	  the	  human	  population,	  and	  has	  been	  associated	  with	  human	  
respiratory	  disease	  [158-­‐160].	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Various	  chlamydial	  species	  have	  been	  associated	  with	  epitheliocystis	  in	  wild	  and	  farmed	  
fish	   species,	   these	   include	   Syngamydia	   salmonis	   [161],	   Clavochlamydia	   salmonicola	  
[162],	   Piscichlamydia	   salmonis	   [163],	   Parilichlamydia	   carangidicola	   [164]	   and	  
Actinochlamydia	   clariae	   [165].	   [165]. Many	   of	   these	   species	   are	   the	   first	   members	   of	  
recently	  proposed	  and	  novel	  families	  within	  the	  order	  Chlamydiales.	  	  
Chlamydiales	   also	   infect	   arthropods:	   Fritschea	   species	   (family	   Simkaniaceae)	   are	  
secondary	   endosymbionts	   of	   whiteflies	   and	   scale	   insects	   [166-­‐168],	   whilst	  
Rhabdochlamydia	  species	  infect	  isopods	  and	  cockroaches	  [169,	  170]	  
GENOMICS	  OF	  CHLAMYDIA	  
With	   the	   advancement	   of	   next-­‐generation	   sequencing	   technologies,	   over	   250	   whole	  
genome	   and	   plasmid	   assemblies	   of	   members	   from	   the	   Chlamydiae	   have	   become	  
available	  on	  public	  databases.	  This	  has	  allowed	  researchers	  to	  not	  only	  compare	  strains	  
within	   chlamydial	   species,	   but	   also	   to	   determine	   the	   similarities	   between	   the	  
Chlamydiaceae	  and	  other	  chlamydial	  phyla.	  
The	   Chlamydiaceae	   were	   thought	   to	   have	   diverged	   from	   the	   symbiotic	   and	  
environmental	  Chlamydiae	  some	  700	  million	  years	  ago,	  the	  last	  common	  ancestor	  of	  the	  
Chlamydiae	  having	  split	  from	  the	  planctobacterial	  phylum	  2	  billion	  years	  ago	  [171,	  172].	  
Members	   of	   the	   Chlamydiaceae	   have	   small,	   compact	   genomes	   compared	   to	   other	  
Chlamydiae	   (Table	   2),	   as	   the	   result	   of	   genome	   reduction	   and	   host	   adaptation.	   In	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comparing	   chromosomal	   size	   between	   Chlamydiales,	   the	   Parachlamydiaceae	   have	   the	  
largest	  chromosome	  (3Mbp)	  and	  Chlamydiaceae	  smallest	  (1Mbp).	  	  
	  
Loss	   of	   metabolic	   and	   biosynthetic	   pathways,	   with	   an	   increase	   in	   genes	   encoding	   for	  
transporter	   systems	   to	   allow	   for	   uptake	   of	   nutrients	   from	   the	   host	   cell	   are	   common	  
features	   in	   genomes	  of	   obligate	   intracellular	   pathogens	   and	   endosymbionts	   [173-­‐175].	  
Paradoxically,	   this	   characteristic	   is	   not	   confined	   to	   host-­‐restricted	   intracellular	  
pathogens.	  Studies	  in	  free	  living	  bacterial	  species	  have	  also	  demonstrated	  that	  the	  loss	  of	  
certain	  biosynthetic	  pathways	  through	  random	  mutations	  confer	  an	  unexpected	  increase	  
in	   fitness	   and	   virulence	   [176-­‐178],	   suggesting	   that	   loss	   of	   these	   pathways	   may	   be	   a	  
mechanism	  for	  establishing	  parasitism.	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Table	  2	   -­‐	  Representative	  chromosomal	  size	  and	  gene	  content	   for	  chlamydial	   species	  with	  whole	  genome	  




GC%	   Protein	   rRNA	   tRNA	  
Other	  
RNA	  
Gene	   Pseudogene	  
Protochlamydia	  
amoebophila	  	   2.41	   34.7	   1,855	   7	   35	   1	   1,938	   40	  
Chlamydia	  avium	   1.04	   36.9	   831	   3	   39	   1	   937	   63	  
Chlamydia	  muridarum	   1.07	   40.3	   892	   6	   37	   1	   937	   1	  
Chlamydia	  pecorum	   1.11	   41.1	   931	   3	   38	   1	   980	   7	  
Chlamydia	  pneumoniae	   1.23	   40.6	   1,029	   3	   38	   2	   1,091	   19	  
Chlamydia	  psittaci	   1.17	   39.1	   971	   3	   38	   1	   1,018	   5	  
Chlamydia	  trachomatis	   1.04	   41.3	   887	   6	   37	   2	   935	   3	  
Chlamydia	  caviae	   1.17	   39.2	   966	   3	   38	   1	   1,022	   14	  
Chlamydia	  felis	   1.17	   39.4	   961	   3	   38	   1	   1,015	   12	  
Criblamydia	  sequanensis	   2.97	   38.2	   2,407	   -­‐	   39	   1	   2,491	   40	  
Neochlamydia	  sp.	  S13	   3.19	   38	   2,175	   10	   42	   1	   2,581	   352	  
Parachlamydia	  
acanthamoeba	   3.07	   39	   2,531	   10	   40	   1	   2,618	   36	  
Simkania	  negevensis	   2.5	   41.8	   2,218	   3	   35	   1	   2,274	   17	  
Waddlia	  chondrophila	   2.12	   43.8	   1,828	   6	   37	   1	   1,889	   17	  
In	   spite	   of	   the	   considerable	   difference	   in	   chromosomal	   size	   and	   gene	   content	   of	  
members	  in	  the	  Chlamydiae,	  they	  share	  a	  highly	  conserved	  core	  genome	  of	  560	  genes,	  as	  
shown	  in	  Figure	  2.	  The	  majority	  of	  these	  are	  conserved	  housekeeping	  genes,	  whilst	  over	  
100	  core	  genes	  have	  no	  assigned	  function	  and	  27	  are	  specific	  to	  the	  Chlamydiae	  with	  no	  
orthologs	  in	  other	  bacterial	  species	  [179].	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Figure	  2	   -­‐	  Venn	  diagram	   illustrating	   the	  number	  of	   shared	  and	  accessory	   (family-­‐specific)	  genes	   found	   in	  
various	  members	  of	  the	  Chlamydiae.	  Figure	  taken	  from	  Collingro	  et	  al.	  2011	  [179]	  
The	  chromosome	  of	  Simkania,	  Parachlamydia,	  Waddlia	  and	  Protochlamydia	  species	  are	  
at	  least	  twice	  the	  size	  of	  Chlamydia	  species,	  and	  many	  genes	  specific	  to	  these	  genus	  are	  
involved	   in	   chemosensory	   systems,	   complex	   biosynthetic	   pathways	   and	   transporters	  
which	  facilitate	  the	  diversity	  of	  these	  species	  in	  free-­‐living	  amoebae,	  but	  would	  serve	  no	  
purpose	   in	   Chlamydia	   [179,	   180].	   Conversely,	   many	   species	   lack	   structural,	  
immunomodulatory	   and	   nutrient	   transport	   genes,	   common	   in	   the	   Chlamydia,	   such	   as	  
translocating	  actin	   recruitment	  protein	   (TarP),	  members	  of	   the	   inclusion	  protein	   family	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(IncB	   -­‐	   G)	   and	   lipid-­‐droplet	   associated	   proteins	   -­‐	   required	   for	   host	   cell	   invasion,	  
reorganisation	  of	  the	  host	  cytoskeleton	  and	  formation	  of	  the	  chlamydial	   inclusion	  [181-­‐
187].	  	  
	  
Although	  species	  within	  the	  genus	  Chlamydia	  demonstrate	  considerable	  synteny	  in	  their	  
gene	  content	  and	  order,	  they	  differ	  in	  the	  presence	  of	  a	  number	  of	  important	  metabolic	  
pathways,	  virulence	  determinants	  and	  niche-­‐specific	  genes.	  	  Perhaps	  the	  most	  important	  
of	   these	   differences	   is	   the	   presence	   or	   absence	   of	   the	   tryptophan	   synthase	   operon	  
(trpABFCDR,	   kynU.	   prsA,	   tph)	   and	   transport	   (tyrP,	   Aro-­‐AAH)	   genes.	   Many	   species	   of	  
Chlamydia	   are	   tryptophan	   auxotrophs,	  while	   others	   differ	   in	   their	   ability	   to	   synthesise	  
tryptophan	  dependent	  on	  the	  complement	  of	  tryptophan	  synthase	  genes	  encoded	  in	  the	  
plasticity	   zone	   of	   the	   chromosome	   [188-­‐192].	   The	   absence	   of	   the	   tryptophan	   operon	  
appears	   to	   leave	   the	   pathogen	   utterly	   reliant	   on	   the	   host	   tryptophan	   supply	   and	  
vulnerable	  to	  host	   immune	  defenses	  via	   IFN-­‐γ	   -­‐mediated	  tryptophan	  starvation	  [27,	  32,	  
34].	  	  
	  
C.	   pneumoniae	   encodes	   an	   aromatic	   amino	   acid	   hydroxylase	   (Aro-­‐AAH),	   which	  
hydroxylates	   all	   three	   aromatic	   amino	   acids	   (phenylalanine,	   tyrosine	   and	   tryptophan)	  
and	   is	   expressed	   in	   the	   first	   24	   hours	   post-­‐infection	   [193].	   Genes	   similar	   to	   C.	  
pneumoniae	   Aro-­‐AAH	  are	  present	   in	   the	   genomes	  of	  C.	   caviae,	   C.	   abortus	   and	   C.	   felis,	  
however	   these	   genes	   share	  only	   44%	   identity	  with	   the	  C.	   pneumoniae	   gene	   [193].	   	  All	  
members	   of	   the	  Chlamydiaceae	   code	   for	   at	   least	   one	   copy	  of	   the	   tyrosine/tryptophan	  
transporter	   permease	   gene	   (tyrP),	   with	   nucleotide	   polymorphisms	   and	   differences	   in	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gene	  copy	  number	  reportedly	  associated	  with	  tissue	  tropism	  in	  both	  C.	  trachomatis	  and	  
C.	  pneumoniae	  [91,	  188,	  194,	  195].	  
The	   chlamydial	   plasticity	   zone	   (PZ)	   encompasses	   the	   terminus	   of	   replication	   in	   the	  
Chlamydiae,	   and	   displays	   considerable	   diversity	   in	   gene	   content	   and	   coding	   capacity	  
between	  species	  [190].	  This	  region	  spans	  from	  less	  than	  10kbp	  (C.	  pneumoniae	  LPCoLN)	  
to	   over	   50kpb	   (C.	   muridarum	   Nigg)	   (Figure	   3)	   and	   codes	   for	   a	   number	   of	   metabolic,	  
virulence	   and	   host-­‐interaction	   genes,	   with	   differences	   in	   the	   presence	   and	   number	   of	  
particular	  genes	  between	  species	  [196].	  
Figure	   3	   -­‐	   A	   comparison	   of	   genes	   encoded	   in	   the	   plasticity	   zone	   of	   various	   species	   of	   Chlamydiaceae.	  
Differences	   in	  coding	  capacity,	  gene	  content	  and	  read	  direction	  are	  noted	  between	  different	  species	  and	  
different	  strains.	  Figure	  taken	  from	  Nunes	  and	  Gomes,	  2014.	  [196].	  	  
In	   addition	   to	   encoding	   the	   trp	   operon,	   the	   PZ	   of	   various	   species	   codes	   for	   purine	  
biosynthesis	   genes	   (guaA/B-­‐add)	   [190,	   191,	   197,	   198],	   single	   or	   multiple	   copies	   of	  
cytotoxin	  genes	  which	  share	  domain	  homology	  to	  clostridial	  and	  yersinal	  cytotoxins	  [190,	  
199],	   as	   well	   as	   phospolipase	   D	   and	   MACPF	   genes,	   whose	   products	   are	   thought	   to	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facilitate	   host-­‐lipid	   acquisition	   and	   play	   a	   role	   in	   host	   immune	   evasion	   [21,	   200,	   201].	  
Inter-­‐strain	   diversity	   in	   the	   PZ	   is	   particularly	   apparent	   in	   C.	   pneumoniae,	   with	   animal	  
strains	   encoding	   a	   more	   compact	   PZ	   with	   a	   MACPF	   gene	   but	   no	   purine	   biosynthesis	  
operon,	  whilst	  human	  strains	  encode	  a	  number	  of	  fragmented	  remnants	  of	  membrane-­‐
bound	  proteins,	  a	  purine	  biosynthesis	  operon	  and	  partial	  MACPF	  [110].	  Differences	  in	  the	  
number	   of	   cytotoxin	   and	   phospholipase	   D	   genes	   are	   apparent	   the	   PZ	   of	   C.	   pecorum	  
strains	  with	  fragmentation	  of	  cytotoxin	  genes	  observed	  in	  cattle	  and	  koala	  strains	  whilst	  
an	   additional	   cytotoxin	   gene	   has	   been	   described	   in	   a	   porcine	  C.	   pecorum	   strain	   [116].	  
Diversity	   in	   cytotoxin	   genes	   has	   also	   been	   observed	   between	   urogenital	   and	  
lymphogranuloma	   C.	   trachomatis	   strains	   [202],	   whilst	   a	   single	   nucleotide	   deletion	   in	  
ocular	  C.	  trachomatis	  strains	  renders	  the	  trp	  operon	  non-­‐functional	  in	  these	  strains	  [189].	  
Membrane	  and	  inclusion	  proteins	  are	  also	  variable	  in	  both	  number	  and	  function	  among	  
the	   Chlamydiae.	   	   The	   polymorphic	   membrane	   proteins	   (Pmp)	   are	   a	   family	   of	  
autotransporter	   proteins	   genetically	   similar	   to	   the	   type	   V	   secretion	   system	   of	   gram-­‐
negative	  bacteria	  [203,	  204].	  The	  number	  of	  Pmps	  per	  species	  is	  variable	  [192,	  205-­‐207].	  
In	  comparing	  the	  genomes	  of	  C.	  trachomatis	  and	  C.	  pneumoniae,	  approximately	  188kb	  of	  
additional	  nucleotide	  sequence	  was	  noted	  in	  C.	  pneumoniae	  and	  22%	  of	  this	  accounted	  
for	   the	   difference	   in	   number	   of	   pmp	   homologs	   –	   21	   for	   C.	   pneumoniae	   and	   9	   for	   C.	  
trachomatis	  [192].	  pmps	  encode	  for	  a	  characteristic	  repeat	  amino	  acid	  motif:	  GGA(I,L,V)	  
and	   FXXN.	   The	  motif	   GGA(I,L,V)	   is	   repeated	   up	   to	   12	   times	   at	   the	  N-­‐terminus	   of	   each	  
protein	   and	   The	   FXXN	   motif	   occurs	   up	   to	   23	   times	   at	   the	   N-­‐terminal	   region.	   The	  
GGA(I,LV)	  motif	   is	  exceptionally	  rare	   in	  other	  organisms	  [208].	  Many	  pmps	  also	  encode	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for	  additional	   functional	  motifs,	  such	  as	  RGD	  cell	  attachment	  sequences,	   leucine	  zipper	  
and	  ATP	  binding	  motifs,	  which	  could	  play	  a	  role	   in	  host	  cell	  attachment	  and	  chlamydial	  
virulence	  [204].	  	  
	  
A	   characteristic	   morphological	   feature	   of	   the	   chlamydial	   developmental	   cycle	   is	   the	  
formation	   of	   a	   host-­‐derived	   parasitophorous	   vacuole,	   known	   as	   the	   inclusion.	   The	  
inclusion	   is	  at	   the	   forefront	  of	   the	  host-­‐pathogen	   interaction,	   facilitating	   the	  uptake	  of	  
metabolites,	   regulation	   of	   the	   immunomodulatory	   response	   and	   control	   of	   the	  
chlamydial	  developmental	  cycle	  [209-­‐212].	  	  The	  inclusion	  protein	  IncA	  was	  discovered	  as	  
a	  result	  of	  the	  immunogenicity	  of	  this	  protein	  in	  guinea	  pig	  sera	  [213],	  and	  all	  members	  
of	  the	  Chlamydiae	  have	  been	  demonstrated	  to	  contain	  homologs	  of	  this	  protein.	  The	  Inc	  
family	  was	  expanded	  to	  encompass	  IncA	  -­‐	  G	  [214,	  215],	  and	  whilst	  these	  proteins	  share	  
little	  sequence	  similarity	  between	  them,	  they	  are	  characterised	  based	  on	  a	  signature	  bi-­‐
lobed	   hydrophobic	  motif	   and	   their	   localisation	   to	   the	   inclusion	  membrane	   [216,	   217].	  
Members	   of	   the	   Chlamydiae	   encode	   for	   different	   'sets'	   of	   Inc	   genes,	   and	   not	   every	  
species	   encodes	   for	   the	   entire	   complement	   of	   the	   IncA	   -­‐	   G	   family	   [218].	   Additionally,	  
numbers	  of	  Inc	  homologs	  can	  vary	  widely	  between	  the	  species	  [218-­‐220].	  	  
	  
The	   T3S	   is	   a	   complex	   protein	   secretion	   system,	   which	   translocates	   proteins	   across	  
bacterial	  membranes	  into	  the	  host	  cell	  cytoplasm	  [221,	  222].	  The	  T3S	  is	  believed	  to	  have	  
originated	   as	   a	   flagellar	   protein	   system	   [223]	   and	   the	   Chlamydiae	   are	   the	   only	   non-­‐
proteobacterial	   phylum	   known	   to	   possess	   a	   T3S	   [224].	   Phylogenetic	   analysis	   of	   T3S	  
components	  in	  various	  bacterial	  species	  place	  the	  chlamydial	  homologs	  at	  the	  root	  of	  the	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tree	  –	  suggesting	  that	  the	  presence	  of	  T3S	  genes	   in	  the	  Proteobacteria	  are	  resultant	  of	  
horizontal	  gene	  transfer	  from	  a	  chlamydial	  ancestor	  [225].	   In	  the	  Proteobacteria,	  genes	  
which	   encode	   the	   T3S	   and	   its	   associated	   effector	   proteins	   are	   clustered	   within	  
pathogenicity	  islands,	  either	  on	  a	  plasmid	  or	  within	  the	  chromosome	  [222],	  however	  the	  
genes	   which	   code	   for	   the	   chlamydial	   T3S	   are	   encoded	   in	   least	   four	   clusters	   located	  
throughout	  the	  bacterial	  chromosome	  [226].	  
The	  location	  of	  three	  clusters	  of	  structural	  genes	  appears	  to	  be	  conserved	  in	  all	  species	  
however	   effector-­‐encoding	   (Inc,	   cop	   and	   tarP	   –	   cluster	   four)	   genes	   demonstrate	   clear	  
differences	   in	   both	   location	   and	   read	   direction	   between	   different	   species	   in	   the	  
Chlamydiaceae	   as	   shown	   in	   Figure	  4	   [226].	  Compared	   to	   the	   structural	   components	  of	  
the	  T3S,	  effectors	  demonstrate	  little	  sequence	  homology,	  even	  though	  they	  show	  similar	  
enzymatic	  activities	  across	  all	  bacterial	  genera.	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Figure	  4	   -­‐	  Genetic	  organisation	  of	  T3S	  structural	  and	  effector	  genes	   in	  six	  chlamydial	  species.	  Blue	  bands	  
indicate	  the	  rearrangement	  of	  cluster	  four	  Inc	  and	  tarP	  genes,	  Designations	  for	  structural	  genes	  involved	  in	  
T3S	  machinery	  are	  as	  labeled.	  Figure	  taken	  from	  Beeckman	  et	  al.	  2010	  [226].	  
The	  chlamydial	  plasmid	  is	  considered	  a	  virulence	  factor	  as,	  where	  it	  is	  present,	  it	  encodes	  
a	  number	  of	  regulatory	  proteins	  involved	  in	  controlling	  the	  expression	  of	  virulence	  genes	  
on	   the	   chromosome	   [227,	   228].	   Of	   the	   11	   species	   in	   the	   Chlamydiaceae,	   all	   but	   C.	  
abortus	   possess	   an	   extrachromosomal	   plasmid	   [1],	   whilst	   only	   animal	   C.	   pneumoniae	  
strains	   possess	   the	   extrachromosomal	   plasmid	   [95,	   102,	   110].	   Several	   strains	   of	   C.	  
psittaci,	  C.	  pecorum	  and	  at	  least	  one	  clinical	  strain	  of	  C.	  trachomatis	  have	  been	  identified	  
lacking	  a	  plasmid	  [229,	  230].	  Chlamydial	  plasmids	  vary	  in	  size	  from	  7.1	  –	  7.9Kbp,	  however	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each	  plasmid	  contains	  eight	  open	  reading	  frames,	  with	  a	  high	  degree	  of	  synteny	  in	  amino	  
acid	  sequence	  across	  all	  species	  [231].	  	  
	  
COMPARATIVE	  GENOMICS	  OF	  CHLAMYDIA	  PNEUMONIAE	  
Prior	  to	  this	  study,	  whole	  genome	  comparisons	  of	  C.	  pneumoniae	  strains	  were	  restricted	  
to	  strains	  obtained	  from	  a	  human	  ocular	  isolate	  (TW183)	  [81],	  three	  respiratory	  isolates	  
(AR39,	  CWL029,	  J138)	  [192,	  198,	  232]	  and	  a	  single	  animal	  C.	  pneumoniae	   isolated	  from	  
the	   nasopharynx	   of	   a	   koala	   (LPCoLN)	   [110].	   Whole	   genome	   and	   single	   nucleotide	  
polymorphism	   (SNP)	   comparisons	   of	   the	   four	   human	   strains	   revealed	   remarkable	  
synteny	   in	   their	   gene	   content,	   arrangement	   and	   nucleotide	   usage,	  with	   99%	  pair	  wise	  
nucleotide	  identity	  between	  human	  C.	  pneumoniae	  strains	  [233].	  	  
Sequencing	   of	   the	   koala	   LPCoLN	   strain	   provided	   a	   new	   perspective	   on	  C.	   pneumoniae	  
evolution	  [110].	  Whilst	  the	  core	  genome	  of	  the	  LPCoLN	  strain	  was	  highly	  congruent	  with	  
the	   human	   C.	   pneumoniae	   strains,	   the	   chromosome	   was	   12Kbp	   larger	   and	   encoded	  
several	   full-­‐length	   genes	   which	   were	   split	   or	   truncated	   in	   the	   human	   strains.	  	  
Additionally,	   an	  extrachromosomal	  plasmid	  was	  described	  which	  was	  absent	   in	  human	  
strains.	  	  
Of	   the	   1000+	   coding	   genes	   in	   human	   C.	   pneumoniae,	   186	   genes	   were	   considered	   C.	  
pneumoniae-­‐specific,	   having	   no	   homologs	   in	   any	   other	   organism	   including	   other	  
chlamydial	   species	   [192],	  whilst	   the	   LPCoLN	   strain	   had	   an	   additional	   93	   unique	   coding	  
sequences	  compared	  to	  AR39	  [110].	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In	  spite	  of	  the	  limited	  genetic	  differences	  reported	  in	  human	  and	  animal	  C.	  pneumoniae	  
strains,	  there	  have	  nevertheless	  been	  several	  attempts	  to	  segregate	  genetic	  differences	  
to	  particular	  hosts,	  diseases	  or	  tissues.	   	  A	  major	  difference	  between	  human	  strains	  has	  
been	   attributed	   to	   the	   tyrP	   copy	  number.	   Strains	  with	   a	   single	   copy	  of	   this	   gene	  have	  
been	  associated	  with	  vascular	   tropism	  [194,	  195],	  whilst	  neural	  and	  Alzheimer’s	  strains	  
had	  been	  putatively	  identified	  as	  encoding	  for	  three	  copies	  of	  this	  gene	  [91].	  Additional	  
large-­‐scale	   genetic	   differences	   were	   observed	   in	   genes	   encoding	   for	   polymorphic	  
membrane	  proteins	  (pmp)	  and	  the	  Inclusion	  protein	  family	  (Inc)	  [102,	  234].	  	  In	  comparing	  
pmps	  across	  human	  C.	  pneumoniae	  strains,	  distinct	  differences	  were	  noted	  at	  both	  the	  
nucleotide	   [208,	   235]	   and	   expression	   level	   [236-­‐238].	   The	   IncA	   gene	   family	   is	  
considerably	  expanded	  in	  C.	  pneumoniae,	  with	  up	  to	  117	  characterised	  and	  putative	  Incs	  
identified	   in	   human	   and	   animal	   C.	   pneumoniae	   strains	   [218-­‐220].	   	   Furthermore,	   there	  
was	  evidence	   for	  animal-­‐like	  human	  C.	  pneumoniae	   strains,	   through	  the	  molecular	  and	  
phylogenetic	   characterisation	   of	   two	   respiratory	   isolates	   from	   Australian	   indigenous	  
individuals	   at	   several	   genetic	   loci	   [102].	   The	   similarity	   of	   these	   strains	   to	   the	   koala	  
LPCoLN	  strain	  at	  these	  loci	  suggested	  at	  least	  one	  zoonotic	  C.	  pneumoniae	  transmission	  
from	  animals	  to	  humans	  sometime	  in	  the	  distant	  past.	  
More	  recently,	  19	  new	  whole	  genome	  sequences	  for	  C.	  pneumoniae	  strains	  isolated	  from	  
respiratory	   and	   cardiovascular	   sites	  were	   analysed	   and	   characteristic	   non-­‐synonymous	  
SNPs	  were	  demonstrated	  in	  cardiovascular	  strains	  which	  clearly	  segregated	  by	  pathology,	  
and	   were	   putatively	   involved	   in	   chlamydial	   growth	   and	   stress	   response	   [195,	   239].	   In	  
comparing	  the	  clinical	  isolates	  in	  this	  study	  to	  the	  DC9	  frog	  strain,	  54	  genes	  were	  shown	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to	   be	   under	   positive	   selection	   in	   adaptation	   to	   the	   human	   host,	   whilst	   recombination	  
was	   detected	   amongst	   human	   isolates	   but	   not	   between	   human	   and	   animal	   isolates	  
[195].	  	  
	  
Prior	   to	   the	   study	   presented	   in	   this	   thesis,	   only	   a	   single	   animal	  C.	   pneumoniae	   whole	  
genome	   sequence	   was	   publicly	   available	   (LPCoLN)	   [110],	   though	   several	   targeted	  
molecular	   studies	   investigated	   the	   genetic	   diversity	   in	   animal	   C.	   pneumoniae	   from	   a	  
number	  of	  cold-­‐	  and	  warm-­‐blooded	  hosts.	  	  Differences	  in	  the	  sequence	  of	  16S	  rRNA	  and	  
ompA	  between	  animal	  hosts	  have	  been	  described	  in	  horses	  [95],	  frogs	  	  [99,	  100,	  240]	  and	  
reptiles	  [99,	  103].	  The	  koala	  C.	  pneumoniae	  biovar	  has	  been	  extensively	  investigated	  and	  
found	  to	  be	  identical	  between	  samples	  from	  different	  animals	  and	  different	  anatomical	  
sites	  for	  a	  number	  of	  gene	  loci	  [112,	  241],	  though	  minor	  differences	  in	  ompA	  genotypes	  
have	   been	   observed	   in	   peripheral	   blood	  mononuclear	   cell	   fractions	   from	   some	   koalas	  
[242].	  C.	  pneumoniae	  is	  common	  in	  Australian	  fauna,	  with	  identical	  16S	  rRNA	  and	  ompA	  
genotypes	  to	  the	  LPCoLN	  strain	  described	  in	  frogs	  [101],	  bandicoots	  [243]	  and	  potoroos	  
[102].	   Further	   observations	   on	   the	   genetic	   diversity	   of	   animal	   C.	   pneumoniae	   strains	  
were	  made	   in	   a	   study	   that	   examined	   the	   nucleotide	   sequence	  of	   23	   gene	   targets	   in	   a	  
variety	   of	  mammalian,	  marsupial,	   amphibian	   and	   reptile	   samples	   as	  well	   as	   human	  C.	  
pneumoniae	   strains.	   Based	   on	   sequence	   polymorphisms	   and	   phylogenetic	   analyses	   of	  
chromosomal	   and	   plasmid	  molecular	   targets,	   five	   separate	   genotypes	  were	   identified,	  
three	   with	   distinct	   biogeographical	   distributions	   [102].	   Strains	   in	   genotype	   A	   were	  
identical	  in	  sequence	  for	  all	  molecular	  markers	  tested	  and	  were	  found	  to	  be	  prevalent	  in	  
isolates	   from	   Australian	   fauna,	   whilst	   genotype	   E,	   consisting	   of	   a	   single	   strain	   N16	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isolated	  from	  a	  horse	  in	  the	  United	  Kingdom	  [95]	  exhibited	  enough	  nucleotide	  diversity	  
at	   a	   number	   of	   genetic	   loci	   to	   support	   the	   proposal	   of	   an	   equine	   C.	   pneumoniae	  
subspecies	  [244].	  	  
CONCLUDING	  REMARKS	  
The	   Chlamydiae	   are	   ubiquitous	   pathogens	   with	   distinct	   developmental	   and	   biological	  
characteristics	  that	  enable	  them	  to	  infect	  a	  diverse	  range	  of	  eukaryotic	  hosts	  in	  a	  number	  
of	   ecological	   niches.	  Chlamydia	   pneumoniae	   is	   unique	   in	   that	   it	   has	   the	   broadest	   host	  
range	   of	   any	   member	   of	   the	   Chlamydiaceae,	   infecting	   both	   cold-­‐	   and	   warm-­‐blooded	  
hosts,	   in	   addition	   to	   its	   association	  with	  numerous	   acute	   and	   chronic	  human	  diseases.	  
Previous	  molecular	  typing	  studies	  of	  Chlamydia	  pneumoniae	  suggested	  that	  both	  human	  
and	  animal	  strains	  were	  highly	  conserved	  in	  both	  gene	  content	  and	  nucleotide	  sequence.	  
Advances	   in	   next	   generation	   whole	   genome	   and	   RNA	   sequencing	   technologies	   have	  
allowed	  researchers	  to	  characterise	  numerous	  new	  chlamydial	  species	  as	  well	  as	  identify	  
inter-­‐strain	  differences	   in	   genome	   sequence	  and	  expression	   that	   correlate	   to	  host	   and	  
disease	   tropisms.	   Whole	   genome	   sequencing	   has	   allowed	   researchers	   to	   further	  
elucidate	   the	  evolution	  of	   the	  Chlamydiae	   in	  human	  and	  veterinary	  disease,	   as	  well	   as	  
providing	  an	  avenue	  for	  discovery	  of	  novel	  molecular	  markers,	  which	  may	  be	  utilised	  for	  
the	   identification	   of	   specific	   strains	   in	   clinical	   settings,	   or	   targets	   for	   prophylactic	   and	  
therapeutic	  interventions.	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ABSTRACT	  
Chlamydia	   pneumoniae	   is	   a	   ubiquitous	   intracellular	   pathogen,	   first	   associated	   with	  
human	   respiratory	   disease,	   and	   subsequently	   detected	   in	   a	   range	   of	   mammals,	  
amphibians	  and	  reptiles.	  Here	  we	  report	  the	  draft	  genome	  sequence	  for	  the	  strain	  B21	  of	  
C.	  pneumoniae	   isolated	  from	  the	  endangered	  Australian	  marsupial,	  the	  Western	  Barred	  
Bandicoot.	  
Chlamydia	  pneumoniae	  is	  an	  obligate	  intracellular	  bacterium	  associated	  with	  community-­‐
acquired	  pneumonia	  and	  detected	  in	  cold	  and	  warm-­‐blooded	  hosts	  such	  as	  amphibians,	  
reptiles,	  marsupials	  and	  humans.	  [1-­‐3].	  Although	  minor	  genetic	  differences	  suggest	  that	  
human	   strains	   are	   a	   result	   of	   several	   zoonotic	   events	   in	   this	   pathogen’s	   history,	   both	  
human	   and	   koala	   strains	   of	  C.	   pneumoniae	   are	   highly	   conserved	   in	   their	   gene	   content	  
and	  organisation	  [4].	  Interestingly,	  a	  previous	  study	  examining	  selected	  molecular	  targets	  
in	   marsupial	   C.	   pneumoniae	   isolates	   demonstrated	   identical	   sequences	   for	   all	   isolates	  
tested	   [5].	  With	   this	   in	  mind,	  we	   sequenced	   the	   chromosome	   and	   plasmid	   of	   B21,	   an	  
isolate	   from	   the	   Western	   Barred	   Bandicoot	   (Perameles	   bougainville),	   an	   endangered	  
Western	  Australian	  marsupial.	  
The	  C.	  pneumoniae	  B21	  chromosome	  and	  plasmid	  were	  sequenced	  in	  duplicate	  using	  the	  
Ion	  Torrent	  platform	  P1	  chip	  with	  200bp	  chemistry,	  resulting	   in	  over	  120	  million	  reads.	  
Read	   quality	   analyses	   were	   performed	   using	   FASTQC	   ver.	   0.10.1	   (version	   0.10.1;	  
Babraham	  Bioinformatics	  group	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  [http://www.bioinformatics.bbsrc.ac.uk/projects/fastqc]),	  with	  average	  Phred	  scores	  of	  
24.	   CLC	   Genomics	   Workbench	   (version	   6.0.2;	   CLC	   bio,	   Denmark)	   was	   used	   to	   trim	  
sequences	  as	  well	  as	  perform	  de	  novo	  assembly	  and	  readmapping,	  with	  read	  coverages	  
exceeding	  5000×.	  The	  de	  novo	  assembly	  consists	  of	  164	  chromosomal	  contig	  sequences	  
and	   a	   single	   contig	   for	   the	   plasmid.	   The	   predicted	   length	   of	   the	   C.	   pneumoniae	   B21	  
chromosome	   is	   1,241,009bp	  with	   GC	   content	   of	   40.5%.	   The	   B21	   plasmid	   is	   7529nt	   in	  
length	  with	  GC	  content	  of	  33.0%.	   	  Automatic	  annotation	  was	  performed	  using	  RAST	  [6]	  
and	  manually	  curated	  using	  Artemis	  [7].	  	  
	  
The	   draft	   B21	   chromosome	   and	   plasmid	   were	   pairwise	   aligned	   to	   all	   available	   C.	  
pneumoniae	   genome	   and	   plasmid	   sequences	   [4,	   8-­‐11],	   using	   MAFFT	   [12].	   	   The	   B21	  
chromosome	  contains	  1308	  predicted	  coding	   regions	   (CDS)	  with	  37	   tRNAs	  and	  a	   single	  
rRNA	  operon,	  whilst	  the	  B21	  plasmid	  has	  eight	  predicted	  CDS.	  Nucleotide	  variants	  were	  
predicted	   by	  mapping	   the	   reads	   of	  C.	   pneumoniae	   B21	   to	   the	   complete	   genome	  of	  C.	  
pneumoniae	  LPCoLN,	  a	  koala	  strain.	  Twenty-­‐six	  variants	  were	  predicted,	  of	  which	  fifteen	  
are	  within	  homopolymeric	  tracts	  of	  varying	   lengths.	   	  Four	  variants	  are	  predicted	  within	  
intergenic	   regions.	   PCR	   and	   sequencing	   analysis	   of	   four	   variants	   has	   demonstrated	  
identical	  sequence	  to	  that	  of	  LPCoLN.	  The	  B21	  chromosome	  is	  99.99%	  identical	  to	  that	  of	  
LPCoLN	   and	   96.9%	   identical	   to	   human	   strains.	   Two	  ORFs	   are	   predicted	   for	   the	   pmp18	  
(pmpE/F)	   B21	   homolog,	   which	   are	   full	   length	   in	   human	   strains	   and	   a	   pseudogene	   in	  
LPCoLN.	  The	  B21	  plasmid	  has	  99.99%	  nucleotide	   identity	   to	  the	  LPCoLN	  plasmid,	  and	  a	  
96.3%	  identity	  to	  the	  horse	  C.	  pneumoniae	  N16	  plasmid	  isolate[13].	  A	  single	  nucleotide	  
deletion	   is	   noted	   at	   the	   3'	   end	   of	   locus	   X556p_1186	   in	   the	   B21	   plasmid	   within	   a	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homopolymeric	  tract,	  resulting	  in	  the	  truncation	  of	  X556p_1186	  in	  B21	  by	  8	  amino	  acids.	  
X556p_1186	   is	   predicted	   to	   encode	   for	   pGP3-­‐D,	   a	   putative	   virulence	   factor	   associated	  
with	  growth	  of	  Chlamydia	  in	  mammalian	  cells	  [14].	  	  	  
	  
Nucleotide	  sequence	  and	  accession	  numbers.	  This	  Whole	  Genome	  Shotgun	  project	  has	  
been	   deposited	   at	   DDBJ/EMBL/GenBank	   under	   the	   accession	   AZNB00000000.	   The	  
version	  described	  in	  this	  paper	  is	  version	  AZNB01000000.	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ABSTRACT	  
Chlamydia	  pneumoniae	   is	  an	  obligate	  intracellular	  bacterium	  implicated	  in	  a	  wide	  range	  
of	   human	   diseases	   including	   atherosclerosis	   and	   Alzheimer’s	   disease.	   Efforts	   to	  
understand	   the	   relationships	   between	  C.	   pneumoniae	   detected	   in	   these	   diseases	   have	  
been	   hindered	   by	   the	   availability	   of	   sequence	   data	   for	   non-­‐respiratory	   strains.	   In	   this	  
study,	   we	   sequenced	   the	   whole	   genomes	   for	   C.	   pneumoniae	   isolates	   from	  
atherosclerosis	  and	  Alzheimer’s	  disease,	  and	  compared	  these	  to	  previously	  published	  C.	  
pneumoniae	   genomes.	   Phylogenetic	   analyses	   of	   these	   new	   C.	   pneumoniae	   strains	  
indicates	   two	   sub-­‐groups	   within	   human	   C.	   pneumoniae,	   and	   suggest	   that	   both	  
recombination	  and	  mutation	  events	  have	  driven	  the	  evolution	  of	  human	  C.	  pneumoniae.	  
Further	   fine-­‐detailed	   analyses	   of	   these	   new	   C.	   pneumoniae	   sequences	   show	   several	  
genetically	  variable	  loci.	  This	  suggests	  that	  similar	  strains	  of	  C.	  pneumoniae	  are	  found	  in	  
the	  brain,	  lungs	  and	  cardiovascular	  system	  and	  that	  only	  minor	  genetic	  differences	  may	  
contribute	  to	  the	  adaptation	  of	  particular	  strains	  in	  human	  disease.	  
	  
INTRODUCTION	  	  
The	   Chlamydiae	   are	   a	   phylum	   of	   obligate	   intracellular	   bacterial	   parasites	   infecting	   a	  
broad	   range	  of	   eukaryotic	  hosts	   including	  amoebae,	   invertebrates	   such	  as	   insects,	   and	  
vertebrates	   including	   humans	   [1,	   2].	   All	   members	   of	   this	   phylum	   share	   a	   biphasic	  
developmental	   cycle	   that	   is	   unique	   in	   the	   bacterial	   kingdom,	   consisting	   of	   an	  
extracellular,	   infectious	  elementary	  body	  (EB)	  and	  the	   intracellular,	  metabolically	  active	  
non-­‐infectious	   reticulate	   body	   (RB),	   which	   replicates	   within	   a	   host-­‐derived	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parasitophorous	  vacuole	   termed	  "inclusion"	   [3].	  Members	  of	   the	   family	  Chlamydiaceae	  
are	  well-­‐described	  eukaryotic	  pathogens:	  These	  include	  the	  human	  pathogen	  Chlamydia	  
trachomatis	  [4],	  the	  zoonotic	  pathogen	  Chlamydia	  psittaci	  [5],	  and	  respiratory	  pathogen	  
Chlamydia	  pneumoniae	  [6,	  7].	  	  	  
	  
C.	  pneumoniae	  was	  first	   identified	  as	  the	  cause	  of	  two	  human	  pneumonia	  epidemics	   in	  
1985,	   and	   later	   associated	   with	   a	   range	   of	   chronic	   diseases	   such	   as	   asthma,	  
cardiovascular	  disease,	  arthritis	  and	  Alzheimer's	  disease	  (reviewed	  in	  [8]).	  The	  first	  report	  
of	  C.	  pneumoniae	   infection	   in	  a	  non-­‐human	  host	  came	  with	   its	   isolation	  from	  horses	   in	  
1993	   [9],	  and	   it	  was	  subsequently	   identified	  as	  one	  of	   two	  chlamydial	   species	   infecting	  
koalas	   in	   1994	   [10].	   Subsequently,	   C.	   pneumoniae	   has	   been	   identified	   worldwide	   in	   a	  
wide	   range	  of	   cold	  and	  warm-­‐blooded	  animals,	  making	   it	   the	  most	  cosmopolitan	  of	  all	  
chlamydial	  species	  [9,	  11-­‐13].	  	  
	  
The	  Chlamydiaceae	  are	  characterized	  by	  their	  compact,	  highly	  conserved	  genomes,	  and	  
in	  spite	  of	  the	  wide	  range	  of	  hosts	  and	  diseases	  caused,	  all	  members	  of	  this	  phylum	  share	  
a	  highly	   conserved	  core	  genome	  of	  over	  500	  genes,	  equating	   to	  half	   the	  gene	   set	  of	  a	  
member	  of	   the	  Chlamydiaceae	   [3].	   Species	   and	   strain-­‐specific	   differences	   amongst	   the	  
Chlamydiaceae	   consist	   of	   nucleotide	   differences	   in	   various	   metabolic	   genes	   including	  
tryptophan	   [14]	   and	   purine	   [15]	   biosynthesis	   pathways	   and	   potential	   virulence	   factors	  
such	  as	  polymorphic	  membrane	  protein	   families	   [16,	  17],	   inclusion	  membrane	  proteins	  	  
[18-­‐22],	   type	   three	   secretion	   effectors	   [23-­‐25]	   as	   well	   as	   functionally	   uncharacterized	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hypothetical	   proteins,	   commonly	   located	   within	   a	   distinct	   genetic	   region	   termed	   the	  
plasticity	  zone.	  
	  
Human	  strains	  of	  C.	  pneumoniae	  have	  been	  described	  as	  highly	  conserved	  in	  both	  their	  
gene	  and	  nucleotide	  content	  [26],	  with	  only	  around	  300	  single	  nucleotide	  polymorphisms	  
(SNPs)	   identified	   that	   separate	   the	   four	  human	  C.	   pneumoniae	   respiratory	   strains	  with	  
whole	   genome	   sequences	   available	   to	   date	   [27].	   The	   genomes	   of	   koala	   [27]	   and	  
bandicoot	   [28]	  C.	   pneumoniae	   were	   recently	   sequenced	   revealing	   that	  C.	   pneumoniae	  
strains	  between	  humans	  and	  animals	  are	  much	  more	  variable	  -­‐	  although	  it	  is	  interesting	  
to	  note	  that	  like	  the	  human	  strains,	  the	  animal	  strains	  are	  themselves	  virtually	  identical.	  	  
	  
Whilst	   there	   are	   limited	   genetic	   differences	   reported	   between	   human	   C.	   pneumoniae	  
strains,	   there	  have	  nevertheless	  been	  several	  attempts	   to	  correlate	  genetic	  differences	  
to	   tropism	  for	  particular	   tissues.	  One	  such	  difference	  between	  human	  strains	  has	  been	  
attributed	  to	  the	  tyrosine	  permease	  (tyrP)	  copy	  number;	  strains	  with	  a	  single	  copy	  of	  this	  
gene	   have	   been	   suggested	   to	   be	   associated	   with	   vascular	   tropism	   [29].	   The	   other	  
“major”	  genetic	  differences	  observed	  to	  date	  between	  respiratory	  C.	  pneumoniae	  strains	  
are	   mostly	   limited	   to	   genes	   encoding	   (i)	   the	   polymorphic	   membrane	   proteins	   (pmp),	  
outer	  membrane	  proteins	  [30]	  [31];	  and	  (ii)	  the	  inclusion	  membrane	  protein	  family	  (inc)	  
[22].	   Sequences	   encoding	   the	   pmp	   genes	   in	   C.	   pneumoniae	  makes	   up	   to	   22	   %	   of	   the	  
difference	   in	   extra	   coding	   capacity	   when	   comparing	   human	   C.	   pneumoniae	   and	   C.	  
trachomatis	   [15].	   In	   comparing	   pmps	   across	   human	   C.	   pneumoniae	   strains,	   distinct	  
differences	  have	  been	  noted	  at	  both	   the	  nucleotide	   [17,	  32]	  and	  gene	  expression	   level	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[33-­‐35].	   The	   incA	   family	   is	   also	   considerably	   expanded	   in	  C.	   pneumoniae	   compared	   to	  
other	  members	   of	   the	  Chlamydiae,	  with	   over	   one	   hundred	   characterised	   and	   putative	  
incs	   identified	   in	   human	   C.	   pneumoniae	   strains	   [18,	   19,	   21].	   However,	   the	   ability	   to	  
correlate	   any	   of	   these	   genetic	   changes	   to	   potential	   phenotypes	   has	   been	   otherwise	  
limited	   due	   to	   the	   lack	   of	   genome	   sequences	   for	  C.	   pneumoniae	   strains	   isolated	   from	  
other	  human	  tissues.	  	  
	  
In	   this	   study,	   we	   determined	   the	   whole	   genome	   sequences	   for	   two	   C.	   pneumoniae	  
strains	   of	   non-­‐respiratory	   origin	   (A03	   and	   TOR-­‐1)	   [36,	   37],	   and	   compared	   them	   to	  
previously	  sequenced	  C.	  pneumoniae	  strains,	  thereby	  providing	  a	  broader	  insight	  into	  the	  
genetic	  diversity	  of	  strains	  isolated	  from	  different	  human	  tissues.	  	  	  
	  
MATERIALS	  AND	  METHODS	  
	  
Description	  of	  Chlamydia	  pneumoniae	  strains,	  cell	  culturing	  and	  DNA	  purification	  
Two	   previously	   described	   C.	   pneumoniae	   strains	   isolated	   from	   either	   human	   heart	   (C.	  
pneumoniae	   A03	   [36])	   or	   brain	   tissue	   (C.	   pneumoniae	   TOR-­‐1	   [37])	   were	   used	   for	  
comparative	  genomics	  analysis.	  The	  human	  C.	  pneumoniae	  A03	  cardiovascular	  strain	  was	  
obtained	   from	   the	   American	   Type	   Culture	   Collection	   (ATCC®	   VR-­‐1452).	   This	   strain	  was	  
originally	  isolated	  from	  the	  coronary	  artery	  of	  a	  patient	  undergoing	  heart	  transplantation	  
in	  1995	  [36].	  C.	  pneumoniae	  strain	  TOR-­‐1	  was	  originally	  isolated	  from	  post-­‐mortem	  brain	  
tissue	  of	  an	  Alzheimer’s	  disease	  patient	  in	  2003	  [37].	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Isolate	   A03	  was	   propagated	   on	  HEp-­‐2	   cells	   in	   T75	   flasks	   for	   five	   passages,	   based	   on	   a	  
previously	  described	  method	  [38].	   Infected	  cells	  were	  pooled	  and	  semi-­‐purified	  using	  a	  
probe	   sonication	   and	   centrifugation	   method	   prior	   to	   passage.	   The	   final	   semi-­‐purified	  
product	  was	   stored	   in	   an	   equal	   volume	  of	   SPG	  media	   [39].	   100µl	   of	   this	   semi-­‐purified	  
material	  was	  used	  for	  DNA	  extraction.	  100µl	  of	  ultra-­‐purified	  TOR-­‐1	  culture	  material	  was	  
used	  for	  DNA	  extraction,	   its	   isolation	  and	  propagation	  has	  been	  previously	  described	  in	  
Dreses-­‐Werringloer	  et	  al.	  [37].	  	  
	  
DNA	  extraction	  for	  both	  samples	  was	  performed	  using	  the	  QIAGEN	  PureGene	  kit,	  as	  per	  
the	   manufacturer’s	   instructions,	   with	   final	   hydration	   of	   the	   DNA	   pellet	   into	   50µl	   of	  
hydration	   buffer.	   500ng	   of	   extracted	   DNA	  was	   used	   to	   perform	   pan-­‐Chlamydiales	   16S	  
rRNA	   [40]	   and	   C.	   pneumoniae	   specific	   rpoB	   [41]	   PCR	   to	   confirm	   the	   presence	   of	   C.	  
pneumoniae	  DNA,	  and	  500ng	  of	  stock	  DNA	  was	  electrophoresed	  on	  a	  0.8%	  TBE	  agarose	  
gel	   to	  confirm	  high	  molecular	  weight	  DNA.	  Each	  extraction	  yielded	  greater	   than	  2µg	  of	  
high	  molecular	  weight	  genomic	  DNA,	  which	  was	  used	  for	  sequence	  capture	  and	  Illumina	  
whole	  genome	  sequencing	  at	  the	  Institute	  for	  Genome	  Sciences,	  Baltimore,	  Maryland.	  
	  
Sequence	  capture,	  whole	  genome	  sequencing	  and	  assembly	  
Sequence	   capture	   was	   performed	   on	   total	   DNA	   extracted	   from	   A03	   and	   TOR-­‐1	   with	  
Agilent	   probes	   designed	   to	   C.	   pneumoniae	   reference	   strain	   AR39,	   using	   a	   DNA	  
hybridisation	   capture	  and	  amplification	  process	  based	  on	   the	  methods	  of	  Gnirke	  et	  al.	  
that	  has	  been	  recently	  adapted	  for	  Chlamydia	  [42-­‐44].	  Captured	  and	  amplified	  products	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were	   sequenced	   using	   the	   Illumina	   HiSeq	   2500	   platform,	   resulting	   in	   paired-­‐end	   100	  
base-­‐pair	   reads.	  Read	  quality	  analyses	  were	  performed	  using	  FastQC	  0.10.1	   (Babraham	  
Bioinformatics	   group	   [http://www.bioinformatics.bbsrc.ac.uk/projects/fastqc])	   to	  
determine	  read	  quality	  cut-­‐offs.	  De	  novo	  assembly	  and	  readmapping	  of	  paired-­‐end	  data	  
from	  A03	   and	   TOR-­‐1	  was	   performed	   using	   CLC	   genomics	  workbench	   (CLC	   -­‐	   Denmark),	  
after	   trimming	   for	  size	  and	  quality.	  Contig	  sequences	  were	  mapped	  to	   reference	  strain	  
AR39	  using	   the	  CONTIGuator	  web	   server	   [45],	   and	   stop	   gap	   spacers	  manually	   inserted	  
before	   concatenation	   in	   Geneious	   6.18	   [46].	   Concatenated	   genome	   sequences	   were	  
annotated	  using	  the	  RAST	  pipeline	  [47]	  and	  manually	  curated	  using	  ARTEMIS	  [48].	  	  	  
	  
The	  A03	  and	  TOR-­‐1	  whole	  genome	  sequencing	  projects	  can	  be	  found	  on	  National	  Center	  
for	  Biotechnology	  Information	  (NCBI)	  BioProject	  under	  accession	  numbers	  PRJNA239383	  
and	   PRJNA239384	   with	   reads	   deposited	   in	   the	   Short	   Reads	   Archive	   under	   accession	  
numbers	  SRR1954962	  and	  SRR1954966	  respectively.	  
	  
Whole	  genome	  comparative	  analyses	  and	  phylogeny	  
Consensus	   sequences	   for	  A03	  and	  TOR-­‐1	  extracted	   from	  readmapped	  assemblies	  were	  
aligned	   to	   the	   existing	   human	   C.	   pneumoniae	   whole	   genome	   sequences	   of	   AR39,	  
CWL029,	   J138	   and	   TW183	   [15,	   26,	   49,	   50]	   in	   Geneious	   using	   the	   MAFFT	   plugin	  
implementation	  [51].	  Coverage	  analyses	  for	  readmapped	  sequences	  and	  manual	  curation	  
of	  annotated	  genomes	  was	  performed	  using	  ARTEMIS	  [48].	  Coding	  sequences	  identified	  
as	  polymorphic	  in	  A03	  or	  TOR-­‐1	  were	  translated	  and	  functional	  changes	  were	  predicted	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following	   analysis	   of	   encoded	   sequences	   using	   Simple	  Modular	   Architecture	   Research	  
Tool	  (SMART)	  [52].	  	  
	  
Bayesian	   phylogenetic	   analyses	   were	   performed	   on	   C.	   pneumoniae	   whole	   genome	  
alignments,	   with	   the	   LPCoLN	   koala	   C.	   pneumoniae	   strain	   [27]	   included	   as	   an	   outlier.	  
Whole	   genome	   alignments	  were	   also	   filtered	   for	   poorly	   aligned	   and	   gap	   regions	   using	  
Gblocks	   0.91b	   [53].	  Mid-­‐point	   rooted	   trees	  were	   constructed	  with	   the	  MrBayes	   plugin	  
[54]	  in	  Geneious,	  utilising	  a	  Jukes-­‐Cantor	  substitution	  model	  with	  with	  four	  Markov	  Chain	  
Monte	  Carlo	  (MCMC)	  chains	  and	  1.1	  million	  cycles,	  sampled	  every	  1000	  generations	  and	  
the	  first	  10,000	  trees	  discarded	  as	  burn-­‐in.	  Estimates	  of	  strain	  evolution	  over	  time	  were	  
performed	  on	  whole	  genome	  alignments	  using	  the	  BEAST	  package	  [55].	  Respiratory	  and	  
non-­‐respiratory	   isolates	   were	   defined	   in	   separate	   taxon	   sets	   and	   a	   GTR	   nucleotide	  
substitution	  model	  was	  employed.	  Tip	  dates	  and	  taxon	  designations	  are	  outlined	  in	  Table	  
1.	  MRCA	  priors	  were	  set	  at	  a	  normal	  distribution	  with	  a	  mean	  of	  95.2	  +/-­‐	  7.4	  given	  the	  
estimates	  of	  the	  last	  common	  ancestor	  of	  C.	  pneumoniae	  and	  its	  transmission	  to	  humans	  
at	   150,000	   years	   [56].	  MCMC	  chain	   length	  was	   set	   to	   5x107to	   ensure	  effective	   sample	  
sizes	   were	   sufficient	   for	   strong	   posterior	   distribution	   statistics.	   ClonalFrame	   [57]	   was	  
used	   to	  determine	  homologous	   recombination	  within	  human	  C.	  pneumoniae	   genomes,	  
and	   progressive	   MAUVE	   [58]	   was	   used	   to	   generate	   the	   input	   alignments.	   Three	  
successive	  runs	  of	  ClonalFrame	  were	  performed	  on	  the	  whole	  genome	  alignment,	  with	  
20,000	  iterations	  and	  10,000	  of	  these	  discarded	  as	  burn-­‐in.	  The	  three	  runs	  were	  checked	  
for	  convergence	  and	  their	  trees	  combined	  for	  analysis.	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Table	  1.	  Tip	  dates	  and	  taxon	  designations	  for	  C.	  pneumoniae	  strains	  used	  in	  BEAST	  analyses	  
	  
Strain	   Tip	  
Date	  
Taxon	   Reference	  
A03	  	   1995	   Non-­‐respiratory	   [36]	  
AR39	   1983	   Respiratory	   [49]	  
CWL029	   1987	   Respiratory	   [15]	  
J138	   1994	   Respiratory	   [26]	  
TOR-­‐1	   2003	   Non-­‐respiratory	   [37]	  
TW183	   1965	   Non-­‐respiratory	   [50]	  
	  
The	   GenBank	   accession	   numbers	   for	   the	   following	   C.	   pneumoniae	   whole	   genome	  
sequences	  were	  used	  in	  the	  comparative	  analyses	  and	  phylogenies:	  AR39	  (NC_002179.2),	  
CWL029	   (NC_000922.1),	   TW183	   (NC_005043.1),	   J138	   (NC_002491.1),	   LPCoLN	  
(NC_017285.1),	  A03	  (SRR1954962)	  and	  TOR-­‐1	  (SRR1954966)	  
	  
RESULTS	  
Genome	  assembly	  of	  C.	  pneumoniae	  strains	  A03	  and	  TOR-­‐1	  	  
We	  obtained	  whole	  genome	  sequences	  for	  two	  human	  C.	  pneumoniae	  strains	  (A03	  and	  
TOR-­‐1)	   and	   used	   de	   novo	   and	   readmapping	   assemblies	   for	   these	   strains	   to	   perform	  
genome	  wide	  comparative	  analyses.	  Sequence	  capture	  of	  C.	  pneumoniae-­‐specific	   reads	  
was	   performed	   using	   probes	   designed	   to	   the	   C.	   pneumoniae	   AR39	   strain,	   yielding	  
approximately	  90%	  or	   greater	  mapping	  of	   single	  end	   chlamydial	   reads	   from	  single	   raw	  
reads.	  De	  novo	  assembly	  of	  paired-­‐end	  data	  from	  A03	  and	  TOR-­‐1	  was	  performed	  using	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CLC	   genomics	  workbench	   (CLC	   -­‐	   Denmark),	   after	   trimming	   for	   quality	   (excluding	   reads	  
less	  than	  Q20)	  and	  size	  (excluding	  reads	  less	  than	  100bp).	  	  	  
	  	  
The	  CONTIGuator	  web	  server	   [45]	  was	  used	   to	  map	  contig	   sequences,	  using	  AR39	  as	  a	  
reference.	   De	   novo	   assemblies	   resulted	   in	   two	   (TOR-­‐1)	   or	   three	   (A03)	   contigs	   which	  
mapped	   to	  AR39;	  with	  a	   single	  contig	  exceeding	  1Mbp	   for	  each	  strain,	   total	   lengths	  of	  
1,225,511bp	   and	   1,222,742bp	   respectively,	   and	   average	   coverage	   for	   each	   mapped	  
contig	   exceeding	   4500x.	   Unmapped	   contigs	   were	   considerably	   shorter	   than	   mapped	  
contigs	  (average	  length	  350bp)	  with	  much	  lower	  coverage	  (average	  coverage	  11.77).	  The	  
majority	  of	  BLAST	  hits	  returned	  for	  unmapped	  contig	  sequences	  were	  for	  Homo	  sapiens,	  
as	  expected	  for	  Chlamydiae	  propagated	  in	  human	  cell	  lines.	  
	  
Using	  respiratory	  strain	  AR39	  as	  a	  reference,	  pairwise	  identities	  for	  AR39,	  A03	  and	  TOR-­‐1	  
were	   calculated	   from	   de	   novo	   assemblies	   using	   MAFFT.	   This	   analysis	   revealed	   99.3%	  
sequence	   similarity	   between	   A03	   and	   the	   AR39,	   accounting	   for	   406	   SNPs	   observed	  
between	  these	  strains.	  TOR-­‐1	  was	  also	  similar,	  sharing	  99.6%	  sequence	  similarity	  to	  the	  
AR39	  strain,	  and	  109	  SNPs.	  Pairwise	  comparisons	  between	  the	  TOR-­‐1	  brain	   isolate	  and	  
the	  A03	   cardiac	   tissue	   isolate	   themselves	   revealed	  99.3%	   sequence	   similarity	  with	  429	  
SNPs	   observed.	   It	   should	   be	   noted	   that	   the	   complete	   AR39	   genome	   published	   in	  
GenBank	  contains	  60	  degenerate	  nucleotides.	  
	  	  
The	  RAST	  annotation	  pipeline	  was	  used	   to	  predict	   coding	   regions	   and	   regulatory	   rRNA	  
loci	  for	  the	  A03	  and	  TOR-­‐1	  de	  novo	  assemblies.	  A03	  was	  predicted	  to	  encode	  1156	  open	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reading	   frames	   (CDS),	   whilst	   TOR-­‐1	   encoded	   an	   additional	   three	   CDS,	   with	   1159	   CDS	  
predicted.	  The	  number	  of	  CDS	  is	  comparable	  to	  that	  of	  the	  AR39	  genome,	  which	  contains	  
1167	  CDS	  in	  total.	  Each	  isolate	  encoded	  38	  tRNAs	  and	  3	  rRNAs,	  which	  were	  in	   identical	  
positions	  to	  those	  of	  AR39.	  	  
	  
Differential	  phylogenetic	  groupings	  of	  C.	  pneumoniae	  A03	  and	  TOR-­‐1	  
We	  used	   the	  whole	  genome	  sequences	  of	   six	  human	  C.	  pneumoniae	   isolates,	   including	  
our	  newly	  sequenced	  A03	  and	  TOR-­‐1	  strains	  to	  construct	  Bayesian	  phylogenies	  based	  on	  
whole	   genome	  alignments.	  Gblocks	   0.91b	  was	   used	   to	   filter	   the	  C.	   pneumoniae	  whole	  
genome	  alignment	  for	  gaps,	  poorly	  aligned	  regions	  and	  discontiguous	  blocks,	  resulting	  in	  
an	   alignment	   of	   total	   length	   of	   1,183,789bp,	   with	   99.6%	   pairwise	   identity	   and	   98.7%	  
identical	  sites	  over	  557	  blocks.	  A	  Bayesian	  phylogenetic	  tree	  was	  constructed	  from	  whole	  
genome	  alignments	  using	  a	  Jukes-­‐Cantor	  nucleotide	  substitution	  model,	  as	  implemented	  
in	  the	  MrBayes	  plugin	  in	  Geneious.	  The	  posterior	  output	  phylogeny	  is	  depicted	  in	  Figure	  
1.	   Interestingly,	  C.	   pneumoniae	   A03	   and	  TW183	  appear	   to	   form	  a	  well	   supported	   sub-­‐
group	   branching	   off	   from	   the	   respiratory	   strain,	  C.	   pneumoniae	   CWL029,	   and	   forms	   a	  
separate	  clade	  away	   from	  the	  other	  C.	  pneumoniae	  strains.	  Within	   the	  main	  human	  C.	  
pneumoniae	  grouping,	  strains	  AR39	  and	  TOR-­‐1	  also	  appear	  to	  be	  closely	  related,	  forming	  
a	  sub-­‐group	  away	  from	  strain	  J183.	   In	  defining	  the	  distances	  between	  strains	  using	  the	  
number	  of	  inter-­‐strain	  nucleotide	  differences,	  we	  find	  that	  A03	  and	  TW183	  differ	  by	  only	  
18	  nucleotides,	  whilst	   the	   largest	  number	  of	  nucleotide	  differences	   in	  human	  strains	   is	  
between	  A03	  and	   J138	  with	  620	  non-­‐identical	   residues,	  with	  279	  nsSNPs	   in	  346	  genes	  
and	  127	  SNPs	  in	  intergenic	  regions.	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Figure	   1.	   	   Phylogenetic	   distances	   of	   human	   and	   animal	   C.	   pneumoniae	   strains.	   Whole	   genome	  
phylogenies	  computed	  in	  MrBayes	  using	  a	  Jukes-­‐Cantor	  substitution	  model.	  Posterior	  probabilities	  >	  0.90	  
are	  displayed	  on	  each	  node	  
	  
	  
In	  order	  to	  estimate	  the	  rate	  of	  evolution	  across	  human	  C.	  pneumoniae,	  and	  detect	  the	  
presence	   of	   homologous	   recombination	   within	   human	   C.	   pneumoniae,	   we	   performed	  
BEAST	  and	  ClonalFrame	  analyses	  on	  whole	  genome	  alignments	  of	  human	  C.	  pneumoniae	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strains.	   As	   for	   our	  MrBayes	   analysis,	   the	   phylogenetic	   trees	   constructed	   in	   BEAST	   and	  
ClonalFrame	  demonstrate	  highly	  supported	  A03/TW183	  and	  AR39/TOR-­‐1	  sub-­‐groupings,	  
however	  the	  inferred	  phylogenies	  of	  respiratory	  strains	  CWL029	  and	  J138	  differ,	   in	  that	  
CWL029	   groups	   with	   A03	   and	   TW183	   for	   both	   methods	   (Figure	   2	   A	   and	   B).	   BEAST	  
estimates	  a	  mean	  rate	  of	  1.7x10-­‐6	  substitutions	  per	  site	  per	  year,	  with	  a	  date	  for	  the	  most	  
recent	   common	   ancestor	   (MCRA)	   of	   727	  with	   a	   95%	   confidence	   interval	   between	   689	  
and	  765.	  MCRA	  of	  the	  respiratory	  taxon	  is	  estimated	  at	  1151	  +/-­‐	  20	  years.	  	  
ClonalFrame	  estimates	  a	  mean	  rate	  of	  1.3x10-­‐6	  substitutions	  per	  site	  per	  year,	  in	  general	  
agreement	  with	   the	   rate	  derived	   from	  BEAST,	  whilst	   estimates	  of	   the	  MRCA	  are	  1400.	  
Tests	   for	   the	  effect	  and	   frequency	  of	   recombination	  vs	  mutation	  were	  performed.	  The	  
probability	  that	  a	  site	  is	  altered	  through	  recombination	  vs	  mutation	  (r/m)	  is	  21.87	  with	  a	  
95%	   credibility	   interval	   between	  10.33	   and	  41.20,	  whilst	   the	   ratio	  of	   recombination	   vs	  
mutation	  (ρ/θ)	  is	  0.44	  with	  a	  confidence	  interval	  between	  0.26	  and	  0.64.	  These	  statistics	  
suggest	  that	  recombination	  has	  played	  a	  significant	  part	   in	  the	  diversification	  of	  human	  
C.	   pneumoniae,	   with	   approximately	   22	   nucleotides	   affected	   for	   every	   single	   mutation	  
event,	   however	   an	  equal	   ratio	  of	   recombination	  and	  mutation	  events	   appear	   to	   affect	  
the	  genome.	  	  
	  
Genome-­‐wide	   recombination	   events	   appear	   to	   be	   located	   within	   a	   few	   discrete	   loci	  
when	   strains	  A03/TW183	   and	   TOR-­‐1/AR39	   are	   compared	   (events	   above	  node	  A	   and	  B	  
respectively),	  whilst	  recombination	  events	  are	  more	  common	  when	  comparing	  the	  TOR-­‐
1/AR39	   sub-­‐group	   to	   the	  branch	   containing	   strains	  A03/TW183	  and	  CWL029	   shown	  at	  
node	  C	  (Figure	  2C).	  Mutation	  events	  appear	  to	  be	  closely	  correlated	  with	  recombination	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at	  node	  C,	  whilst	  mutations	  are	  noted	   in	   loci	  outside	   recombination	  areas	   for	  nodes	  A	  
and	   B.	   The	   large	   zone	   of	  mutation	   and	   recombination	   exhibited	   at	   node	   C	   appears	   to	  
span	  the	  genomic	  region	  flanking	  the	  plasticity	  zone,	  which	   is	  demonstrated	  to	  contain	  
several	  polymorphic	  hotspots	  and	  noted	  to	  contain	  members	  of	  the	  IncA	  and	  pmp	  family	  
genes,	  as	  well	  as	  the	  tyrosine	  permease	  (tyrP)	  duplication.	  	  
	  
	  
Figure	  2.	  BEAST	  and	  ClonalFrame	  analyses	  of	  human	  C.	  pneumoniae.	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a)	   and	   b)	   Phylogenetic	   constructions	   of	   human	   C.	   pneumoniae	   strains	   in	   BEAST	   and	   ClonalFrame	  
demonstrate	   identical	   arrangement,	   with	   strains	   A03	   and	   TW183	   forming	   a	   sub-­‐group	   off	   the	   CWL029	  
branch.	  Substitution	  rate	  outputs	  between	  the	  two	  programs	  are	  comparable.	  c)	  Heat	  map	  representation	  
of	  recombination	  and	  mutation	  events	  at	  nodes	  A,	  B	  and	  C	  from	  figure	  2b.	  Red	  denotes	  estimates	  of	  a	  high	  
posterior	  probability	  of	   recombination	  along	  positions	  of	   the	  genome	  denoted	  on	   the	  x-­‐axis.	  Green	  ticks	  
represent	  loci	  where	  nucleotide	  substitution	  as	  a	  result	  of	  mutation	  is	  the	  predominant	  diversifying	  mode.	  
	  
Description	  of	  genetically	  variable	  regions	  of	  C.	  pneumoniae	  genomes	  from	  respiratory,	  
brain	  and	  heart	  isolates.	  	  
While	  the	  overall	  level	  of	  sequence	  similarity	  between	  the	  sequenced	  isolates	  was	  high,	  
consistent	  with	  previous	  reports	  of	  C.	  pneumoniae	   isolates	  from	  respiratory	  tissues	  [26,	  
56],	   closer	   inspection	   of	   the	   newly	   sequenced	   C.	   pneumoniae	   strains	   A03	   and	   TOR-­‐1	  
revealed	   a	   number	   of	   potentially	   interesting	   areas	   of	   genetic	   variation	   between	   these	  
strains	  and	  those	  isolated	  from	  other	  human	  tissues.	  	  	  
	  
The	  most	  prominent	  difference	  between	  the	  C.	  pneumoniae	  A03	  genome	  sequence	  and	  
the	   respiratory	  C.	   pneumoniae	   AR39	   isolate	  was	   a	   2.5Kbp	  deletion	   in	   the	  A03	  genome	  
centred	   around	   a	   family	   of	   two	   hypothetical	   proteins	   (CP730	   and	   CP729)	   which	   are	  
predicted	   to	   be	  members	   of	   the	   IncA	   gene	   family	   through	   structural	   homology	   at	   the	  
amino	   acid	   level	   [19].	   Alignments	   of	   this	   region	   between	   all	   available	   C.	   pneumoniae	  
genome	  sequences	  reveals	   that	  A03	  appears	   to	  have	  no	  homologs	   for	   the	  AR39	  CP730	  
and	  CP729	  hypothetical	  protein	  genes,	  whilst	  TOR-­‐1	  does	  have	  homologs	  for	  both	  genes,	  
identical	   to	   those	   of	   AR39.	   Interestingly,	   the	   C.	   pneumoniae	   TW183	   genome,	   isolated	  
from	  the	  conjunctiva	   [56],	  also	  appears	   to	  share	  this	  exact	  deletion	  with	  A03,	  however	  
the	   genes	   adjacent	   to	   this	   deletion	   are	   otherwise	   virtually	   identical	   for	   all	   genome	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sequences	  examined	  (Figure	  3).	  A	  second	  putative	  IncA	  family	  gene,	  homologous	  to	  AR39	  
locus	  CP0769	  was	   found	  to	  contain	  a	  330bp	  deletion	   in	  A03	  and	  TOR-­‐1	   isolates	   (Figure	  
4A)	  and	   is	  predicted	  to	  remove	  one	  of	  the	  three	  predicted	  bi-­‐lobed	  hydrophobic	   (IncA)	  
domains	   identified	   in	   the	   sequence	   of	   AR39	   CP0769.	   The	   respiratory	   isolate	   J138	   also	  
contains	   this	   deletion	   (Figure	   4B).	   C.	   pneumoniae	   is	   the	   only	   chlamydial	   species	   to	  
contain	  inclusion	  proteins	  with	  multiple	  IncA	  domains.	  	  
	  
	  
Figure	  3.	  Deletion	  of	  IncA	  family	  genes	  in	  A03.	  A	  deletion	  of	  putative	  IncA	  family	  genes	  is	  evident	  in	  strain	  
A03.	   This	   deletion	   spans	   2.5kbp	   and	   is	   shared	   with	   strain	   TW183.	   All	   other	   human	   strains	   contain	   full	  
sequence	   at	   this	   locus	   (AR39	   locus	   CP0730	   and	   CP0729).	   	   Blue	   arrows	   designate	   gene	   locus	   tags,	   grey	  
blocks	   designate	   homologous	   genetic	   sequence,	   thin	   black	   horizontal	   lines	   represent	   missing	   genetic	  
sequence	  and	  short	  black	  lines	  within	  grey	  blocks	  represent	  SNPs.	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Figure	  4.	  A	  shared	  deletion	  of	  bi-­‐lobed	  hydrophobic	  domain	  in	  A03	  and	  TOR-­‐1.	  a)	  A	  deletion	  of	  330bp	  is	  
shared	  between	  strains	  A03	  and	  TOR-­‐1,	  at	  the	  5’	  end	  of	  a	  putative	  IncA	  family	  gene	  (CP0769).	  This	  deletion	  
is	  also	  found	  in	  strain	  J138.	  The	  darker	  blue	  block	  within	  the	  AR39	  locus	  represents	  additional	  nucleotide	  
sequence.	  The	  deletion	  removes	  one	  of	  three	  bi-­‐lobed	  hydrophobic	  domains	  in	  these	  strains.	  b)	  TMHMM	  
transmembrane	  predictions	   for	  strains	  A03	  and	  AR39	  depicting	   the	  difference	   in	   the	  number	  of	  bi-­‐lobed	  
hydrophobic	  domains.	  The	  coiled-­‐coil	  motifs	  remain	  conserved	  across	  all	  human	  strains.	  	  
	  
The	  second	  major	  difference	  between	  the	  brain	  and	  cardiac	  tissue	  isolates	  is	  at	  the	  tyrP	  
locus,	  previously	  linked	  to	  tissue	  tropism	  in	  C.	  pneumoniae	  [29].	  De	  novo	  assembly	  of	  our	  
A03	  and	  TOR-­‐1	   sequences	   indicate	   that	   these	   isolates	   carry	  a	   single	   copy	  of	   this	   gene.	  
This	  contrasts	  with	  previously	  published	  data	  from	  southern	  blot	  analysis	  indicating	  that	  
TOR-­‐1	   carries	   three	   copies	  of	   the	   tyrP	   gene	   [37].	   Coverage	  of	   the	  TOR-­‐1	   isolate	   at	   the	  
tyrP	   locus	  was	  more	  than	  double	  that	  of	  the	  average	  coverage	  level	  across	  the	  genome	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(>9000x	   coverage).	   In	   order	   to	   determine	   the	   number	   of	   copies	   of	   tyrP	   in	   the	   TOR-­‐1	  
isolate,	  reads	  were	  mapped	  to	  a	  5500bp	  region	  of	  the	  AR39	  genome	  encompassing	  the	  
tyrP	  duplication	  and	  flanking	  genes.	  The	  average	  read	  coverage	  across	  this	  fragment	  was	  
2500x,	  except	  at	  the	  locus	  spanning	  tyrP1	  (homologous	  to	  CP0889)	  where	  the	  coverage	  
was	  approximately	  4000x	  with	  spikes	  of	  >9000x	  coverage	  as	   shown	   in	   figure	  5a.	  These	  
findings	  suggest	  that	  isolate	  TOR-­‐1	  harbours	  three	  copies	  of	  the	  tyrP	  gene,	  two	  of	  which	  
are	   identical	   to	   AR39	   tyrP1	   (CP0889)	   and	   a	   single	   identical	   to	   that	   of	   tyrP2	   (CP0891).	  
Unfortunately	  the	  gene	  order	  of	  the	  three	  tyrP	  copies	  cannot	  be	  determined	  confidently	  
from	  this	   information.	   In	  comparing	  SNPs	  across	  the	  tyrP	   locus,	  we	  find	  that	  TOR-­‐1	  has	  
copies	  of	  tyrP	  identical	  to	  that	  of	  AR39	  tyrP1	  and	  tyrP2,	  whilst	  A03	  tyrP	  is	  identical	  to	  the	  
sequence	  of	  tyrP	  from	  TW183.	  Characterisation	  of	  SNPs	  at	  the	  tyrP	  locus	  for	  all	  human	  C.	  
pneumoniae	  strains	  is	  outlined	  in	  Figure	  5b.	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Figure	  5.	  Tyrosine	  permease	  gene	  comparisons.	  a)	  Readmapping	  of	  TOR-­‐1	  to	  AR39	  tyrP	  duplication	  locus.	  
Coverage	   spanning	   genes	   CP0889	   through	   CP0891	   is	   considerably	   higher	   than	   the	   average	   surrounding	  
coverage,	  confirming	  multiple	  copies	  of	  tyrP	  are	  present.	  Within	  this	  locus,	  TOR-­‐1	  reads	  map	  with	  greater	  
coverage	  to	  the	  CP0889	  homolog	  than	  the	  CP0891	  homolog,	  suggesting	  more	  than	  one	  copy	   identical	   to	  
CP0889.	  b)	  Comparison	  of	  SNPs	  at	  the	  tyrP	  locus	  in	  C.	  pneumoniae.	  A)	  C/T	  transitions	  are	  demonstrated	  at	  
three	  distinct	  loci	  in	  human	  C.	  pneumoniae	  strains,	  and	  a	  total	  of	  four	  tyrP	  haplotypes	  exist	  for	  human	  C.	  
pneumoniae.	  	  
	  
A	  comparison	  of	  the	  A03	  strain	  with	  the	  AR39	  strain	  also	  identified	  a	  deletion	  in	  CP0309,	  
an	  AR39	  gene	  that	  appears	  to	  be	  full-­‐length	  in	  the	  A03	  isolate.	  In	  AR39,	  CP0309	  is	  3831bp	  
in	  size	  and	  is	  predicted	  to	  encode	  PmpG,	  a	  member	  of	  the	  outer	  membrane	  protein	  and	  
autotransporter	  family	  [59].	  The	  A03	  homolog	  of	  this	  gene	  contains	  a	  393bp	  insertion	  at	  
position	  1268bp,	  the	  translation	  of	  which	  encodes	  for	  4x	  GGA(I,L,V)	  and	  3x	  FXXN	  amino	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acid	  repeats.	  SMART	  domain	  analyses	  of	  the	  full-­‐length	  A03	  homolog	  of	  CP0309	  suggest	  
that	   this	   region	   encodes	   two	   additional	   parallel	   beta	   helices	   and	   a	   single	  pmp	   domain	  
(Figure	  6).	  The	  variation	  is	  this	  gene	  has	  been	  previously	  described	  [60],	  and	  both	  TW183	  
and	  CWL029	  share	  genes	  of	  identical	  length	  to	  that	  of	  the	  A03	  homolog.	  	  
	  
	  
Figure	  6.	  Deletion	  of	  pmpG	  protein	  motifs	  in	  AR39	  and	  TOR-­‐1.	  	  a)	  A	  393bp	  deletion	  within	  the	  pmpG	  gene	  
is	  noted	  in	  strains	  AR39	  (CP0309)	  and	  TOR-­‐1.	  This	  393bp	  deletion	  is	  one	  of	  three	  amino	  acid	  repeat	  motifs	  
that	  make	  up	  the	  pmp	  domain,	  and	  is	  shared	  with	  strain	  J138.	  Strains	  A03	  and	  CWL029	  carry	  the	  full-­‐length	  
pmpG	   gene.	   The	   black	   block	   within	   the	   A03	   locus	   represents	   the	   additional	   nucleotide	   sequence.	   	   b)	  
Changes	  in	  domain	  organization	  as	  a	  result	  of	  the	  393bp	  deletion	  depicted	  in	  strains	  A03	  and	  AR39.	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SNPs	   appeared	   to	   be	   evenly	   scattered	   across	   the	   three	   genomes	   analysed,	   with	   no	  
apparent	   SNP	   hotspots	   except	   in	   a	   single	   region	   of	   TOR-­‐1,	   homologous	   to	   AR39	   gene	  
CP0543	  (Hypothetical	  protein	  gene).	  This	  polymorphism	  hotspot	  has	  17	  SNPs	  and	  a	  single	  
nucleotide	  deletion	  spanning	  a	  region	  334bp	   in	   length	  and	  covering	  the	  entirety	  of	   the	  
CP0543	  gene.	  This	  was	  also	  the	  largest	  number	  of	  SNPs	  demonstrated	  in	  any	  one	  gene	  in	  
our	  comparisons.	  Nucleotide	  BLAST	  returns	  significant	  hits	  for	  Chlamydiaphage	  CPAR39	  
for	  the	  5’	  end	  of	  this	  region.	  Interestingly,	  this	  locus	  is	  interrupted	  by	  920bp	  of	  additional	  
integrated	  Chlamydiaphage	  sequence	  in	  the	  koala	  and	  bandicoot	  strains	  (Figure	  7).	  The	  
largest	  number	  of	  SNPs	  in	  any	  single	  gene	  for	  A03	  was	  14	  SNPs	  in	  the	  region	  homologous	  
to	  a	  hypothetical	  protein	  CP0764,	  8	  of	  which	  are	  nsSNPs	  and	  13	  of	  which	  are	  clustered	  at	  
the	  3'	  end	  of	  the	  locus.	  	  Descriptions	  of	  SNPs	  for	  isolates	  A03	  and	  TOR-­‐1	  are	  expanded	  in	  
supplementary	  material	  (Supplementary	  S1	  and	  S2).	  
	  	  
	  
Figure	   7.	   A	   dense	   locus	   of	   SNPs	   is	   demonstrated	   in	   TOR-­‐1.	   Alzheimer’s	   disease	   isolate	   TOR-­‐1	  
demonstrates	  17	  SNPs	  and	  8	  substitutions	  within	  a	  locus	  homologous	  to	  CP0543	  -­‐	  a	  gene	  that	  is	  identical	  in	  
all	  other	  human	  C.	  pneumoniae	  strains.	  This	  locus	  contains	  a	  short	  region	  of	  homology	  at	  the	  5’	  end	  to	  ORF	  
CPA0007	  of	  the	  AR39	  Chlamydiaphage.	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DISCUSSION	  
C.	   pneumoniae	   has	   been	   primarily	   characterised	   as	   a	   respiratory	   pathogen	   [61]	   and	  
whilst	   its	   associations	   with	   cardiovascular	   and	   Alzheimer's	   disease	   have	   been	  
described[37,	   62-­‐65],	  whole	   genome	   sequences	   had	   not	   yet	   been	   obtained	   for	   strains	  
isolated	  from	  these	  pathologies.	  Previous	  studies	  suggested	  that	  C.	  pneumoniae	  human	  
isolates	   were	   highly	   conserved	   in	   nucleotide	   sequence	   [15,	   26,	   49],	   with	   PCR	   studies	  
linking	   genetic	   differences	   to	   different	   disease	   tropisms[29].	   In	   this	   study,	   we	   utilised	  
next	   generation	   sequencing	   technologies	   to	   obtain	   whole	   genome	   sequences	   for	   two	  
new	  strains	  isolated	  from	  a	  coronary	  atheroma	  (A03)	  [36]	  and	  post-­‐mortem	  Alzheimer's	  
brain	  tissue	  (TOR-­‐1)	  [37],	  and	  used	  a	  comparative	  genomics	  approach	  to	  characterise	  the	  
evolutionary	  and	  genetic	  differences	  between	   these	  new	  strains	  and	   those	  available	   in	  
GenBank.	  	  
	  
Bayesian	   phylogenetic	   analysis	   was	   performed	   on	   whole	   genome	   alignments	   of	   all	  
available	  C.	  pneumoniae	  strains	  including	  A03	  and	  TOR-­‐1,	  with	  the	  koala	  C.	  pneumoniae	  
strain	   LPCoLN	  designated	  as	   an	  outgroup.	   Posterior	  output	   analysis	   split	   the	  human	  C.	  
pneumoniae	   strains	   into	   two	  distinct	   clades	   consisting	   of	   A03	   plus	   TW183	   strains,	   and	  
respiratory	  strains	  plus	  TOR-­‐1.	  This	  suggests	  that	  the	  atherosclerosis	  isolate	  A03	  is	  more	  
closely	   related	   to	   strain	   TW-­‐183,	   an	   unusual	   non-­‐respiratory	   strain	   isolated	   from	   the	  
conjunctiva	  of	  a	  child	  in	  Taiwan	  during	  a	  trachoma	  study	  in	  1965	  [66],	  than	  to	  either	  the	  
three	  human	  respiratory	  strains	  or	   the	  single	  Alzheimer's	  disease	  C.	  pneumoniae	   strain	  
(TOR-­‐1).	  Likewise,	  the	  Alzheimer's	  disease	  isolate	  TOR-­‐1	  appears	  to	  be	  closely	  related	  to	  
the	   respiratory	   strain	   AR39.	   Irrespective	   of	   the	   potential	   groupings	   within	   human	   C.	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pneumoniae,	  the	  SNPs	  that	  we	  observed	  in	  isolates	  from	  cardiac	  and	  brain	  tissues	  were	  
similar	   to	   those	   in	   previously	   characterised	  C.	   pneumoniae	   strains.	   These	   observations	  
are	   made	   with	   some	   caution,	   however,	   since	   our	   non-­‐respiratory	   sequences	   were	  
obtained	   from	  single	   isolates	   collected	   from	  different	  patients.	  Hence,	  we	  cannot	   infer	  
that	  all	  cardiovascular	   isolates	  will	  have	   identical	  sequence	  or	  growth	  characteristics	   to	  
that	  of	  A03	  for	  example.	  	  	  
	  
Additionally,	   C.	   pneumoniae	   A03	   and	   TOR-­‐1	   having	   such	   similar	   genetic	   sequence	   to	  
previously	   characterised	   human	   C.	   pneumoniae	   strains,	   raises	   the	   question	   of	  
contamination	  during	   chlamydial	   culture.	   In	   the	   case	  of	  TOR-­‐1,	   the	  DNA	  was	  extracted	  
from	  an	  original	  culture	  [37]	  without	  further	  passage	  in	  our	  laboratory.	  Bacterial	  culture	  
was	   obtained	   from	   the	   ATCC	   for	   strain	   A03,	   passaged	   and	   semi-­‐purified	   within	   our	  
laboratory,	   however	   strain	   TW-­‐183,	   to	   which	   it	   is	   most	   genetically	   similar,	   has	   never	  
been	  grown	  in	  our	  laboratory.	  With	  this	  in	  mind,	  it	  is	  highly	  unlikely	  that	  strains	  A03	  and	  
TOR-­‐1	   could	   have	   been	   contaminated	   with	   other	   C.	   pneumoniae	   strains	   prior	   to	  
sequencing.	  	  
	  
In	   order	   to	   determine	   the	   sequence	   diversification	   of	   human	   C.	   pneumoniae,	   we	  
performed	   BEAST	   [55]	   and	   ClonalFrame	   [57]	   analyses	   to	   characterise	   evolutionary	  
changes	   over	   time	   and	   the	   presence	   and	   effect	   of	   homologous	   recombination.	   Both	  
BEAST	  and	  ClonalFrame	  phylogenetic	  outputs	  placed	   the	  A03/TW183	   sub-­‐group	  within	  
the	   CWL029	   branch,	   whereas	   MrBayes	   analyses	   had	   the	   A03/TW183	   completely	  
separate	  from	  human	  respiratory	  strains.	  There	  was	  general	  agreement	  with	  the	  rate	  of	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substitutions	  per	  site	  per	  year	  between	  the	  two	  programs,	  however	  the	  MRCA	  for	  each	  
program	   predicted	   slightly	   different	   divergence	   times	   (727	   for	   BEAST	   and	   1400	   for	  
ClonalFrame).	  The	  difference	  in	  estimated	  divergence	  times	  between	  the	  two	  programs	  
is	  accounted	   for	  by	   their	  estimation	  methods:	  ClonalFrame	  calculates	   the	  MRCA	  based	  
on	  mutation	  events	  after	  detection	  of	  recombination,	  whilst	  BEAST	  calculations	  take	  into	  
account	  all	  diversity	  events,	  caused	  by	  both	  mutation	  and	  recombination,	  as	  well	  as	  an	  
estimated	  substitution	  rate	  and	  tip	  dates	  [67].	  The	  rate	  of	  substitution	  is	  significantly	  less	  
than	  that	  reported	  for	  another	  chlamydial	  species,	  Chlamydia	  psittaci	  which	  has	  a	  much	  
higher	  mutation	  rate	  estimated	  at	  1.682x10-­‐4	  or	  1.74x10-­‐5	  mutations	  per	  site	  per	  year	  by	  
BEAST	   and	   ClonalFrame	   analyses	   respectively	   [67].	   In	   regards	   to	   the	   difference	   in	  
substitution	  rates	  for	  these	  two	  chlamydial	  species,	  two	  mechanisms	  may	  be	  responsible	  
for	  the	  lower	  substitution	  rate	  in	  C.	  pneumoniae:	  a)	  it	  has	  a	  lower	  substitution	  rate	  as	  a	  
result	   of	   its	   relatively	   recent	   expansion	   into	   the	   human	   host	   [27,	   60],	   having	   had	   less	  
time	  to	  evolve	  major	  changes	  to	  its	  sequence	  and	  b)	  C.	  pneumoniae	  is	  a	  considerably	  less	  
virulent	  organism	  than	  C.	  psittaci	   [68,	  69]	  and	  as	  such	   is	  not	  subject	   to	  the	  heightened	  
level	   of	   host	   immune	   response	   and	   consequent	   selective	   pressure.	   The	   difference	   in	  
substitution	  rates	  between	  these	  two	  chlamydial	   species	  may	  also	  be	  attributed	  to	   the	  
experimental	  limitations	  and	  design	  of	  this	  study:	  Our	  study	  examines	  six	  strains	  isolated	  
from	   separate	   human	   hosts,	   whereas	   the	   C.	   psittaci	   study	   examines	   twenty	   strains	  
isolated	  from	  a	  variety	  of	  avian	  and	  mammalian	  hosts	  [67].	  	  
	  
Genome-­‐wide	   homologous	   recombination	   appears	   to	   play	   a	   part	   in	   the	   evolution	   of	  
human	   C.	   pneumoniae,	   with	   an	   estimate	   of	   22	   nucleotides	   affected	   at	   each	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recombination	   event	   and	   an	   almost	   equal	   ratio	   of	   recombination	   to	   mutation	   events	  
influencing	  sequence	  diversity.	  Previous	  studies	  examining	  homologous	  recombination	  in	  
C.	  trachomatis	  and	  C.	  psittaci	  suggest	  that	  whilst	  recombination	  frequency	  in	  Chlamydiae	  
is	  low	  compared	  to	  other	  bacterial	  species	  [67,	  70,	  71],	  recombination	  events	  still	  appear	  
to	  be	  a	  common	  and	  effective	  evolutionary	  driver	  of	  sequence	  diversity.	  Recombination	  
events	   in	  C.	   trachomatis	  have	  been	   reported	   to	  affect	  an	  average	  of	  357bp	   [71]	  whilst	  
the	  average	  segment	  length	  affected	  by	  recombination	  in	  C.	  psittaci	  is	  over	  1000bp	  [67].	  
When	  comparing	  the	  ratio	  of	  the	  frequency	  of	  recombination	  vs	  mutation	  (ρ/θ)	  in	  other	  
chlamydial	   species,	   we	   find	   that	   mutation	   is	   a	   more	   prominent	   driver	   of	   diversity:	  
estimates	  of	  ρ/θ	  in	  C.	  trachomatis	  range	  from	  0.10	  to	  0.23	  [71]	  whilst	  ρ/θ	  	  in	  C.	  psittaci	  
ranges	   from	   0.054	   to	   0.065,	   suggesting	   that	   mutation	   occurs	   twenty	   times	   more	  
frequently	   in	  C.	  psittaci	  compared	  to	  recombination	  [67].	  The	  average	  ρ/θ	  of	  0.44	   in	  C.	  
pneumoniae	  suggests	  an	  equal	  effect	  of	  mutation	  and	  recombination	  in	  the	  evolution	  of	  
the	  C.	   pneumoniae	   genome	   -­‐	   presumably,	   this	   rate	   is	   higher	   than	  C.	   trachomatis	   or	  C.	  
psittaci	   given	   the	   mechanism	   of	   transmission	   in	   C.	   pneumoniae,	   where	   airborne	  
transmission	   facilitates	   co-­‐infection	   with	   multiple	   strains,	   potentially	   allowing	   for	  
fusogenic	  contact	  between	  inclusions	  and	  increasing	  the	  probability	  of	  recombination.	  As	  
with	  other	  members	  of	  the	  Chlamydiaceae,	  C.	  pneumoniae	  genomes	  encode	  for	  proteins	  
involved	   with	   DNA	   repair	   [72,	   73],	   which	   theoretically	   provide	   a	   mechanism	   for	  
intragenic	   recombination.	   Recombination	   across	   the	   C.	   pneumoniae	   pan-­‐genome	  
appears	  to	  centre	  around	  the	  plasticity	  zone	  and	  flanking	  regions	  (between	  base	  pairs	  6	  
to	  9	  x105	  as	  depicted	  in	  Figure	  2C),	  which	  includes	  several	  gene	  families	  demonstrated	  to	  
have	   polymorphisms,	   duplications	   and	   numerous	   homologs	   in	   both	   this	   and	   previous	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studies,	  including	  the	  pmp	  gene	  family,	  the	  incA	  gene	  family	  and	  the	  tyrP	  duplication.	  It	  is	  
not	   surprising	   that	   the	  highest	   level	  of	   recombination	   in	  human	  C.	   pneumoniae	   strains	  
occurs	   at	   this	   locus:	   both	  pmp	   and	   incA	  gene	   families	   are	   considerably	  expanded	   in	  C.	  
pneumoniae	  [17,	  18],	  and	  are	  identified	  as	  potential	  virulence	  factors	  comprising	  surface	  
expressed	   proteins	   which	   interact	   with	   the	   host	   cell,	   driving	   sequence	   diversity	   and	  
antigenic	  shift	  within	  these	  genes	  in	  order	  to	  subvert	  the	  host	  immune	  response	  [31,	  74].	  	  
	  
Upon	   fine	   detailed	   comparative	   analysis	   of	   C.	   pneumoniae	  A03	   and	   TOR-­‐1	   to	   existing	  
human	   C.	   pneumoniae	   genomes,	   several	   loci	   of	   gene	   loss	   and	   sequence	   decay	   were	  
evident	   including	   (i)	   IncA-­‐like	   proteins;	   (ii)	   tyrP;	   and	   (iii)	   pmpG.	  Many	   of	   the	   genes	   at	  
these	   loci	   were	   associated	   with	   potential	   virulence	   mechanisms,	   and	   the	   genetic	  
differences	   between	   respiratory	   and	   cardiovascular	   strains	   at	   these	   loci	   appeared	   to	  
have	   an	   effect	   on	   the	   domain	   architecture	   of	   their	   predicted	   proteins,	  without	   loss	   of	  
functionality	   or	   a	   decrease	   in	   overall	   fitness	   to	   the	   infecting	   isolate.	   These	   genetic	  
differences	   are	   particularly	   interesting	   given	   the	   biological	   and	   developmental	  
differences	   exhibited	   by	   respiratory	   strain	   AR39	   and	   cardiovascular	   strain	   A03	   in	   cell	  
culture	   experiments	   [75].	   These	   loci	   with	   gene	   loss	   and	   sequence	   decay	   may	   be	   an	  
example	  of	  Muller's	  ratchet	  operating	  within	  C.	  pneumoniae	  -­‐	  where	  slightly	  deleterious	  
mutations	   accumulate	  within	   an	  organism	   that	   replicates	  within	   a	   confined	  population	  
with	   little	   opportunity	   for	   horizontal	   gene	   transfer	   and	   is	   constantly	   subject	   to	  
evolutionary	  bottlenecks	  [76,	  77].	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A	  recent	  study	  by	  our	  group	  has	  shown	  that	  significant	  biological	  differences	  exist	  in	  the	  
response	  to	  IFN-­‐γ	  mediated	  tryptophan	  starvation	  and	  rescue	  between	  respiratory	  strain	  
AR39	   and	   cardiovascular	   strain	   A03	   [75].	   Interestingly,	   IncA,	   tyrP	   and	   the	   pmp	   gene	  
family	   have	   also	   been	   shown	   to	   play	   a	   role	   in	   host	   cell	   immune	   modulation	   and	  
resistance	  to	  host	  immune	  signalling	  and	  it	  is	  tempting	  to	  speculate	  that	  the	  differences	  
in	   tyrP	   copy	   number	   and	   the	   genetic	   differences	   in	   putative	   IncA	   genes	   may	   be	  
connected	   to	   the	   variation	   in	   IFN-­‐γ	   sensitivity	   and	   increased	   tryptophan	   rescue	  
demonstrated	  in	  A03.	  In	  C.	  pneumoniae	  AR39,	  the	  putative	  IncA	  CP0236	  has	  been	  shown	  
to	   modulate	   the	   host	   IL-­‐17	   signalling	   pathway	   by	   preventing	   NF-­‐kappaβ	   activation,	  
effectively	   protecting	   C.	   pneumoniae	   from	   the	   host	   immune	   response	   [78].	   The	  
tryptophan	   synthesis	  pathway	  has	  been	   correlated	   to	  host	   and	   tissue	   tropism	   in	  other	  
chlamydial	   species	   [79-­‐81],	   and	   whilst	   this	   pathway	   is	   absent	   in	   C.	   pneumoniae,	   it	   is	  
possible	   that	  multiple	   copies	   of	   the	   tyrP	   gene	   in	   AR39	   allow	   this	   respiratory	   strain	   to	  
more	   effectively	   scavenge	   tryptophan,	   as	   demonstrated	   by	   the	   log	   difference	   in	  
infectious	   progeny	   yield	   between	   AR39	   and	   A03	   during	   tryptophan	   starvation	   [75].	   A	  
study	   examining	   the	   effects	   of	   IFN-­‐γ	   induced	   growth	   inhibition	   in	   two	   different	   C.	  
trachomatis	   serovar	   A	   strains	   demonstrated	   similar	   results	   [82].	   Variability	   in	   the	  
nucleotide	   and	   amino	   acid	   sequence	   of	   pmp	   genes	   is	   considered	   to	   be	   an	   immuno-­‐
escape	   strategy	   of	   Chlamydiae	   [83,	   84]	   and	   has	   also	   been	   linked	   to	   tropism	   in	   C.	  
trachomatis	   [85-­‐87].	   In	   C.	   pneumoniae,	   members	   of	   the	   pmp	   gene	   family	   have	   been	  
shown	  to	  stimulate	  the	  production	  of	  IL-­‐6	  and	  MCP-­‐1	  (a	  chemokine	  which	  regulates	  the	  
migration	  of	  monocytes),	  which	  have	  been	  associated	  with	  endothelial	  inflammation	  and	  
potential	  atherogenesis,	  by	  activation	  of	  the	  NF-­‐kβ	  pathway	  [88].	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CONCLUSION	  
In	  this	  study,	  we	  generated	  whole	  genome	  sequences	  for	  C.	  pneumoniae	  A03	  and	  TOR-­‐1:	  
Two	  human	  C.	  pneumoniae	   strains	   isolated	   from	  atherosclerosis	  or	  Alzheimer's	  disease	  
patients	   respectively.	   When	   we	   compared	   these	   strains	   to	   a	   previously	   characterised	  
respiratory	  C.	   pneumoniae	   strain,	  we	  observed	  whole	   gene	   loss	  within	  A03	   and	   TOR-­‐1	  
strains,	   within	   the	   IncA	   and	   tyrP	   gene	   families	   –	   both	   considered	   potential	   virulence	  
factors.	   Smaller	   loci	   of	   nucleotide	   diversity	   were	   also	   demonstrated,	   consisting	   of	  
deletions	  within	  IncA	  and	  pmpG	  genes,	  and	  variable	  SNPs	  between	  strains.	  The	  strength	  
of	  this	  study	  is	  in	  the	  phylogenetic	  and	  recombination	  analyses,	  which	  include	  all	  human	  
C.	  pneumoniae	  genomes.	  In	  constructing	  phylogenetic	  trees	  we	  demonstrate	  that	  strains	  
A03	   and	   TOR-­‐1	   are	   relatively	   similar	   in	   genome	   sequence	   and	   content	   to	   the	   non-­‐
respiratory	   strain	   TW-­‐183	   and	   the	   respiratory	   strain	  AR39	   respectively,	   and	   both	   form	  
distinct	   sub-­‐groupings	   within	   the	   phylogeny	   of	   human	   C.	   pneumoniae.	   Additionally,	  
homologous	   recombination	   appears	   to	   have	   played	   a	   significant	   role	   in	   diversifying	  
human	  C.	  pneumoniae	  strains	  and	  this	  is	  particularly	  apparent	  in	  the	  region	  including	  and	  
flanking	   the	   plasticity	   zone	   which	   demonstrates	   polymorphism	   and	   duplication	   or	  
homologous	  expansion	  of	  gene	  families.	  
	  
Whilst	   we	   have	   extended	   the	   number	   of	  C.	   pneumoniae	   whole	   genome	   sequences	   to	  
include	   two	   non-­‐respiratory	   strains,	   caution	   should	   be	   exercised	   in	   making	   any	  
assumptions	   regarding	   the	   diversity	   demonstrated	   in	   these	   genes	   as	   markers	   of	  
respiratory	   and	  non-­‐respiratory	   tropism,	   due	   to	   the	   small	   sample	   size	   of	   this	   study.	   In	  
spite	   of	   this,	   the	   observations	   made	   in	   this	   study	   regarding	   the	   differences	   in	   gene	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content	  and	  variability	  in	  sequence	  between	  human	  C.	  pneumoniae	  strains	  isolated	  from	  
different	  diseases	  warrant	  further	  study	  and	  may	  facilitate	  molecular	  characterisation	  of	  
these	  loci	  in	  C.	  pneumoniae	  clinical	  studies.	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SUPPORTING	  INFORMATION	  
	  
Supplementary	   S1.	   AR39_A03	   Variants.	   Single	   nucleotide	   polymorphisms	   between	   AR39	   and	   A03.	   Table	   includes	   gene	   locus	   tag	  
designation	   (AR39	  numbering),	   position	   (AR39	  numbering),	   nucleotide	   change,	   amino	  acid	   change	  and	  product	  description	  of	   the	   gene.	  
Predicted	  SNPs	  resulting	  from	  degeneracies	  in	  the	  annotated	  AR39	  genome	  are	  not	  included.	  	  
AR39	   to	   A03	   single	   nucleotide	   variants	   (degenerate	   nucleotides	   in	   AR39	   not	  
included)	   	  
locus_tag	  
Polymorphism	  
Type	   Length	   Minimum	   Maximum	   Change	  
Amino	  
Acid	  
Change	   product	  
CP0002	  
SNP	  
(transition)	   1	   1,058	   1,058	   A	  -­‐>	  G	   	  




(transversion)	   1	   10,213	   10,213	   C	  -­‐>	  G	   K	  -­‐>	  N	   exodeoxyribonuclease	  V,	  beta	  chain	  
CP0008	  
SNP	  
(transition)	   1	   11,092	   11,092	   C	  -­‐>	  T	   G	  -­‐>	  R	   exodeoxyribonuclease	  V,	  gamma	  subunit	  
	  
SNP	  
(transition)	   1	   17,597	   17,597	   T	  -­‐>	  C	   	   	  
	  
SNP	  
(transition)	   1	   19,574	   19,574	   G	  -­‐>	  A	   	   	  
CP0017	  
SNP	  
(transversion)	   1	   22,048	   22,048	   T	  -­‐>	  A	   S	  -­‐>	  R	   hypothetical	  protein	  
CP0017	  
SNP	  
(transition)	   1	   22,329	   22,329	   A	  -­‐>	  G	   H	  -­‐>	  R	   hypothetical	  protein	  
	  
SNP	  
(transition)	   1	   39,879	   39,879	   T	  -­‐>	  C	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CP0034	  
SNP	  
(transversion)	   1	   42,413	   42,413	   A	  -­‐>	  C	   E	  -­‐>	  D	   hypothetical	  protein	  
CP0034	  
SNP	  
(transition)	   1	   42,920	   42,920	   T	  -­‐>	  C	   	   hypothetical	  protein	  
CP0043	  
SNP	  
(transition)	   1	   51,373	   51,373	   A	  -­‐>	  G	   I	  -­‐>	  V	   serine/threonine-­‐protein	  kinase	  
	  
SNP	  
(transition)	   1	   61,404	   61,404	   T	  -­‐>	  C	   	   	  
CP0052	  
SNP	  
(transversion)	   1	   63,869	   63,869	   A	  -­‐>	  C	   N	  -­‐>	  H	   penicillin-­‐binding	  protein	  
CP0055	  
SNP	  
(transition)	   1	   68,320	   68,320	   A	  -­‐>	  G	   	   ABC	  transporter	  ATP-­‐binding	  protein	  
CP0055	  
SNP	  
(transition)	   1	   68,446	   68,446	   A	  -­‐>	  G	   	   ABC	  transporter	  ATP-­‐binding	  protein	  
CP0056	  
SNP	  
(transition)	   1	   69,608	   69,608	   T	  -­‐>	  C	   	   hypothetical	  protein	  
	  
SNP	  
(transition)	   1	   71,212	   71,212	   A	  -­‐>	  G	   	   	  
CP0069	  
SNP	  
(transition)	   1	   80,650	   80,650	   T	  -­‐>	  C	   	   hypothetical	  protein	  
CP0070	  
SNP	  
(transition)	   1	   81,610	   81,610	   C	  -­‐>	  T	   S	  -­‐>	  L	   hypothetical	  protein	  
CP0074	  
SNP	  
(transition)	   1	   86,053	   86,053	   T	  -­‐>	  C	   H	  -­‐>	  R	   hypothetical	  protein	  
CP0079	  
SNP	  
(transversion)	   1	   89,424	   89,424	   T	  -­‐>	  G	   M	  -­‐>	  L	   hypothetical	  protein	  
CP0084	  
SNP	  
(transition)	   1	   98,267	   98,267	   G	  -­‐>	  A	   	   histidyl-­‐tRNA	  synthetase	  
CP0098	  
SNP	  
(transition)	   1	   109,546	   109,546	   G	  -­‐>	  A	   V	  -­‐>	  I	   methionyl-­‐tRNA	  formyltransferase	  
CP0099	  
SNP	  
(transition)	   1	   109,805	   109,805	   G	  -­‐>	  A	   A	  -­‐>	  T	   hypothetical	  protein	  
CP0105	  
SNP	  
(transition)	   1	   114,237	   114,237	   C	  -­‐>	  T	   	   50S	  ribosomal	  protein	  L22	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CP0108	  
SNP	  
(transition)	   1	   115,468	   115,468	   A	  -­‐>	  G	   S	  -­‐>	  G	   50S	  ribosomal	  protein	  L29	  
CP0121	  
SNP	  
(transition)	   1	   122,882	   122,882	   T	  -­‐>	  C	   I	  -­‐>	  T	   DNA-­‐directed	  RNA	  polymerase	  subunit	  alpha	  
CP0124	  
SNP	  
(transition)	   1	   124,412	   124,412	   G	  -­‐>	  A	   V	  -­‐>	  I	   hypothetical	  protein	  
CP0129	  
SNP	  
(transition)	   1	   128,823	   128,823	   A	  -­‐>	  G	   	   lipoate-­‐protein	  ligase-­‐related	  protein	  
CP0130	  
SNP	  
(transition)	   1	   130,241	   130,241	   G	  -­‐>	  A	   	  
tRNA	   uridine	   5-­‐carboxymethylaminomethyl	  
modification	  enzyme	  GidA	  
CP0131	  
SNP	  
(transition)	   1	   131,364	   131,364	   G	  -­‐>	  A	   	   replicative	  DNA	  helicase	  
CP0131	  
SNP	  
(transition)	   1	   132,117	   132,117	   A	  -­‐>	  G	   	   replicative	  DNA	  helicase	  
CP0135	  
SNP	  
(transition)	   1	   136,791	   136,791	   C	  -­‐>	  T	   	   DNA	  polymerase	  I	  
CP0135	  
SNP	  
(transition)	   1	   138,319	   138,319	   A	  -­‐>	  G	   R	  -­‐>	  G	   DNA	  polymerase	  I	  
CP0135	  
SNP	  
(transition)	   1	   139,164	   139,164	   A	  -­‐>	  G	   	   DNA	  polymerase	  I	  
CP0149	  
SNP	  
(transition)	   1	   151,155	   151,155	   T	  -­‐>	  C	   I	  -­‐>	  T	   peptide	  ABC	  transporter	  substrate-­‐binding	  protein	  
CP0151	  
SNP	  
(transition)	   1	   154,710	   154,710	   A	  -­‐>	  G	   	   peptide	  ABC	  transporter	  permease	  
CP0154	  
SNP	  
(transition)	   1	   157,072	   157,072	   C	  -­‐>	  T	   C	  -­‐>	  Y	   phenylalanyl-­‐tRNA	  synthetase	  subunit	  beta	  
CP0154	  
SNP	  
(transition)	   1	   157,584	   157,584	   T	  -­‐>	  C	   	   phenylalanyl-­‐tRNA	  synthetase	  subunit	  beta	  
CP0155	  
SNP	  
(transition)	   1	   159,603	   159,603	   G	  -­‐>	  A	   	   hypothetical	  protein	  
CP0166	  
SNP	  
(transition)	   1	   169,221	   169,221	   C	  -­‐>	  T	   A	  -­‐>	  T	   hypothetical	  protein	  
CP0166	  
SNP	  
(transition)	   1	   169,716	   169,716	   A	  -­‐>	  G	   S	  -­‐>	  P	   hypothetical	  protein	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CP0168	  
SNP	  
(transition)	   1	   171,070	   171,070	   T	  -­‐>	  C	   T	  -­‐>	  A	   tRNA	  pseudouridine	  synthase	  A	  
CP0174	  
SNP	  
(transition)	   1	   175,021	   175,021	   A	  -­‐>	  G	   	   acetyltransferase	  
CP0177	  
SNP	  
(transition)	   1	   177,407	   177,407	   T	  -­‐>	  C	   	   hypothetical	  protein	  
CP0183	  
SNP	  
(transition)	   1	   185,223	   185,223	   A	  -­‐>	  G	   	   UDP	  pyrophosphate	  synthase	  
CP0186	  
SNP	  
(transition)	   1	   187,510	   187,510	   A	  -­‐>	  G	   	   preprotein	  translocase	  subunit	  SecD/SecF	  
CP0188	  
SNP	  
(transition)	   1	   193,375	   193,375	   C	  -­‐>	  T	   H	  -­‐>	  Y	   hypothetical	  protein	  
CP0188	  
SNP	  
(transition)	   1	   194,450	   194,450	   G	  -­‐>	  A	   R	  -­‐>	  Q	   hypothetical	  protein	  
CP0190	  
SNP	  
(transition)	   1	   196,890	   196,890	   G	  -­‐>	  A	   	   glutamyl-­‐tRNA	  synthetase	  
	  
SNP	  
(transition)	   1	   197,855	   197,855	   A	  -­‐>	  G	   	   	  
CP0195	  
SNP	  
(transition)	   1	   199,757	   199,757	   C	  -­‐>	  T	   T	  -­‐>	  I	   OmcB	  
CP0197	  
SNP	  
(transition)	   1	   201,901	   201,901	   A	  -­‐>	  G	   	   tail-­‐specific	  protease	  precursor	  
CP0197	  
SNP	  
(transition)	   1	   202,090	   202,090	   C	  -­‐>	  T	   A	  -­‐>	  T	   tail-­‐specific	  protease	  precursor	  
CP0197	  
SNP	  
(transition)	   1	   202,475	   202,475	   G	  -­‐>	  A	   	   tail-­‐specific	  protease	  precursor	  
CP0199	  
SNP	  
(transition)	   1	   203,686	   203,686	   C	  -­‐>	  T	   A	  -­‐>	  V	   hypothetical	  protein	  
	  
SNP	  
(transition)	   1	   210,767	   210,767	   G	  -­‐>	  A	   	   	  
	  
SNP	  
(transition)	   1	   210,817	   210,817	   C	  -­‐>	  T	   	   	  
CP0212	  
SNP	  
(transition)	   1	   216,291	   216,291	   T	  -­‐>	  C	   I	  -­‐>	  V	   polymorphic	  membrane	  protein	  B/C	  family	  protein	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SNP	  
(transversion)	   1	   225,054	   225,054	   C	  -­‐>	  A	   	   	  
CP0224	  
SNP	  
(transition)	   1	   231,436	   231,436	   A	  -­‐>	  G	   	   sodium:dicarboxylate	  symporter	  family	  protein	  
CP0225	  
SNP	  
(transversion)	   1	   232,092	   232,092	   A	  -­‐>	  C	   N	  -­‐>	  H	  




(transition)	   1	   232,545	   232,545	   A	  -­‐>	  G	   I	  -­‐>	  V	  




(transition)	   1	   235,148	   235,148	   T	  -­‐>	  C	   	   	  
CP0230	  
SNP	  
(transition)	   1	   236,606	   236,606	   G	  -­‐>	  A	   P	  -­‐>	  L	   hypothetical	  protein	  
CP0231	  
SNP	  
(transition)	   1	   236,893	   236,893	   A	  -­‐>	  G	   F	  -­‐>	  L	   uroporphyrinogen-­‐III	  synthase	  
CP0236	   SNP	   1	   241,948	   241,948	   S	  -­‐>	  C	   ?	  -­‐>	  P	   hypothetical	  protein	  
CP0237	  
SNP	  
(transition)	   1	   242,919	   242,919	   G	  -­‐>	  A	   R	  -­‐>	  Q	   hypothetical	  protein	  
CP0239	  
SNP	  
(transition)	   1	   245,408	   245,408	   G	  -­‐>	  A	   A	  -­‐>	  V	   hypothetical	  protein	  
CP0241	  
SNP	  
(transition)	   1	   246,909	   246,909	   T	  -­‐>	  C	   T	  -­‐>	  A	   hypothetical	  protein	  
CP0247	  
SNP	  
(transition)	   1	   252,252	   252,252	   T	  -­‐>	  C	   	   hypothetical	  protein	  
CP0253	  
SNP	  
(transversion)	   1	   257,821	   257,821	   T	  -­‐>	  A	   	   heat-­‐inducible	  transcription	  repressor	  
CP0258	  
SNP	  
(transition)	   1	   264,204	   264,204	   G	  -­‐>	  A	   P	  -­‐>	  L	   hypothetical	  protein	  
CP0268	  
SNP	  
(transition)	   1	   274,906	   274,906	   G	  -­‐>	  A	   V	  -­‐>	  I	   sodium:solute	  symporter	  family	  protein	  
CP0271	  
SNP	  
(transition)	   1	   277,138	   277,138	   T	  -­‐>	  C	   	   hypothetical	  protein	  
CP0271	  
SNP	  
(transition)	   1	   277,927	   277,927	   A	  -­‐>	  G	   	   hypothetical	  protein	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CP0271	  
SNP	  
(transition)	   1	   278,106	   278,106	   A	  -­‐>	  G	   Y	  -­‐>	  H	   hypothetical	  protein	  
CP0271	  
SNP	  
(transition)	   1	   278,334	   278,334	   C	  -­‐>	  T	   D	  -­‐>	  N	   hypothetical	  protein	  
CP0272	  
SNP	  
(transition)	   1	   280,062	   280,062	   C	  -­‐>	  T	   H	  -­‐>	  Y	   amino	  acid	  ABC	  transporter	  substrate-­‐binding	  protein	  
	  
SNP	  
(transition)	   1	   281,461	   281,461	   G	  -­‐>	  A	   	   	  
CP0274	  
SNP	  
(transition)	   1	   282,646	   282,646	   C	  -­‐>	  T	   	   hypothetical	  protein	  
CP0280	  
SNP	  
(transition)	   1	   291,294	   291,294	   A	  -­‐>	  G	   	   hypothetical	  protein	  
CP0281	  
SNP	  
(transversion)	   1	   292,022	   292,022	   C	  -­‐>	  A	   P	  -­‐>	  Q	   hypothetical	  protein	  
CP0282	  
SNP	  
(transition)	   1	   295,535	   295,535	   A	  -­‐>	  G	   	   hypothetical	  protein	  
	  
SNP	  
(transition)	   1	   301,215	   301,215	   C	  -­‐>	  T	   	   	  
CP0286	  
SNP	  
(transversion)	   1	   306,687	   306,687	   A	  -­‐>	  C	   S	  -­‐>	  A	   polymorphic	  membrane	  protein	  E/F	  family	  protein	  
CP0287	  
SNP	  
(transition)	   1	   308,487	   308,487	   G	  -­‐>	  A	   R	  -­‐>	  H	   hypothetical	  protein	  
CP0288	  
SNP	  
(transition)	   1	   308,928	   308,928	   C	  -­‐>	  T	   R	  -­‐>	  W	   hypothetical	  protein	  
CP0289	  
SNP	  
(transversion)	   1	   309,153	   309,153	   A	  -­‐>	  C	   E	  -­‐>	  A	   hypothetical	  protein	  
	  
SNP	  
(transition)	   1	   312,746	   312,746	   C	  -­‐>	  T	   	   	  
CP0291	  
SNP	  
(transition)	   1	   313,058	   313,058	   G	  -­‐>	  A	   R	  -­‐>	  Q	   hypothetical	  protein	  
CP0291	  
SNP	  
(transition)	   1	   313,473	   313,473	   A	  -­‐>	  G	   	   hypothetical	  protein	  
CP0294	  
SNP	  
(transition)	   1	   315,505	   315,505	   G	  -­‐>	  A	   G	  -­‐>	  E	   hypothetical	  protein	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CP0294	  
SNP	  
(transition)	   1	   317,098	   317,098	   A	  -­‐>	  G	   H	  -­‐>	  R	   hypothetical	  protein	  
CP0295	  
SNP	  
(transition)	   1	   318,518	   318,518	   G	  -­‐>	  A	   G	  -­‐>	  E	   hypothetical	  protein	  
	  
SNP	  
(transition)	   1	   319,620	   319,620	   C	  -­‐>	  T	   	   	  
CP0297	  
SNP	  
(transversion)	   1	   319,957	   319,957	   T	  -­‐>	  G	   	   hypothetical	  protein	  
CP0298	  
SNP	  
(transition)	   1	   324,071	   324,071	   T	  -­‐>	  C	   N	  -­‐>	  D	   polymorphic	  membrane	  protein	  H	  family	  protein	  
CP0298	  
SNP	  
(transition)	   1	   324,234	   324,234	   T	  -­‐>	  C	   	   polymorphic	  membrane	  protein	  H	  family	  protein	  
CP0302	  
SNP	  
(transition)	   1	   332,033	   332,033	   T	  -­‐>	  C	   	   polymorphic	  membrane	  protein	  G	  family	  protein	  
CP0303	  
SNP	  
(transition)	   1	   334,342	   334,342	   G	  -­‐>	  A	   	   polymorphic	  membrane	  protein	  G	  family	  protein	  
	  
SNP	  
(transition)	   1	   337,824	   337,824	   G	  -­‐>	  A	   	   	  
CP0306	  
SNP	  
(transition)	   1	   339,444	   339,444	   G	  -­‐>	  A	   	   polymorphic	  membrane	  protein	  G	  family	  protein	  
CP0307	  
SNP	  
(transition)	   1	   341,633	   341,633	   C	  -­‐>	  T	   	   polymorphic	  membrane	  protein	  G	  family	  protein	  
CP0308	  
SNP	  
(transition)	   1	   344,153	   344,153	   A	  -­‐>	  G	   Y	  -­‐>	  H	   polymorphic	  membrane	  protein	  G	  family	  protein	  
CP0309	  
SNP	  
(transition)	   1	   347,907	   347,907	   T	  -­‐>	  C	   	   polymorphic	  membrane	  protein	  G	  family	  protein	  
CP0309	  
SNP	  
(transition)	   1	   348,654	   348,654	   T	  -­‐>	  C	   	   polymorphic	  membrane	  protein	  G	  family	  protein	  
	  
SNP	  
(transition)	   1	   350,980	   350,980	   A	  -­‐>	  G	   	   	  
CP0310	  
SNP	  
(transition)	   1	   352,029	   352,029	   T	  -­‐>	  C	   M	  -­‐>	  V	   hypothetical	  protein	  
CP0311	  
SNP	  
(transversion)	   1	   352,697	   352,697	   T	  -­‐>	  G	   N	  -­‐>	  H	   hypothetical	  protein	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CP0312	  
SNP	  
(transition)	   1	   353,378	   353,378	   A	  -­‐>	  G	   Y	  -­‐>	  H	   hypothetical	  protein	  
CP0312	  
SNP	  
(transition)	   1	   353,889	   353,889	   C	  -­‐>	  T	   	   hypothetical	  protein	  
CP0314	  
SNP	  
(transition)	   1	   355,273	   355,273	   A	  -­‐>	  G	   L	  -­‐>	  P	   hypothetical	  protein	  
CP0319	  
SNP	  
(transition)	   1	   361,717	   361,717	   T	  -­‐>	  C	   I	  -­‐>	  T	   hypothetical	  protein	  
CP0320	  
SNP	  
(transition)	   1	   363,808	   363,808	   T	  -­‐>	  C	   	   glycine	  cleavage	  system	  protein	  H	  
CP0327	  
SNP	  
(transition)	   1	   369,204	   369,204	   C	  -­‐>	  T	   	   hypothetical	  protein	  
CP0337	  
SNP	  
(transition)	   1	   378,686	   378,686	   T	  -­‐>	  C	   	   N-­‐acetylmuramoyl-­‐L-­‐alanine	  amidase	  
CP0341	  
SNP	  
(transition)	   1	   381,966	   381,966	   T	  -­‐>	  C	   	   ABC	  transporter	  ATP-­‐binding	  protein	  
CP0341	  
SNP	  
(transversion)	   1	   382,052	   382,052	   A	  -­‐>	  C	   K	  -­‐>	  T	   ABC	  transporter	  ATP-­‐binding	  protein	  
CP0341	  
SNP	  
(transition)	   1	   382,477	   382,477	   A	  -­‐>	  G	   I	  -­‐>	  V	   ABC	  transporter	  ATP-­‐binding	  protein	  
CP0355	  
SNP	  
(transition)	   1	   394,057	   394,057	   G	  -­‐>	  A	   T	  -­‐>	  M	   hypothetical	  protein	  
	  
SNP	  
(transition)	   1	   395,690	   395,690	   T	  -­‐>	  C	   	   	  
	  
SNP	  
(transition)	   1	   395,742	   395,742	   C	  -­‐>	  T	   	   	  
CP0365	  
SNP	  
(transition)	   1	   402,097	   402,097	   A	  -­‐>	  G	   	   Holliday	  junction	  DNA	  helicase	  RuvB	  
CP0365	  
SNP	  
(transition)	   1	   402,353	   402,353	   A	  -­‐>	  G	   T	  -­‐>	  A	   Holliday	  junction	  DNA	  helicase	  RuvB	  
CP0374	  
SNP	  
(transition)	   1	   411,255	   411,255	   A	  -­‐>	  G	   	   hypothetical	  protein	  
CP0386	  
SNP	  
(transition)	   1	   423,589	   423,589	   T	  -­‐>	  C	   	   hypothetical	  protein	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CP0404	  
SNP	  
(transversion)	   1	   441,692	   441,692	   C	  -­‐>	  G	   R	  -­‐>	  G	   hypothetical	  protein	  
CP0404	  
SNP	  
(transition)	   1	   441,858	   441,858	   A	  -­‐>	  G	   D	  -­‐>	  G	   hypothetical	  protein	  
CP0405	  
SNP	  
(transversion)	   1	   443,134	   443,134	   C	  -­‐>	  A	   	   hypothetical	  protein	  
CP0405	  
SNP	  
(transversion)	   1	   443,283	   443,283	   C	  -­‐>	  G	   A	  -­‐>	  P	   hypothetical	  protein	  
CP0405	  
SNP	  
(transversion)	   1	   443,338	   443,338	   C	  -­‐>	  A	   	   hypothetical	  protein	  
CP0407	  
SNP	  
(transition)	   1	   444,392	   444,392	   T	  -­‐>	  C	   K	  -­‐>	  R	   hypothetical	  protein	  
CP0407	  
SNP	  
(transversion)	   1	   444,402	   444,402	   G	  -­‐>	  T	   Q	  -­‐>	  K	   hypothetical	  protein	  
CP0407	  
SNP	  
(transversion)	   1	   444,510	   444,510	   G	  -­‐>	  C	   R	  -­‐>	  G	   hypothetical	  protein	  
CP0408	  
SNP	  
(transition)	   1	   445,780	   445,780	   G	  -­‐>	  A	   	   ADP,	  ATP	  carrier	  protein	  
CP0417	  
SNP	  
(transition)	   1	   455,927	   455,927	   C	  -­‐>	  T	   M	  -­‐>	  I	   hypothetical	  protein	  
	  
SNP	  
(transition)	   1	   457,154	   457,154	   G	  -­‐>	  A	   	   	  
CP0419	  
SNP	  
(transversion)	   1	   458,536	   458,536	   T	  -­‐>	  G	   Y	  -­‐>	  S	   DNA	  polymerase	  III	  subunit	  beta	  
CP0437	  
SNP	  
(transition)	   1	   476,504	   476,504	   T	  -­‐>	  C	   E	  -­‐>	  G	   bifunctional	  riboflavin	  kinase/FMN	  adenylyltransferase	  
CP0440	  
SNP	  
(transition)	   1	   480,041	   480,041	   T	  -­‐>	  C	   T	  -­‐>	  A	   translation	  initiation	  factor	  IF-­‐2	  
CP0448	  
SNP	  
(transition)	   1	   488,011	   488,011	   C	  -­‐>	  T	   	   inner	  membrane	  protein	  translocase	  component	  YidC	  
CP0451	  
SNP	  
(transition)	   1	   493,086	   493,086	   C	  -­‐>	  T	   	   glycogen	  phosphorylase	  
CP0455	  
SNP	  
(transition)	   1	   498,889	   498,889	   G	  -­‐>	  A	   G	  -­‐>	  S	   hypothetical	  protein	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CP0458	  
SNP	  
(transition)	   1	   501,782	   501,782	   G	  -­‐>	  A	   	   outer	  membrane	  protein	  
CP0458	  
SNP	  
(transversion)	   1	   502,630	   502,630	   C	  -­‐>	  A	   A	  -­‐>	  S	   outer	  membrane	  protein	  
	  
SNP	  
(transition)	   1	   504,360	   504,360	   T	  -­‐>	  C	   	   	  
CP0461	  
SNP	  
(transition)	   1	   505,621	   505,621	   C	  -­‐>	  T	   	   ACP	  S-­‐malonyltransferase	  
CP0468	  
SNP	  
(transition)	   1	   512,752	   512,752	   A	  -­‐>	  G	   L	  -­‐>	  P	   sodium-­‐dependent	  transporter	  
CP0469	  
SNP	  
(transition)	   1	   514,622	   514,622	   C	  -­‐>	  T	   E	  -­‐>	  K	   sodium:dicarboxylate	  symporter	  family	  protein	  
	  
SNP	  
(transition)	   1	   522,722	   522,722	   A	  -­‐>	  G	   	   	  
	  
SNP	  
(transition)	   1	   526,308	   526,308	   A	  -­‐>	  G	   	   	  
CP0478	  
SNP	  
(transversion)	   1	   526,770	   526,770	   A	  -­‐>	  C	   K	  -­‐>	  N	   ABC	  transporter	  ATP-­‐binding	  protein	  
CP0480	  
SNP	  
(transition)	   1	   528,329	   528,329	   G	  -­‐>	  A	   	   lipoprotein	  
CP0485	  
SNP	  
(transition)	   1	   533,079	   533,079	   T	  -­‐>	  C	   	   DNA	  gyrase	  subunit	  A	  
CP0489	  
SNP	  
(transition)	   1	   537,880	   537,880	   T	  -­‐>	  C	   S	  -­‐>	  P	   Sua5/YciO/YrdC	  family	  protein	  
CP0506	  
SNP	  
(transversion)	   1	   551,490	   551,490	   G	  -­‐>	  C	   G	  -­‐>	  R	   hypothetical	  protein	  
CP0512	  
SNP	  
(transition)	   1	   556,177	   556,177	   A	  -­‐>	  G	   N	  -­‐>	  D	   hypothetical	  protein	  
	  
SNP	  
(transition)	   1	   561,096	   561,096	   A	  -­‐>	  G	   	   	  
CP0524	  
SNP	  
(transition)	   1	   566,165	   566,165	   C	  -­‐>	  T	   	   glucose-­‐6-­‐phosphate	  1-­‐dehydrogenase	  
CP0526	  
SNP	  
(transition)	   1	   568,091	   568,091	   C	  -­‐>	  T	   R	  -­‐>	  K	   CTP	  synthetase	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CP0532	  
SNP	  
(transition)	   1	   571,119	   571,119	   T	  -­‐>	  C	   S	  -­‐>	  P	   hypothetical	  protein	  
CP0537	  
SNP	  
(transition)	   1	   576,031	   576,031	   T	  -­‐>	  C	   	   disulfide	  oxidoreductase	  
	  
SNP	  
(transversion)	   1	   578,792	   578,792	   A	  -­‐>	  C	   	   	  
	  
SNP	  
(transition)	   1	   579,522	   579,522	   G	  -­‐>	  A	   	   	  
	  
SNP	  
(transition)	   1	   583,928	   583,928	   T	  -­‐>	  C	   	   	  
CP0550	  
SNP	  
(transition)	   1	   584,296	   584,296	   T	  -­‐>	  C	   	   hypothetical	  protein	  
CP0567	  
SNP	  
(transition)	   1	   598,769	   598,769	   T	  -­‐>	  C	   	   peptide	  ABC	  transporter	  permease	  
	  
SNP	  
(transition)	   1	   602,031	   602,031	   A	  -­‐>	  G	   	   	  
CP0575	  
SNP	  
(transition)	   1	   608,957	   608,957	   C	  -­‐>	  T	   	   amino	  acid	  ABC	  transporter	  permease	  
CP0577	  
SNP	  
(transition)	   1	   610,341	   610,341	   C	  -­‐>	  T	   G	  -­‐>	  S	   hypothetical	  protein	  
CP0577	  
SNP	  
(transition)	   1	   610,912	   610,912	   C	  -­‐>	  T	   	   hypothetical	  protein	  
CP0578	  
SNP	  
(transition)	   1	   612,826	   612,826	   C	  -­‐>	  T	   	   hypothetical	  protein	  
CP0586	  
SNP	  
(transition)	   1	   621,161	   621,161	   A	  -­‐>	  G	   I	  -­‐>	  V	   acetyl-­‐CoA	  carboxylase	  biotin	  carboxylase	  subunit	  
CP0602	  
SNP	  
(transition)	   1	   631,793	   631,793	   C	  -­‐>	  T	   	   hypothetical	  protein	  
CP0606	  
SNP	  
(transversion)	   1	   633,913	   633,913	   G	  -­‐>	  T	   Q	  -­‐>	  K	   hypothetical	  protein	  
CP0610	  
SNP	  
(transition)	   1	   636,984	   636,984	   A	  -­‐>	  G	   	   dienelactone	  hydrolase	  family	  protein	  
CP0617	  
SNP	  
(transition)	   1	   642,699	   642,699	   G	  -­‐>	  A	   A	  -­‐>	  V	   3-­‐deoxy-­‐D-­‐manno-­‐octulosonic-­‐acid	  transferase	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CP0620	  
SNP	  
(transition)	   1	   646,203	   646,203	   T	  -­‐>	  C	   	   hypothetical	  protein	  
CP0623	  
SNP	  
(transition)	   1	   648,971	   648,971	   C	  -­‐>	  T	   G	  -­‐>	  E	   hypothetical	  protein	  
CP0624	  
SNP	  
(transition)	   1	   653,609	   653,609	   A	  -­‐>	  G	   	   NAD-­‐dependent	  DNA	  ligase	  LigA	  
CP0625	  
SNP	  
(transition)	   1	   655,612	   655,612	   T	  -­‐>	  C	   I	  -­‐>	  V	   hypothetical	  protein	  
CP0625	  
SNP	  
(transition)	   1	   656,229	   656,229	   G	  -­‐>	  A	   A	  -­‐>	  V	   hypothetical	  protein	  
CP0631	  
SNP	  
(transition)	   1	   665,422	   665,422	   C	  -­‐>	  T	   	   ribose-­‐5-­‐phosphate	  isomerase	  A	  
CP0634	  
SNP	  
(transversion)	   1	   667,749	   667,749	   A	  -­‐>	  C	   K	  -­‐>	  Q	   glutamate-­‐1-­‐semialdehyde	  aminotransferase	  
CP0636	  
SNP	  
(transition)	   1	   670,195	   670,195	   G	  -­‐>	  A	   	   oligoendopeptidase	  F	  
CP0645	  
SNP	  
(transition)	   1	   679,438	   679,438	   C	  -­‐>	  T	   	   hypothetical	  protein	  
CP0646	  
SNP	  
(transition)	   1	   679,929	   679,929	   T	  -­‐>	  C	   R	  -­‐>	  G	   hypothetical	  protein	  
CP0649	  
SNP	  
(transition)	   1	   683,683	   683,683	   C	  -­‐>	  T	   R	  -­‐>	  K	   hypothetical	  protein	  
CP0650	  
SNP	  
(transition)	   1	   685,177	   685,177	   G	  -­‐>	  A	   	   exodeoxyribonuclease	  V,	  alpha	  subunit	  
CP0651	  
SNP	  
(transition)	   1	   687,662	   687,662	   A	  -­‐>	  G	   V	  -­‐>	  A	   methionyl-­‐tRNA	  synthetase	  
CP0659	  
SNP	  
(transition)	   1	   694,234	   694,234	   G	  -­‐>	  A	   	  




(transition)	   1	   697,964	   697,964	   A	  -­‐>	  G	   	   signal	  peptidase	  I	  
CP0665	  
SNP	  
(transition)	   1	   701,196	   701,196	   A	  -­‐>	  G	   Y	  -­‐>	  H	   isoleucyl-­‐tRNA	  synthetase	  
CP0668	  
SNP	  
(transition)	   1	   705,384	   705,384	   A	  -­‐>	  G	   S	  -­‐>	  P	   phoH	  family	  protein	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CP0671	  
SNP	  
(transversion)	   1	   708,675	   708,675	   C	  -­‐>	  G	   	   cytochrome	  D	  ubiquinol	  oxidase,	  subunit	  II	  
CP0673	  
SNP	  
(transition)	   1	   711,685	   711,685	   G	  -­‐>	  A	   	   hypothetical	  protein	  
	  
SNP	  
(transition)	   1	   713,129	   713,129	   T	  -­‐>	  C	   	   	  
CP0675	  
SNP	  
(transversion)	   1	   713,385	   713,385	   T	  -­‐>	  G	   L	  -­‐>	  V	   hypothetical	  protein	  
CP0676	  
SNP	  
(transition)	   1	   714,580	   714,580	   A	  -­‐>	  G	   T	  -­‐>	  A	   lipid	  A	  biosynthesis	  lauroyl	  acyltransferase	  
CP0681	  
SNP	  
(transition)	   1	   727,996	   727,996	   G	  -­‐>	  A	   	   hypothetical	  protein	  
CP0687	  
SNP	  
(transition)	   1	   735,027	   735,027	   C	  -­‐>	  T	   R	  -­‐>	  Q	   hypothetical	  protein	  
CP0687	  
SNP	  
(transition)	   1	   735,196	   735,196	   C	  -­‐>	  T	   V	  -­‐>	  I	   hypothetical	  protein	  
CP0699	  
SNP	  
(transition)	   1	   749,225	   749,225	   G	  -­‐>	  A	   T	  -­‐>	  M	   transcription	  antitermination	  protein	  NusG	  
	  
SNP	  
(transversion)	   1	   751,909	   751,909	   G	  -­‐>	  C	   	   	  
CP0704	  
SNP	  
(transition)	   1	   753,109	   753,109	   G	  -­‐>	  A	   V	  -­‐>	  M	   hypothetical	  protein	  
CP0709	  
SNP	  
(transition)	   1	   760,727	   760,727	   T	  -­‐>	  C	   M	  -­‐>	  V	   hypothetical	  protein	  
CP0714	  
SNP	  
(transition)	   1	   764,883	   764,883	   A	  -­‐>	  G	   	   PTS	  system,	  IIA	  component	  
CP0717	  
SNP	  
(transition)	   1	   766,628	   766,628	   T	  -­‐>	  C	   	   acetyl-­‐CoA	  carboxylase	  subunit	  beta	  
CP0719	  
SNP	  
(transition)	   1	   768,747	   768,747	   T	  -­‐>	  C	   	   phosphoglucomutase/phosphomannomutase	  
CP0719	  
SNP	  
(transition)	   1	   769,150	   769,150	   G	  -­‐>	  A	   T	  -­‐>	  I	   phosphoglucomutase/phosphomannomutase	  
CP0720	  
SNP	  
(transition)	   1	   770,464	   770,464	   G	  -­‐>	  A	   	   hypothetical	  protein	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CP0721	  
SNP	  
(transition)	   1	   771,251	   771,251	   A	  -­‐>	  G	   M	  -­‐>	  V	   ribonuclease	  III	  
CP0726	  
SNP	  
(transition)	   1	   775,329	   775,329	   T	  -­‐>	  C	   I	  -­‐>	  V	   hypothetical	  protein	  
CP0726	  
SNP	  
(transition)	   1	   776,296	   776,296	   T	  -­‐>	  C	   	   hypothetical	  protein	  
	  
SNP	  
(transition)	   1	   779,950	   779,950	   A	  -­‐>	  G	   	   	  
	  
SNP	  
(transversion)	   1	   779,953	   779,953	   G	  -­‐>	  T	   	   	  
	  
SNP	  
(transition)	   1	   779,955	   779,955	   T	  -­‐>	  C	   	   	  
	  
SNP	  
(transition)	   1	   779,961	   779,961	   T	  -­‐>	  C	   	   	  
	  
SNP	  
(transition)	   1	   779,967	   779,967	   G	  -­‐>	  A	   	   	  
	  
SNP	  
(transition)	   1	   779,968	   779,968	   C	  -­‐>	  T	   	   	  
CP0730	  
SNP	  
(transition)	   1	   782,394	   782,394	   A	  -­‐>	  G	   S	  -­‐>	  P	   hypothetical	  protein	  
CP0730	  
SNP	  
(transition)	   1	   782,397	   782,397	   T	  -­‐>	  C	   I	  -­‐>	  V	   hypothetical	  protein	  
CP0730	  
SNP	  
(transition)	   1	   782,398	   782,398	   C	  -­‐>	  T	   	   hypothetical	  protein	  
CP0730	  
SNP	  
(transition)	   1	   782,401	   782,401	   T	  -­‐>	  C	   	   hypothetical	  protein	  
CP0730	  
SNP	  
(transition)	   1	   782,434	   782,434	   G	  -­‐>	  A	   	   hypothetical	  protein	  
CP0737	  
SNP	  
(transition)	   1	   788,827	   788,827	   C	  -­‐>	  T	   V	  -­‐>	  I	   phosphoenolpyruvate-­‐protein	  phosphotransferase	  
CP0741	  
SNP	  
(transition)	   1	   790,127	   790,127	   T	  -­‐>	  C	   Y	  -­‐>	  H	   hypothetical	  protein	  
CP0741	  
SNP	  
(transition)	   1	   791,397	   791,397	   C	  -­‐>	  T	   T	  -­‐>	  I	   hypothetical	  protein	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CP0746	  
SNP	  
(transition)	   1	   796,801	   796,801	   T	  -­‐>	  C	   	   hypothetical	  protein	  
CP0749	  
SNP	  
(transition)	   1	   798,960	   798,960	   G	  -­‐>	  A	   	   Lon	  family	  protease	  
CP0750	  
SNP	  
(transition)	   1	   801,542	   801,542	   G	  -­‐>	  A	   	   hypothetical	  protein	  
CP0750	  
SNP	  
(transition)	   1	   801,964	   801,964	   G	  -­‐>	  A	   G	  -­‐>	  E	   hypothetical	  protein	  
CP0755	  
SNP	  
(transition)	   1	   806,845	   806,845	   A	  -­‐>	  G	   I	  -­‐>	  V	   hypothetical	  protein	  
CP0756	  
SNP	  
(transition)	   1	   809,758	   809,758	   C	  -­‐>	  T	   	   hypothetical	  protein	  
	  
SNP	  
(transition)	   1	   811,017	   811,017	   G	  -­‐>	  A	   	   	  
	  
SNP	  
(transition)	   1	   814,081	   814,081	   A	  -­‐>	  G	   	   	  
	  
SNP	  
(transition)	   1	   814,127	   814,127	   G	  -­‐>	  A	   	   	  
	  
SNP	  
(transversion)	   1	   819,679	   819,679	   T	  -­‐>	  G	   	   	  
CP0762	  
SNP	  
(transition)	   1	   823,342	   823,342	   C	  -­‐>	  T	   	   hypothetical	  protein	  
CP0763	  
SNP	  
(transition)	   1	   825,063	   825,063	   C	  -­‐>	  T	   	   hypothetical	  protein	  
CP0764	  
SNP	  
(transition)	   1	   825,259	   825,259	   G	  -­‐>	  A	   	   hypothetical	  protein	  
CP0764	  
SNP	  
(transversion)	   1	   825,263	   825,263	   G	  -­‐>	  T	   T	  -­‐>	  N	   hypothetical	  protein	  
CP0764	  
SNP	  
(transition)	   1	   825,272	   825,272	   G	  -­‐>	  A	   S	  -­‐>	  F	   hypothetical	  protein	  
CP0764	  
SNP	  
(transversion)	   1	   825,274	   825,274	   A	  -­‐>	  T	   	   hypothetical	  protein	  
CP0764	  
SNP	  
(transition)	   1	   825,283	   825,283	   A	  -­‐>	  G	   	   hypothetical	  protein	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CP0764	  
SNP	  
(transition)	   1	   826,424	   826,424	   C	  -­‐>	  T	   G	  -­‐>	  D	   hypothetical	  protein	  
CP0764	  
SNP	  
(transition)	   1	   827,406	   827,406	   G	  -­‐>	  A	   	   hypothetical	  protein	  
CP0764	  
SNP	  
(transversion)	   1	   827,428	   827,428	   T	  -­‐>	  G	   	   hypothetical	  protein	  
CP0770	  
SNP	  
(transversion)	   1	   836,123	   836,123	   C	  -­‐>	  G	   A	  -­‐>	  P	   polymorphic	  membrane	  protein	  G	  family	  protein	  
CP0771	  
SNP	  
(transition)	   1	   837,614	   837,614	   T	  -­‐>	  C	   	   aspartyl/glutamyl-­‐tRNA	  amidotransferase	  subunit	  B	  
CP0772	  
SNP	  
(transition)	   1	   838,917	   838,917	   T	  -­‐>	  C	   M	  -­‐>	  V	   aspartyl/glutamyl-­‐tRNA	  amidotransferase	  subunit	  A	  
CP0779	  
SNP	  
(transition)	   1	   844,478	   844,478	   G	  -­‐>	  A	   	   hypothetical	  protein	  
CP0779	  
SNP	  
(transition)	   1	   844,775	   844,775	   A	  -­‐>	  G	   	   hypothetical	  protein	  
	  
SNP	  
(transition)	   1	   845,719	   845,719	   C	  -­‐>	  T	   	   	  
CP0791	  
SNP	  
(transition)	   1	   855,902	   855,902	   C	  -­‐>	  T	   R	  -­‐>	  K	   dimethyladenosine	  transferase	  
CP0791	  
SNP	  
(transversion)	   1	   856,061	   856,061	   T	  -­‐>	  G	   K	  -­‐>	  T	   dimethyladenosine	  transferase	  
CP0793	  
SNP	  
(transition)	   1	   857,966	   857,966	   C	  -­‐>	  T	   C	  -­‐>	  Y	   hypothetical	  protein	  
CP0793	  
SNP	  
(transition)	   1	   858,727	   858,727	   T	  -­‐>	  C	   	   hypothetical	  protein	  
	  
SNP	  
(transversion)	   1	   859,837	   859,837	   T	  -­‐>	  G	   	   	  
CP0796	  
SNP	  
(transversion)	   1	   861,770	   861,770	   A	  -­‐>	  T	   S	  -­‐>	  T	   hypothetical	  protein	  
CP0797	  
SNP	  
(transition)	   1	   862,929	   862,929	   C	  -­‐>	  T	   G	  -­‐>	  D	   hypothetical	  protein	  
CP0797	  
SNP	  
(transition)	   1	   863,911	   863,911	   G	  -­‐>	  A	   	   hypothetical	  protein	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CP0797	  
SNP	  
(transversion)	   1	   863,933	   863,933	   T	  -­‐>	  G	   	   hypothetical	  protein	  
CP0803	  
SNP	  
(transversion)	   1	   868,189	   868,189	   T	  -­‐>	  G	   S	  -­‐>	  R	   aspartate	  kinase	  
CP0804	  
SNP	  
(transition)	   1	   869,461	   869,461	   C	  -­‐>	  T	   	   aspartate-­‐semialdehyde	  dehydrogenase	  
CP0806	  
SNP	  
(transversion)	   1	   870,933	   870,933	   A	  -­‐>	  C	   E	  -­‐>	  D	   aromatic	  amino	  acid	  hydroxylase	  
CP0819	  
SNP	  
(transition)	   1	   883,944	   883,944	   A	  -­‐>	  G	   I	  -­‐>	  V	   hypothetical	  protein	  
CP0821	  
SNP	  
(transition)	   1	   887,076	   887,076	   A	  -­‐>	  G	   	   amino	  acid	  permease	  
CP0827	  
SNP	  
(transition)	   1	   892,851	   892,851	   A	  -­‐>	  G	   V	  -­‐>	  A	   glucose-­‐6-­‐phosphate	  isomerase	  
CP0827	  
SNP	  
(transversion)	   1	   893,790	   893,790	   C	  -­‐>	  A	   W	  -­‐>	  L	   glucose-­‐6-­‐phosphate	  isomerase	  
CP0831	  
SNP	  
(transition)	   1	   896,009	   896,009	   G	  -­‐>	  A	   G	  -­‐>	  D	   hypothetical	  protein	  
CP0835	  
SNP	  
(transition)	   1	   900,994	   900,994	   T	  -­‐>	  C	   I	  -­‐>	  V	   hypothetical	  protein	  
CP0837	  
SNP	  
(transition)	   1	   902,316	   902,316	   A	  -­‐>	  G	   L	  -­‐>	  S	   hypothetical	  protein	  
CP0839	  
SNP	  
(transition)	   1	   907,004	   907,004	   G	  -­‐>	  A	   	   sulfate	  transporter	  family	  protein	  
CP0843	  
SNP	  
(transition)	   1	   912,028	   912,028	   C	  -­‐>	  T	   S	  -­‐>	  F	   hypothetical	  protein	  
	  
SNP	  
(transition)	   1	   914,593	   914,593	   T	  -­‐>	  C	   	   	  
CP0850	  
SNP	  
(transition)	   1	   916,761	   916,761	   G	  -­‐>	  A	   	   hypothetical	  protein	  
CP0855	  
SNP	  
(transition)	   1	   919,038	   919,038	   G	  -­‐>	  A	   V	  -­‐>	  I	   polynucleotide	  phosphorylase/polyadenylase	  
CP0859	  
SNP	  
(transition)	   1	   925,425	   925,425	   T	  -­‐>	  C	   S	  -­‐>	  P	   hypothetical	  protein	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CP0861	  
SNP	  
(transition)	   1	   928,282	   928,282	   A	  -­‐>	  G	   	   hypothetical	  protein	  
CP0867	  
SNP	  
(transition)	   1	   932,783	   932,783	   C	  -­‐>	  T	   L	  -­‐>	  F	   UDP-­‐N-­‐acetylenolpyruvoylglucosamine	  reductase	  
CP0872	  
SNP	  
(transition)	   1	   938,581	   938,581	   T	  -­‐>	  C	   	   ribonucleotide-­‐diphosphate	  reductase	  subunit	  alpha	  
CP0887	  
SNP	  
(transition)	   1	   955,056	   955,056	   C	  -­‐>	  T	   R	  -­‐>	  W	   signal	  recognition	  particle	  protein	  FtsY	  
CP0889	  
SNP	  
(transition)	   1	   956,908	   956,908	   C	  -­‐>	  T	   	   Mtr/TnaB/TyrO	  permease	  family	  protein	  
CP0889	  
SNP	  
(transversion)	   1	   957,391	   957,391	   C	  -­‐>	  G	   	   Mtr/TnaB/TyrO	  permease	  family	  protein	  
CP0891	  
SNP	  
(transition)	   1	   958,557	   958,557	   C	  -­‐>	  T	   	   Mtr/TnaB/TyrO	  permease	  family	  protein	  
CP0893	  
SNP	  
(transition)	   1	   961,629	   961,629	   A	  -­‐>	  G	   	   phosphoglucosamine	  mutase	  
CP0893	  
SNP	  
(transition)	   1	   962,181	   962,181	   C	  -­‐>	  T	   	   phosphoglucosamine	  mutase	  
CP0894	  
SNP	  
(transition)	   1	   963,862	   963,862	   G	  -­‐>	  A	   R	  -­‐>	  Q	   poly(A)	  polymerase	  family	  protein	  
CP0894	  
SNP	  
(transition)	   1	   963,981	   963,981	   C	  -­‐>	  T	   L	  -­‐>	  F	   poly(A)	  polymerase	  family	  protein	  
CP0897	  
SNP	  
(transition)	   1	   971,134	   971,134	   T	  -­‐>	  C	   	   polymorphic	  membrane	  protein	  D	  family	  protein	  
CP0906	  
SNP	  
(transition)	   1	   983,314	   983,314	   C	  -­‐>	  T	   	   50S	  ribosomal	  protein	  L9	  
	  
SNP	  
(transition)	   1	   993,270	   993,270	   C	  -­‐>	  T	   	   	  
CP0931	  
SNP	  
(transition)	   1	   1,005,480	   1,005,480	   A	  -­‐>	  G	   K	  -­‐>	  R	   cysteinyl-­‐tRNA	  synthetase	  
CP0935	  
SNP	  
(transition)	   1	   1,008,321	   1,008,321	   T	  -­‐>	  C	   M	  -­‐>	  V	   hypothetical	  protein	  
CP0937	  
SNP	  
(transition)	   1	   1,009,235	   1,009,235	   G	  -­‐>	  A	   R	  -­‐>	  H	   hypothetical	  protein	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CP0952	  
SNP	  
(transition)	   1	   1,025,124	   1,025,124	   G	  -­‐>	  A	   A	  -­‐>	  V	   hypothetical	  protein	  
CP0954	  
SNP	  
(transversion)	   1	   1,027,024	   1,027,024	   T	  -­‐>	  G	   Y	  -­‐>	  S	   hypothetical	  protein	  
CP0956	  
SNP	  
(transition)	   1	   1,028,390	   1,028,390	   T	  -­‐>	  C	   	   tRNA	  delta(2)-­‐isopentenylpyrophosphate	  transferase	  
CP0961	  
SNP	  
(transition)	   1	   1,032,154	   1,032,154	   A	  -­‐>	  G	   L	  -­‐>	  P	  









(transversion)	   1	   1,038,919	   1,038,919	   A	  -­‐>	  C	   S	  -­‐>	  A	   phospho-­‐N-­‐acetylmuramoyl-­‐pentapeptide-­‐	  transferase	  
CP0967	  
SNP	  










(transversion)	   1	   1,040,612	   1,040,612	   A	  -­‐>	  C	   	   	  
CP0978	  
SNP	  
(transition)	   1	   1,056,116	   1,056,116	   G	  -­‐>	  A	   R	  -­‐>	  H	   protoporphyrinogen	  oxidase	  
CP0978	  
SNP	  
(transition)	   1	   1,056,939	   1,056,939	   G	  -­‐>	  A	   M	  -­‐>	  I	   protoporphyrinogen	  oxidase	  
CP0979	  
SNP	  
(transition)	   1	   1,057,854	   1,057,854	   C	  -­‐>	  T	   G	  -­‐>	  R	   hypothetical	  protein	  
CP0983	  
SNP	  
(transition)	   1	   1,063,176	   1,063,176	   C	  -­‐>	  T	   	   Na(+)-­‐translocating	  NADH-­‐quinone	  reductase	  subunit	  F	  
CP0994	  
SNP	  
(transition)	   1	   1,077,315	   1,077,315	   A	  -­‐>	  G	   	   hypothetical	  protein	  
CP1006	  
SNP	  
(transition)	   1	   1,090,317	   1,090,317	   G	  -­‐>	  A	   	   phosphoglyceromutase	  
CP1011	  
SNP	  
(transition)	   1	   1,094,786	   1,094,786	   C	  -­‐>	  T	   H	  -­‐>	  Y	   type	  III	  secretion	  system	  ATPase	  
CP1013	  
SNP	  
(transition)	   1	   1,097,066	   1,097,066	   C	  -­‐>	  T	   	   UDP-­‐N-­‐acetylglucosamine	  pyrophosphorylase	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CP1028	  
SNP	  
(transition)	   1	   1,116,724	   1,116,724	   C	  -­‐>	  T	   	   preprotein	  translocase	  subunit	  SecA	  
CP1037	  
SNP	  
(transversion)	   1	   1,130,302	   1,130,302	   A	  -­‐>	  C	   K	  -­‐>	  T	   dihydrolipoamide	  dehydrogenase	  
CP1041	  
SNP	  
(transition)	   1	   1,133,397	   1,133,397	   G	  -­‐>	  A	   T	  -­‐>	  I	   hypothetical	  protein	  
CP1040	  
SNP	  
(transition)	   1	   1,133,397	   1,133,397	   G	  -­‐>	  A	   V	  -­‐>	  M	   hypothetical	  protein	  
	  
SNP	  
(transition)	   1	   1,140,488	   1,140,488	   T	  -­‐>	  C	   	   	  
CP1064	  
SNP	  
(transition)	   1	   1,156,514	   1,156,514	   T	  -­‐>	  C	   N	  -­‐>	  S	   hypothetical	  protein	  
CP1064	  
SNP	  
(transition)	   1	   1,156,798	   1,156,798	   T	  -­‐>	  C	   	   hypothetical	  protein	  
CP1070	  
SNP	  
(transition)	   1	   1,163,330	   1,163,330	   G	  -­‐>	  A	   	   excinuclease	  ABC	  subunit	  B	  
CP1071	  
SNP	  
(transition)	   1	   1,165,197	   1,165,197	   G	  -­‐>	  A	   G	  -­‐>	  E	   phosphopyruvate	  hydratase	  
CP1071	  
SNP	  
(transition)	   1	   1,165,855	   1,165,855	   T	  -­‐>	  C	   	   phosphopyruvate	  hydratase	  
CP1071	  
SNP	  
(transversion)	   1	   1,165,973	   1,165,973	   T	  -­‐>	  G	   S	  -­‐>	  A	   phosphopyruvate	  hydratase	  
CP1073	  
SNP	  
(transition)	   1	   1,167,855	   1,167,855	   T	  -­‐>	  C	   D	  -­‐>	  G	   hypothetical	  protein	  
CP1079	  
SNP	  
(transition)	   1	   1,174,880	   1,174,880	   G	  -­‐>	  A	   	   regulatory	  protein	  
CP1081	  
SNP	  
(transition)	   1	   1,179,362	   1,179,362	   C	  -­‐>	  T	   P	  -­‐>	  S	   hypothetical	  protein	  
CP1082	  
SNP	  
(transition)	   1	   1,181,204	   1,181,204	   C	  -­‐>	  T	   V	  -­‐>	  M	   succinate	  dehydrogenase	  iron-­‐sulfur	  subunit	  
CP1083	  
SNP	  
(transition)	   1	   1,182,013	   1,182,013	   A	  -­‐>	  G	   	   succinate	  dehydrogenase	  flavoprotein	  subunit	  
CP1084	  
SNP	  
(transition)	   1	   1,183,862	   1,183,862	   A	  -­‐>	  G	   I	  -­‐>	  T	   succinate	  dehydrogenase,	  cytochrome	  b558	  subunit	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CP1089	  
SNP	  
(transversion)	   1	   1,190,058	   1,190,058	   T	  -­‐>	  A	   H	  -­‐>	  Q	   hypothetical	  protein	  
CP1090	  
SNP	  
(transition)	   1	   1,190,380	   1,190,380	   T	  -­‐>	  C	   	   translocation	  protein	  TolB	  
CP1095	  
SNP	  
(transition)	   1	   1,194,585	   1,194,585	   C	  -­‐>	  T	   G	  -­‐>	  R	   molecular	  chaperone	  GroEL	  
CP1100	  
SNP	  
(transition)	   1	   1,199,318	   1,199,318	   C	  -­‐>	  T	   	   ATP-­‐dependent	  helicase	  PcrA	  
CP1100	  
SNP	  
(transition)	   1	   1,200,678	   1,200,678	   G	  -­‐>	  A	   A	  -­‐>	  T	   ATP-­‐dependent	  helicase	  PcrA	  
CP1106	  
SNP	  
(transition)	   1	   1,208,502	   1,208,502	   A	  -­‐>	  G	   K	  -­‐>	  R	   hypothetical	  protein	  
CP1108	  
SNP	  
(transition)	   1	   1,210,278	   1,210,278	   G	  -­‐>	  A	   E	  -­‐>	  K	   hypothetical	  protein	  
CP1110	  
SNP	  
(transition)	   1	   1,212,599	   1,212,599	   G	  -­‐>	  A	   E	  -­‐>	  K	   recombinase	  A	  
CP1117	  
SNP	  
(transition)	   1	   1,218,734	   1,218,734	   G	  -­‐>	  A	   	   hypothetical	  protein	  
CP1121	  
SNP	  
(transition)	   1	   1,222,885	   1,222,885	   T	  -­‐>	  C	   N	  -­‐>	  D	   hypothetical	  protein	  
CP1127	  
SNP	  
(transition)	   1	   1,229,386	   1,229,386	   C	  -­‐>	  T	   	   hypothetical	  protein	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Supplementary	   S2.	   AR39_TOR-­‐1	   Variants.	   Single	   nucleotide	   polymorphisms	   between	   AR39	   and	   TOR-­‐1.	   Table	   includes	   gene	   locus	   tag	  
designation	   (AR39	  numbering),	   position	   (AR39	  numbering),	   nucleotide	   change,	   amino	  acid	   change	  and	  product	  description	  of	   the	   gene.	  
Predicted	  SNPs	  resulting	  from	  degeneracies	  in	  the	  annotated	  AR39	  genome	  are	  not	  included.	  	  
	  
AR39	  to	  TOR-­‐1	  variants	  (degenerate	  nucleotides	  in	  AR39	  not	  included)	   	  
locus_tag	  
Polymorphism	  
Type	   Length	   Minimum	   Maximum	   Change	  
Amino	  
Acid	  
Change	   product	  
CP0007	  
SNP	  
(transversion)	   1	   10,414	   10,414	   C	  -­‐>	  G	   K	  -­‐>	  N	   exodeoxyribonuclease	  V,	  beta	  chain	  
CP0079	  
SNP	  
(transversion)	   1	   89,625	   89,625	   T	  -­‐>	  G	   M	  -­‐>	  L	   hypothetical	  protein	  
CP0189	  
SNP	  
(transition)	   1	   195,261	   195,261	   G	  -­‐>	  A	   	   hypothetical	  protein	  
CP0404	  
SNP	  
(transversion)	   1	   441,893	   441,893	   C	  -­‐>	  G	   R	  -­‐>	  G	   hypothetical	  protein	  
CP0405	  
SNP	  
(transversion)	   1	   443,335	   443,335	   C	  -­‐>	  A	   	   hypothetical	  protein	  
CP0405	  
SNP	  
(transversion)	   1	   443,484	   443,484	   C	  -­‐>	  G	   A	  -­‐>	  P	   hypothetical	  protein	  
CP0405	  
SNP	  
(transversion)	   1	   443,539	   443,539	   C	  -­‐>	  A	   	   hypothetical	  protein	  
CP0407	  
SNP	  
(transversion)	   1	   444,603	   444,603	   G	  -­‐>	  T	   Q	  -­‐>	  K	   hypothetical	  protein	  
CP0407	  
SNP	  
(transversion)	   1	   444,711	   444,711	   G	  -­‐>	  C	   R	  -­‐>	  G	   hypothetical	  protein	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CP0543	  
SNP	  
(transversion)	   1	   578,450	   578,450	   T	  -­‐>	  A	   	   hypothetical	  protein	  
CP0543	  
SNP	  
(transition)	   1	   578,465	   578,465	   T	  -­‐>	  C	   	   hypothetical	  protein	  
CP0543	  
SNP	  
(transition)	   1	   578,496	   578,496	   T	  -­‐>	  C	   E	  -­‐>	  G	   hypothetical	  protein	  
CP0543	  
SNP	  
(transversion)	   1	   578,520	   578,520	   G	  -­‐>	  T	   S	  -­‐>	  Y	   hypothetical	  protein	  
CP0543	  
SNP	  
(transition)	   1	   578,522	   578,522	   A	  -­‐>	  G	   	   hypothetical	  protein	  
CP0543	  
SNP	  
(transversion)	   1	   578,663	   578,663	   A	  -­‐>	  C	   	   hypothetical	  protein	  
CP0543	  
SNP	  
(transition)	   1	   578,690	   578,690	   A	  -­‐>	  G	   	   hypothetical	  protein	  
CP0543	  
SNP	  
(transversion)	   1	   578,719	   578,719	   A	  -­‐>	  C	   L	  -­‐>	  V	   hypothetical	  protein	  
CP0543	  
SNP	  
(transversion)	   1	   578,726	   578,726	   A	  -­‐>	  T	   	   hypothetical	  protein	  
CP0543	  
SNP	  
(transversion)	   1	   578,729	   578,729	   G	  -­‐>	  T	   N	  -­‐>	  K	   hypothetical	  protein	  
CP0543	  
SNP	  
(transversion)	   1	   578,764	   578,764	   C	  -­‐>	  A	   A	  -­‐>	  S	   hypothetical	  protein	  
CP0543	  
SNP	  
(transversion)	   1	   578,774	   578,774	   T	  -­‐>	  A	   	   hypothetical	  protein	  
	  
SNP	  
(transition)	   1	   578,780	   578,780	   C	  -­‐>	  T	   	   	  
	  
SNP	  
(transversion)	   1	   578,783	   578,783	   C	  -­‐>	  A	   	   	  
	  
SNP	  
(transversion)	   1	   623,551	   623,551	   A	  -­‐>	  T	   	   	  
CP0593	  
SNP	  
(transition)	   1	   625,992	   625,992	   A	  -­‐>	  G	   	   hypothetical	  protein	  
CP0595	  
SNP	  
(transversion)	   1	   626,586	   626,586	   G	  -­‐>	  T	   	   hypothetical	  protein	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CP0769	  
SNP	  
(transition)	   1	   833,292	   833,292	   A	  -­‐>	  G	   L	  -­‐>	  P	   hypothetical	  protein	  
	  
SNP	  
(transversion)	   1	   861,833	   861,833	   T	  -­‐>	  G	   	   	  
	  
SNP	  
(transversion)	   1	   861,836	   861,836	   T	  -­‐>	  G	   	   	  
	  
SNP	  
(transition)	   1	   861,842	   861,842	   A	  -­‐>	  G	   	   	  
CP0796	  
SNP	  
(transition)	   1	   862,320	   862,320	   A	  -­‐>	  G	   	   hypothetical	  protein	  
CP0796	  
SNP	  
(transversion)	   1	   862,328	   862,328	   C	  -­‐>	  G	   E	  -­‐>	  Q	   hypothetical	  protein	  
CP0796	  
SNP	  
(transversion)	   1	   862,633	   862,633	   T	  -­‐>	  A	   Y	  -­‐>	  F	   hypothetical	  protein	  
CP0796	  
SNP	  
(transition)	   1	   862,640	   862,640	   A	  -­‐>	  G	   S	  -­‐>	  P	   hypothetical	  protein	  
CP0797	  
SNP	  
(transversion)	   1	   863,338	   863,338	   A	  -­‐>	  C	   W	  -­‐>	  G	   hypothetical	  protein	  
CP0797	  
SNP	  
(transition)	   1	   863,349	   863,349	   A	  -­‐>	  G	   L	  -­‐>	  P	   hypothetical	  protein	  
CP0797	  
SNP	  
(transversion)	   1	   863,662	   863,662	   A	  -­‐>	  T	   L	  -­‐>	  M	   hypothetical	  protein	  
CP0891	  
SNP	  
(transition)	   1	   959,241	   959,241	   T	  -­‐>	  C	   	   Mtr/TnaB/TyrO	  permease	  family	  protein	  
CP0892	  
SNP	  
(transition)	   1	   959,755	   959,755	   G	  -­‐>	  A	   A	  -­‐>	  V	   glucosamine-­‐-­‐fructose-­‐6-­‐phosphate	  aminotransferase	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ABSTRACT	   39 
Background:	   The	   obligate	   intracellular	   bacterium	   Chlamydia	   pneumoniae	   is	   a	   40 
common	  respiratory	  pathogen,	  which	  has	  been	  found	   in	  a	  range	  of	  hosts	   including	   41 
humans,	   marsupials	   and	   amphibians.	   Whole	   genome	   comparisons	   of	   human	   C.	   42 
pneumoniae	   have	   previously	   highlighted	   a	   highly	   conserved	   nucleotide	   sequence,	   43 
with	  minor	  but	  key	  polymorphisms	  and	  additional	  coding	  capacity	  when	  human	  and	   44 
animal	  strains	  are	  compared.	  	   45 
Results:	  In	  this	  study,	  we	  sequenced	  three	  Australian	  human	  C.	  pneumoniae	  strains,	   46 
two	  of	  which	  were	   isolated	   from	  patients	   in	   remote	   indigenous	   communities,	   and	   47 
compared	  them	  to	  all	  available	  C.	  pneumoniae	  genomes.	  Our	  study	  demonstrated	  a	   48 
phylogenetically	  distinct	  human	  C.	  pneumoniae	  clade	  containing	  the	  two	  indigenous	   49 
Australian	   strains,	  with	   estimates	   that	   the	  most	   recent	   common	  ancestor	  of	   these	   50 
strains	   predates	   the	   arrival	   of	   European	   settlers	   to	   Australia.	  We	   describe	   several	   51 
polymorphisms	  characteristic	  to	  these	  strains,	  some	  of	  which	  are	  similar	  in	  sequence	   52 
to	   animal	   C.	   pneumoniae	   strains,	   as	   well	   as	   evidence	   to	   suggest	   that	   several	   53 
recombination	  events	  have	  shaped	  these	  distinct	  strains.	  	   54 
Conclusions:	   Our	   study	   reveals	   a	   greater	   sequence	   diversity	   amongst	   both	   human	   55 
and	  animal	  C.	  pneumoniae	  strains,	  and	  suggests	  that	  a	  wider	  range	  of	  strains	  may	  be	   56 
circulating	  in	  the	  human	  population	  than	  current	  sampling	  indicates.	  	   57 
	   58 
BACKGROUND	   59 
Chlamydia	   pneumoniae	   is	   an	   obligate	   intracellular	   bacterium	   and	   member	   of	   the	   60 
Chlamydiaceae,	  a	   family	  of	  pathogens	  of	  higher	  eukaryotes	  with	  a	  distinct	  biphasic	   61 
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development	   cycle	   [1].	   Whilst	   C.	   pneumoniae	   is	   primarily	   recognised	   as	   an	   62 
aetiological	  agent	  of	  community	  acquired	  pneumonia	  and	  other	  respiratory	  diseases	   63 
in	   humans	   [2],	   it	   has	   a	   broad	   host	   range	   encompassing	   both	  warm	   [3-­‐5]	   and	   cold	   64 
blooded	  animals	   [6,	  7].	   	  Members	  of	   the	  Chlamydiaceae	   are	  characterised	  by	   their	   65 
compact	   genomes	   and	   highly	   conserved	   gene	   content	   [8].	  C.	   pneumoniae	  has	   the	   66 
greatest	  coding	  capacity	  of	  the	  Chlamydiaceae,	  with	  animal	  strains	  of	  C.	  pneumoniae	   67 
having	   between	   20Kbp	   (animal	   versus	   human	   C.	   pneumoniae)	   to	   almost	   200Kbp	   68 
(animal	  C.	  pneumoniae	  versus	  C.	   trachomatis	   serovar	  D)	   [9,	  10]	  of	  extra	  nucleotide	   69 
sequence.	   The	   additional	   coding	   capacity	   of	   C.	   pneumoniae	   is	   predominantly	   70 
accounted	   for	   by	   the	   expansion	   of	   the	   polymorphic	  membrane	   protein	   (pmp)	   and	   71 
inclusion	  membrane	  protein	  (inc)	  gene	  families	  [10-­‐12],	  both	  of	  which	  are	  involved	  in	   72 
the	  formation	  and	  maintenance	  of	  the	  chlamydial	  inclusion	  body,	  modulation	  of	  the	   73 
host	  cell	   response	   [12,	  13],	  as	  well	  as	  a	   large	  number	  of	   species-­‐specific	  metabolic	   74 
and	  hypothetical	  protein	  genes	  [9,	  10,	  14].	  	  	   75 
	   76 
In	  addition	  to	  its	  description	  as	  a	  cause	  of	  human	  respiratory	  disease,	  C.	  pneumoniae	   77 
has	   been	   implicated	   in	   a	   variety	   of	   human	   pathologies,	   including	   cardiovascular	   78 
disease,	  Alzheimer’s	  disease,	  ischaemic	  stroke,	  asthma	  and	  lung	  cancer[15-­‐18].	  Until	   79 
recently,	  the	  majority	  of	  fully	  sequenced	  C.	  pneumoniae	  whole	  genomes	  were	  from	   80 
strains	   that	   were	   isolated	   from	   respiratory	   pathologies	   [10,	   19,	   20],	   and	   81 
demonstrated	   highly	   conserved	   nucleotide	   sequence	   content	   and	   gene	   order.	   82 
Recently,	   several	   genomes	   from	   respiratory	   and	   cardiovascular	   strains	   were	   83 
reported,	  as	  were	  whole	  genome	  sequences	  from	  atherosclerotic	  and	  Alzheimer's	  C.	   84 
pneumoniae	  strains,	  which	  allowed	  for	  comparison	  of	  strains	  isolated	  from	  different	   85 
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diseases,	   and	   demonstrated	   that	   only	   minor	   genetic	   differences	   were	   found	   86 
between	  these	  strains	  [9,	  21,	  22].	  	   87 
	   88 
A	   previous	   study	   examining	   the	   genetic	   diversity	   between	   human	   and	   animal	   C.	   89 
pneumoniae	  suggested	  that	  a	  genetically	  distinct	  strain	  of	  human	  C.	  pneumoniae	  was	   90 
present	  and	  circulating	  within	  Australian	  indigenous	  communities	  [23].	  PCR	  analysis	   91 
of	  a	  small	  number	  of	  selected	  target	  genes	  was	  performed	  on	  two	  respiratory	  strains	   92 
isolated	  from	  Indigenous	  Australian	  patients	  in	  geographically	  separate	  regions	  [24,	   93 
25]	   and	   these	   were	   shown	   to	   have	   nucleotide	   sequence,	   that	   in	   some	   instances,	   94 
placed	  these	  strains	  phylogenetically	  closer	  to	  animal	  strains	  of	  C.	  pneumoniae	  than	   95 
those	  circulating	  in	  human	  populations	  in	  Australia	  and	  worldwide	  [23].	  	   96 
	   97 
To	  further	  explore	  the	  genetic	  diversity	  of	  Australian	  human	  C.	  pneumoniae	  strains,	   98 
we	   genome	   sequenced	   and	   performed	   comparative	   genomic	   and	   phylogenetic	   99 
analyses	   of	   two	   human	   Australian	   indigenous	   C.	   pneumoniae	   strains	   and	   a	   third	   100 
strain	  from	  an	  Australian	  Caucasian	  patient.	  In	  doing	  so,	  we	  (i)	  demonstrate	  that	  the	   101 
indigenous	   Australian	   human	   strains	   form	   a	   separate	   clade	   branching	   earlier	   than	   102 
other	   human	   C.	   pneumoniae	   strains;	   (ii)	   identify	   genetic	   markers	   unique	   to	   103 
Australian	  indigenous	  and	  non-­‐indigenous	  strains;	  and	  (iii)	  reveal	  evidence	  of	  limited	   104 
recombination	  within	  C.	  pneumoniae	  strains	  from	  the	  greater	  human	  C.	  pneumoniae	   105 
clade.	   106 
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MATERIALS	  AND	  METHODS	   109 
	   110 
Description	  of	  Chlamydia	  pneumoniae	  strains,	  cell	  culturing	  and	  DNA	  purification	   111 
Three	  Australian	  C.	  pneumoniae	  cultured	  isolates	  (WA97001,	  SH511	  and	  1979)	  were	   112 
used	  for	  comparative	  analyses	  in	  this	  study.	  The	  non-­‐indigenous	  isolate	  WA97001	  is	   113 
a	  clinical	  nasopharyngeal	   isolate	   from	  Western	  Australia	   [26]	  whilst	   isolates	  SH511	   114 
and	  1979	   are	   indigenous	  Australian	   isolates	   from	   two	   separate	  patients	   in	   remote	   115 
Northern	  Territory	  communities	  [24,	  25].	   116 
	   117 
Isolate	   WA97001	   was	   propagated	   on	   McCoy	   cells	   in	   T75	   flasks	   for	   five	   passages,	   118 
based	  on	  a	  previously	  described	  method	  [27].	  Infected	  cells	  were	  pooled	  and	  semi-­‐ 119 
purified	   using	   a	   sonication	   and	   centrifugation	   method	   prior	   to	   passage.	   The	   final	   120 
semi-­‐purified	  product	  was	  stored	  in	  an	  equal	  volume	  of	  SPG	  media	  [28].	  500µl	  of	  this	   121 
semi-­‐purified	  material	  was	  used	  for	  DNA	  extraction.	   Isolates	  SH511	  and	  1979	  were	   122 
extracted	   from	  non-­‐viable	  archival	   culture	  material	   [23];	  500µl	   of	  each	   isolate	  was	   123 
used	  for	  DNA	  extraction.	  	  	   124 
	   125 
DNA	   extraction	   was	   performed	   using	   phenol:chloroform:IAA,	   based	   on	   a	   well	   126 
described	   method	   [29],	   with	   the	   addition	   of	   2µl	   of	   glycogen	   prior	   to	   ethanol	   127 
precipitation	  at	  -­‐20°C	  overnight.	  Precipitated	  DNA	  was	  dissolved	  in	  50µl	  of	  TE	  buffer.	   128 
500ng	  of	  extracted	  DNA	  was	  used	  to	  perform	  pan-­‐Chlamydiales	  16S	  rRNA	  [30]	  and	  C.	   129 
pneumoniae	  specific	  RpoB	  [31]	  PCR	  to	  confirm	  the	  presence	  of	  C.	  pneumoniae	  DNA,	   130 
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and	  500ng	  of	  stock	  DNA	  was	  electrophoresed	  on	  a	  0.8%	  TBE	  agarose	  gel	  to	  confirm	   131 
high	  molecular	  weight	  DNA.	   	  Each	  DNA	  extraction	  yielded	  greater	  than	  2µg	  of	  high	   132 
molecular	  weight	  genomic	  DNA,	  which	  was	  used	  for	  sequence	  capture	  and	  Illumina	   133 
HiSeq	   2500	   whole	   genome	   sequencing	   at	   the	   Institute	   for	   Genome	   Sciences,	   134 
Baltimore,	  Maryland.	   135 
	   136 
Sequence	  capture,	  whole	  genome	  sequencing	  and	  assembly	   137 
Sequence	  capture	  was	  performed	  on	  total	  DNA	  extracted	  from	  WA97001,	  SH511	  and	   138 
1979	   with	   Agilent	   SureSelectXT	   DNA	   capture	   probes	   designed	   to	   C.	   pneumoniae	   139 
reference	  strain	  AR39,	  using	  a	  hybridisation	  capture	  and	  amplification	  process	   [32-­‐ 140 
34].	  Captured	  and	  amplified	  products	  were	  sequenced	  using	  the	  Illumina	  HiSeq	  2500	   141 
platform,	  resulting	  in	  paired-­‐end	  100	  base	  pair	  reads.	  Read	  quality	  was	  checked	  with	   142 
FastQC	  (http://www.bioinformatics.bbsrc.ac.uk/projects/fastqc/)	  and	  genomes	  were	   143 
assembled	  de	  novo	  using	  SPAdes	  3.0.0	  with	  SPAdes	  3.0.0	  with	  k-­‐mer	  values	  set	  to	  of	   144 
15,	  21,	  33,	  51	  and	  71	   [35].	  All	   assembled	   contigs	  were	  aligned	   to	   the	   reference	  C.	   145 
pneumoniae	   AR39	   genome	   using	   BLASTn	   to	   remove	   non-­‐chlamydial	   contigs.	   146 
Concatenated	   genome	   contigs	   were	   annotated	   using	   the	   RAST	   pipeline	   [36]	   and	   147 
manually	   curated	   using	   ARTEMIS	   [37].	   Total	   read	   depth	   of	   WA97001,	   SH511	   and	   148 
1979	   was	   calculated	   by	   mapping	   the	   raw	   reads	   to	   complete	   genome	   of	   C.	   149 
pneumoniae	  AR39	  using	  the	  BWA-­‐backtrack	  algorithm	  with	  BWA	  aligner	  [38].	   	  Raw	   150 
reads	   were	   also	   mapped	   to	   the	   complete	   genome	   of	   C.	   pneumoniae	   LPCoLN	   for	   151 
comparison.	  The	  BWA	  parameters	  used	   include	   the	  number	  of	  differences	  allowed	   152 
between	  the	  reference	  and	  query	  set	  at	  0.04	  and	  the	  number	  of	  differences	  allowed	   153 
in	  the	  seed	  was	  2.	  The	  maximum	  number	  of	  gaps	  allowed	  in	  the	  alignment	  was	  1	  and	   154 
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the	  gap	  penalty	  was	  set	  at	  11.	   155 
	   156 
Availabilty	  of	  supporting	  data	   157 
The	  WA97001,	  SH511	  and	  1979	  whole	  genome	  sequencing	  projects	  can	  be	  found	  on	   158 
National	   Center	   for	   Biotechnology	   Information	   (NCBI)	   BioProject	   under	   accession	   159 
numbers	   [Bioproject:PRJNA291806,	   Bioproject:PRJNA291802	   and	   160 
Bioproject:PRJNA291805]	   with	   reads	   deposited	   in	   the	   Short	   Reads	   Archive	   under	   161 
accession	   numbers	   [SRA:SRR2144962,	   SRA:SRR2144961	   and	   SRA:SRR2144960]	   162 
respectively.	   163 
	   164 
Phylogenetic	  and	  recombination	  analyses	   165 
De	  novo	  assemblies	  and	  readmapped	  assembled	  consensus	  sequences	  for	  WA97001,	   166 
SH511	  and	  1979	  were	  aligned	  to	  the	  existing	  human	  C.	  pneumoniae	  whole	  genome	   167 
sequences	   [10,	  19-­‐22,	  39]	  and	  animal	  C.	  pneumoniae	  strains	  LPCoLN,	  B21	  and	  DC9	   168 
[9,	   22,	   40]	   in	   Geneious	   6.1.8	   [41]	   using	   the	   MAFFT	   plugin	   implementation	   [42].	   169 
Coverage	   analyses	   for	   readmapped	   assemblies	   and	  manual	   curation	   of	   annotated	   170 
genomes	  was	  performed	  using	  ARTEMIS	  [37].	  	   171 
	   172 
Phylogenetic	   analyses	   were	   performed	   on	   whole	   genome	   alignments,	   with	   the	   173 
LPCoLN	   koala	   [9]	   C.	   pneumoniae	   strain	   indicated	   as	   an	   outlier.	   Whole	   genome	   174 
alignments	  were	  also	  filtered	  for	  poorly	  aligned	  and	  gap	  regions	  using	  Gblocks	  0.91b	   175 
[43].	   Mid-­‐point	   rooted	   trees	   were	   constructed	   with	   the	   MrBayes	   plugin	   [44]	   in	   176 
Geneious,	  utilising	  a	   Jukes-­‐Cantor	   substitution	  model	  with	  with	   four	  Markov	  Chain	   177 
Monte	  Carlo	  (MCMC)	  chains	  and	  1.1	  million	  cycles,	  sampled	  every	  1000	  generations	   178 
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and	   the	   first	   10,000	   trees	   discarded	   as	   burn-­‐in.	   Estimates	   of	   strain	   evolution	   over	   179 
time	  were	  performed	  on	  whole	  genome	  alignments	  using	   the	  BEAST	  package	   [45].	  	   180 
Indigenous,	  non-­‐indigenous	  and	  animal	  isolates	  were	  defined	  in	  separate	  taxon	  sets	   181 
and	  a	  GTR	  nucleotide	  substitution	  model	  was	  employed.	  MRCA	  priors	  were	  set	  at	  a	   182 
normal	  distribution	  with	  a	  mean	  of	  95.2	  +/-­‐	  7.4	  [46].	  	  MCMC	  chain	  length	  was	  set	  to	   183 
5x107	   to	   ensure	   effective	   sample	   sizes	   were	   sufficient	   for	   strong	   posterior	   184 
distribution	   statistics.	   	   ClonalFrame	   [47]	   was	   used	   to	   determine	   homologous	   185 
recombination	   within	   C.	   pneumoniae	   genomes,	   and	   progressive	   MAUVE	   [48]	   was	   186 
used	  to	  generate	  the	   input	  alignments.	  Three	  successive	  runs	  of	  ClonalFrame	  were	   187 
performed	  on	  the	  whole	  genome	  alignment,	  each	  with	  20,000	  iterations	  and	  10,000	   188 
of	   these	   discarded	   as	   burn-­‐in.	   The	   three	   runs	   were	   checked	   for	   convergence	   and	   189 
their	   trees	   combined	   for	   analysis.	   	   An	   additional	   Phi	   test	   for	   recombination	   was	   190 
performed	   in	   SplitsTree4	   [49]	   using	   the	   whole	   genome	   alignment	   generated	   by	   191 
MAFFT	  in	  Geneious.	  	   192 
	   193 
The	  accession	  numbers	  for	  the	  C.	  pneumoniae	  whole	  genome	  sequences	  used	  in	  the	   194 
comparative	  analyses	  and	  phylogenies	  are	  outlined	  in	  Table	  1.	   195 
	   196 
197 
	  Chapter	  Five:	  Phylogenetic	  analysis	  of	  human	  Chlamydia	  pneumoniae	  strains	  reveals	  a	  distinct	  Australian	  
indigenous	  clade	  that	  predates	  European	  exploration	  of	  the	  continent	   136	  
	   197 
Table	  1:	  C.	  pneumoniae	  strain	  designations	  and	  accession	  numbers	   198 
Strain	  designation	   Accession	  number	   Reference/s	  
A03	   SRP056807	   [15,	  21]	  
AR39	   NC_002179.2	   [19]	  
B21	   NZ_AZNB01000000	  
	  
[37]	  
CM1	   ERS640705	   [22]	  
CV14	   ERS640706	   [22]	  
CV15	   ERS640707	   [22]	  
CWL011	   ERS640708	   [22]	  
CWL029	   NC_000922.1	   [10]	  
DC9	   ERS640710	   [22]	  
GiD	   ERS640711	   [22]	  
H12	   ERS640712	   [22]	  
IOL207	   -­‐	   [22]	  
J138	   NC_002491.1	   [20]	  
K7	   ERS640713	   [22]	  
LPCoLN	   NC_017285.1	   [9]	  
MUL2216	   ERS640714	   [22]	  
Panola	   ERS640715	   [22]	  
PB1	   ERS640716	   [22]	  
PB2	   ERS640717	   [22]	  
SH511	   SRP061961	   [25]	  This	  study	  
TOR-­‐1	   SRP056806	   [21,	  16]	  
TW183	   NC_005043.1	   Unpublished	  
U1271	   ERS640718	   [22]	  
UZG1	   ERS640719	   [22]	  
WA97001	   SRP062032	   [26]	  This	  study	  
Wien1	   ERS640720	   [22]	  
Wien2	   ERS640721	   [22]	  
Wien3	   ERS640722	   [22]	  
YK41	   ERS640723	   [22]	  
1979	   SRP062031	   [25]	  This	  study	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Description	  of	  polymorphic	  hotspots	  in	  C.	  pneumoniae	  whole	  genome	  alignments	  
De	  novo	  and	  readmapping	  assemblies	  were	  used	  to	  construct	  whole	  genome	  alignments	  
with	  previously	  described	  human	  and	  animal	  C.	  pneumoniae	  whole	  genomes	   in	  MAFFT	  
[42]	   in	  Geneious	   [41].	  Single	  nucleotide	  polymorphisms	   (SNPs)	  and	   insertions/deletions	  
were	  detected	  using	   the	  Variations/SNPs	   tool	   in	  Geneious,	  and	   larger	   scale	  differences	  
were	  detected	  via	  manual	  scanning	  of	  the	  genome	  alignment.	  Sequence	  for	  genes	  which	  
appeared	   to	   have	   significant	   deletions	   or	   insertions	   were	   manually	   extracted	   and	  
sequence	   run	   against	   the	   BLAST	   [50]	   database	   to	   determine	   closest	   homologs.	  
Sequences	  were	  translated	  and	  searched	  against	  the	  SMART	  database	  [51]	  to	  predict	  any	  




Phylogenetic	   relationships	   in	   human	   C.	   pneumoniae	   reveal	   a	   distinct	   Australian	  
indigenous	  clade	  predating	  European	  exploration	  of	  the	  continent	  
C.	   pneumoniae	   strains	   SH511,	   1979	   [24,	   25]	   and	   WA97001	   [26]	   were	   sequenced	  
following	  capture	  of	  C.	  pneumoniae	  DNA	  using	  a	  set	  of	  species-­‐specific	  SureSelectXT	  RNA	  
probes	   [32-­‐34].	   Sequencing	   reads	   of	   C.	   pneumoniae	  WA97001,	   SH511	   and	   1797	  were	  
mapped	   to	   the	   reference	   genome,	   C.	   pneumoniae	   AR39,	   to	   check	   the	   efficacy	   of	   the	  
SureSelectXT	  DNA	  captures.	  The	  genome	  of	  SH511	  had	  the	  highest	  mean	  read	  depth	  of	  
1944x,	   followed	   by	   1979,	  which	   had	   an	   average	   read	   depth	   of	   1887x.	   The	   SH511	   and	  
1979	  assembled	  into	  10	  contigs	  and	  31	  contigs,	  respectively.	  In	  contrast,	  C.	  pneumoniae	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WA97001	  genome	  had	  a	  significantly	   lower	   read	  depth	  of	  15x	  and	  assembled	   into	  104	  
contigs.	  	  
In	   order	   to	   determine	   the	   evolutionary	   and	   phylogenetic	   relationships	   between	   the	  
Australian	   C.	   pneumoniae	   strains	   and	   those	   previously	   published,	   Bayesian	   and	  
coalescent	   estimation	   methods	   were	   used	   to	   construct	   phylogenetic	   trees	   based	   on	  
whole	  genome	  alignments	  of	  all	  human	  C.	  pneumoniae	  strains	  and	  the	  three	  published	  
animal	  C.	  pneumoniae	  strains.	  	  
	  
Percentage	   pairwise	   identities	   between	   indigenous	   and	   non-­‐indigenous	   strains	   ranged	  
from	   98.4	   to	   98.8%,	   whilst	   non-­‐indigenous	   strains	   were	   99.0%	   or	   greater.	   Percentage	  
identities	   of	   all	   strains	   used	   in	   the	   MrBayes	   analysis	   are	   outlined	   in	   Table	   2.
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Table	  2	  -­‐	  Percentage	  nucleotide	  pairwise	  identities	  of	  all	  C.	  pneumoniae	  strains	  
CM1	   GiD	  
TOR-­‐
1	   AR39	   YK41	   J138	   CV14	   PB2	   PB1	   CWL011	   Wien3	   CWL029	   U1271	   CV15	   Wien1	   K7	   Wien2	   MUL2216	   Panola	   H12	   UZG1	   TW183	   A03	   WA97001	   1979	   SH511	   IOL207	   DC9	   LPCoLN	   B21	  
CM1	   100	   100	   100	   99.9	   99.7	   99.7	   99.7	   99.7	   99.8	   99.8	   99.6	   99.8	   99.7	   99.7	   99.8	   99.8	   99.8	   99.8	   99.4	   99.6	   99.6	   99.5	   99.7	   98.6	   98.7	   99.2	   97.9	   94.6	   94.6	  
GiD	   100	   100	   100	   99.9	   99.7	   99.7	   99.7	   99.7	   99.8	   99.8	   99.6	   99.8	   99.7	   99.7	   99.8	   99.8	   99.8	   99.8	   99.4	   99.6	   99.6	   99.5	   99.7	   98.6	   98.7	   99.2	   97.9	   94.6	   94.6	  
TOR-­‐1	   100	   100	   100	   99.9	   99.7	   99.7	   99.7	   99.7	   99.8	   99.8	   99.6	   99.8	   99.7	   99.7	   99.8	   99.8	   99.8	   99.8	   99.4	   99.6	   99.6	   99.5	   99.7	   98.6	   98.7	   99.2	   97.9	   94.6	   94.6	  
AR39	   100	   100	   100	   99.9	   99.7	   99.7	   99.7	   99.7	   99.8	   99.8	   99.6	   99.8	   99.7	   99.7	   99.8	   99.8	   99.8	   99.8	   99.4	   99.6	   99.6	   99.5	   99.7	   98.6	   98.7	   99.2	   97.9	   94.6	   94.6	  
YK41	   99.9	   99.9	   99.9	   99.9	   99.6	   99.7	   99.7	   99.7	   99.7	   99.7	   99.6	   99.7	   99.7	   99.7	   99.7	   99.7	   99.7	   99.7	   99.4	   99.5	   99.5	   99.5	   99.7	   98.6	   98.6	   99.2	   97.9	   94.6	   94.6	  
J138	   99.7	   99.7	   99.7	   99.7	   99.6	   99.7	   99.7	   99.7	   99.7	   99.7	   99.6	   99.7	   99.7	   99.7	   99.7	   99.7	   99.7	   99.7	   99.4	   99.5	   99.5	   99.5	   99.5	   98.7	   98.7	   99.2	   97.9	   94.8	   94.8	  
CV14	   99.7	   99.7	   99.7	   99.7	   99.7	   99.7	   100	   100	   100	   100	   99.8	   100	   100	   100	   100	   100	   100	   100	   99.6	   99.7	   99.7	   99.6	   99.5	   98.7	   98.7	   99.4	   98	   94.7	   94.7	  
PB2	   99.7	   99.7	   99.7	   99.7	   99.7	   99.7	   100	   100	   100	   100	   99.8	   100	   100	   100	   99.9	   99.9	   99.9	   99.9	   99.6	   99.7	   99.7	   99.6	   99.5	   98.7	   98.7	   99.4	   98	   94.7	   94.7	  
PB1	   99.7	   99.7	   99.7	   99.7	   99.7	   99.7	   100	   100	   100	   100	   99.8	   100	   100	   100	   100	   100	   100	   99.9	   99.6	   99.7	   99.7	   99.6	   99.5	   98.7	   98.7	   99.4	   98	   94.7	   94.7	  
CWL011	   99.8	   99.8	   99.8	   99.8	   99.7	   99.7	   100	   100	   100	   100	   99.9	   100	   100	   100	   100	   100	   100	   100	   99.7	   99.7	   99.7	   99.6	   99.5	   98.7	   98.8	   99.4	   98	   94.7	   94.7	  
Wein3	   99.8	   99.8	   99.8	   99.8	   99.7	   99.7	   100	   100	   100	   100	   99.9	   100	   100	   100	   100	   100	   100	   100	   99.7	   99.7	   99.7	   99.6	   99.5	   98.7	   98.8	   99.4	   98	   94.7	   94.7	  
CWL029	   99.6	   99.6	   99.6	   99.6	   99.6	   99.6	   99.8	   99.8	   99.8	   99.9	   99.9	   99.9	   99.8	   99.8	   99.9	   99.9	   99.9	   99.9	   99.5	   99.6	   99.6	   99.8	   99.4	   98.9	   98.9	   99.3	   97.9	   94.6	   94.6	  
U1271	   99.8	   99.8	   99.8	   99.8	   99.7	   99.7	   100	   100	   100	   100	   100	   99.9	   100	   100	   100	   100	   100	   100	   99.7	   99.7	   99.7	   99.6	   99.5	   98.7	   98.8	   99.4	   98	   94.7	   94.7	  
CV15	   99.7	   99.7	   99.7	   99.7	   99.7	   99.7	   100	   100	   100	   100	   100	   99.8	   100	   100	   100	   100	   100	   100	   99.6	   99.7	   99.7	   99.6	   99.5	   98.7	   98.7	   99.4	   98	   94.7	   94.7	  
Wein1	   99.7	   99.7	   99.7	   99.7	   99.7	   99.7	   100	   100	   100	   100	   100	   99.8	   100	   100	   100	   100	   100	   100	   99.6	   99.7	   99.7	   99.6	   99.5	   98.7	   98.7	   99.4	   98	   94.7	   94.7	  
K7	   99.8	   99.8	   99.8	   99.8	   99.7	   99.7	   100	   99.9	   100	   100	   100	   99.9	   100	   100	   100	   100	   100	   100	   99.7	   99.7	   99.7	   99.6	   99.5	   98.7	   98.8	   99.4	   98	   94.7	   94.7	  
Wein2	   99.8	   99.8	   99.8	   99.8	   99.7	   99.7	   100	   99.9	   100	   100	   100	   99.9	   100	   100	   100	   100	   100	   100	   99.7	   99.7	   99.7	   99.6	   99.5	   98.7	   98.8	   99.4	   98	   94.7	   94.7	  
MUL2216	   99.8	   99.8	   99.8	   99.8	   99.7	   99.7	   100	   99.9	   100	   100	   100	   99.9	   100	   100	   100	   100	   100	   100	   99.7	   99.7	   99.7	   99.6	   99.5	   98.7	   98.8	   99.4	   98	   94.7	   94.7	  
Panola	   99.8	   99.8	   99.8	   99.8	   99.7	   99.7	   100	   99.9	   99.9	   100	   100	   99.9	   100	   100	   100	   100	   100	   100	   99.7	   99.7	   99.7	   99.6	   99.5	   98.7	   98.8	   99.4	   98	   94.7	   94.7	  
H12	   99.4	   99.4	   99.4	   99.4	   99.4	   99.4	   99.6	   99.6	   99.6	   99.7	   99.7	   99.5	   99.7	   99.6	   99.6	   99.7	   99.7	   99.7	   99.7	   99.4	   99.4	   99.3	   99.2	   98.4	   98.4	   99.1	   97.8	   94.4	   94.4	  
UZG1	   99.6	   99.6	   99.6	   99.6	   99.5	   99.5	   99.7	   99.7	   99.7	   99.7	   99.7	   99.6	   99.7	   99.7	   99.7	   99.7	   99.7	   99.7	   99.7	   99.4	   100	   99.6	   99.3	   98.8	   98.8	   99.2	   98.2	   94.5	   94.5	  
TW183	   99.6	   99.6	   99.6	   99.6	   99.5	   99.5	   99.7	   99.7	   99.7	   99.7	   99.7	   99.6	   99.7	   99.7	   99.7	   99.7	   99.7	   99.7	   99.7	   99.4	   100	   99.6	   99.3	   98.8	   98.8	   99.2	   98.2	   94.5	   94.5	  
A03	   99.5	   99.5	   99.5	   99.5	   99.5	   99.5	   99.6	   99.6	   99.6	   99.6	   99.6	   99.8	   99.6	   99.6	   99.6	   99.6	   99.6	   99.6	   99.6	   99.3	   99.6	   99.6	   99.3	   98.9	   98.9	   99.1	   97.9	   94.5	   94.4	  
WA97001	   99.7	   99.7	   99.7	   99.7	   99.7	   99.5	   99.5	   99.5	   99.5	   99.5	   99.5	   99.4	   99.5	   99.5	   99.5	   99.5	   99.5	   99.5	   99.5	   99.2	   99.3	   99.3	   99.3	   98.8	   98.8	   99	   97.8	   94.5	   94.5	  
1979	   98.6	   98.6	   98.6	   98.6	   98.6	   98.7	   98.7	   98.7	   98.7	   98.7	   98.7	   98.9	   98.7	   98.7	   98.7	   98.7	   98.7	   98.7	   98.7	   98.4	   98.8	   98.8	   98.9	   98.8	   99.7	   98.4	   97.5	   94.2	   94.2	  
SH511	   98.7	   98.7	   98.7	   98.7	   98.6	   98.7	   98.7	   98.7	   98.7	   98.8	   98.8	   98.9	   98.8	   98.7	   98.7	   98.8	   98.8	   98.8	   98.8	   98.4	   98.8	   98.8	   98.9	   98.8	   99.7	   98.4	   97.5	   94.3	   94.3	  
IOL207	   99.2	   99.2	   99.2	   99.2	   99.2	   99.2	   99.4	   99.4	   99.4	   99.4	   99.4	   99.3	   99.4	   99.4	   99.4	   99.4	   99.4	   99.4	   99.4	   99.1	   99.2	   99.2	   99.1	   99	   98.4	   98.4	   97.6	   94.3	   94.3	  
DC9	   97.9	   97.9	   97.9	   97.9	   97.9	   97.9	   98	   98	   98	   98	   98	   97.9	   98	   98	   98	   98	   98	   98	   98	   97.8	   98.2	   98.2	   97.9	   97.8	   97.5	   97.5	   97.6	   93.6	   93.6	  
LPCoLN	   94.6	   94.6	   94.6	   94.6	   94.6	   94.8	   94.7	   94.7	   94.7	   94.7	   94.7	   94.6	   94.7	   94.7	   94.7	   94.7	   94.7	   94.7	   94.7	   94.4	   94.5	   94.5	   94.5	   94.5	   94.2	   94.3	   94.3	   93.6	   100	  
B21	   94.6	   94.6	   94.6	   94.6	   94.6	   94.8	   94.7	   94.7	   94.7	   94.7	   94.7	   94.6	   94.7	   94.7	   94.7	   94.7	   94.7	   94.7	   94.7	   94.4	   94.5	   94.5	   94.4	   94.5	   94.2	   94.3	   94.3	   93.6	   100	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The	   resulting	   phylogenetic	   tree	   as	   represented	   in	   Figure	   1,	   demonstrates	   a	   clear	  
demarcation	  of	  animal	  and	  human	  clades.	  The	  majority	  of	  non-­‐indigenous	  human	  strains	  
cluster	   into	   two	   clades:	   a	   large	   single	   clade	   that	   contains	   the	   AR39	   and	   CWL029	  
subclades,	   and	   the	   smaller	   TW183	   clade	   [22].	   Interestingly,	   the	   two	   Australian	  
indigenous	   C.	   pneumoniae	   strains,	   SH511	   and	   1979,	   formed	   their	   own	   clade	   which	  
branched	   deepest	   from	   the	   main	   human	   C.	   pneumoniae	   grouping,	   but	   was	   also	  
considerably	  distant	  to	  the	  animal	  C.	  pneumoniae	  clade.	  	  The	  Australian	  caucasian	  strain	  
WA97001	  and	  IOL207	  (a	  strain	  isolated	  from	  a	  case	  of	  acute	  conjunctivitis)	  [52]	  formed	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Figure	   1	   -­‐	   Chlamydia	   pneumoniae	   whole	   genome	   phylogeny	   constructed	   using	   MrBayes.	   Posterior	  
probabilities	  >0.75	  shown.	  Animal	  and	  human	  C.	  pneumoniae	  strains	  form	  the	  two	  major	  clades,	  with	  four	  
distinct	  clades	  within	  the	  human	  C.	  pneumoniae	  tree.	  	  
To	   investigate	   the	   evolutionary	   relationships	   of	   these	   deep-­‐branching	   Australian	  
indigenous	  human	  strains	  further,	  we	  determined	  the	  date	  of	  the	  most	  recent	  common	  
ancestor	  (MRCA)	  of	  the	  indigenous	  Australian	  C.	  pneumoniae	  strains	  by	  using	  BEAST	  [45]	  
and	  ClonalFrame	  [53]	  coalescent	  estimation	  methods.	  BEAST	  analysis	  of	  indigenous	  and	  
non-­‐indigenous	  C.	  pneumoniae	  strains	   reveals	  an	  MRCA	  for	   indigenous	  strains	  at	  1028,	  
with	  a	  95%	  credibility	  interval	  between	  996	  and	  1062	  years.	  The	  mean	  substitution	  rate	  
was	  determined	  to	  be	  4.64x10-­‐4	  substitutions	  per	  site,	  per	  year.	  ClonalFrame	  analysis	  of	  
indigenous	  and	  non-­‐indigenous	  C.	  pneumoniae	   strains	   reveals	   a	  MRCA	  of	   1425	   for	   the	  
indigenous	  strains,	  with	  a	  mean	  substitution	  rate	  of	  2.36x10-­‐5	  per	  site	  per	  year.	  Though	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there	  are	  minor	  differences	   in	  the	  predicted	  MRCA	  and	  substitution	  rates	  between	  the	  
two	  programs,	  which	  can	  be	  accounted	  for	  by	  the	  difference	  in	  their	  calculation	  methods	  
[54],	  their	  estimates	  support	  similar	  evolutionary	  timelines	  and	  dates.	  	  
	  
Identification	   of	   genetic	   markers	   that	   distinguish	   Australian	   indigenous	   strains	   from	  
non-­‐indigenous	  and	  animal	  C.	  pneumoniae	  strains.	  
Using	   a	   PCR-­‐based	   sequencing	   approach,	  we	  previously	   identified	   a	   series	   of	   potential	  
genetic	  markers	   that	   could	   be	   used	   to	   distinguish	   Caucasian	  C.	   pneumoniae	   strains	   of	  
different	  origins	  [23].	  In	  the	  current	  study,	  fine-­‐detailed	  genomic	  comparisons	  identified	  
a	  series	  of	  novel	  genetic	  markers	  unique	  to	  the	  Australian	  indigenous	  strains,	  as	  well	  as	  
unexpected	  sequence	  diversity	  in	  the	  DC9,	  WA97001	  and	  IOL207	  strains,	  which	  support	  
their	  distinct	  phylogenetic	  positions	  in	  the	  C.	  pneumoniae	  tree.	  	  
	  
One	  of	  the	  most	  significant	  regions	  of	  genetic	  variation	  identified	  is	  located	  around	  four	  
full-­‐length	  IncA	  genes	  annotated	  in	  koala	  strain	  LPCoLN	  (CPK_ORF00546	  to	  CPKORF00549	  
[9]);	  the	  differences	  of	  which	  support	  our	  phylogenetic	  results.	  The	  most	  notable	  finding	  
in	   this	   region	   for	   the	   three	   Australian	   strains	   was	   the	   observation	   that	   the	   Australian	  
indigenous	   strains	   contain	   a	   full-­‐length	   homolog	   of	   CPK_ORF00549	   sharing	   99.4%	  
nucleotide	  pairwise	  identity	  to	  the	  koala	  homolog	  (Figure	  2).	  The	  presence	  of	  this	  gene	  in	  
strains	   SH511	   and	   1979,	   and	   its	   significant	   sequence	   identity	   to	   the	   koala/bandicoot	  
homolog	   supports	   the	   branching	   of	   the	   Australian	   indigenous	   clade	   earliest	   in	   the	  
greater	  human	  C.	  pneumoniae	  phylogeny.	  Conversely,	  the	  Australian	   indigenous	  strains	  
do	  not	  have	  a	  copy	  of	  CPK_ORF00547.	  This	   locus	   is	  also	  absent	   in	  the	  frog	  (DC9)	  strain	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and	   all	   strains	  within	   the	   TW183	   clade,	   but	   is	   found	   in	   fragmented	   forms	   in	   all	   other	  
human	  strains.	  Gene	  copy	  numbers	  and	  fragmentation	  with	  respect	  to	  the	  koala	  LPCoLN	  
strain	  is	  represented	  in	  figure	  2.	  
	  
Figure	  2	  -­‐	  The	   IncA	  gene	  expansion	  and	  recombination	  locus	  spanning	  homologs	  of	  CPK_ORF546	  through	  
549	   (LPCoLN	   locus	   numbering).	   Human	   and	   frog	  C.	   pneumoniae	   strains	   encode	   for	   either	   two	   or	   three	  
copies	  with	  various	  levels	  of	  fragmentation	  between	  strains.	  Different	  clades	  within	  human	  C.	  pneumoniae	  
encode	   for	   identical	   sequence	   length	   across	   this	   locus.	   The	   Australian	   indigenous	   strains	   are	   the	   only	  
known	  human	  C.	  pneumoniae	  strains	  to	  encode	  for	  a	  CPK_ORF00549	  homolog.	  
	  
Another	   genetic	   marker	   unique	   to	   the	   Australian	   indigenous	   C.	   pneumoniae	   strains	  
SH511	  and	  1979,	  was	  the	  presence	  of	  a	  159bp	  insertion	  in	  the	  gene	  homologous	  to	  koala	  
CPK_ORF0341	   (585bp	   insertion	   compared	   to	   the	   AR39	   homolog).	   	   Translation	   of	   the	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open	  reading	  frame	  suggests	  that	  this	  is	  a	  putative	   IncA	  gene	  which	  is	  full	   length	  in	  the	  
koala	   strain.	   However,	   this	   gene	   is	   slightly	   truncated	   by	   84	   amino	   acids	   in	   indigenous	  
strains	   (354	   amino	   acids	   in	   length)	   and	   is	   only	   154	   amino	   acids	   in	   length	   in	   all	   other	  
strains,	   including	   frog	   DC9	   -­‐	   due	   to	   a	   single	   nucleotide	   insertion	   3'	   which	   results	   in	   a	  
frame	   shift	   (Figure	   3).	   Again,	   the	   large,	   strain-­‐specific	   insertion	   and	   its	   sequence	  
similarity	   to	   the	   koala	   homolog,	   supports	   the	   earliest	   branching	   of	   the	   Australian	  
indigenous	  strains	  in	  the	  major	  human	  C.	  pneumoniae	  clade.	  	  
	  
	  
Figure	  3	   -­‐	  A	   large	   sequence	   insertion	   is	   specific	   to	   indigenous	   strains	  SH511	  and	  1979,	  within	  a	  putative	  
IncA	  gene	  homologous	  to	  CPK_ORF341.	  This	  insertion	  encodes	  an	  almost	  full-­‐length	  IncA	  homolog	  similar	  
to	  that	   in	  the	  koala	  and	  bandicoot	  strains.	  Sequences	  at	  this	   locus	  for	  SH511	  and	  1979	  are	   identical,	  and	  
are	  shown	  compared	  to	  human	  strain	  AR39	  and	  koala	  strain	  LPCoLN.	  
	  
Sequence	   polymorphism	  has	   been	   described	   in	   the	  guaB/A-­‐add	   operon	   in	   human	   and	  
animal	  C.	  pneumoniae	  strains,	  with	  previous	  studies	  detailing	  that	  human	  C.	  pneumoniae	  
strains	  encode	   fragmented	   inosine-­‐5-­‐monophosphate	  dehydrogenase	   (guaB)	   genes	   [9].	  	  
In	  this	  study,	  we	  found	  that	  like	  the	  DC9	  frog	  strain,	  the	  Australian	  indigenous	  strains	  and	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strain	  IOL207	  encode	  for	  a	  full	  length,	  intact	  guaB	  gene.	  By	  comparison,	  all	  other	  human	  
strains	   have	   a	   T/C	   transition	   at	   nucleotide	  position	   262,	  which	   results	   in	   a	   stop	   codon	  
(Figure	  4).	  Varied	  levels	  of	  sequence	  decay	  are	  evident	  in	  the	  Australian	  strains	  for	  GMP	  
synthase	   (guaA)	  and	  adenosine	  deaminase	   (add).	   	  Deletions	   in	  both	   the	  guaA	   and	  add	  
homologs	   of	   WA97001	   result	   in	   truncations	   of	   these	   genes	   with	   loss	   of	   functional	  
domains,	   whilst	   the	   Australian	   indigenous	   strains	   exhibit	   extensive	   sequence	   decay	   at	  
this	   locus,	   resulting	   in	   the	   absence	   of	   guaA-­‐add	   and	   the	   downstream	   hypothetical	  
protein.	   Interestingly,	  whilst	   the	  entire	  guaA/B-­‐add	  operon	   is	  absent	   in	  both	  koala	  and	  
bandicoot	  strains,	  these	  genes	  are	  present	  in	  the	  frog	  strain	  DC9.	  	  
	  
	  
Figure	  4	  -­‐	  A	  single	  nucleotide	  transition	  in	  strains	  SH511,	  1979,	  DC9	  and	  IOL207	  results	  in	  a	  full-­‐length	  guaB	  
gene,	  compared	  to	  fragmented	  genes	  in	  other	  human	  C.	  pneumoniae	  represented	  by	  AR39.	  The	  amino	  acid	  
residue	  change	  at	  position	  88	  in	  strains	  IOL207,	  1979,	  SH511	  and	  DC9	  is	  highlighted	  in	  the	  pink	  box,	  whilst	  
the	   black	   arrow	   below	   the	   AR39	   sequence	   indicates	   the	  guaB	   stop	   codon	  which	   is	   present	   in	   all	   other	  
human	  C.	  pneumoniae	  strains.	  	  The	  IOL207	  homolog	  is	  N-­‐terminal	  truncated	  by	  23	  amino	  acids.	  
	  
Various	  sequence	  polymorphisms	  are	  evident	  in	  the	  Australian	  C.	  pneumoniae	  strains	  for	  
the	  pmpE/F4	  gene.	  Both	  indigenous	  Australian	  strains	  1979	  and	  SH511	  are	  truncated	  as	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the	  result	  of	  several	  deletions,	  whilst	  a	  single	  nucleotide	  insertion	  in	  WA97001	  results	  in	  
a	   frameshift	   causing	   truncation	   of	   this	   gene.	   This	   results	   in	   the	   loss	   of	   the	   C-­‐terminal	  
autotransporter	  domain	  for	  all	  three	  strains	  -­‐	  however	  the	  mid-­‐gene	  region	  encoding	  for	  
nine	   FXXN	   and	   eight	   GGA(I,L,V)	   amino	   acid	  motifs	   are	   highly	   conserved	   across	   all	   the	  
human	   C.	   pneumoniae	   strains	   (Figure	   5).	   Additionally,	   whilst	   both	   the	   koala	   and	  
bandicoot	  homologs	  of	  this	  gene	  display	  extensive	  sequence	  polymorphism,	  the	  DC9	  frog	  
homolog	   is	   highly	   similar	   in	   sequence	   to	   the	   non-­‐indigenous	   human	   pmpE/F4	   and	  
encodes	  for	  the	  full-­‐length	  protein.	  	  	  
	  
	  
Figure	   5	   -­‐	  pmpE/F4	   displays	   significant	   sequence	   polymorphism	   and	   decay	   in	   Australian	  C.	   pneumoniae	  
strains	  SH511,	  1979	  and	  WA97001,	  resulting	  in	  truncated	  homologs	  of	  this	  protein.	  The	  frog	  DC9	  homolog	  
is	  similar	   in	  sequence	  to	  human	  C.	  pnuemoniae	   strains,	  unlike	  the	  koala	  and	  bandicoot	  strains	  which	  are	  
highly	   polymorphic	   at	   this	   locus.	   The	   GGA(I,L,V)	   -­‐	   FXXN	   amino	   acid	   repeat	   motifs	   characteristic	   to	   the	  
polymorphic	   membrane	   protein	   gene	   family	   are	   highlighted,	   whilst	   sequence	   for	   the	   C-­‐terminal	  
autotransporter	  domain	  is	  clearly	  absent	  in	  SH511,	  1979,	  WA97001	  and	  LPCoLN	  strains.	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Australian	   indigenous	   strains	   demonstrate	   characteristic	   recombination	   profiles	  with	  
only	  a	  few	  instances	  shared	  with	  non-­‐indigenous	  strains.	  
In	  addition	  to	  estimation	  of	  the	  MRCA	  and	  mean	  substitution	  rate,	  ClonalFrame	  was	  used	  
to	   determine	   the	   recombination	   profiles	   and	   any	   shared	   recombination	   loci	   in	   C.	  
pneumoniae.	  Our	  study	  found	  that	  the	  Australian	  indigenous	  strains	  SH511	  and	  1979	  had	  
a	   distinct	   and	   almost	   identical	   recombination	   and	   nucleotide	   substitution	   profile,	  with	  
only	  a	  single	  difference	  in	  recombination	  locus	  between	  the	  two:	  SH511	  between	  296000	  
and	  298000bp	  and	  1979	  between	  310000	  and	  316000bp.	  Additionally,	  SH511	  and	  1979	  
share	  a	  strongly	  supported	  recombination	  event	  with	  the	  atherosclerosis	  strain	  A03	  and	  
to	  a	  lesser	  extent	  with	  Australian	  non-­‐indigenous	  strain	  WA97001	  between	  778000	  and	  
784000,	  which	  encompasses	  hypothetical	  protein	  and	  putative	  IncA	  genes.	  In	  comparing	  
recombination	  profiles	  across	  the	  non-­‐indigenous	  C.	  pneumoniae	  strains,	  the	  Australian	  
WA97001	   strain	   shares	   a	   single	   strong	   recombination	   event	   with	   A03	   and	   TW183	  
between	   823600	   and	   827100bp,	   which	   encompasses	   putative	   IncA	   genes.	   Several	  
nucleotide	   substitution	   events	   are	   shared	   amongst	   the	   various	  C.	   pneumoniae	   strains,	  
though	  the	  highest	  number	  of	  nucleotide	  substitutions	  occur	  in	  strains	  J138,	  IOL207	  and	  
DC9	  (Figure	  6).	  A	  Phi	  test	  for	  recombination	  was	  performed	  on	  the	  C.	  pneumoniae	  whole	  
genome	  alignment	  using	  SplitsTree4	  [49],	  which	  found	  a	  total	  of	  16329	  informative	  sites	  
and	   statistically	   significant	   evidence	   of	   recombination	   (p	   =	   5.538x10-­‐4).	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Figure	   6	   -­‐	   Whole	   genome	   recombination	   mappings	   as	   predicted	   by	   ClonalFrame	   coalescent	   methods.	   Red	   bars	   represent	   recombination	   events	   and	   green	   ticks	  
represent	  mutations.	  Strains	  SH511	  and	  1979	  share	  almost	  identical	  recombination	  profiles,	  with	  non-­‐indigenous	  human	  C.	  pneumoniae	  and	  the	  DC9	  frog	  strain	  sharing	  
recombination	   events	   at	   discrete	   loci.	   The	   predicted	   whole	   genome	   phylogeny	   based	   on	   recombination	   and	   mutation	   events	   is	   consistent	   with	   the	   groupings	  
demonstrated	  using	  BEAST	  and	  MrBayes	  prediction	  methods.	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DISCUSSION	  
C.	  pneumoniae	  has	  been	  described	  as	  an	  ancient	  pathogen,	  with	  the	  broadest	  host	  range	  
of	   any	   member	   of	   the	   Chlamydiaceae	   [55].	   	   Comparative	   whole	   genome	   studies	  
examining	   the	  differences	  between	  human	   respiratory	   [20],	   non-­‐respiratory	   [9,	   21,	   22,	  
56]	   and	   animal	   C.	   pneumoniae	   strains	   [9]	   all	   demonstrate	   a	   highly	   conserved	   core	  
genome	   with	   subtle	   strain-­‐specific	   differences.	   	   We	   previously	   characterized	   some	   of	  
these	   subtle	   differences	   using	   a	   PCR/sequencing	   approach	   and	   revealed	   that	   the	   two	  
human	   Australian	   indigenous	   human	   strains	   sequenced	   in	   this	   study	   shared	   genetic	  
markers	  with	   the	  koala	  LPCoLN	  strain	   [9]	   for	   some	  genes	  and	  away	   from	  other	  human	  
non-­‐Australian	   indigenous	  strains	  [23].	  To	  further	  explore	  the	  relationship	  of	  Australian	  
indigenous	  and	  non-­‐indigenous	  human	  strains,	  in	  the	  current	  study,	  we	  obtained	  whole	  
genome	  sequences	  for	  three	  Australian	  respiratory	  strains	  (SH511,	  1979	  and	  WA97001)	  
and	   performed	   comparative	   analyses	   to	   further	   understand	   their	   relationship	   to	   other	  
previously	  characterized	  human	  and	  animal	  C.	  pneumoniae	  strains.	  	  
	  
Using	   a	   variety	   of	   phylogenomic	   tools,	   our	   analysis	   suggests	   that	   the	   Australian	   C.	  
pneumoniae	  indigenous	  strains	  form	  a	  phylogenetically	  distinct	  clade	  away	  from	  all	  other	  
human	   C.	   pneumoniae	   strains	   sequenced	   to	   date.	   This	   is	   substantiated	   by	   unique	  
sequence	   polymorphisms	   and	   recombination	   profiles	   associated	   with	   the	   Australian	  
indigenous	  strains.	  	  In	  contrast	  to	  previous	  phylogenies	  constructed	  using	  sequenced	  PCR	  
fragments,	  which	  alternately	  placed	   the	  Australian	   indigenous	   strains	  within	  either	   the	  
human	  or	  animal	  branches	  of	  the	  tree	  [23],	  the	  use	  of	  whole	  genome	  sequences	  gives	  a	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more	   accurate	   description	   of	   the	   position	   of	   these	   strains	   within	   the	   greater	   C.	  
pneumoniae	  evolutionary	  tree.	  Fine-­‐detailed	  genomic	  comparisons	  also	  revealed	  several	  
novel	   genetic	  markers	   in	   Australian	   indigenous	   human	  C.	   pneumoniae	   strains,	   beyond	  
those	  previously	  identified	  in	  previous	  PCR-­‐based	  studies	  [23].	  	  
	  
The	   Australian	   indigenous	   strains	   demonstrate	   a	   copy	   number	   incongruity	   within	   the	  
CPK_ORF00546	  to	  CPK_ORF00549	  IncA	  gene	  family.	  This	  gene	  family	  expansion	  was	  first	  
described	   in	   the	   koala	   LPCoLN	   strain	   [9]	  with	   human	  C.	   pneumoniae	   strains	   exhibiting	  
variable	   levels	   of	   gene	   fragmentation	   and	   gene	   loss	   at	   this	   locus.	   The	   Australian	  
indigenous	   strains	   are	   unique	   in	   that	   they	   specifically	   encode	   a	   homolog	   to	  
CPK_ORF00549:	  to	  date,	  SH511	  and	  1979	  are	  the	  only	  human	  C.	  pnuemoniae	  strains	  that	  
encode	  for	  this	  homolog.	  Previous	  studies	  have	  shown	  that	  C.	  pneumoniae	  encodes	  a	  far	  
larger	  number	  of	  IncA	  and	  putative	  IncA	  proteins	  compared	  to	  other	  Chlamydiae	  [11,	  12],	  
many	   of	   which	   are	   species-­‐specific.	   Strong	   recombination	   signals	   were	   also	   detected	  
within	   several	   human	   C.	   pneumoniae	   strains	   at	   loci	   encoding	   IncA	   proteins,	   which	  
suggests	  that	  recombination	  may	  account	  for	  the	  expanded	  number	  of	  IncA	  proteins	  in	  C.	  
pneumoniae.	  	  
	  
One	  of	  the	  more	  subtle	  genetic	  differences	  observed	  between	  the	  strains	  analysed	  was	  
the	  maintenance	  of	  a	  partial	  purine	  biosynthesis	  pathway	  encoded	  by	  guaA/B-­‐add	  [10].	  
Previous	   studies	   demonstrated	   that	   the	   guaB	   gene	   is	   fragmented	   in	   human	   C.	  
pneumoniae	  strains	  [14],	  however	  in	  this	  study	  we	  demonstrate	  that	  strains	  DC9,	  SH511	  
and	  1979	  encode	  for	  an	  intact	  guaB	  gene.	  Given	  that	  the	  Australian	  indigenous	  strains	  do	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not	   encode	  guaA-­‐add,	   it	   is	   likely	   that	   the	   sequence	   for	  guaB	   was	   a	   recent	   acquisition	  
from	  a	  strain	  most	  similar	  to	  DC9.	  	   Interestingly,	   in	  contrast	  to	  the	  koala	  and	  bandicoot	  
strains	   where	   the	   entire	   guaA/B-­‐add	   operon	   is	   absent	   [9,	   40],	   the	   frog	   DC9	   strain	  
encodes	   guaA/B-­‐add	   genes,	   with	   >99.5%	   nucleotide	   pairwise	   identity	   to	   all	   human	   C.	  
pneumoniae	  strains,	  with	  the	  exception	  of	  the	  three	  Australian	  strains.	  Studies	  in	  both	  C.	  
psittaci	   and	  Chlamydia	   caviae	   have	   found	  evidence	   for	   horizontal	   gene	   transfer	   of	   the	  
guaA/B-­‐add	  operon	   between	   different	   chlamydial	   strains	   and	   species	   [54,	   57],	   lending	  
further	  support	   for	   the	  recent	  acquisition	  of	  guaB	  by	   the	  Australian	   indigenous	  strains.	  	  
Whilst	   it	   is	   unclear	   what	   effect	   the	   presence	   or	   absence	   of	   guaA/B-­‐add	   has	   on	   the	  
growth	   and	   virulence	   of	   human	   and	   animal	   C.	   pneumoniae	   strains,	   a	   previous	   study	  
examining	   the	  effect	  of	  mutations	   in	   the	  Chlamydia	  muridarum	   plasticity	   zone	   suggest	  
that	   5'	   point	  mutations	   of	  guaB	   and	  add	   result	   in	   attenuated	   virulence	   in	   vivo,	   whilst	  
guaA/B-­‐add	  mutations	  do	  not	  affect	   the	  growth	  characteristics	  of	   these	  strains	   in	  vitro	  
[58].	   These	  observations	  are	   similar	   to	   those	   reported	   for	   the	  growth	  and	  virulence	  of	  
Borrelia	  burgdorferi	  and	  Francisella	  tularensis	  guaA/B	  +/-­‐	  strains	  in	  vitro	  and	  in	  vivo	  [59,	  
60].	  
	  
In	  order	  to	  further	  explore	  the	  evolutionary	  relationships	  of	  the	  Australian	  indigenous	  C.	  
pneumoniae	  strains,	  BEAST	  and	  ClonalFrame	  analyses	  predicted	  that	  these	  strains	  had	  an	  
MRCA	   of	   1028	   and	   1425,	   respectively.	   Both	   of	   these	   estimations	   pre-­‐date	   the	   known	  
colonization	  of	  the	  Australian	  continent	  by	  Europeans	  by	  several	  hundred	  years,	  but	  are	  
virtually	   identical	   to	   the	   previously	   estimated	   MRCA	   for	   strains	   within	   the	   non-­‐
indigenous	  clade	  at	  1151	  +/-­‐	  20	  years	  [21].	  
	  Chapter	  Five:	  Phylogenetic	  analysis	  of	  human	  Chlamydia	  pneumoniae	  strains	  reveals	  a	  distinct	  Australian	  indigenous	  
clade	  that	  predates	  European	  exploration	  of	  the	  continent	   154	  
	  
Given	  this	  new	  evidence	  and	  our	  previous	  data	  suggesting	  that	  C.	  pneumoniae	  strains	  in	  
humans	  likely	  originated	  from	  a	  zoonotic	  event(s)[9,	  23],	  it	  is	  interesting	  to	  speculate	  on	  
the	  origin	  of	  these	  indigenous	  human	  C.	  pneumoniae	  strains.	  Two	  possible	  evolutionary	  
hypotheses	   to	   explain	   the	   deep-­‐branching	   of	   these	   strains	   are	   proposed:	   (A),	   the	  
Australian	  indigenous	  strains	  have	  evolved	  from	  a	  separate	  zoonotic	  transmission	  event,	  
or	   alternate	   intermediate	   strain,	   to	   that	   of	   the	   other	   human	   C.	   pneumoniae	   strains.	  	  
These	   ancestral	   strains	   were	   subsequently	   endemic	   on	   the	   Australian	   continent	   and	  
continued	   to	   evolve	   in	   isolation	   to	   the	   non-­‐indigenous	   C.	   pneumoniae	   strains.	  
Alternatively	   (B),	   all	   human	   C.	   pneumoniae	   strains	   disseminated	   from	   a	   common	  
intermediate	  strain,	   resultant	   from	  a	  single	  zoonotic	  event	  several	   thousand	  years	  ago,	  
and	  evolved	   separately	   in	   response	   to	   their	  different	  ecological	   niches	   (Figure	  7).	   	  Our	  
findings	  provide	  support	  for	  both	  hypotheses.	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Figure	  7	  -­‐	  Evolutionary	  hypothesis	  model	  describing	  two	  alternate	  hypotheses	  for	  the	  characteristic	  deep-­‐
branching	   of	   the	   Australian	   indigenous	   strains	   SH511	   and	   1979.	   In	   hypothesis	   A,	   Australian	   indigenous	  
strains	  evolved	  from	  a	  separate	  zoonotic	  (or	  intermediate)	  transmission	  event,	  and	  continued	  to	  evolve	  in	  
isolation	   from	  non-­‐indigenous	   human	  C.	   pneumoniae	   strains.	   In	   hypothesis	   B,	   all	   human	  C.	   pneumoniae	  
strains	  disseminated	  from	  a	  single	  zoonotic	  (or	  intermediate)	  transmission	  event	  and	  evolved	  separately	  in	  
response	  to	  differing	  ecological	  functions.	  	  
	  
With	  respect	  to	  hypothesis	  (A),	  estimations	  from	  both	  BEAST	  and	  ClonalFrame	  analyses	  
indicate	   an	   MRCA	   for	   the	   indigenous	   strains	   several	   hundred	   years	   prior	   to	   the	   first	  
reported	  visitation	  of	  the	  Australian	  continent	  by	  Dutch	  or	  British	  explorers	  [61,	  62].	  This	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suggests	   the	   possibility	   that	   an	   endemic	   strain	   similar	   to	   our	   strains	   may	   have	   been	  
circulating	  within	  the	  indigenous	  population	  prior	  to	  the	  arrival	  of	  European	  colonisation.	  
Given	   the	   sequence	   similarity	   of	   the	   indigenous	   strains	   to	   the	   koala	   and	   bandicoot	  C.	  
pneumoniae	   strains	   at	   several	   key	   loci	   (the	   absence	   of	   guaA-­‐add,	   polymorphisms	   in	  
pmpE/F4	  and	  the	   IncA	  gene	  expansion),	  as	  well	  as	  those	  previously	  described	  [23],	   it	   is	  
possible	   that	   a	   strain	   similar	   to	   these	   animal	   strains	   was	   zoonotically	   transmitted	   to	  
humans	   on	   the	   Australian	   continent.	   	   Hunter-­‐gatherer	   communities	   lived	   in	   close	  
proximity	   and	   interacted	   with	   wild	   animals	   throughout	   human	   history,	   which	   would	  
facilitate	   the	   transmission	  of	   a	  pathogen	   to	  humans.	   Serological	   studies	   examining	   the	  
prevalence	   of	   chlamydial	   infection	   in	   remote	   indigenous	   communities	   have	   reported	  
levels	  of	  almost	  60%	  adult	  female	  seroprevalence	  to	  C.	  pneumoniae	  [24].	  Several	  species	  
of	  native	  Australian	  marsupials	  [9,	  23,	  40,	  63]	  as	  well	  as	  an	  amphibian	  [7,	  23]	  have	  been	  
demonstrated	   to	   have	   genetic	   sequence	   similar	   to	   that	   of	   the	   koala	   LPCoLN	   strain.	  
Studies	   have	   shown	   that	   koala	   and	   bandicoot	   C.	   pneumoniae	   strains	   readily	   infect	  
various	  human-­‐derived	  cell	   lines	  [3,	  27,	  64],	  and	  evidence	  for	  human	  carotid	  artery	  and	  
PBMC	  strains	  which	  are	  genotypically	  similar	  to	  the	  koala	  strain	  at	  the	  ompA	  and	  yge-­‐urk	  
intergenic	  spacer	  loci	  have	  been	  reported	  [65].	  	  If	  the	  distinct	  phylogenetic	  clustering	  of	  
SH511	  and	  1979	   is	  a	   result	  of	  a	   separate	  zoonotic	  event	   to	   that	  of	   the	  main	  human	  C.	  
pneumoniae	  lineage,	  then	  it	  is	  likely	  that	  the	  animal	  strain	  that	  they	  have	  evolved	  from	  is	  
still	   unknown,	   and	   probably	   more	   similar	   to	   the	   frog	   DC9	   strain	   in	   sequence	   and	  
nucleotide	  content.	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The	  alternate	  hypothesis	  (B),	  is	  that	  all	  human	  C.	  pneumoniae	  strains	  disseminated	  from	  
a	  single	  zoonotic	  event	  (presumably	  in	  Americas	  or	  Europe)	  and	  then	  differentiated	  along	  
separate	   evolutionary	   paths,	   dependent	   on	   their	   geographical	   and	   disease	   niche.	   The	  
estimated	  MRCA	   for	   indigenous	  and	  non-­‐indigenous	  human	  strains	  differs	  by	   less	   than	  
200	   years,	   whilst	   their	   phylogenetic	   distance	   is	   significantly	   closer,	   compared	   to	   the	  
animal	   strains.	   The	   overall	   nucleotide	   pairwise	   identity	   of	   the	   Australian	   indigenous	  
strains	   is	  more	  similar	   to	  other	  human	  strains	  of	  C.	  pneumoniae,	  even	  when	  significant	  
similarities	   to	   animal	   strains	   at	   discrete	   loci	   are	   included.	   There	   are	   two	   possible	  
mechanisms	   to	   explain	   the	   dissemination	   of	   these	   particular	   strains:	   Firstly	   -­‐	   various	  
strains	   of	   C.	   pneumoniae	   were	   circulating	   in	   the	   worldwide	   human	   population	  
approximately	   40	   thousand	   years	   ago,	   which	   is	   well	   prior	   to	   the	   colonisation	   of	   the	  
Australian	  continent	  [66],	  and	  that	  one	  or	  some	  of	  these	  strains	  came	  to	  the	  continent	  
with	   the	   arrival	   of	   the	   indigenous	   peoples.	   This	   would	   account	   for	   the	   characteristic	  
sequence	   polymorphisms	   present	   in	   the	   SH511	   and	   1979	   but	   not	   in	   other	   human	   C.	  
pneumoniae	  strains.	  Alternately	  -­‐	  the	  worldwide	  variation	  in	  human	  C.	  pneumoniae	  is	  far	  
greater	  than	  has	  yet	  been	  determined,	  and	  several	  strain	  types	  were	   introduced	  to	  the	  
Australian	   continent	   with	   European	   colonisation.	   This	   in	   turn	   accounts	   for	   the	   overall	  
sequence	   similarity	   of	   the	   SH511	   and	   1979	   strains	   to	   non-­‐indigenous	   human	   C.	  
pneumoniae	  strains,	  in	  particular	  WA97001,	  with	  which	  it	  shares	  a	  considerable	  number	  
of	  SNPs,	  as	  opposed	  to	  the	  Australian	  marsupial	  strains,	  LPCoLN	  and	  B21.	  In	  both	  cases,	  
genetically	  distinct	  subpopulations	  of	  C.	  pneumoniae	  could	  have	  spread	  throughout,	  and	  
evolved	   in	   isolation	   within	   the	   indigenous	   Australian	   population.	   Genotypic	   variation	  
amongst	   concurrent	   populations	   of	   monomorphic	   bacteria	   resulting	   from	   selective	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sweeps	  is	  well	  documented	  in	  both	  Chlamydia	  [67,	  68]	  and	  other	  bacterial	  species	  [69].	  	  
The	  differentiation	  of	  the	  main	  human	  C.	  pneumoniae	  lineage	  from	  both	  the	  indigenous	  
and	  animal	   lineages	   could	  be	  explained	  by	  adaptation	  of	   these	   strains	   to	   selective	  and	  
antigenic	  pressure	  as	  a	  result	  of	  extensive	  antibiotic	  treatment	  regimes	  [70].	  
	  
Whilst	  our	  study	  provides	  evidence	  for	  a	  phylogenetically	  and	  genetically	  distinct	  branch	  
of	  human	  C.	  pneumoniae,	   these	   inferences	  are	  made	  on	  a	   relatively	   small	   sample	   size,	  
taken	   from	   two	   individuals	   from	   remote	   communities	   in	   the	   same	   state,	   over	   two	  
decades	  ago.	  It	  is	  highly	  unlikely	  that	  sampling	  from	  the	  same	  remote	  communities	  and	  
wider	   ranging	  communities	  will	  uncover	   the	  same	  strains	  as	  documented	   in	   this	   study;	  
given	   the	   increased	   interaction	   between	  members	   of	   remote	   indigenous	   communities	  
and	   neighbouring	   townships,	   as	   well	   as	   expanded	   antibiotic	   treatment	   regimes	   for	   a	  
range	   of	   bacterial	   infections,	   including	  Chlamydia,	  within	   these	   communities.	   It	   is	   also	  
possible	   that	   greater	   sampling	   for	  C.	   pneumoniae	   in	   countries	   outside	  Australia	  would	  
uncover	  a	  wider	  range	  of	  strains,	  some	  of	  which	  may	  be	  similar	  to	  those	  described	  in	  this	  
study.	  	  	  
	  
CONCLUDING	  REMARKS	  
In	  summary,	  we	  used	  a	  combination	  of	  comparative	  genomic	  and	  phylogenetic	  methods	  
to	  determine	  the	  evolutionary	  position	  of	  three	  Australian	  human	  C.	  pneumoniae	  strains	  
within	   the	   greater	   C.	   pneumoniae	   tree.	   Our	   study	   demonstrated	   a	   phylogenetically	  
distinct	  human	  C.	  pneumoniae	  clade	  consisting	  of	  two	  Australian	  indigenous	  strains,	  that	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branched	  earlier	  in	  the	  human	  C.	  pneumoniae	  evolutionary	  tree	  with	  an	  estimated	  MRCA	  
predating	   the	   exploration	   and	   colonisation	   of	   the	   continent	   by	   European	   settlers	   by	  
several	   hundred	   years.	   Our	   findings	   indicate	   that	   a	   unique	   strain	   of	   C.	   pneumoniae	  
evolved	   in	   isolation	   within	   the	   Australian	   indigenous	   population,	   as	   evidenced	   by	   the	  
unique	   recombination	   profiles	   and	   distinct	   sequence	   polymorphisms	   in	   these	   strains.	  
This	  suggests	  that	  a	  far	  greater	  level	  of	  sequence	  diversity	  is	  present	  amongst	  human	  and	  
animal	  C.	  pneumoniae	  strains	  than	  previously	  surmised,	  and	  that	  further	  sampling	  of	  C.	  
pneumoniae	   isolates	   from	  wider	   geographical	   regions	  may	   uncover	   strains	  which	   have	  
evolved	  similarly	  to	  this	  unique	  C.	  pneumoniae	  clade.	  	  
	  
Whilst	   we	   have	   extended	   the	   number	   of	  C.	   pneumoniae	   whole	   genome	   sequences	   to	  
include	   two	   non-­‐respiratory	   strains,	   caution	   should	   be	   exercised	   in	   making	   any	  
assumptions	   regarding	   the	   diversity	   demonstrated	   in	   these	   genes	   as	   markers	   of	  
respiratory	   and	  non-­‐respiratory	   tropism,	   due	   to	   the	   small	   sample	   size	   of	   this	   study.	   In	  
spite	   of	   this,	   the	   observations	   made	   in	   this	   study	   regarding	   the	   differences	   in	   gene	  
content	  and	  variability	  in	  sequence	  between	  human	  C.	  pneumoniae	  strains	  isolated	  from	  
different	  diseases	  warrant	  further	  study	  and	  may	  facilitate	  molecular	  characterisation	  of	  
these	  loci	  in	  C.	  pneumoniae	  clinical	  studies.	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ABSTRACT	  
Chlamydia	  pneumoniae	  is	  a	  cosmopolitan	  intracellular	  pathogen	  with	  a	  wide	  host	  range	  
and	   diverse	   presentation	   in	   both	   human	   and	   veterinary	   disease.	   Previous	   studies	  
demonstrated	  stark	  differences	  in	  the	  growth	  and	  development	  of	  human	  and	  animal	  C.	  
pneumoniae	   strains,	   as	   well	   as	   their	   response	   to	   interferon-­‐γ	   and	   antibiotics,	   whilst	  
comparative	   genetic	   analyses	   of	   human	   and	   animal	   C.	   pneumoniae	   strains	   indicated	  
relatively	  minor	  differences	  in	  gene	  content	  and	  nucleotide	  sequence.	  In	  this	  study,	  we	  
use	  RNAseq	  to	  compare	  the	  transcriptomes	  of	  two	  C.	  pneumoniae	  strains:	  LPCoLN	  from	  
the	   koala	   and	   A03,	   a	   human	   atherosclerosis	   strain.	   	  Whilst	   our	   experiments	   achieved	  
lower	  than	  expected	  read	  coverage,	  we	  were	  able	  to	  identify	  several	  gene	  families	  and	  
pathways	  that	  were	  highly	  expressed	  at	  the	  48	  hour	  time	  point	  in	  both	  strains,	  as	  well	  as	  
a	  number	  of	  strain-­‐specific	  genes.	  We	  found	  that	  genes	  involved	  in	  active	  transcription	  
and	  replication	  of	  the	  chlamydial	  chromosome	  were	  most	  highly	  represented,	  as	  well	  as	  
members	  of	  the	  IncA	  gene	  family.	  Genes	  encompassing	  the	  plasticity	  zone	  appeared	  to	  
be	  highly	  expressed	  in	  both	  strains	  and	  this	  region	  made	  up	  10%	  of	  all	  genes	  detected	  in	  
A03.	  Whilst	  a	  greater	  number	  of	  expressed	  genes	  were	  detected	  for	  the	  LPCoLN	  strain,	  
we	  found	  that	  similar	  genes	  and	  gene	  families	  were	  highly	  expressed	  in	  both	  strains.	  	  	  	  	  
	  
INTRODUCTION	  
C.	  pneumoniae	  is	  frequently	  presented	  in	  community	  acquired	  pneumonia	  [1-­‐3],	  as	  well	  
as	   being	   associated	   with	   a	   number	   of	   chronic	   diseases	   such	   as	   asthma	   [4-­‐7],	  
cardiovascular	   disease	   [8-­‐14]	   and	   Alzheimer's	   disease	   [15-­‐17].	   Additionally,	   it	   has	   a	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broad	   host	   range	   in	   animals,	   including	   marsupials	   and	   reptiles	   [18-­‐24],	   where	   it	  
commonly	   presents	   with	   a	   wide	   range	   of	   symptoms	   including	   ocular	   and	   respiratory	  
infection	  and	  systemic	  granulomatous	   lesions.	   	  Despite	  the	  wide	  range	  of	  diseases	  and	  
hosts	   from	   which	   C.	   pneumoniae	   has	   been	   isolated,	   their	   genetic	   sequence	   is	   highly	  
conserved.	  In	  comparing	  human	  strains	  isolated	  from	  different	  tissues	  and	  pathologies,	  
a	  few	  notable	  differences	   in	  gene	  content	  and	  single	  nucleotide	  polymorphisms	  (SNPs)	  
are	   demonstrated	   [25-­‐30].	   Comparisons	   between	   human	   and	   animal	   strains	  
demonstrate	  a	  larger	  number	  of	  SNPs,	  as	  well	  expanded	  gene	  families	  and	  several	  full-­‐
length	  gene	  homologs	  that	  are	  fragmented	  in	  human	  C.	  pneumoniae	  strains	  [18,	  31-­‐33].	  
Furthermore,	   animal	   C.	   pneumoniae	   comparisons	   suggest	   that	   there	   may	   also	   be	  
significant	  differences	  between	  strains	   isolated	  from	  different	  animals	  [25,	  34].	   	  Whilst	  
there	  have	  been	   several	   studies	   that	  have	   identified	  putative	  molecular	  markers	  of	  C.	  
pneumoniae	   tissue	   tropism	   in	   human	   disease	   [25,	   27,	   30]	   and	   animal	   hosts	   [31],	  
definitive	  genetic	  determinants	  of	  C.	  pneumoniae	  tissue	  and	  host	  specificity	  have	  yet	  to	  
be	  confirmed.	  
	  
The	  genetic	  conservation	  of	  human	  and	  animal	  C.	  pneumoniae	  strains	  is	  confounded	  by	  
differences	   in	   development	   and	   cellular	   biological	   characteristics	   of	   animal	   strains	   as	  
well	   as	   dramatic	   differences	   between	   human	   respiratory	   and	   cardiovascular	   strains	   in	  
response	   to	   nutrient	   starvation	   and	   induction	   of	   persistence.	   C.	   pneumoniae	   strains	  
isolated	   from	   marsupials	   (LPCoLN	   -­‐	   koala,	   Phascolarctos	   cinereus	   and	   B21	   -­‐	   western	  
barred	  bandicoot,	  Perameles	  bougainville)	  readily	   infect	   immortalised	  human	  epithelial	  
cell	   lines	   [35,	   36],	   and	   these	   animal	   strains	   display	   distinct	   morphologies	   growth	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characteristics	   when	   compared	   to	   human	   C.	   pneumoniae	   strains	   [35,	   37].	   Human	  
respiratory	  and	  cardiovascular	  C.	  pneumoniae	  strains	  have	  almost	  identical	  development	  
and	   growth	   characteristics	   during	   a	   typical	   acute	   infection,	   however	   the	   A03	  
cardiovascular	  strain	  exhibits	  a	  drastic	  decrease	  in	  inclusion	  size,	  alteration	  of	  inclusion	  
morphology	  and	  production	  of	  viable	  progeny	  at	  very	   low	  doses	  of	   IFN-­‐γ	   compared	  to	  
the	  respiratory	  AR39	  strain	  as	  a	  result	  of	  tryptophan	  sensitivity	  [37].	  	  
	  
Previous	   studies	  have	   investigated	   the	  differential	  expression	  of	  a	  number	  of	  genes	   in	  
human	  C.	   pneumoniae	   during	   acute	   infection	   [38-­‐42],	   and	   through	   simulation	   of	   host	  
cell	   immune	   response	  models	   such	   as	   IFN-­‐γ	   [43-­‐45],	   Iron	   (Fe)	   limitation	   [46,	   47]	   and	  
antibiotic	   induced	   persistence	   [48-­‐50].	   However,	   none	   have	   examined	   the	   expression	  
profiles	   between	   two	   C.	   pneumoniae	   strains,	   nor	   have	   any	   investigated	   the	  
transcriptome	  of	  a	  non-­‐human	  C.	  pneumoniae	  infection.	  	  
	  
In	   this	   study,	  we	  aimed	   to	  address	  both	  of	   these	  gaps	  by	  using	  RNAseq	   to	  obtain	  and	  
compare	   transcriptomes	   for	   a	   human	   cardiovascular	   strain	   A03	   and	   an	   animal	   C.	  
pneumoniae	  strain	  LPCoLN	  at	  48	  hours	  post-­‐infection	  in	  vitro.	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MATERIALS	  AND	  METHODS	  
	  
Cell	  lines	  and	  C.pneumoniae	  strains	  used	  in	  this	  study	  
Immortalized	  human	  lung	  epithelial	  cell	  line	  BEAS-­‐2B	  (ATCC	  CRL	  9609)	  [51,	  52]	  was	  used	  
for	  propagation	  of	   the	  C.	  pneumoniae	   infection	  and	   for	  confocal	  microscopy.	  We	  used	  
koala	   respiratory	  C.	   pneumoniae	   strain	   LPCoLN	   [53]	   and	   human	   atherosclerosis	   strain	  
A03	  [9]	  for	  RNAseq	  analysis	  and	  confocal	  microscopy.	  
	  
C.	   pneumoniae	   infection	   of	   BEAS-­‐2B	   cell	   lines	   for	   RNA	   extraction	   and	   confocal	  
microscopy	  	  
BEAS-­‐2B	   cell	   lines	   were	   propagated	   by	   continuous	   passage	   in	   T75	   flasks.	   Cells	   were	  
passaged	  every	   three	  days	  upon	   reaching	  confluency,	  at	  a	  1:5	   ratio	  and	  maintained	   in	  
RPMI	  1640	  culture	  medium	  (Invitrogen)	  supplemented	  with	  10%	  FCS	  (Invitrogen),	  100μg	  
ml−1	  streptomycin	  at	  37°C	  and	  5%	  CO2.	  
	  
LPCoLN	  and	  A03	  C.	  pneumoniae	  strains	  were	  used	  to	  infect	  BEAS-­‐2B	  cells	  at	  an	  MOI	  of	  1	  
in	  T75	  flasks	  and	  coverslips	  concurrently.	  8mm	  coverslips	  in	  48	  well	  plates	  were	  seeded	  
with	  2.5x104	   cells	   and	   infected	  with	  either	   LPCoLN	  or	  A03	  after	  24	  hours.	  Plates	  were	  
centrifuged	  at	  2000x	  g	   for	  1	  hour	  at	  25°C,	  media	  aspirated	  and	  replenished	  with	   fresh	  
growth	   media	   at	   3hrs	   PI.	   Plates	   were	   incubated	   for	   48	   hours	   at	   37°C	   and	   5%	  
CO2.Coverslips	  were	  washed	  twice	  with	  warm	  PBS	  and	  fixed	  with	  ice-­‐cold	  methanol	  for	  
10	  minutes.	   Coverslips	  were	   stained	  with	   fluorescein	   isothiocyanate	   (FITC)-­‐conjugated	  
Chlamydia-­‐specific	   anti-­‐lipopolysaccharide	   (anti-­‐LPS)	   monoclonal	   antibody	   to	   visualise	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chlamydial	   inclusions	   and	   counterstained	  with	   Evan’s	   blue	   to	   visualise	   host	   cells	   (Cell	  
labs,	  Australia).	  Coverslips	  were	  mounted	  on	  to	  slides	  with	  Prolong	  Gold	  (Invitrogen)	  and	  
cured	  overnight	  at	  room	  temperature	  in	  darkness.	  Confocal	  images	  were	  obtained	  using	  
Leica	  TCS	  SP5	  confocal	  laser	  scanning	  microscope	  (Leica	  Microsystems,	  Germany)	  with	  a	  
40×	  oil	  objective.	  Excitation	  and	  emission	  wavelengths	  were	  chosen	  from	  the	  provided	  
software	  (Leica	  application	  suite	  for	  advanced	  fluorescence)	  for	  each	  fluorophore	  used	  
in	  this	  study.	  Images	  were	  processed	  for	  presentation	  using	  the	  Leica	  software	  suite.	  
Flasks	   were	   seeded	   with	   2.1x106	   cells	   and	   infected	   after	   24	   hours.	   Flasks	   were	  
centrifuged	   at	   2000x	   g	   for	   1	   hour	   at	   25°C.	  Media	  was	   aspirated	   and	   replenished	   at	   3	  
hours	  PI.	  Flasks	  were	  incubated	  for	  48	  hours	  at	  37°C	  and	  5%	  CO2	  .	  	  
	  
Harvest	  of	  C.	  pneumoniae	  infected	  cells	  for	  RNA	  extraction	  	  
Growth	  medium	  was	  aspirated	  from	  the	  flasks	  and	  cells	  were	  gently	  washed	  with	  warm	  
PBS	  for	  two	  minutes.	  PBS	  was	  aspirated	  from	  flasks	  and	  1ml	  of	  warm	  trypsin	  was	  added,	  
with	   flasks	   incubated	   at	   37°C	   for	   five	  minutes	   to	   dislodge	   cells.	   5mL	  of	   growth	  media	  
was	  added	  to	  each	  flask	  to	  deactivate	  trypsin	  and	  cells	  collected	  in	  15mL	  Falcon	  tubes.	  
Tubes	   were	   centrifuged	   at	   900x	   g	   for	   five	   minutes	   at	   25°C	   to	   pellet	   cells,	   and	  
supernatant	  removed,	  after	  which	  the	  pellet	  was	  resuspended	  in	  1mL	  of	  warm	  PBS.	  For	  
each	   Falcon	   tube,	   500µL	   of	   resuspended	   cells	   were	   aliquoted	   into	   a	   1.5mL	   cryotube,	  
1mL	   of	   RNAlater	   (Invitrogen)	   added	   and	   immediately	   stored	   at	   -­‐80°C.	   	   The	   remaining	  
500µL	  was	   aliquoted	   into	   1.5ml	   Eppendorf	   tubes,	   immediately	   placed	   on	   ice	  with	   the	  
addition	  of	  800µl	  of	  TRIzol	  (Invitrogen),	  and	  cells	  ruptured	  by	  repetitive	  pipetting.	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Extraction	  of	  total	  RNA	  
Ruptured	  cells	  in	  TRIzol	  were	  incubated	  at	  room	  temperature	  for	  five	  minutes.	  200µL	  of	  
chloroform	  was	  added	  to	  each	  tube	  and	  shaken	  vigorously	  for	  20	  seconds.	  Tubes	  were	  
incubated	  at	  room	  temperature	  for	  three	  minutes	  and	  then	  centrifuged	  at	  12000g	  for	  15	  
minutes	   at	   4°C.	   The	   aqueous	   phase	  was	   aliquoted	   into	   a	   fresh	   1.5mL	   Eppendorf	   tube	  
and	  re-­‐extracted	  with	  a	  further	  200µl	  of	  chloroform	  with	  centrifugation	  at	  12000x	  g	  for	  
15	  minutes	  at	  4°C.	  The	  aqueous	  phase	  was	  aspirated	  into	  a	  fresh	  1.5mL	  Eppendorf	  tube,	  
with	   the	   addition	   of	   5µL	   of	   RNAse-­‐free	   glycogen	   (QIAgen)	   and	   500µl	   of	   ice-­‐cold	  
isopropanol.	   Tubes	   were	   gently	   inverted	   five	   times	   and	   stored	   upright	   at	   -­‐20°C	  
overnight.	  Total	  RNA	  was	  precipitated	  from	  the	  isopropanol	  samples	  by	  centrifugation	  at	  
12000g	  for	  15	  minutes	  at	  4°C.	  A	  large	  white	  pellet	  was	  obtained,	  isopropanol	  was	  gently	  
drained	  from	  the	  tube	  and	  the	  pellet	  washed	  with	  250µl	  of	  75%	  ethanol	  in	  DEPC-­‐treated	  
water,	  with	  gentle	  vortexing.	  Tubes	  were	  centrifuged	  at	  7500x	  g	  for	  five	  minutes	  at	  4°C.	  
The	   ethanol	  was	   gently	   drained	   from	   the	   pellet	   and	   the	   pellet	   air	   dried	   on	   ice	   for	   10	  
minutes.	   Pellet	  was	   dissolved	   in	   100µl	   of	   TE-­‐buffer,	   a	   trace	   performed	   on	   the	   DU800	  
spectrophotometer	  (BioRad)	  to	  detect	  presence	  of	  phenol/TRIzol	  carry-­‐over	  at	  <260nm.	  
Samples	  with	   detectable	   phenol	   carry-­‐over	  were	   subject	   to	   overnight	   re-­‐precipitation	  
(2.5	  volumes	  100%	  ethanol,	  0.1	  volumes	  of	  3M	  NaOAc,	  2.5µl	  glycogen.	  Gentle	  inversion	  
5x	  and	  precipitated	  overnight	  at	  -­‐20°C,	  centrifuge	  at	  12000x	  g	  for	  15	  minutes	  at	  4°C	  then	  
proceed	  with	  wash	  and	  solvation	  steps)	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DNAse	  treatment	  of	  total	  RNA	  samples	  
DNAse	   treatment	   of	   samples	   was	   performed	   to	   remove	   contaminating	   DNA	   prior	   to	  
mRNA	  enrichment	  for	  RNAseq.	  We	  used	  the	  Turbo	  DNA-­‐free	  kit	  (Ambion)	  and	  employed	  
the	  rigorous	  method	  as	  per	  manufacturer’s	  instructions.	  Briefly:	  Samples	  were	  diluted	  to	  
200µg	   mL-­‐1	   if	   required.	   50µl	   of	   the	   samples	   were	   transferred	   to	   0.65mL	   Eppendorf	  
tubes,	  with	  the	  addition	  of	  0.1x	  volume	  of	  reaction	  buffer	  and	  1.5µl	  of	  Turbo	  DNAse.	  The	  
samples	  were	  incubated	  in	  a	  thermocycler	  at	  37°C	  for	  30	  minutes,	  after	  which	  a	  further	  
1.5µl	  of	  Turbo	  DNAse	  was	  added.	  The	  samples	  were	  incubated	  for	  a	  further	  30	  minutes	  
at	   37°C.	   	   0.1x	   total	   volume	  of	  deactivation	   reagent	  was	   added	  and	  mixed	   thoroughly.	  
The	   samples	  were	   incubated	   at	   room	   temperature	   for	   five	  minutes	  with	   intermittent	  
mixing.	   Samples	   were	   then	   centrifuged	   at	   10000x	   g	   for	   2	   minutes,	   the	   supernatant	  
volume	   measured	   and	   transferred	   to	   a	   fresh	   0.65mL	   tube.	   The	   rigorous	   treatment	  
process	  was	  repeated	  a	  further	  four	  times	  (for	  a	  total	  of	  five	  rounds	  of	  rigorous	  DNAse	  
treatment)	   and	   the	   treated	  RNA	  checked	   for	  DNA	  contamination	  by	  pan-­‐Chlamydiales	  
16S	   rRNA	   PCR	   [54]	   run	   for	   40	   cycles.	   The	   DNA-­‐free	   RNA	   samples	   were	   ethanol	  
precipitated	  at	  -­‐20°C	  overnight,	  as	  described	  in	  previous	  section,	  and	  pellets	  dissolved	  in	  
50µl	  of	  TE	  buffer	  for	  bacterial	  RNA	  enrichment.	  
	  
Poly-­‐A	  subtraction	  and	  mRNA	  enrichment	  of	  treated	  RNA	  samples	  
DNA-­‐depleted	  samples	  were	  subjected	  to	  poly-­‐adenylated	  RNA	  (poly-­‐A)	  subtraction	  for	  
removal	   of	   eukaryotic	   transcripts,	   and	   rRNA	   depletion.	   The	   MICROBEnrich	   and	  
MICROBExpress	   kits	   (Invitrogen)	  were	  used	   as	   per	  manufacturer’s	   instructions	   for	   this	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purpose.	  A	  brief	  summary	  of	   the	  process	   is	  as	   follows:	   	  5µg	  of	   total	  RNA	  was	  used	  for	  
each	   poly-­‐A	   subtraction	   using	   the	   MICROBEnrich	   kit.	   300µl	   of	   MICROBEnrich	   binding	  
buffer	  was	  mixed	  with	  5µg	  of	  total	  RNA	  in	  15µl,	  2µl	  of	  capture	  oligo	  mix	  was	  added	  and	  
the	   samples	   were	   incubated	   at	   70°C	   for	   10	  minutes	   to	   denature	   RNA	   structures	   and	  
hybridize	  the	  RNA.	  The	  samples	  were	  then	  incubated	  at	  37°C	  for	  1	  hour	  to	  anneal	  poly-­‐A	  
RNA	  as	  well	  as	  eukaryotic	  18S	  and	  28S	   rRNAs.	  25µl	  of	  oligo-­‐MagBeads	  are	   transferred	  
into	  a	  1.5µl	  Eppendorf	  tube	  and	  captured	  using	  a	  magnetic	  stand.	  The	  supernatant	  was	  
aspirated	   and	   the	  beads	  were	   resuspended	   in	   25µl	   of	   nuclease-­‐free	  water.	   The	  beads	  
were	  recaptured	  using	  the	  magnetic	  stand	  and	  nuclease-­‐free	  water	  aspirated	  from	  the	  
tube.	  The	  beads	  were	  then	  resuspended	  in	  25µl	  of	  binding	  buffer,	  recaptured	  with	  the	  
magnetic	   stand,	   binding	   buffer	   aspirated	   and	   the	   beads	   stored	   on	   ice	   until	   5	  minutes	  
prior	  to	  use.	  The	  RNA	  sample	  was	  added	  to	  the	  beads	  and	  gently	  vortexed	  thoroughly.	  
The	  MagBead	  mixture	  is	  incubated	  at	  37°C	  for	  15	  minutes,	  after	  which	  the	  beads	  were	  
recaptured,	  the	  supernatant	  aspirated	  and	  stored	  in	  a	  fresh	  Eppendorf	  tube.	  The	  beads	  
are	   resuspended	   in	   100µl	   of	   pre-­‐warmed	   wash	   solution,	   incubated	   at	   37°C	   for	   five	  
minutes	   and	   recaptured	  on	   the	  magnetic	   stand.	   The	  wash	   solution	  was	   aspirated	   and	  
added	   to	   the	   RNA	   supernatant	   in	   the	   Eppendorf	   tube.	   The	   eluted	   RNA	   was	   further	  
enriched	  to	  remove	  prokaryotic	  rRNA	  with	  the	  MICROBExpress	  kit.	  The	  oligo-­‐MagBeads	  
were	  prepared	  as	  previously	  described	  and	  the	  final	  bead	  slurry	  was	  incubated	  at	  37°C	  
until	  required.	  The	   input	  RNA	  is	  mixed	  with	  200µl	  of	  binding	  buffer	  and	  4µl	  of	  capture	  
oligo	  mix.	  The	  sample	  was	  incubated	  at	  70°C	  for	  10	  minutes	  to	  hybridize	  the	  rRNA	  then	  
incubated	   at	   37°C	   for	   15	   minutes	   to	   anneal	   the	   rRNA	   to	   the	   capture	   oligos.	   50µl	   of	  
MagBead	  slurry	  was	  added	  to	  the	  RNA/oligo	  sample,	  gently	  mixed	  and	  incubated	  at	  37°C	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for	  15	  minutes.	  The	  beads	  were	  captured	  from	  the	  sample	  using	  the	  magnetic	  stand	  and	  
the	  supernatant	  aspirated	   into	  a	  new	  1.5mL	  Eppendorf	   tube.	  A	   further	  wash	  step	  was	  
performed	  and	  the	  supernatant	  pooled	  with	   the	  enriched	  mRNA.	  The	  mRNA	  was	   then	  
precipitated	   overnight	   as	   previously	   described	   and	   pellet	   resuspended	   in	   25µl	   of	   TE	  
buffer.	  	  
	  
Enriched	  mRNA	  samples	  were	  quantified	  using	  the	  DU800	  spectrophotometer	  and	  2µl	  of	  
each	   sample	   submitted	   for	   quantification	   and	   quality	   control	   using	   the	   Agilent	   2100	  
BioAnalyzer	   on	   an	   RNA-­‐6000	   pico-­‐chip	   at	   the	  Molecular	   Genetics	   Research	   Facility	   at	  
Gardens	  Point,	  QUT.	  
	  
Sequence	  quality	  check	  and	  bioinformatic	  analyses	  
Sequencing	  of	  the	  enriched	  mRNA	  samples	  was	  performed	  at	  the	  Institute	  for	  Genome	  
Sciences,	  Maryland,	  Baltimore	  on	  the	  Illumina	  HiSeq2500	  sequencer,	  using	  the	  methods	  
outlined	  in	  Humphrys	  et	  al.	  2013	  [55]	  and	  100bp	  chemistry.	  	  
FastQC	   was	   performed	   on	   each	   dataset	   to	   determine	   the	   quality	   of	   the	   reads	   and	  
determine	  trimming	  cut-­‐offs	  
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/).	  
	  CLC	  genomics	  workbench	  (CLC	  Bio)	  was	  used	  to	  trim	  and	  assemble	  the	  reads	  against	  the	  
LPCoLN	  [18]	  and	  A03	  [30]	  C.	  pneumoniae	  genomes.	  Readmapped	  data	  was	  converted	  to	  
RPKM	   (reads	   per	   kilobase	   per	  million	   reads	  mapped)	   and	   TMM	  normalised	   (Trimmed	  
Mean	  of	  M-­‐value	  normalisation)	   using	   the	  CLC	   genomics	   package.	  Genes	   identified	   as	  
having	  mapped	  reads	  were	  sorted	  into	  those	  with	  data	  mapping	  to	  a	  single	  replicate	  or	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greater	   than	   a	   single	   replicate.	   Expressed	   genes	  were	   compared	   between	   strains	   and	  
also	   scrutinised	   against	   the	   UniProt	   (http://www.uniprot.org/uniprot/)	   and	   STRINGdb	  
v10	   [56]	   databases	   to	   determine	   functional	   properties	   and	   map	   protein-­‐protein	  
interactions.	  KEGG	  PATHWAY	  [57]	  was	  used	  to	  investigate	  functional	  pathways	  for	  genes	  
expressed	  in	  LPCoLN.	  	  	  Bowtie2-­‐2.2.5	  [58]	  was	  used	  to	  map	  A03	  reads	  to	  Homo	  sapiens	  




Propagation	  of	  LPCoLN	  and	  A03	  C.	  pneumoniae	  strains	  in	  vitro	  
To	  confirm	  successful	  C.	  pneumoniae	   infection	  of	  BEAS-­‐2B	  cells,	   immunohistochemical	  
staining	   and	   confocal	   laser	   scanning	   microscopy	   was	   performed	   at	   48	   hours	   post-­‐
infection.	   	   Microscopic	   images	   for	   strains	   A03	   and	   LPCoLN	   demonstrated	   clear	  
differences	  in	  the	  size	  and	  shape	  of	  the	  chlamydial	  inclusion	  (Figure	  1)	  at	  this	  time	  point,	  
with	  the	  LPCoLN	  inclusion	  encompassing	  much	  of	  the	  host	  cell	  surrounding	  the	  nucleus,	  
whilst	  A03	  exhibited	  multiple	  small	  round	  inclusions	  surrounding	  the	  nucleus.	  	  
Both	   experiments	   were	   carried	   out	   using	   an	   MOI	   =	   1	   and	   imaged	   at	   48	   hours	   post-­‐
infection,	  which	  resulted	  in	  26%	  infection	  rate	  in	  LPCoLN	  and	  59%	  infection	  rate	  in	  A03.	  
The	  discrepancy	  between	  the	  two	  strains	  can	  be	  accounted	  for	  by	  the	  presence	  of	  host	  
cells	  containing	  multiple	  discrete	  inclusions	  in	  A03	  (a	  few	  cells	  contained	  greater	  than	  10	  
inclusions	   per	   cell)	   compared	   with	   LPCoLN	   where	   each	   cell	   contained	   one	   large,	  
amorphous	   inclusion.	   Given	   the	   fusogenic	   phenotype	   of	   the	   LPCoLN	   strain	   [35],	   it	   is	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likely	   that	   these	   large	   inclusions	   were	   resultant	   from	   fusion	   of	   multiple	   discrete	  
inclusions	  at	  an	  earlier	   time	  point.	  When	  the	   infection	  rate	  of	  A03	   is	  calculated	  by	  the	  
number	  of	   infected	   cells,	   regardless	  of	   the	  number	  of	   inclusions,	   the	   rate	   is	   19%.	   The	  
size	   and	   shape	   of	   the	   inclusions	   were	   vastly	   divergent	   between	   the	   A03	   and	   LPCoLN	  
infections.	  The	  A03	  infection	  exhibited	  small,	  round	  discrete	  inclusions	  with	  an	  average	  
size	  of	  5	  µm	  (ranging	  from	  2	  µm	  up	  to	  10	  µm)	  that	  clustered	  tightly	  around	  the	  host	  cell	  
nucleus	   (Figure	   1B).	   Conversely,	   the	   LPCoLN	   infection	   demonstrated	   large,	   variably	  
shaped	  inclusions	  filling	  a	  considerable	  area	  of	  host	  cell	  cytoplasmic	  space	  and	  ranging	  
from	  10	  x	  10	  µm	  up	  to	  40	  x	  50	  µm	  in	  size	  (Figure	  1A).	  The	  size	  and	  morphology	  of	  the	  
chlamydial	   inclusions	   in	   both	   LPCoLN	   and	   A03	   are	   consistent	   with	   observations	   in	  
previous	  studies	  [35,	  37].	  	  
	  
	  
Figure	  1	  -­‐	  	  Confocal	  images	  of	  LPCoLN	  (koala)	  and	  A03	  (human)	  taken	  at	  48	  hours	  post-­‐infection.	  	  
Characteristic	  fusogenic	  inclusions	  demonstrated	  in	  LPCoLN	  (A)	  and	  small,	  round	  inclusions	  shown	  in	  A03	  
(B).	  A	  considerable	  amount	  of	  fluorescent	  cell	  debris	  is	  also	  noted	  adherent	  to	  cells	  for	  the	  A03	  infection.	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Experimental	  quality	  control	  and	  metrics	  of	  RNASeq	  data	  
	  
Prokaryotic	  RNA	  enrichment	  and	  BioAnalyzer	  trace	  	  
In	   order	   to	   obtain	   optimal	   RNAseq	   results,	   all	   traces	   of	   contaminating	   DNA	   must	   be	  
removed	   from	   the	   sample.	   DNA	   that	   is	   present	   during	   preparation	   of	   the	   sequencing	  
libraries	   is	   carried	   over	   and	   sequenced	   along	   with	   mRNA	   transcripts.	   In	   the	   current	  
experiment,	   After	   five	   rounds	   of	   DNAse	   treatment,	   no	   product	   was	   detected	   by	   16S	  
rRNA	   PCR.	   The	   total	   RNA	   sub-­‐sample	   obtained	   after	   the	   DNAse	   process	   was	   then	  
subjected	  to	  two	  enrichment	  steps.	  	  The	  first	  step	  was	  performed	  to	  enrich	  prokaryotic	  
RNA	  from	  poly-­‐A	  tagged	  host	  RNA	  and	  eukaryotic	  rRNAs,	  and	  the	  second	  step	  to	  enrich	  
prokaryotic	   mRNA	   away	   from	   the	   16S	   and	   23S	   rRNA	   subunits.	   BioAnalyzer	  
electrophoretic	  and	  electropherogram	  traces	  were	  used	  to	  determine	  the	  concentration	  
and	  purity	  of	  the	  enriched	  mRNA	  samples	  and	  the	  presence	  of	  any	  contaminating	  rRNA.	  
An	  unexpected	  difference	  in	  the	  concentration	  and	  quality	  of	  chlamydial	  mRNA	  obtained	  
was	  observed	  between	  the	  A03	  and	  LPCoLN	  samples	  (Table	  1).	  
	  
Table	  1	  -­‐	  Total	  RNA	  concentration	  and	  quality	  for	  LPCoLN	  and	  A03	  samples	  estimated	  by	  BioAnalyzer.	  
Sample	   RNA	  Conc	  (ng/uL)	   A260/280	   A260/230	  
LPCoLN	  1	   84.2	   1.64	   0.84	  
LPCoLN	  2	   104.4	   1.67	   0.89	  
LPCoLN	  3	   89.2	   1.65	   0.87	  
LPCoLN	  4	   77.2	   1.67	   0.82	  
LPCoLN	  5	   95.0	   1.72	   0.99	  
LPCoLN	  6	   101.4	   1.77	   1.06	  
A03	  1	   704	   2.01	   1.95	  
A03	  2	   586	   2.04	   1.94	  
A03	  3	   629.8	   2.02	   1.94	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There	   was	   considerable	   variation	   in	   fragment	   lengths	   apparent	   with	   the	   LPCoLN	  
samples.	   Samples	   one	   through	   three	   in	   Figure	   2	   demonstrated	   a	   diffuse	   band	   of	   size	  
<200nt	  in	  length,	  whilst	  samples	  four	  through	  six	  demonstrated	  strong	  bands	  at	  <200nt	  
in	   length	  and	  diffuse	  bands	  up	   to	  2000nt	   in	   length.	   The	  A03	   samples	  exhibited	   strong	  
bands	  at	  <200nt	  in	  length	  (Figure	  2).	  	  
	  	  	  
	  
Figure	  2	  -­‐	  BioAnalyzer	  electrophoretic	  size	  estimation	  of	  enriched	  mRNA	  from	  A03	  and	  LPCoLN	  samples.	  
Lane	   L	   contains	   a	   standardised	   molecular	   weight	   marker	   including	   the	   25bp	   reference	   fragment	   used	  
across	   all	   lanes	   to	   standardise	   the	   alignment.	   Lanes	   1	   through	  6	   contain	   LPCoLN	   samples	   1-­‐6.	   The	  high	  
molecular	   weight	   fragments	   seen	   in	   LPCoLN	   lanes	   4-­‐6	   are	   indicative	   of	   rRNA	   contamination.	   Lanes	   7	  
through	  9	  contain	  A03	  samples	  1-­‐3,	  whilst	  lanes	  10	  and	  11	  are	  empty.	  There	  are	  no	  traces	  of	  nucleic	  acids	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>2000bp	   in	   length,	  which	  would	   indicate	  genomic	  DNA	  contamination,	   therefore	  confirming	  earlier	  PCR	  
results.	  
	  	  
Intense	  bands	  of	  less	  than	  200bp	  in	  length	  were	  seen	  in	  all	  lanes,	  however	  lanes	  4,	  5	  and	  
6	   (LPCoLN	   4,5,6)	   show	   extensive	   nucleic	   acid	   fragments	   >200bp	   in	   length,	   suggesting	  
rRNA	  contamination.	  
Electropherogram	  traces	  detected	  no	  rRNA	  contamination	  in	  any	  of	  the	  A03	  samples,	  as	  
seen	  in	  Figure	  3A,	  however	  samples	  five	  and	  six	  of	  LPCoLN	  demonstrated	  0.7%	  and	  2.4%	  
of	   the	   total	   RNA	   consisted	  of	   rRNA	   fragments,	  which	   are	   denoted	  by	   the	  presence	  of	  
high	  molecular	  weight	  nucleic	  acids	  with	  peaks	  at	  specified	  intervals	  	  (Figure	  3B).	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Figure	  3A	  -­‐	  Electropherogram	  traces	  of	  enriched	  mRNA	  from	  A03	  samples	  1	  through	  3	  showing	  large,	  sharp	  peaks	  consisting	  of	  nucleic	  acids	  less	  than	  200bp	  in	  
size.	  The	  25bp	  reference	  fragment	  is	  denoted	  as	  a	  small	  peak	  within	  each	  panel.	  The	  electrophoretic	  trace	  for	  each	  sample	  is	  also	  shown.	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Figure	  3B	  -­‐	  Electropherogram	  traces	  of	  enriched	  mRNA	  from	  LPCoLN	  samples	  1	  through	  6.	  LPCoLN	  samples	  1	  through	  3	  demonstrate	  small	  peaks	  of	  nucleic	  acids	  
less	  than	  200bp	  in	  length,	  whilst	  the	  signal	  from	  the	  25bp	  reference	  fragment	  is	  considerably	  taller	  than	  that	  from	  the	  mRNA.	  This	  accounts	  for	  the	  lower	  nucleic	  
acid	  concentration	  in	  samples	  1	  to	  3.	  LPCoLN	  samples	  4	  through	  6	  have	  much	  higher	  mRNA	  yields,	  however	  samples	  5	  and	  6	  also	  contain	  significant	  amounts	  of	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rRNA	  and	  large	  nucleic	  acid	  fragments,	  as	  indicated	  by	  the	  drawn	  out	  signal	  and	  peaks	  indicated	  by	  the	  red	  arrows.	  The	  electrophoretic	  trace	  for	  each	  sample	  is	  
also	  shown.	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RNAseq	  library	  preparation	  and	  Illumina	  sequencing	  was	  performed	  on	  50µl	  of	  samples	  
one	   through	   three	   for	   both	   A03	   and	   LPCoLN	   at	   the	   Institute	   for	   Genome	   Sciences,	  
Baltimore,	  Maryland,	  USA.	  
	  
FastQC	  analysis	  of	  read	  quality	  for	  A03	  and	  LPCoLN	  RNA	  sequencing	  data	  
RNAseq	  data	  was	  obtained	  for	  all	  three	  A03	  replicates,	  and	  replicates	  two	  and	  three	  of	  
LPCoLN	   -­‐	   the	   first	   replicate	   having	   failed	   to	   pass	   QC	   at	   the	   IGS	   facility.	   Read	   quality	  
analyses	  were	  performed	  using	  FastQC	  on	  a	  subset	  of	  1	  million	  reads	  from	  each	  dataset	  
to	  determine	  average	  read	  quality,	  Phred	  scores,	  read	  binning	  and	  trimming	  cut-­‐offs.	  	  
The	  average	  GC	  content	  for	  all	  samples	  exceeded	  50%,	  suggesting	  the	  presence	  of	  non-­‐
chlamydial	   transcripts,	   as	   the	   average	  GC	   content	  of	  C.	   pneumoniae	   is	   40%	   [28].	   Base	  
pair	  quality	  for	  all	  samples	  averaged	  Q36,	  and	  all	  datasets	  demonstrated	  a	  large	  number	  
of	   10+	   sequence	   duplication	   binnings;	   this	   is	   expected	   for	   transcriptome	   data	   where	  
multiple	  transcripts	  of	  the	  same	  sequence	  are	  expressed.	  	  
	  
CLC	  genomics	  workbench	  and	  Bowtie2	  RNAseq	  reference	  mapping	  
Trimmed	   and	   untrimmed	   paired-­‐end	   reads	   were	   mapped	   to	   reference	   sequences	  
LPCoLN	  and	  A03	   for	   corresponding	   samples.	  Using	  both	  CLC	  genomics	  workbench	  and	  
Bowtie2	   mapping	   methods,	   less	   than	   1%	   of	   reads	   from	   any	   sample	   aligned	   to	   the	  
corresponding	  reference	  genome.	  This	  is	  demonstrated	  in	  the	  overall	  alignment	  rate,	  or	  	  	  
the	  percentage	  of	  paired	  reads	  mapped	  to	   the	  reference,	   in	  Table	  2.	  Paired-­‐end	  reads	  
were	  mapped	   against	   human	   chromosomes	   1	   and	   2	   using	   Bowtie2	   to	   determine	   the	  
percentage	   of	   non-­‐prokaryotic	   reads	   (Table	   2).	   The	   significantly	   greater	   overall	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alignment	   rate	   of	   A03	   run	   reads	   to	   human	   chromosomes	   suggests	   that	   the	   poly-­‐A	  
subtraction	  step	   in	   the	  chlamydial	  mRNA	  enrichment	  process	  was	   insufficient,	  and	  not	  
enough	  host	  mRNA	  was	  removed.	  This	  also	  supports	  the	  higher	  GC	  content	  of	  the	  reads	  
by	  FastQC	  analysis.	  	  
	  
Table	  2	  -­‐	  Reads	  mapped	  to	  chromosome:	  A03,	  LPCoLN	  and	  Homo	  sapiens	  Chr	  1	  and	  2.	  





rate	  	  *	  
Number	  















LPCoLN	  run	  2	   2767	   0.04	   	   	   	   	  
LPCoLN	  run	  3	   7100	   0.13	   	   	   	   	  
A03	  run	  1	   80	   0.02	   	   	   	   	  
A03	  run	  2	   413	   0.05	   	   	   	   	  
A03	  run	  3	   173	   0.03	   >10000	   22.31	   >10000	   26.55	  
*	   -­‐	   percentage	   of	   total	   reads	   from	   respective	   run	   aligned	   to	   either	  C.	   pneumoniae	   LPCoLN	   genome,	  C.	  
pneumoniae	  A03	  genome.	  #	  -­‐	  percentage	  of	  total	  reads	  from	  A03	  run	  3	  mapped	  to	  human	  chromosomes	  1	  
and	  2.	  	  
	  
Notwithstanding	  the	  low	  overall	  alignment	  rate	  and	  low	  number	  of	  mapped	  chlamydial	  
reads,	   over	   100	   genes	   for	   which	   one	   or	   more	   replicates	   had	   reads	   mapped	   were	  
demonstrated	  for	  both	  A03	  and	  LPCoLN,	  as	  shown	  in	  Figure	  4	  A	  and	  B.	  	  
	  Chapter	  Six:	  RNA-­‐seq	  analysis	  of	  gene	  expression	  in	  acute	  infection	  of	  a	  human	  lung	  epithelial	  cell	  line	  with	  a	  koala	  respiratory	  and	  a	  human	  cardiovascular	  strain	  of	  Chlamydia	  pneumoniae	  187	  
	  
Figure	  4	  A	  and	  B	  	  -­‐	  Ring	  images	  comparing	  the	  location	  of	  expressed	  genes	  in	  strains	  LPCoLN	  and	  A03.	  Gene	  loci	  are	  denoted	  by	  red	  lines	  and	  gene	  names	  or	  locus	  tags	  are	  
indicated.	  Figure	  4A	  clearly	  demonstrates	  a	  greater	  number	  of	  expressed	  genes	   in	  LPCoLN,	  which	  appear	  to	  be	  evenly	  spaced	  around	  the	  chromosome,	  except	   in	  small	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regions	  where	  a	  number	  of	  consecutive	  or	  directly	  adjacent	  genes	  are	  expressed,	  such	  as	  at	  20kpb,	  300kpb,	  500kpb	  and	  740kpb.	  A	  much	  smaller	  number	  of	  expressed	  
genes	  is	  noted	  in	  Figure	  4B	  for	  A03,	  with	  a	  notable	  absence	  of	  expressed	  genes	  from	  200kpb	  to	  290kpb,	  and	  again	  from	  300kpb	  to	  380kpb.	  The	  extended	  plasticity	  zone	  is	  
particularly	  evident	  as	  a	  region	  of	  high	  expression	  in	  the	  A03	  image,	  located	  from	  600kpb	  to	  640kpb.	  Images	  were	  generated	  using	  BRIG	  0.95	  [59].	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Both	  A03	  and	  LPCoLN	  had	  considerably	  more	  reads	  mapped	  to	  rRNA	   loci	   than	  to	  non-­‐
rRNA	  loci,	  as	  shown	  in	  Table	  3,	  suggesting	  that	  the	  final	  mRNA	  enrichment	  step	  was	  not	  
entirely	  successful.	  The	  rRNA	  mappings	  were	  not	  included	  in	  our	  analyses.	  
	  









Taking	  into	  account	  the	  low	  level	  of	  transcript	  signal	  and	  low	  overall	  alignment	  rate	  for	  
LPCoLN	   and	   A03,	   mapping	   of	   chlamydial	   transcripts	   in	   these	   experiments	   was	  
considered	  to	  be	  at	  the	  absolute	  limit	  of	  detection	  and	  that	  detected	  transcripts	  would	  
be	  from	  highly	  to	  very	  highly	  expressed	  genes	  at	  this	  time	  point.	  	  
A03	  mapping	   demonstrated	   110	   genes	   for	  which	   one	  or	  more	   reads	  were	  mapped	   in	  
one	  or	  more	  replicates	  (Figure	  5A).	  This	  number	  decreases	  to	  84	  genes	  when	  those	  with	  
only	   one	   mapped	   read	   are	   discarded.	   Of	   the	   110	   genes,	   20	   genes	   had	   two	   or	   more	  
replicates	   with	   mapped	   reads	   (18%);	   five	   had	   reads	   mapped	   at	   all	   three	   replicates	  
(0.045%).	  	  
Sample/Mapping	   Number	   of	  
reads	  mapped	  




mapped	   to	  
16S	  rRNA	  
Reads	  
mapped	   to	  
23S	  rRNA	  
LPCoLN	  run	  2	   2767	   106	   849	   3059	  
LPCoLN	  run	  3	   7100	   122	   207	   551	  
A03	  run	  1	   80	   15	   352	   813	  
A03	  run	  2	   413	   96	   954	   3245	  
A03	  run	  3	   173	   18	   914	   1166	  
	  Chapter	  Six:	  RNA-­‐seq	  analysis	  of	  gene	  expression	  in	  acute	  infection	  of	  a	  human	  lung	  epithelial	  cell	  line	  with	  a	  koala	  
respiratory	  and	  a	  human	  cardiovascular	  strain	  of	  Chlamydia	  pneumoniae	   190	  
LPCoLN	  resulted	   in	  185	  genes	   that	  had	  one	  or	  more	  reads	  mapped	   in	  either	   replicate.	  
Only	  one	  gene	  had	  a	  single	  read	  mapped	  in	  one	  of	  the	  two	  replicates.	  Of	  the	  185	  genes,	  
44	  had	  reads	  mapped	   for	  both	   replicates	   (23%)	   (Figure	  5B).	   In	  comparing	  homologous	  
matches	  between	  the	  strains,	  the	  data	  identified	  37	  genes	  that	  were	  expressed	  in	  both	  
A03	  and	  LPCoLN,	  as	  shown	  in	  Figure	  5C.	  This	  amounts	  to	  34.5%	  of	  A03	  transcripts	  and	  
20%	  of	  LPCoLN	  transcripts.	  	  
	  
	  
Figure	  5	  -­‐	  Venn	  diagrams	  illustrating	  number	  of	  genes	  mapped	  and	  shared	  between	  runs	   in	  A03	  (A)	  and	  
LPCoLN	   (B).	   Panel	   C	   illustrates	   the	   total	   number	   of	   genes	   mapped	   for	   each	   strain	   and	   the	   number	   of	  
shared	  genes	  mapped	  between	  them.	  	  
	  
Quantification	  of	  gene	  expression	  
The	   number	   of	   mapped	   reads	   to	   each	   locus	   were	   normalised	   against	   length,	   by	  
converting	   to	  RPKM	   (reads	  per	   kilobase	  mapped).	   This	  normalisation	  method	  gives	  an	  
effective	  estimate	  of	  coverage	  or	  gene	  expression;	  however	  signal	  from	  the	  most	  highly	  
expressed	  genes	  biases	  representation	  against	  genes	  that	  have	  a	  lower	  signal.	  Data	  was	  
further	  normalised	  using	   the	  Trimmed	  Mean	  of	  M-­‐values	   (TMM),	  which	  assumes	   total	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RNAseq	  output	  is	  identical	  across	  all	  replicates,	  allowing	  for	  relative	  comparison	  of	  gene	  
expression	  between	  experimental	  replicates	  and	  data	  from	  both	  strains.	  	  
The	   number	   of	   genes	   detected	  with	   any	   level	   of	   expression	   in	   any	   replicate	   for	   both	  
strains	  covered	  approximately	  10%	  of	  the	  total	  genome	  (100	  genes	  out	  of	  1000	  genes).	  
Genes	  that	  were	  not	  detected	  had	  no	  reads	  mapped	  in	  any	  of	  the	  replicates.	  
Read	  depth	   per	   locus	  was	   considerably	   higher	   for	   the	   LPCoLN	   replicates	   compared	   to	  
A03,	  which	  also	  resulted	   in	  higher	  RPKM	  values.	   In	  both	  strains,	  genes	  that	  had	  higher	  
expression	   levels	   exhibited	  marked	   heteroscedasticity	   between	   replicates.	   Normalised	  
expression	  levels	  were	  on	  average	  slightly	  lower	  for	  A03	  replicates	  compared	  to	  LPCoLN,	  
but	  this	  is	  likely	  due	  to	  the	  overall	  lower	  number	  of	  mapped	  reads	  for	  A03.	  	  
	  Tables	  4	  and	  5	  outline	  the	  number	  of	  mapped	  reads,	  RPKM	  and	  TMM	  for	  experimental	  
replicates	  in	  LPCoLN	  and	  A03	  respectively.	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Table	  4	  -­‐	  LPCoLN	  mapped	  reads,	  RPKM	  and	  TMM	  normalisation	  data	  for	  experimental	  replicates	  3	  and	  2.	  	  
Gene	  product	   Locus	  Tag	  
LPCoLN	   3	  
Unique	  
gene	  reads	  




LPCoLN	   2	  
Unique	  
gene	  reads	  




acpP	   CPK_ORF00803	   353	   206374.8188	   12.5	   218	   328273.702	   12.4	  
atpB	   CPK_ORF00599	   25	   2663.467948	   8.1	   0	   0	   0	  
cdsA	   CPK_ORF01084	   0	   0	   0	   4	   1559.448719	   7.2	  
clpB	   CPK_ORF00656	   10	   539.4521012	   6.4	   0	   0	   0	  
putative	  membrane	  protein	   CPK_ORF00048	   8	   1120.251429	   7.2	   0	   0	   0	  
putative	  orthophosphate	  transport	   CPK_ORF00082	   21	   4365.246403	   8.6	   15	   8031.160904	   8.8	  
Major	  outer	  membrane	  protein	   CPK_ORF00098	   9	   1079.319165	   7.1	   0	   0	   0	  
T3S	  protein/YscN	   CPK_ORF00106	   0	   0	   0	   12	   1571.31409	   7.2	  
T3S	  effector	  protein	   CPK_ORF00131	   0	   0	   0	   14	   2027.095901	   7.4	  
T3S	  effector	  protein	   CPK_ORF00132	   18	   964.3401478	   7	   0	   0	   0	  
Hypothetical	   CPK_ORF00133	   20	   1434.677827	   7.4	   0	   0	   0	  
Hypothetical	   CPK_ORF00148	   12	   3924.796965	   8.5	   9	   7581.865189	   8.7	  
Polyprenyl	  synthetase	  (lipid	  biosynthesis)	   CPK_ORF00154	   0	   0	   0	   10	   4154.048744	   8.1	  
DUF1347/N-­‐term	  TM	   CPK_ORF00157	   15	   1150.094193	   7.2	   0	   0	   0	  
Hypothetical	   CPK_ORF00184	   39	   14031.14915	   9.8	   24	   22240.13789	   9.8	  
LysM	  domain	  protein	  (bacterial	  cell	  wall	  degradation)	   CPK_ORF00186	   14	   3178.577478	   8.2	   8	   4678.346158	   8.3	  
TolQ	  like	  protein	  (translocation	  of	  proteins	  across	  membrane)	   CPK_ORF00191	   0	   0	   0	   2	   1034.055052	   6.8	  
Integral	  membrane	  protein	  (putative	  nucleoside	  sugar	  transporter)	   CPK_ORF00215	   20	   3056.89524	   8.2	   0	   0	   0	  
tRNA	  nucleotidyltransferase/poly(A)	  polymerase	   CPK_ORF00251	   6	   682.7809806	   6.7	   0	   0	   0	  
SNF2/helicase	  domain	  protein	   CPK_ORF00255	   0	   0	   0	   10	   1032.282893	   6.8	  
Putative	  outer	  membrane	  protein	  (Signal	  peptide)	   CPK_ORF00259	   25	   3389.166462	   8.3	   12	   4190.170907	   8.2	  
Hypothetical	   CPK_ORF00263	   4	   1520.991778	   7.5	   11	   10773.50853	   9.1	  
putative	  lipoprotein	   CPK_ORF00282	   29	   6221.763385	   8.9	   0	   0	   0	  
phosphatidylethanolamine-­‐binding	  protein	   CPK_ORF00284	   13	   4026.599094	   8.5	   0	   0	   0	  
KH	   domain/Bacterial	   organelle	   PNPases	   (phosphate	   dependent	  
exonuclease)	   CPK_ORF00318	   11	   3476.185601	   8.3	   0	   0	   0	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radical	  SAM	  domain-­‐containing	  protein	   CPK_ORF00322	   0	   0	   0	   5	   1701.517141	   7.3	  
Hypothetical	   CPK_ORF00324	   10	   844.2328009	   6.9	   0	   0	   0	  
iojap	  family	  protein	   CPK_ORF00326	   24	   9354.099434	   9.4	   0	   0	   0	  
acyltransferase	  family	  protein	   CPK_ORF00332	   20	   3682.716313	   8.4	   7	   3319.96809	   7.9	  
Hypothetical	   CPK_ORF00335	   14	   2897.287435	   8.2	   0	   0	   0	  
Putative	  IncA	   CPK_ORF00351	   7	   2059.078492	   7.8	   0	   0	   0	  
Alkaline	  shock	  protein	  (Alkaline	  pH	  tolerance)	   CPK_ORF00352	   0	   0	   0	   11	   8440.392033	   8.8	  
peptidase,	  M16	  family	   CPK_ORF00372	   0	   0	   0	   17	   2171.734921	   7.5	  
ribonuclease,	  Rne/Rng	  family	   CPK_ORF00374	   4	   362.5619936	   6	   7	   1634.247858	   7.2	  
ribonucleoside-­‐diphosphate	  reductase,	  alpha	   CPK_ORF00394	   7	   401.2175002	   6.1	   0	   0	   0	  
DUF648	   CPK_ORF00401	   44	   5546.905325	   8.8	   10	   3247.100096	   7.9	  
DUF648	   CPK_ORF00402	   0	   0	   0	   20	   7003.919393	   8.7	  
peptidase,	  M16	  (pitrilysin)	  family	   CPK_ORF00406	   0	   0	   0	   20	   2471.126432	   7.6	  
ribonucleoside-­‐diphosphate	  reductase	  subunit	  alpha	   CPK_ORF00409	   4	   179.0258265	   5.3	   0	   0	   0	  
ribonucleoside-­‐diphosphate	  reductase	  subunit	   CPK_ORF00410	   0	   0	   0	   5	   1735.841694	   7.3	  
Hypothetical	   CPK_ORF00420	   33	   2263.088573	   7.9	   10	   1766.384363	   7.3	  
putative	  permease,	  YjgP/YjgQ	  family	   CPK_ORF00421	   0	   0	   0	   13	   4374.515018	   8.2	  
Putative	  membrane	  protein	   CPK_ORF00428	   12	   2378.160873	   8	   0	   0	   0	  
DUF720	   CPK_ORF00432	   73	   21075.5944	   10.2	   43	   31975.91842	   10.1	  
Putativemembrane	  protein	   CPK_ORF00446	   0	   0	   0	   14	   3300.477084	   7.9	  
Hypothetical	   CPK_ORF00448	   11	   1056.417801	   7.1	   0	   0	   0	  
Putative	  membrane	  protein	   CPK_ORF00457	   19	   3243.209658	   8.3	   0	   0	   0	  
Putative	  IncA	   CPK_ORF00479	   16	   969.3367289	   7	   0	   0	   0	  
Hypothetical	   CPK_ORF00485	   12	   6526.115884	   9	   0	   0	   0	  
Helix-­‐turn-­‐helix	  +	  TM	   CPK_ORF00494	   22	   7145.492623	   9.1	   0	   0	   0	  
TM	  +	  DUF2608	   CPK_ORF00499	   0	   0	   0	   7	   2907.834121	   7.8	  
Putative	  IncA	   CPK_ORF00508	   0	   0	   0	   11	   1461.016041	   7.1	  
Putative	  IncA	   CPK_ORF00513	   8	   482.7922289	   6.3	   0	   0	   0	  
signal	  peptide	  +	  low	  complexity	   CPK_ORF00521	   16	   1075.183843	   7.1	   0	   0	   0	  
ABC	  transporter	  ATP-­‐binding	  protein	   CPK_ORF00524	   0	   0	   0	   7	   1588.082665	   7.2	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Putative	  IncA	   CPK_ORF00537	   0	   0	   0	   12	   3409.455101	   8	  
phosphoenolpyruvate-­‐protein	  phosphotransferase	   CPK_ORF00541	   14	   1144.732448	   7.2	   0	   0	   0	  
Putative	  IncA	   CPK_ORF00546	   5	   302.5258549	   5.8	   0	   0	   0	  
	  	   CPK_ORF00550	   30	   20942.01366	   10.2	   0	   0	   0	  
putative	  hydrolase	  (7TM	  hydrolases)	   CPK_ORF00551	   21	   1391.190426	   7.4	   0	   0	   0	  
Putative	  IncA	   CPK_ORF00552	   0	   0	   0	   8	   6099.615877	   8.5	  
similar	  to	  CT296	  (C.tr)	   CPK_ORF00558	   20	   6034.902861	   8.9	   0	   0	   0	  
signal	  peptide	  and	  C-­‐term	  TM	   CPK_ORF00566	   10	   1012.348424	   7.1	   0	   0	   0	  
	  	   CPK_ORF00571	   12	   10393.44382	   9.5	   0	   0	   0	  
ferredoxin	   CPK_ORF00593	   61	   22464.56951	   10.2	   29	   27508.30703	   10	  
DUF2764	   CPK_ORF00597	   19	   3328.237626	   8.3	   14	   6316.643408	   8.6	  
signal	  peptide	   CPK_ORF00623	   0	   0	   0	   3	   1434.135876	   7.1	  
Putative	  IncA	   CPK_ORF00638	   25	   1465.241139	   7.5	   0	   0	   0	  
signal	  peptide	  +	  Transglutaminase/Tetratricopeptide	  repeats	   CPK_ORF00657	   22	   1967.401411	   7.8	   0	   0	   0	  
Protein	  kinase/Fe	  dependent	  oxidoreductase	   CPK_ORF00662	   13	   980.6717149	   7	   8	   1554.41824	   7.2	  
Putative	  IncA	   CPK_ORF00664	   3	   91.22983843	   4.6	   0	   0	   0	  
Hypothetical	   CPK_ORF00671	   0	   0	   0	   10	   17980.21098	   9.6	  
KDO-­‐transferase	  family	  protein	   CPK_ORF00673	   7	   983.1636042	   7	   0	   0	   0	  
dienelactone	  hydrolase	  family	  protein	   CPK_ORF00676	   10	   1694.583231	   7.6	   0	   0	   0	  
DUF648	   CPK_ORF00677	   141	   19226.35598	   10.1	   19	   6673.122034	   8.6	  
DUF648	   CPK_ORF00678	   67	   9731.749411	   9.4	   16	   5985.958438	   8.5	  
Putative	  IncA	   CPK_ORF00680	   73	   9405.637172	   9.4	   15	   4977.992296	   8.3	  
Putative	  IncA	   CPK_ORF00683	   11	   1405.67068	   7.4	   8	   2633.16751	   7.7	  
MAC/perforin	  domain	  protein	   CPK_ORF00685	   0	   0	   0	   8	   1176.726872	   6.9	  
Putative	  IncA	   CPK_ORF00692	   16	   1908.999885	   7.7	   0	   0	   0	  
coiled	  coil	   CPK_ORF00696	   0	   0	   0	   4	   1063.729921	   6.8	  
Putative	  IncA	   CPK_ORF00719	   11	   1179.989608	   7.2	   0	   0	   0	  
Putative	  IncA	   CPK_ORF00720	   7	   779.5082862	   6.8	   0	   0	   0	  
Putative	  membrane	  protein	  (7TM)	  -­‐	  DUF165	   CPK_ORF00724	   0	   0	   0	   12	   6312.702894	   8.6	  
Hypothetical	   CPK_ORF00729	   1	   383.3647309	   6.1	   0	   0	   0	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signal	  peptide	   CPK_ORF00743	   0	   0	   0	   12	   6231.073115	   8.5	  
Putative	  IncA	   CPK_ORF00751	   25	   8063.878822	   9.2	   0	   0	   0	  
Putative	  IncA	   CPK_ORF00754	   10	   3317.056537	   8.3	   0	   0	   0	  
Hypothetical	   CPK_ORF00766	   16	   2580.441223	   8	   0	   0	   0	  
SEC-­‐C	  domain-­‐containing	  protein	   CPK_ORF00769	   13	   3640.817145	   8.4	   11	   7934.979337	   8.8	  
2xDUF161,	  DUF2179	  (6xTM)	   CPK_ORF00772	   0	   0	   0	   6	   2433.685123	   7.6	  
putative	  4-­‐hydroxybenzoate	   CPK_ORF00774	   37	   5807.075152	   8.9	   21	   8489.314379	   8.8	  
Sua5/YciO/YrdC/YwlC	  family	  protein	   CPK_ORF00778	   0	   0	   0	   11	   4617.217942	   8.3	  
DNA	  polymerase	  III,	  delta	  subunit	   CPK_ORF00779	   24	   3754.153619	   8.4	   0	   0	   0	  
lipoprotein,	  NPLA	  family	   CPK_ORF00787	   0	   0	   0	   9	   3971.453194	   8.1	  
ABC	  transporter	  permease	   CPK_ORF00788	   6	   1264.067491	   7.3	   0	   0	   0	  
ABC	  transporter	  ATP-­‐binding	  protein	   CPK_ORF00789	   32	   4376.18687	   8.6	   13	   4579.170691	   8.2	  
Putative	  IncA	   CPK_ORF00791	   0	   0	   0	   8	   1736.467223	   7.3	  
Putative	  IncA	   CPK_ORF00793	   11	   1065.166602	   7.1	   0	   0	   0	  
cyclic	  nucleotide-­‐binding	  domain-­‐containing	  protein	   CPK_ORF00802	   35	   11862.08262	   9.6	   0	   0	   0	  
surface	  antigen	  repeat/outer	  membrane	  protein,	   CPK_ORF00808	   120	   7095.397801	   9.1	   49	   7462.583141	   8.7	  
Putative	  IncA	   CPK_ORF00811	   183	   24665.70888	   10.3	   62	   21524.43701	   9.8	  
putative	  chromosomal	  replication	  initiator	   CPK_ORF00816	   10	   1014.544407	   7.1	   15	   3919.763999	   8.1	  
inner	  membrane	  protein	   CPK_ORF00818	   11	   646.3259659	   6.6	   9	   1362.068746	   7.1	  
Hypothetical	   CPK_ORF00861	   16	   9125.950667	   9.3	   5	   7345.573998	   8.7	  
Putative	  incA	   CPK_ORF00862	   17	   1774.77333	   7.7	   18	   4840.208581	   8.3	  
Putative	  IncA	   CPK_ORF00863	   7	   754.3628576	   6.8	   0	   0	   0	  
Laccase/multi-­‐copper	  oxidoreductase	  (oxidise	  phenolic	  compounds)	   CPK_ORF00884	   0	   0	   0	   9	   4354.243864	   8.2	  
Hypothetical	   CPK_ORF00888	   0	   0	   0	   2	   1617.012263	   7.2	  
5TM	   CPK_ORF00894	   11	   2598.360954	   8	   0	   0	   0	  
alpha	  amylase	  family	  protein	   CPK_ORF00899	   0	   0	   0	   7	   1268.078038	   7	  
class	  V	  aminotransferase	   CPK_ORF00906	   23	   2891.724287	   8.2	   0	   0	   0	  
putative	  lipoprotein	   CPK_ORF00909	   0	   0	   0	   4	   2230.878029	   7.5	  
penicillin-­‐binding	  protein	   CPK_ORF00928	   0	   0	   0	   6	   1113.72031	   6.9	  
putative	  outer	  membrane	  protein	  5	  (PMPG)	   CPK_ORF00956	   2	   66.52986795	   4.3	   0	   0	   0	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methionine	  synthatase	  2	   CPK_ORF00961	   20	   2534.986296	   8	   0	   0	   0	  
polymorphic	  outer	  membrane	  protein	  family	   CPK_ORF00983	   103	   5070.906535	   8.7	   398	   50469.50589	   10.6	  
pmp	  frameshift	  pseudogene	   CPK_ORF00984	   0	   0	   0	   126	   15499.21114	   9.4	  
Hypothetical	   CPK_ORF00988	   0	   0	   0	   4	   1020.910284	   6.8	  
probable	  metal	  dependent	  protein	  hydrolase	   CPK_ORF01006	   20	   3214.467159	   8.3	   0	   0	   0	  
YbeY	   -­‐	   strand-­‐specific	   metallo-­‐endoribonuclease	   involved	   in	   late-­‐
stage	  70S	  ribosome	  quality	  control	   CPK_ORF01024	   0	   0	   0	   9	   6818.910202	   8.6	  
UPF0158	  -­‐	  PFAM	  domain	   CPK_ORF01032	   11	   1573.319477	   7.5	   0	   0	   0	  
DUF164	  -­‐	  putative	  Zinc	  ribbon	  domain	   CPK_ORF01040	   14	   2567.792002	   8	   0	   0	   0	  
sugar	  isomerase,	  KpsF/GutQ	  family	   CPK_ORF01041	   0	   0	   0	   8	   2920.422147	   7.8	  
transporter,	  dicarboxylate/amino	  acid:cation	   CPK_ORF01043	   15	   1690.499898	   7.6	   0	   0	   0	  
putative	  tail-­‐specific	  protease	   CPK_ORF01069	   19	   1375.602858	   7.4	   8	   1491.856515	   7.1	  
HAD-­‐superfamily	  hydrolase	   CPK_ORF01098	   0	   0	   0	   13	   6779.551413	   8.6	  
putative	  lipoprotein	   CPK_ORF01111	   0	   0	   0	   10	   3718.130048	   8	  
putative	  peptide	  ABC	  transporter	  periplasmic	   CPK_ORF01115	   8	   528.480194	   6.4	   0	   0	   0	  
cydA	   CPK_ORF00612	   0	   0	   0	   9	   2414.714303	   7.6	  
cydB	   CPK_ORF00613	   9	   1220.099926	   7.3	   19	   6634.437269	   8.6	  
def	   CPK_ORF00492	   5	   1250.548053	   7.3	   0	   0	   0	  
dnaA	   CPK_ORF00936	   9	   933.3358637	   7	   0	   0	   0	  
dnaE	   CPK_ORF0066	   57	   2148.201723	   7.8	   60	   5824.371325	   8.5	  
efp	  	   CPK_ORF00690	   16	   4023.268574	   8.5	   0	   0	   0	  
ffh	   CPK_ORF00627	   0	   0	   0	   10	   2683.015892	   7.7	  
glgC	   CPK_ORF00006	   10	   1058.156045	   7.1	   0	   0	   0	  
glgP	   CPK_ORF00815	   48	   2721.192563	   8.1	   23	   3358.485469	   7.9	  
gltX	   CPK_ORF01074	   4	   369.7272504	   6	   8	   1904.623139	   7.4	  
gmk	   CPK_ORF00632	   0	   0	   0	   8	   4678.346158	   8.3	  
gyrA	   CPK_ORF00782	   22	   1232.276572	   7.3	   0	   0	   0	  
gyrB	   CPK_ORF00783	   14	   812.3907697	   6.9	   0	   0	   0	  
hemA	   CPK_ORF00118	   2	   275.1205716	   5.7	   0	   0	   0	  
ileS	   CPK_ORF00619	   0	   0	   0	   7	   807.7317001	   6.5	  
infB	   CPK_ORF00825	   0	   0	   0	   4	   547.5791526	   6.2	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ispE	   CPK_ORF00370	   0	   0	   0	   7	   2829.77146	   7.8	  
lgt	   CPK_ORF00819	   0	   0	   0	   14	   5756.12215	   8.5	  
metG	   CPK_ORF00634	   26	   2202.9582	   7.9	   9	   1964.142612	   7.4	  
mip	   CPK_ORF00061	   10	   1805.810702	   7.7	   6	   2790.750893	   7.8	  
murA	   CPK_ORF01087	   0	   0	   0	   9	   2362.106148	   7.6	  
nusA	   CPK_ORF00824	   22	   2365.404455	   7.9	   0	   0	   0	  
nusB	   CPK_ORF00414	   0	   0	   0	   8	   5985.958438	   8.5	  
oppA	  4	   CPK_ORF00704	   0	   0	   0	   13	   2960.446836	   7.8	  
oppA	  2	   CPK_ORF00702	   17	   1505.86828	   7.5	   7	   1597.105862	   7.2	  
pcnB	   CPK_ORF00381	   0	   0	   0	   5	   1444.4534	   7.1	  
pepF	   CPK_ORF00648	   0	   0	   0	   6	   1181.053074	   6.9	  
pheT	   CPK_ORF01110	   3	   176.9375681	   5.3	   10	   1519.135102	   7.2	  
pnpA	   CPK_ORF00424	   28	   1884.279023	   7.7	   0	   0	   0	  
prfA	   CPK_ORF00625	   32	   4180.603099	   8.5	   8	   2692.009242	   7.7	  
priA	   CPK_ORF00334	   0	   0	   0	   9	   1445.608963	   7.1	  
pyrG	   CPK_ORF00745	   13	   1130.142125	   7.2	   0	   0	   0	  
rbfA	   CPK_ORF00826	   0	   0	   0	   11	   10951.58305	   9.1	  
recJ	   CPK_ORF01077	   0	   0	   0	   4	   818.1148629	   6.6	  
recR	   CPK_ORF00807	   0	   0	   0	   6	   3596.042196	   8	  
ribF	   CPK_ORF00829	   11	   1675.81586	   7.6	   0	   0	   0	  
rplL	   CPK_ORF00368	   18	   6475.914993	   9	   0	   0	   0	  
rplO	   CPK_ORF00030	   21	   6773.658211	   9	   0	   0	   0	  
rplQ	   CPK_ORF00025	   21	   6868.394689	   9	   0	   0	   0	  
rplT	   CPK_ORF00417	   18	   6900.565156	   9	   0	   0	   0	  
rplY	   CPK_ORF00364	   22	   5531.994289	   8.8	   0	   0	   0	  
rpmB	   CPK_ORF00837	   0	   0	   0	   5	   6692.634087	   8.6	  
rpmG	   CPK_ORF00761	   10	   8824.622108	   9.3	   7	   15910.79047	   9.5	  
rpoA	   CPK_ORF00026	   30	   3741.639774	   8.4	   17	   5461.189415	   8.4	  
rpoB	   CPK_ORF00590	   4	   149.3072535	   5.1	   13	   1249.861434	   7	  
rpoC	   CPK_ORF00591	   0	   0	   0	   13	   1123.440729	   6.9	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rpoD	   CPK_ORF00162	   17	   1392.466641	   7.4	   0	   0	   0	  
rpsD	   CPK_ORF00139	   0	   0	   0	   10	   5736.543503	   8.5	  
rpsT	   CPK_ORF00160	   106	   49576.727	   11.1	   24	   28912.17926	   10	  
secE	   CPK_ORF00582	   37	   20601.29042	   10.2	   29	   41589.9404	   10.4	  
sucA	   CPK_ORF00887	   0	   0	   0	   2	   265.0548153	   5.5	  
topA	   CPK_ORF00174	   4	   214.543565	   5.5	   0	   0	   0	  
udk	   CPK_ORF00141	   82	   17198.12004	   10	   34	   18367.22897	   9.6	  
uppS	   CPK_ORF01083	   13	   2320.673524	   7.9	   0	   0	   0	  
uvrC	   CPK_ORF00353	   16	   1238.953567	   7.3	   0	   0	   0	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Table	  5	  -­‐	  A03	  mapped	  reads,	  RPKM	  and	  TMM	  normalisation	  data	  for	  experimental	  replicates	  1,	  2	  and	  3.	  	  
Gene	  product	   Locus	  tag	  
A03	   1	   -­‐	  
Unique	  
gene	  
reads	   A03	  1	  -­‐	  RPKM	  
A03	   1	   -­‐	  
TMM	  
A03	   2	   -­‐	  
Unique	  
gene	  
reads	   A03	  2	  -­‐	  RPKM	  
A03	   2	   -­‐	  
TMM	  
A03	   3	   -­‐	  
Unique	  
gene	  
reads	   A03	  3	  -­‐	  RPKM	  
A03	   3	   -­‐	  
TMM	  
acpP	   CP0463	   4	   10345.54107	   8.7	   0	   0	   0	   0	   0	   0	  
acpS	   CP0445	   1	   1682.2018	   7	   0	   0	   0	   0	   0	   0	  
transcript	  cleavage	  factor/GreA	   CP0004	   1	   286.1837088	   5.3	   0	   0	   0	   0	   0	   0	  
uridine	  kinase	   CP0011	   8	   7422.809738	   8.4	   0	   0	   0	   0	   0	   0	  
Hypothetical	  	   CP0022	   1	   752.402987	   6.3	   0	   0	   0	   0	   0	   0	  
DUF1137	   CP0024	   2	   2538.783085	   7.4	   0	   0	   0	   0	   0	   0	  
YscN	  -­‐	  type	  III	  secretion	  system	  ATPase	   CP0039	   0	   0	   0	   2	   343.5039706	   6.8	   0	   0	   0	  
similar	  to	  CT670	  YscO	  homolog	   CP0040	   0	   0	   0	   3	   1350.641352	   8.4	   2	   1698.868723	   7.4	  
FeS	  cluster	  protein	   CP0056	   1	   497.3817823	   5.9	   0	   0	   0	   0	   0	   0	  
GlpT/PgpT/UhpT	  family	  protein	   CP0082	   2	   907.5036028	   6.4	   0	   0	   0	   0	   0	   0	  
DNA-­‐directed	  RNA	  polymerase	  subunit	  
alpha	   CP0121	   0	   0	   0	   0	   0	   0	   9	   3295.892	   8.1	  
glyceraldehyde-­‐3-­‐phosphate	  
dehydrogenase	   CP0123	   3	   1847.418049	   7.1	   0	   0	   0	   0	   0	   0	  
DNA	  polymerase	  I	   CP0135	   1	   237.5554781	   5.2	   0	   0	   0	   0	   0	   0	  
has	  signal	  peptide	   CP0147	   4	   12540.04978	   8.9	   1	   1152.820144	   8.2	   0	   0	   0	  
has	   signal	   peptide	   (Methylated-­‐DNA-­‐
protein-­‐cysteine	  S-­‐methyltransferase)	   CP0153	   3	   1915.840939	   7.1	   0	   0	   0	   0	   0	   0	  
probable	   transcriptional	   regulatory	  
protein	   CP0176	   4	   3462.942618	   7.7	   0	   0	   0	   0	   0	   0	  
probable	   metal	   dependent	   protein	  
hydrolase	   CP0265	   2	   1374.822734	   6.8	   0	   0	   0	   0	   0	   0	  
Peptidase_C65/ubiquitin	   iso-­‐peptidase	  
(Chlamydiae	  only	  prokaryotes	  with	  this	  
domain)	   CP0271	   4	   800.4287096	   6.3	   0	   0	   0	   0	   0	   0	  
GTP-­‐binding	  protein	  HflX	   CP0276	   2	   874.8871942	   6.4	   0	   0	   0	   0	   0	   0	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phospholipase	  D	  family	  protein	   CP0318	   0	   0	   0	   0	   0	   0	   4	   1203.810542	   7.1	  
2TM	   CP0319	   2	   566.8789628	   6	   0	   0	   0	   0	   0	   0	  
N-­‐acetylmuramoyl-­‐L-­‐alanine	  amidase	   CP0337	   2	   1561.591105	   6.9	   0	   0	   0	   0	   0	   0	  
glycosyl	  hydrolase	  family	  protein	   CP0367	   1	   311.1440924	   5.4	   0	   0	   0	   0	   0	   0	  
DUF678	   CP0375	   2	   791.2459711	   6.3	   0	   0	   0	   0	   0	   0	  
ferredoxin	   CP0393	   4	   8996.122671	   8.6	   0	   0	   0	   0	   0	   0	  
Putative	  IncA	   CP0405	   1	   445.9284945	   5.8	   0	   0	   0	   0	   0	   0	  
ABC	  transporter	  ATP-­‐binding	  protein	   CP0412	   2	   1591.621703	   7	   0	   0	   0	   0	   0	   0	  
bifunctional	   riboflavin	   kinase/FMN	  
adenylyltransferase	   CP0437	   2	   1339.228618	   6.8	   0	   0	   0	   0	   0	   0	  
inner	   membrane	   protein	   translocase	  
component	  YidC	   CP0448	   11	   2859.320397	   7.5	   0	   0	   0	   0	   0	   0	  
two	  low	  complexity	  motifs	   CP0455	   1	   596.284788	   6	   0	   0	   0	   3	   1241.104384	   7.1	  
outer	  membrane	  protein	   CP0458	   0	   0	   0	   0	   0	   0	   10	   1810.269951	   7.5	  
cyclic	  nucleotide-­‐binding	  protein	   CP0464	   4	   5997.415114	   8.2	   0	   0	   0	   3	   3120.747981	   8	  
amino	  acid	  antiporter	   CP0476	   3	   1323.523378	   6.8	   0	   0	   0	   0	   0	   0	  
fructose-­‐bisphosphate	  aldolase	   CP0477	   1	   591.1737755	   6	   0	   0	   0	   0	   0	   0	  
Putative	  IncA	   CP0481	   0	   0	   0	   0	   0	   0	   4	   3377.750756	   8.1	  
Sua5/YciO/YrdC	  family	  protein	   CP0489	   1	   720.9436287	   6.2	   0	   0	   0	   0	   0	   0	  
yqfU	  membrane	  protein	   CP0498	   1	   696.6694324	   6.2	   0	   0	   0	   0	   0	   0	  
ABC	  transporter	  ATP-­‐binding	  protein	   CP0513	   2	   1823.002832	   7.1	   0	   0	   0	   0	   0	   0	  
dsbG:	   Thiol/disulphide	   interchange	  
protein	   CP0536	   2	   1768.468559	   7.1	   0	   0	   0	   0	   0	   0	  
Putative	  IncA	   CP0548	   2	   1855.702434	   7.1	   0	   0	   0	   0	   0	   0	  
2TM	   CP0553	   2	   1050.308738	   6.6	   0	   0	   0	   0	   0	   0	  
oppA4	   CP0572	   1	   388.2004155	   5.6	   0	   0	   0	   0	   0	   0	  
N-­‐terminal	  TM	   CP0578	   1	   181.0243407	   4.9	   0	   0	   0	   0	   0	   0	  
IncA	  protein	   CP0581	   1	   529.1836865	   5.9	   0	   0	   0	   0	   0	   0	  
acetyl-­‐CoA	   carboxylase	   biotin	  
carboxylase	  subunit	   CP0586	   0	   0	   0	   2	   334.4445253	   6.8	   0	   0	   0	  
Hypothetical	  	   CP0588	   2	   2236.873745	   7.3	   0	   0	   0	   0	   0	   0	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GuaB	   CP0598	   1	   582.8473843	   6	   0	   0	   0	   0	   0	   0	  
GuaA	   CP0599	   4	   1924.751827	   7.1	   0	   0	   0	   0	   0	   0	  
Add	   CP0600	   2	   1235.288486	   6.7	   0	   0	   0	   3	   1285.561855	   7.2	  
2TM	   CP0602	   10	   7807.955526	   8.5	   9	   2584.057228	   9.2	   5	   2708.573719	   7.9	  
signal	  peptide	   CP0604	   4	   7456.245818	   8.4	   0	   0	   0	   0	   0	   0	  
2TM	   CP0605	   10	   18474.18049	   9.3	   0	   0	   0	   0	   0	   0	  
Hypothetical	  	   CP0606	   26	   27447.35386	   9.6	   4	   1552.778153	   8.6	   26	   19042.93156	   9.9	  
signal	  peptide,	  2TM	  (putative	  incA)	   CP0607	   3	   3337.271313	   7.7	   0	   0	   0	   0	   0	   0	  
DUF648	  domain	   CP0609	   3	   1809.715639	   7.1	   1	   221.8254504	   6.3	   0	   0	   0	  
pfkA	   CP0611	   3	   1138.95865	   6.6	   0	   0	   0	   0	   0	   0	  
Hypothetical	  	   CP0616	   47	   140939.2552	   11.2	   2	   2205.395058	   9	   10	   20804.98654	   9.9	  
Serine/Threonine	   protein	   kinase/Iron	  
dependent	  oxidoreductase	   CP0625	   5	   1668.635657	   7	   0	   0	   0	   0	   0	   0	  
?2TM	   CP0626	   1	   1379.405476	   6.8	   0	   0	   0	   0	   0	   0	  
Oligoendopeptidase	  F	   CP0636	   2	   676.179155	   6.1	   0	   0	   0	   0	   0	   0	  
IncA	   CP0646	   3	   816.7532425	   6.3	   0	   0	   0	   0	   0	   0	  
Signal	  recognition	  particle	  GTPase	   CP0658	   3	   1382.477649	   6.8	   0	   0	   0	   0	   0	   0	  
cytochrome	   D	   ubiquinol	   oxidase,	  
subunit	  I	   CP0672	   1	   460.8258829	   5.8	   0	   0	   0	   0	   0	   0	  
Hypothetical	  	   CP0689	   3	   13794.05476	   9	   0	   0	   0	   0	   0	   0	  
transaldolase	  B	   CP0692	   1	   627.0024892	   6.1	   0	   0	   0	   0	   0	   0	  
RpoC	   CP0693	   0	   0	   0	   0	   0	   0	   2	   205.3711118	   5.3	  
IncA	   CP0728	   4	   1124.515334	   6.6	   0	   0	   0	   0	   0	   0	  
DNA	   polymerase	   III	   subunits	  
gamma/tau	   CP0735	   3	   1401.201951	   6.8	   0	   0	   0	   0	   0	   0	  
Hypothetical	  	   CP0740	   4	   7663.363757	   8.4	   0	   0	   0	   0	   0	   0	  
2-­‐oxoisovalerate	   dehydrogenase	  
subunit	  E1	  alpha/beta	   CP0743	   0	   0	   0	   0	   0	   0	   3	   634.2610035	   6.5	  
Hsp40/molecular	  chaperone	  DnaJ	   CP0744	   8	   4211.925118	   7.9	   12	   2323.240595	   9.1	   9	   3287.505507	   8.1	  
ABC	  transporter	  ATP-­‐binding	  protein	   CP0753	   3	   1168.987692	   6.7	   0	   0	   0	   0	   0	   0	  
pseudogene	   CP0760	   2	   445.6083735	   5.8	   0	   0	   0	   0	   0	   0	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5'	  IncA	  fragment	  missing	  a	  lobe	   CP0766	   1	   772.0553039	   6.3	   0	   0	   0	   0	   0	   0	  
Hypothetical	  	   CP0774	   8	   32456.59944	   9.8	   0	   0	   0	   4	   11259.16919	   9.3	  
1-­‐deoxy-­‐D-­‐xylulose-­‐5-­‐phosphate	  
synthase	   CP0790	   2	   641.5839424	   6.1	   0	   0	   0	   0	   0	   0	  
dethiobiotin	  synthase	  BioD	   CP0810	   1	   940.5037338	   6.5	   0	   0	   0	   0	   0	   0	  
2TM	   CP0825	   2	   785.2403091	   6.3	   0	   0	   0	   0	   0	   0	  
YjgP-­‐YjgQ	  -­‐	  integral	  membrane	  protein	   CP0859	   1	   577.9631884	   6	   0	   0	   0	   0	   0	   0	  
SucA	   succinyl-­‐CoA	   synthetase	   subunit	  
alpha	   CP0885	   8	   5630.226434	   8.2	   6	   1552.778153	   8.6	   0	   0	   0	  
poly(A)	  polymerase	  family	  protein	   CP0894	   5	   2400.357557	   7.3	   0	   0	   0	   0	   0	   0	  
pmpD	   CP0897	   3	   385.5481145	   5.6	   0	   0	   0	   0	   0	   0	  
pseudogene	   CP0905	   2	   695.1091426	   6.2	   0	   0	   0	   0	   0	   0	  
CDP-­‐diacylglycerol-­‐-­‐glycerol-­‐3-­‐
phosphate-­‐3-­‐phosphatidyltransferase	   CP0912	   3	   2998.707557	   7.6	   0	   0	   0	   0	   0	   0	  
2-­‐acylglycerolphosphoethanolamine	  
acyltransferase	   CP0945	   1	   814.6095332	   6.3	   0	   0	   0	   0	   0	   0	  
two	  C-­‐terminal	  coiled	  coil	  domains	   CP0954	   5	   1867.426186	   7.1	   0	   0	   0	   0	   0	   0	  
23sRNA?	  but	  opposite	  read	  direction	   CP0987	   0	   0	   0	   0	   350.6273249	   6.8	   0	   661.5410466	   6.5	  
metallo-­‐beta-­‐lactamase	   family	  
(lactamaseB	  motif)	   CP0990	   2	   1555.720462	   6.9	   0	   0	   0	   0	   0	   0	  
Putative	   SET	   domain	   protein	   (Putative	  
methyl	  transferase)	   CP0991	   4	   3728.122909	   7.8	   0	   0	   0	   0	   0	   0	  
AAA-­‐31	   domain	   (ATPases	   Associated	  
with	  diverse	  cellular	  Activities.)	   CP1066	   1	   808.2453962	   6.3	   0	   0	   0	   0	   0	   0	  
unknown	  function	  similar	  to	  ct548	   CP1068	   4	   4473.747491	   7.9	   0	   0	   0	   0	   0	   0	  
2	  internal	  repeats	   CP1072	   0	   0	   0	   5	   1086.944707	   8.2	   0	   0	   0	  
TM	  +	  2	  internal	  repeats	   CP1073	   2	   1224.324387	   6.7	   0	   0	   0	   3	   1274.151542	   7.2	  
regulatory	  protein	   CP1079	   1	   325.3314802	   5.5	   0	   0	   0	   0	   0	   0	  
N-­‐term	   TM,	   HAMP	   domain	   ((Histidine	  
kinases,	   Adenylyl	   cyclases,	   Methyl	  
binding	   proteins,	   Phosphatases)	   and	  
PP2Cc	   domain	   (serine/theronine	  
phosphatases)	   CP1105	   6	   12540.04978	   8.9	   0	   0	   0	   0	   0	   0	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DUF1347,	  N-­‐terminal	  TM	   CP1121	   6	   2035.188408	   7.2	   0	   0	   0	   0	   0	   0	  
cysS	   CP0931	   2	   871.2034587	   6.4	   0	   0	   0	   0	   0	   0	  
engA	   CP1025	   1	   423.9975849	   5.7	   0	   0	   0	   0	   0	   0	  
gyrB	   CP0484	   0	   0	   0	   0	   0	   0	   8	   1424.857639	   7.3	  
infB	   CP0440	   4	   928.8925766	   6.4	   0	   0	   0	   0	   0	   0	  
mraW	   CP0333	   3	   2082.994847	   7.2	   0	   0	   0	   0	   0	   0	  
prfA	   CP0660	   3	   1733.889565	   7	   0	   0	   0	   0	   0	   0	  
rplQ	   CP0122	   3	   4340.786464	   7.9	   0	   0	   0	   0	   0	   0	  
rpoB	   CP0694	   3	   491.4746352	   5.8	   0	   0	   0	   0	   0	   0	  
rpsC	   CP0106	   1	   923.7090243	   6.4	   9	   3057.031989	   9.4	   0	   0	   0	  
rpsE	   CP0116	   1	   1246.450732	   6.7	   0	   0	   0	   0	   0	   0	  
rpsT	   CP1103	   73	   151044.8996	   11.3	   13	   9891.196835	   10.8	   65	   93310.36463	   11.4	  
surE	   CP0499	   2	   1467.452634	   6.9	   0	   0	   0	   0	   0	   0	  
valS	   CP0680	   0	   0	   0	   8	   646.8533857	   7.6	   0	   0	   0	  
xerD	   CP0828	   0	   0	   0	   3	   755.8224785	   7.7	   0	   0	   0	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Characterisation	   of	   genes	   families	   and	   comparative	   expression	   between	  
strains	  
	  
Description	  of	  gene	  families	  and	  loci	  represented	  in	  RNAseq	  comparisons	  
At	   the	   48-­‐hour	   time	   point,	   C.	   pneumoniae	   is	   undergoing	   replication	   within	   the	  
chlamydial	   inclusion,	   and	   asynchronous	   differentiation	   of	   RB	   to	   EB	   forms	   has	  
commenced	  [60].	  	  
Given	   the	   higher	   expression	   levels	   and	   number	   of	   expressed	   genes	   detected	   in	   the	  
LPCoLN	  strain,	  we	  used	  data	  from	  this	  experiment	  to	  characterise	  which	  gene	  families,	  
metabolic	  pathways	  and	  genomic	  loci	  were	  represented	  in	  the	  LPCoLN	  transcriptome	  at	  
the	   48	   hour	   time	   point.	   We	   also	   compared	   it	   to	   the	   A03	   transcriptome	   where	  
appropriate.	   A	   graphic	   representation	   of	   the	   proportion	   of	   different	   gene	   families	  
represented	   in	   the	   LPCoLN	   transcriptome	   is	   shown	   in	   figure	   6,	   with	   more	   detailed	  
discussion	  on	  specific	  genes	  expressed	  in	  these	  gene	  families	  in	  the	  following	  section.	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Figure	   6	   -­‐	   Representation	   of	   the	   proportion	   of	   different	   gene	   families	   expressed	   in	   the	   LPCoLN	  
experiment.	   Numbers	   denote	   the	   number	   of	   genes	   expressed	   for	   each	   family.	   Genes	   involved	   in	  
transcription	   and	   replication	   of	   the	   chromosome	   are	   most	   highly	   represented	   (51/185	   genes)	   whilst	  
hypothetical	  protein	  and	  membrane-­‐	  associated	  genes	  are	  also	  highly	  represented	  (both	  37/185).	  Genes	  
involved	   in	   various	   metabolic	   processes,	   molecular	   transport	   and	   lipid	   biosynthesis	   also	   make	   up	   a	  
considerable	  number	  of	  genes	  represented	  (15/185,	  14/185	  and	  11/185	  respectively).	  	  
	  
Genes	  associated	  with	  transcriptional	  regulation	  and	  chromosomal	  replication	  	  
The	  majority	  of	  genes	  detected	   in	  both	  LPCoLN	  and	  A03	  experiments	  were	   involved	   in	  
transcriptional	  regulation	  or	  replication	  of	  the	  C.	  pneumoniae	  chromosome.	  At	  48	  hours	  
post-­‐infection,	  C.	   pneumoniae	   is	   still	   replicating,	   whilst	   also	   undergoing	   asynchronous	  
differentiation	  from	  the	  RB	  to	  EB	  form	  [60].	  Genes	  involved	  in	  transcription,	  replication	  
and	   general	   housekeeping	   are	   randomly	   and	   evenly	   distributed	   across	   the	   genome,	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whilst	  some	  genes	  such	  as	  nrdA/B	   (ribonucleoside-­‐diphosphate	  reductase	  A/B),	  gyrA/B	  
(gyrase	  A/B)	  and	  rpoB/C	  (RNA	  polymerase	  B/C)	  are	  direct	  neighbours	  and	  appear	  to	  be	  
expressed	  as	  operons,	  with	  this	  observation	  further	  supported	  by	  co-­‐expression	  and	  co-­‐
ocurrence	  associations	   in	  Chlamydiae	  and	  other	  organisms	  by	  STRINGdb	  analyses	   [56].	  
51	  of	  the	  185	  (27%)	  genes	  expressed	  in	  LPCoLN,	  and	  11	  of	  the	  37	  (29%)	  genes	  expressed	  
in	  both	  A03	  and	  LPCoLN	  have	  primary	  functions	  related	  to	  transcription,	  translation	  or	  
replication.	  	  All	  genes	  in	  the	  RNA	  polymerase	  (rpoA	  through	  rpoD)	  family	  are	  detected	  in	  
LPCoLN	  (47,	  17,	  13	  and	  17	  reads	  respectively),	  whilst	  only	  rpoA/B/C	  are	  detected	  in	  A03	  
(9,	   3	   and	   2	   reads	   respectively).	   An	   interesting	   observation	   is	   made	   in	   the	   apparent	  
expression	   of	   the	   CPK_ORF0394	   gene,	   a	   truncated	   copy	   of	   the	   nrdA	   (ribonucleoside-­‐
diphosphate	  reductase)	  gene	  in	  one	  of	  the	  LPCoLN	  replicates.	  Read	  mapping	  to	  this	  gene	  
differs	  from	  the	  full	   length	  homolog	  in	  that	  only	  the	  3'	  end	  is	  mapped	  (7	  reads),	  whilst	  
both	   the	   5'	   and	   3'	   ends	   of	   the	   full	   length	   homolog	   are	   mapped	   (4	   reads	   total).	   This	  
truncated	   copy	   is	   almost	   identical	   to	   the	   full-­‐length	  nrdA	   gene	   and	   is	   only	   present	   in	  
koala	  and	  bandicoot	  C.	  pneumoniae	  strains.	  As	  the	  3'	  end	  of	  the	  truncated	  nrdA	  gene	  is	  
identical	   in	   sequence	   to	   that	   of	   the	   full-­‐length	   nrdA	   homolog,	   it	   is	   highly	   likely	   that	  
mapping	  to	  this	  locus	  is	  assembly	  artefact.	  	  
	  
We	   performed	   STRINGdb	   network	   analyses	   to	   determine	   which	   genes	   were	   co-­‐
expressed	  based	  on	  evidence	  from	  previous	  studies	  in	  Chlamydia	  and	  other	  organisms,	  
regardless	  of	  the	   level	  of	  expression	   in	  this	  study.	  Our	  analyses	   indicate	  that	  of	  the	  six	  
most	   commonly	   co-­‐expressed	   genes	   (topA,	   SNF2	   helicase,	   rpoB,	   atpB,	   gutQ	   sugar	  
	  Chapter	  Six:	  RNA-­‐seq	  analysis	  of	  gene	  expression	  in	  acute	  infection	  of	  a	  human	  lung	  epithelial	  cell	  line	  with	  a	  koala	  
respiratory	  and	  a	  human	  cardiovascular	  strain	  of	  Chlamydia	  pneumoniae	   207	  
isomerase	   and	  pheT),	   four	   (topA,	   SNF2	   helicase,	   rpoB	   and	  pheT)	   are	   directly	   involved	  




Figure	   7	   -­‐	   The	   most	   commonly	   co-­‐expressed	   genes	   as	   indicated	   by	   STRINGdb	   network	   association	  
analyses.	   Genes	   involved	   in	   replication	   and	   transcription	   of	   the	   LPCoLN	   chromosome	   were	   the	   most	  
commonly	   represented	   in	   STRINGdb	   association	   studies.	   Associations	   were	   resultant	   of	   experimentally	  
confirmed	   co-­‐expression,	   gene	   fusion	   or	   co-­‐occurrence	   in	   Chlamydiae	   and	   other	   organisms.	   Colours	  
represent	  functions	  of	  the	  genes,	  numbers	  represent	  locus	  tags	  whilst	  the	  size	  of	  the	  circle	  represents	  the	  
number	  of	  times	  represented	  in	  the	  network.	  The	  total	  number	  of	  reads	  for	  each	  gene	  are	  also	  listed.	  	  	  	  
	  
Additionally,	   we	   used	   KEGG	   pathway	   to	   investigate	   which	   genes	   were	   expressed	   on	  
replication,	  recombination	  and	  transcription	  pathways.	  We	  demonstrated	  that	  all	  genes	  
involved	   in	   construction	   of	   the	   RNA	   polymerase	   complex	   (RpoA/B/C)	   were	   expressed	  
(Figure	  7A).	  Genes	  involved	  in	  the	  polymerase	  III	  core	  and	  γ-­‐complex	  of	  DNA	  replication	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complex	  were	  also	  expressed,	  as	  were	  genes	  involved	  in	  RecFOR	  and	  RecBC	  homologous	  
recombination	   pathways	   (Figure	   7B	   and	   7C),	   though	   the	   full	   complement	   of	   genes	  
encoded	  for	   in	  C.	  pneumoniae	  were	  not	  detected.	  Finally,	  we	  found	  that	  several	  genes	  
involved	   in	   the	  construction	  of	   the	   large	  and	  small	   ribosomal	  subunits	  were	  expressed	  
(Figure	   7D),	   however	   the	   full	   complement	   of	   genes	   encoding	   for	   the	   large	   and	   small	  
subunits	  in	  C.	  pneumoniae	  were	  not	  detected.	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Figure	   7A	   -­‐	   Schematic	   of	   RNA	   polymerase	   complex.	   Green	   boxes	   represent	   the	   genes	   encoded	   in	   C.	  
pneumoniae,	   whilst	   red	   boxes	   highlight	   the	   genes	   which	   were	   expressed	   in	   the	   LPCoLN	   strain.	   Both	  
LPCoLN	  and	  A03	  had	  all	  subunits	  of	  the	  RNA	  polymerase	  complex	  detected.	  	  
	  
	  
	  Figure	  7B	  -­‐	  DNA	  replication	  complex.	  Green	  boxes	  represent	  genes	  that	  are	  encoded	   in	  C.	  pneumoniae,	  
whilst	  red	  boxes	  highlight	  those	  which	  were	  expressed	  in	  LPCoLN.	  Only	  the	  dnaE	  gene	  of	  the	  polymerase	  
III	  core	  and	  DNA	  polymerase	  III	  delta	  subunits	  were	  detected	  in	  our	  experiments.	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Figure	   7C	   -­‐	   Expression	   of	   genes	   involved	   in	   homologous	   recombination	   complexes	   in	   C.	   pneumoniae.	  
Green	  boxes	  represent	  genes	  that	  are	  encoded	  in	  C.	  pneumoniae,	  whilst	  red	  boxes	  highlight	  those	  which	  
were	  expressed	   in	   LPCoLN.	  Genes	   involved	   in	   filament	   formation	   for	  both	  RecFOR	  and	  RecBC	  pathways	  
were	  detected,	  whilst	  genes	  involved	  in	  strand	  inversion	  and	  replication	  in	  the	  RecBC	  pathway	  were	  also	  
detected.	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Figure	   7D	   -­‐	   Expression	   of	   ribosomal	   proteins	   in	  C.	   pneumoniae.	   Green	   boxes	   represent	   genes	   that	   are	  
encoded	  in	  C.	  pneumoniae,	  whilst	  red	  boxes	  highlight	  those	  which	  were	  expressed	  in	  LPCoLN.	  A	  number	  of	  
genes	   involved	   in	   the	   construction	   of	   the	   large	   and	   small	   ribsomal	   subunits	   were	   detected	   in	   LPCoLN,	  
however	  the	  full	  complement	  of	  genes	  required	  to	  construct	  the	  ribosome	  were	  not	  able	  to	  be	  detected	  in	  
LPCoLN.	  Additionally,	  both	  23S	  and	  16S	  ribsomal	  RNAs	  were	  detected	  in	  LPCoLN	  and	  A03	  experiments.	  	  
	  
IncA,	  putative	  IncA	  family	  genes	  and	  membrane	  associated	  genes	  
The	   C.	   pneumoniae	   genome	   encodes	   for	   over	   100	   IncA	   and	   putative	   IncA	   genes,	   the	  
largest	  number	  of	   any	  member	  of	   the	  Chlamydiae	   [61,	   62].	   24	   IncA	   and	  putative	   IncA	  
genes	  were	  expressed	  in	  the	  LPCoLN	  experiment,	  one	  of	  which	  is	  specific	  to	  the	  LPCoLN	  
strain.	   Six	   IncA	   genes	   are	   evident	   in	   the	   A03	   experiment,	   with	   four	   of	   these	   also	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expressed	  in	  LPCoLN.	  One	  of	  the	  expressed	  IncA	  genes	  in	  A03	  is	  fragmented,	  with	  the	  5'	  
fragment	   containing	   the	   bi-­‐lobed	   hydrophobic	   domain	   expressed.	   Interestingly,	   a	  
pseuodgene	   in	   LPCoLN	   (CPK_ORF00508)	   that	   encodes	   for	   an	   IncA	   gene	   appears	   to	   be	  
transcribed	   up	   to	   the	   stop	   codon.	   This	   includes	   both	   IncA	   domains	   and	   a	   slightly	  
truncated	  DUF1978	  domain,	  whilst	  all	  other	   IncA	  genes	  expressed	   in	  both	  LPCoLN	  and	  
A03	  are	  full	  length	  and	  all	  contain	  the	  C-­‐terminal	  domains	  of	  unknown	  function	  (DUF)	  or	  
coiled-­‐coil	  motifs.	   A	   summary	   of	   Inc	   and	   putative	   Inc	   genes	   present	   and	   expressed	   in	  
LPCoLN	  and	  A03	  are	  outlined	  in	  Table	  6.	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Table	  6	  -­‐	  List	  of	  Inclusion	  family	  protein	  (Inc)	  ORFs	  in	  LPCoLN	  and	  A03,	  their	  type	  designation	  and	  total	  
number	  of	  mapped	  reads	  *	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*	   -­‐	   LPCoLN	   and	   A03	   ORFs	   are	   the	   designated	   locus	   tags.	   Locus	   tags	   of	   homologous	   genes	   are	   directly	  
adjacent	  eachother	  (eg.	  LPCoLN	  locus	  1	  is	  homologous	  to	  A03	  locus	  148,	  LPCoLN	  locus	  719	  is	  homologous	  
to	  A03	  locus	  551).	  	  
	  
Previous	   studies	   have	   indicated	   that	  members	   of	   the	   polymorphic	  membrane	   protein	  
(pmp)	  gene	  family	  are	  alternately	  expressed	  at	  different	  time	  points,	  and	  different	  pmp	  
genes	  are	  expressed	  in	  separate	  inclusions	  within	  the	  same	  host	  cell	  [63].	  In	  our	  study,	  
four	  pmp	  genes	  were	  detected:	  one	  in	  A03	  (pmpD	  -­‐	  3	  reads)	  and	  three	  in	  LPCoLN,	  pmpG	  
pmpE/F3	   and	   pmpE/F4,	   with	   a	   total	   of	   2,	   501	   and	   126	   mapped	   reads	   respectively.	  
Interestingly,	   pmpE/F4	   is	   a	   pseudogene	   in	   LPCoLN	   and	   mappings	   appear	   to	   span	   a	  
chlamydial	  PMP	  repeat	  domain	  and	  part	  of	  the	  autotransporter	  domain.	  	  
Several	  hypothetical	  and	  putative	  membrane	  proteins	  were	  also	  expressed	  in	  LPCoLN,	  as	  
well	  as	  the	  major	  outer	  membrane	  protein	  (ompA	  -­‐	  9	  reads),	  and	  pbp3	  (penicillin	  binding	  
protein	  -­‐	  6	  reads).	   	   In	  total,	  37	  of	  the	  185	  (20%)	  of	  the	  genes	  expressed	   in	  the	  LPCoLN	  
experiments	  were	  membrane	  localised.	  	  
	  
Anabolic	  and	  catabolic	  processes	  
As	  C.	  pneumoniae	  is	  still	  replicating	  at	  the	  48-­‐hour	  time	  point	  [60],	  it	  was	  expected	  that	  a	  
large	  number	  of	  expressed	  genes	  would	  be	  involved	  in	  anabolic	  and	  catabolic	  processes.	  
42	  of	  the	  185	  genes	  in	  detected	  in	  the	  LPCoLN	  experiment	  had	  primary	  functions	  related	  
to	  metabolism	  such	  as	  lipid,	  sugar	  and	  terpenoid	  biosynthesis	  and	  degradation,	  as	  well	  
as	   enzymes	   involved	   in	   proteolytic	   and	   hydrolytic	   processes.	   A	   large	   number	   of	   these	  
genes	  were	   involved	   in	   lipid	  biosynthesis	  pathways	  -­‐	  complementing	  the	   large	  number	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of	   membrane-­‐associated	   genes	   expressed	   in	   the	   study.	   Genes	   such	   as	   ferredoxin	  
(mediates	   electron	   transfer	   in	   metabolic	   processes	   -­‐	   90	   reads),	   both	   copies	   of	   M16	  
pitrilysin	   (a	  metallopeptidase	   -­‐	  17	  and	  20	  reads)	  and	  ptsI	   (phosphenolpyruvate	  protein	  
phosphotransferase,	   involved	   in	   nitrogen	   metabolism	   -­‐	   14	   reads)	   are	   also	   expressed.	  	  
Seven	  genes	  acpP	  (4	  reads),	  acyltransferase	  family	  protein	  (1	  read),	  alpha	  amylase	  family	  
protein	  (1	  read),	  cydA	  (1	  read),	  ispE	  (2	  reads),	  ribF	  (2	  reads)	  	  and	  udk	  (8	  reads)	  were	  also	  
detected	   in	   the	   A03	   experiment.	   KEGG	   pathway	   analyses	   identified	   eight	   genes	  
expressed	   in	   the	   pyrimidine	   and	   purine	   biosynthetic	   pathways,	   with	   only	   one	   gene	  
differing	  between	  each	  pathway	  (udk	  in	  the	  purine	  pathway	  and	  gmk	  in	  the	  pyrimidine	  
pathway).	   Upon	   examining	   the	   expression	   of	   LPCoLN	   genes	   involved	   in	   the	   purine	  
biosynthetic	  pathway,	  we	  find	  that	  they	  are	  predominantly	  involved	  in	  the	  production	  of	  
DNA,	  RNA	  and	  purine	  phosphatases,	   including	  ATP	   (Figure	  8A).	  A03	  encodes	   for	   three	  
additional	  genes,	  guaA,	  guaB	  and	  add.	  	  guaA	  and	  guaB	  are	  involved	  in	  the	  production	  of	  
purine	   phosphatases,	   whilst	   add	   is	   involved	   in	   the	   arginine	   biosynthesis	   pathway.	   All	  
three	  of	  these	  genes	  were	  detected	  in	  the	  A03	  experiment	  (guaA	  -­‐	  4	  reads,	  guaB	  -­‐	  1	  read	  
and	   add	   -­‐	   2	   reads).	   As	   for	   the	   purine	   pathway,	   genes	   expressed	   in	   the	   pyrimidine	  
pathway	   are	   involved	   in	   production	   of	   nucleic	   acids	   and	   nucleic	   acid	   phosphatases,	  
however	   in	   this	   pathway,	  nrdA	   and	  nrdB	   are	   involved	   in	   the	   thioredoxin	   cycle	   (Figure	  
8B).	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Figure	  8A	  -­‐	  Purine	  metabolism	  in	  C.	  pneumoniae.	  Green	  boxes	  represent	  genes	  which	  are	  encoded	  in	  C.	  pneumoniae,	  whilst	  red	  boxes	  highlight	  those	  which	  were	  expressed	  in	  
LPCoLN.	  Blue	  boxes	  represent	  genes	  in	  the	  guaA/B-­‐add	  operon	  present	  and	  expressed	  in	  A03.	  Expressed	  genes	  were	  predominantly	   involved	  in	  the	  synthesis	  of	  DNA,	  RNA	  and	  
nucleic	  acid	  precursors.	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Figure	  8B	  -­‐	  Pyrimidine	  metabolism	  in	  C.	  pneumoniae.	  Green	  boxes	  represent	  genes	  that	  are	  encoded	  in	  C.	  
pneumoniae,	  whilst	   red	  boxes	  highlight	   those	  which	  were	  expressed	   in	  LPCoLN.	  Genes	  expressed	   in	   the	  
purine	   and	   pyrimidine	   pathways	   in	   LPCoLN	   are	   involved	   in	   similar	   processes,	   except	   for	   nrdA/B	   in	   the	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Transporters	  and	  chaperones	  
During	  this	  phase	  of	  C.	  pneumoniae	  development,	  transport	  of	  molecules	  into	  and	  out	  of	  
the	   inclusion	   is	   actively	   occurring	   for	   development	   of	   the	   chlamydial	   bodies	   and	  
modulation	   of	   host	   cell	   response.	   18	   of	   the	   185	   genes	   detected	   in	   the	   LPCoLN	  
experiment	  were	  molecular	   chaperone	  or	   transporter	   genes.	   Expression	   of	   chaperone	  
genes	   included	   tsp	   (tail	   specific	   protease	   -­‐	   27	   reads),	   clpB	   (a	   heat	   induced	   stress	  
chaperone	  -­‐	  10	  reads)	  and	  Alkaline	  pH	  chaperone	  (11	  reads).	  Four	  members	  of	  the	  ABC	  
transporter	   family	   were	   expressed	   (7,	   6	   45	   and	   8	   reads),	   as	   well	   as	   secE	   (protein	  
translocase	  subunit	  E	  -­‐	  66	  reads),	  tolQ-­‐like	  protein	  (a	  membrane	  protein	  translocase	  -­‐	  2	  
reads)	   and	   type	   3	   secretion	   effectors.	   	   Three	   transporter	   genes	   (YjgP/YjgQ	   family	  
permease,	   ABC	   transporter	   and	   Fe-­‐dependent	   oxidoreductase/putative	   permease)	  
shared	  expression	  with	  LPCoLN	  in	  A03.	  	  
	  
Extended	  plasticity	  zone	  
The	   plasticity	   zone	   in	   both	   LPCoLN	   and	  A03	   are	   similar	   in	   nucleotide	   length,	   however	  
LPCoLN	   encodes	   for	   fewer	   open	   reading	   frames	  when	   compared	   to	   A03.	   Both	   strains	  
encode	   for	   several	   "host"	   specific	   genes.	  We	   extended	   our	   comparisons	   to	   cover	   the	  
region	  from	  CPK_ORF0671	  to	  CPK_ORF0700	  (LPCoLN)	  and	  CP0616	  to	  CP0573	  (A03	  with	  
AR39	   locus	   numbering)	   as	   our	   data	   suggest	   a	   considerable	   number	   of	   genes	   encoded	  
within	   this	   extended	   locus	   appear	   to	   be	   expressed	   in	   both	   strains.	   	   11	   genes	   were	  
expressed	  in	  this	  extended	  PZ	  region	  in	  LPCoLN,	  whilst	  15	  were	  expressed	  over	  the	  same	  
region	   in	   A03.	   In	   both	   cases,	   over	   a	   third	   of	   genes	   encoded	   within	   this	   region	   were	  
expressed	  in	  both	  strains	  (Figure	  9).	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Several	  membrane-­‐associated	  proteins	  were	  expressed	  in	  the	  LPCoLN	  strain	  within	  this	  
region,	   including	   MAC/perforin	   and	   three	   putative	   IncA	   proteins.	   	   Additionally,	   KDO-­‐
transferase,	  a	  gene	  involved	  in	  lipopolysaccharide	  synthesis	   is	  expressed	  in	  the	  LPCoLN	  
strain	  as	  well	  as	  Elongation	  factor	  P,	  which	  is	  involved	  in	  peptide	  bond	  synthesis.	  	  
The	  extended	  plasticity	  zone	  is	  comparatively	  more	  transcriptionally	  active	  in	  A03,	  with	  
13%	   of	   all	   transcripts	   detected	   for	   A03	   originating	   from	   this	   region,	   and	   three	   genes	  
demonstrating	  expression	  in	  all	  three	  replicates.	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Figure	  9	  -­‐	  Comparison	  of	  expressed	  genes	  in	  A03/LPCoLN	  extended	  plasticity	  zone.	  	  
	  A	  comparison	  of	  gene	  expression	  across	  the	  extended	  plasticity	  zone	  in	  both	  A03	  and	  LPCoLN	  experiments	  demonstrates	  expression	  of	  several	   'strain'	  specific	  genes,	  such	  as	  
MACPF	  in	  LPCoLN	  and	  the	  guaB/A-­‐add	  operon	  in	  A03.	  Genes	  in	  A03	  are	  the	  top	  row	  (from	  573	  to	  616)	  and	  those	  that	  are	  coloured	  red	  are	  expressed.	  LPCoLN	  is	  the	  bottom	  row	  
(from	  700	  to	  673)	  and	  pink	  genes	  are	  expressed.	  Gene	  products	  are	  labeled	  in	  figure	  except	  A	  through	  J	  which	  are	  outlined	  in	  the	  legend.	  The	  number	  of	  reads	  mapped	  to	  each	  
locus	  for	  both	  strains	  are	  outlined	  in	  the	  legend.	  Three	  genes	  are	  similarly	  expressed	  in	  both	  strains,	  two	  hypothetical	  genes	  and	  one	  IncA	  gene.	  A	  yellow	  line	  connects	  genes	  that	  
are	  expressed	   in	  both	  A03	  and	  LPCoLN.	  Grey	  middle	  band	  represents	   the	  nucleotide	  similarity	  between	  strains,	  with	  darker	  grey	  higher	  similarity	   to	  white	  with	  no	  similarity.	  
Figure	  constructed	  in	  EasyFig	  2.1	  [64].	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Comparative	   expression	   of	   genetically	   polymorphic	   genes	   between	   LPCoLN	   and	  
A03	  
In	   comparing	   human	   and	   animal	  C.	   pneumoniae	   genomes,	   gene	   family	   expansions	  
are	  evident	  in	  LPCoLN	  whilst	  several	  examples	  of	  gene	  fragmentation	  were	  noted	  in	  
human	   C.	   pneumoniae	   strains	   [18,	   30,	   34].	   We	   investigated	   the	   gene	   expression	  
profiles	   between	   the	   LPCoLN	   and	   A03	   strains	   to	   determine	   if	   genes	   that	  
demonstrated	   sequence	   polymorphism	   between	   the	   strains	   (for	   example,	  
fragmented,	   partial	   or	   pseudogenes)	   were	   alternately	   expressed.	   A	   list	   of	  
polymorphic	   genes	   and	   their	   expression	   in	   both	   LPCoLN	   and	   A03	   are	   outlined	   in	  
Table	  7.	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Table	  7	  -­‐	  Comparison	  of	  polymorphic	  genes	  detected	  in	  LPCoLN	  and	  A03	  
	  
LPCoLN	  gene	   Type	   Expressed	   Reads	   A03	  gene	   Type	   Expressed	   Reads	  
ispE	  -­‐	  CPK370	   Full	   Yes	   7	   ispE	  -­‐	  CP0905	   Pseudo	   Yes	   -­‐	   5'-­‐
terminal.	  
2	  
incA	  -­‐	  CPK479	   Full	   Yes	   16	   Hypothetical	   -­‐	  
CP0797	  	  
Pseudo	   No	   -­‐	  
incA	  -­‐	  	  
CPK508	  
Pseudo	   Yes	   11	   Hypothetical	   -­‐	  
CP0769	  
Full	   No	   -­‐	  
incA	  -­‐	  CPK513	   Full	   Yes	   8	   Hypothetical	   -­‐	  
CP0763/762	  	  
Frag	   No	   -­‐	  
KDO-­‐transferase	  -­‐	  
CPK673	  




Frag	   No	   -­‐	  
incA	  -­‐	  CPK680	   Full	   Yes	   88	   Hypothetical	   -­‐	  
CP0607/606	  	  
Frag	   No	   -­‐	  
MACPF	  -­‐	  CPK685	   Full	   Yes	   8	   Hypothetical	   -­‐
CP0593	  	  
Part	   No	   -­‐	  
pmpG	  -­‐	  	  
CPK956	  
Full	   Yes	   2	   pmpG	   -­‐	  
CP0309	  
	  
Full	   No	   -­‐	  
incA	  -­‐	  CPK791	   Full	   Yes	   8	   Hypothetical	   -­‐	  
CP0474/475	  	  
Frag	   No	   -­‐	  
Hypothetical	  -­‐	  	  
CPK729	  
Full	   Yes	   1	   Hypothetical	   -­‐	  
CP0543	  	  
Part	   No	   -­‐	  
pmpE/F3	   -­‐	  
CPK983	  
Full	   Yes	   501	   pmpE/F3	   -­‐	  
CP0284	  	  
Frag	   No	   -­‐	  
pmpE/F4	   -­‐	  
CPK984	  
Pseudo	   Yes	   126	   pmpE/F4	   -­‐	  
CP0283	  	  
Full	   No	   -­‐	  
	  
Our	  group	  previously	   investigated	  the	  genetic	  differences	  between	  the	  cardiac	  A03	  
strain	  and	  other	  human	  C.	  pneumoniae	  strains	  including	  AR39,	  and	  characterised	  five	  
loci	  as	  putative	  polymorphic	  markers	  [30].	  These	  markers	   included	  two	   IncA	  genes,	  
pmpG,	   tyrosine	   permease	   and	   a	   short	   integrated	   phage	   remnant.	   Three	   of	   these	  
markers	  were	  expressed	  in	  LPCoLN	  but	  none	  were	  detected	  in	  A03.	  
The	  first,	  CPK_ORF00508	  (CP0769	  homolog)	  is	  a	  putative	  IncA	  gene	  that	  is	  annotated	  
a	  pseudogene	  in	  the	  koala	  strain,	  resulting	  from	  a	  G-­‐A	  transition	  towards	  the	  3'	  end	  
of	   the	  gene.	  Our	   study	   indicates	   that	   reads	  are	  mapped	  up	   to	   the	   stop	  codon	  and	  
that	  the	  5'	  end	   is	  expressed,	  which	  encodes	  two	   IncA	  domains.	  The	  second	  marker	  
detected	  in	  LPCoLN	  was	  the	  pmpG	  homolog	  CPK_ORF00956	  (CP0309),	  and	  finally,	  we	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detected	  expression	   for	  an	   integrated	  phage	  remnant	   in	  LPCoLN	  at	  CPK_ORF00729	  
(CP0543	   -­‐	   partial	   gene).	   This	   gene	   is	   only	   partial	   length	   in	   A03	   and	   other	   human	  
strains	  and	  encodes	  for	  a	  very	  short	  region	  resembling	  Chlamydiaphage.	  	  
We	   identified	   a	   further	   nine	   genes	   which	   exhibited	   polymorphism	   between	   the	  
LPCoLN	  and	  A03	  strains	  and	  had	  expression	  detected	  in	  at	  least	  one	  strain.	  Eight	  of	  
these	  genes	  were	  identified	  as	  full	  length	  in	  LPCoLN	  with	  the	  exception	  of	  pmpE/F4	  
which	   is	   a	   pseudogene.	   Only	   one	   gene	   -­‐	   ispE	   (4-­‐diphosphocytidyl-­‐2-­‐C-­‐methyl-­‐D-­‐
erythritol	   kinase)	  was	   found	   to	  be	   expressed	   in	   both	   strains	   -­‐	   however,	  A03	  has	   a	  
single	   nucleotide	   deletion	   resulting	   in	   a	   frame	   shift	   and	   therefore	   only	   has	   the	   5'	  




In	   this	   study,	   we	   sought	   to	   compare	   the	   transcriptomes	   of	   two	   C.	   pneumoniae	  
strains,	  A03,	  a	  human	  cardiac	  strain	  isolated	  from	  a	  patient	  with	  atherosclerosis	  [9],	  
and	  LPCoLN,	  an	  animal	  strain	  isolated	  from	  a	  koala	  with	  respiratory	  disease	  [18].	  We	  
chose	  these	  strains	  because	  we	  have	  determined	  the	  full	  genome	  of	  both	  strains	  and	  
have	   identified	   key	   genomic	   differences	   between	   them,	   including	   gene	   loss,	  
fragmentation	  and	  SNPs	  in	  genes	  involved	  in	  metabolism,	  membrane	  biogenesis	  and	  
hypothetical	   proteins	   [18,	   30,	   32].	   	  We	  were	   able	   to	   detect	   expression	   for	   almost	  
twice	  the	  number	  of	  genes	  in	  the	  LPCoLN	  strain	  when	  compared	  to	  A03	  at	  the	  same	  
MOI	  and	  growth	  conditions.	  This	  is	  represented	  by	  the	  ring	  diagrams	  of	  LPCoLN	  and	  
A03	  strains	  with	  the	  positions	  of	  the	  expressed	  genes	  marked,	  as	  in	  Figures	  4	  A	  and	  
B.	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The	  gene	  families	  represented	   in	  both	  A03	  and	  LPCoLN	  experiments	  were	   involved	  
with	  transcription	  and	  replication	  of	  the	  C.	  pneumoniae	  chromosome,	  development	  
and	  maintenance	  of	   the	   chlamydial	   inclusion,	   synthesis	   of	  metabolites,	  membrane	  
precursors,	  molecular	  transports	  and	  chaperones.	  Members	  of	  the	  IncA	  gene	  family	  
were	  the	  most	  commonly	  represented	  genes	  in	  both	  LPCoLN	  and	  A03	  experiments	  -­‐	  
this	  is	  unsurprising	  as	  along	  with	  the	  Pmp	  gene	  family,	  they	  are	  the	  most	  biologically	  
abundant	  genes	  encoded	  in	  the	  C.	  pneumoniae	  genome	  [18,	  28,	  61,	  62].	  	  We	  found	  a	  
considerable	  number	  of	  genes	  within	  and	  directly	   flanking	   the	  plasticity	  zone	  were	  
expressed	   in	   both	   strains,	   and	   that	   approximately	   15%	   of	   the	   genes	   that	   were	  
expressed	  in	  A03	  were	  detected	  in	  this	  region,	  as	  represented	  in	  figure	  4	  B.	  22	  genes	  
were	   commonly	   expressed	   in	   both	   A03	   and	   LPCoLN	   experiments,	   the	   majority	   of	  
which	   were	   involved	   in	   transcriptional	   regulation	   and	   chromosomal	   replication,	  
whilst	  four	  IncA	  genes	  also	  shared	  expression	  between	  the	  two	  strains.	  The	  LPCoLN	  
experiment	   suggested	   that	   two	   pseudogenes	   -­‐	   an	   IncA	   gene	   and	   pmpE/F4	   were	  
transcribed	   to	   the	   stop	   codon,	   and	   that	   the	   ispE	   pseudogene	   in	   A03	   was	   also	  
expressed	  up	  to	  the	  stop	  codon.	  	  
	  
Transcriptome	  studies	  of	  intracellular	  microorganisms	  are	  inherently	  complicated	  by	  
the	   requirement	   of	   a	   host	   cell	   for	   development,	   which	   is	   itself	   constantly	  
undertaking	  active	   transcription	  and	  replication.	  Previous	  chlamydial	   transcriptome	  
studies	   have	   sought	   to	   overcome	   the	   intrinsic	   bias	   between	   the	   level	   of	   host	  
transcript	  and	  chlamydial	  transcript	  by	  increasing	  the	  infectious	  MOI	  to	  levels	  far	  in	  
excess	   of	   that	   expected	   in	   a	   physiologically	   relevant	   infection	   [40,	   42,	   45,	   47,	   65],	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though	  many	   studies	   have	   successfully	   detected	   transcript	   at	  more	   physiologically	  
relevant	  MOIs	  [55,	  66,	  67].	  The	  problem	  with	  transcriptome	  experiments	  undertaken	  
with	  high	  MOI	  is	  the	  likelihood	  of	  biased	  representation	  of	  transcripts	  which	  would	  
not	   normally	   be	   expressed	   in	   a	   physiologically	   relevant	   infection	   -­‐	   the	   higher	  
activation	  of	  host	  cell	  immune	  defences	  acting	  upon	  the	  actively	  replicating	  infection	  
would	  likely	  result	  in	  greater	  expression	  of	  chlamydial	  genes	  involved	  in	  response	  to	  
stress,	   chaperones	   and	   modulation	   of	   the	   host	   cell	   response	   [68-­‐70].	   In	   order	   to	  
provide	  a	  physiologically	  relevant	  baseline	  of	  gene	  expression	  in	  both	  C.	  pneumoniae	  
strains	   used	   in	   this	   experiment	   we	   performed	   the	   infections	   with	   an	   MOI	   of	   1,	  
however,	  results	  from	  immunohistochemical	  staining	  and	  confocal	  laser	  microscopy	  
suggest	   a	   discrepancy	   in	   the	   MOI	   calculated	   between	   LPCoLN	   and	   A03	   strains.	  
Several	   host	   cells	   contained	   greater	   than	  10	  discrete	   inclusions	   for	   the	  A03	   strain,	  
whilst	  singular	  amorphous	  inclusions	  were	  demonstrated	  for	  host	  cells	  infected	  with	  
LPCoLN.	   The	   fusogenic	   phenotype	   of	   the	   LPCoLN	   strain	   may	   account	   for	   the	  
discrepancy	   in	   the	   calculated	  MOI,	   whilst	   the	   large	   number	   of	   inclusions	   in	   some	  
host	   cells	   infected	   with	   A03	   may	   be	   due	   to	   insufficient	   resuspension	   of	   the	   A03	  
inoculum	  prior	  to	  infection.	  
	  	  
Studies	   into	  optimal	   sequencing	   and	  mapping	  depth	  of	   prokaryotic	   transcriptomes	  
suggest	  mapping	   depth	   of	   between	   5	   to	   10	  million	   non-­‐rRNA	   reads	   to	   detect	   the	  
majority	  of	  transcripts	  [55,	  71].	  In	  spite	  of	  the	  rigorous	  purification,	  poly-­‐A	  and	  rRNA	  
subtraction	   processes	   intended	   to	   enrich	   for	   prokaryotic	  mRNA,	   a	   low	   number	   of	  
reads	  mapped	  to	  LPCoLN	  and	  A03,	  with	  the	  signal	  inundated	  by	  host	  cell	  transcript.	  
In	   spite	   of	   this	   limitation,	   we	   successfully	   detected	   and	   analysed	   a	   proportion	   of	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chlamydial	  mRNA	  transcripts	   from	  both	  strains.	  Given	  the	   low	   level	  signal	   that	  was	  
detected	   for	   expressed	   genes	   from	   these	   experiments,	   the	   signal	   was	  most	   likely	  
from	   genes	   which	   are	   highly	   to	   very	   highly	   expressed	   at	   the	   mid-­‐replicative	   time	  
point	  under	  standard	  growth	  conditions.	  	  
	  
Previous	   in	   vitro	   studies	   have	   characterised	   a	   stark	   difference	   in	   growth	   and	  
development	  between	  animal	  (LPCoLN)	  and	  human	  (A03)	  C.	  pneumoniae	  strains	  [35,	  
37].	  At	  48	  hours,	  C.	  pneumoniae	   is	  considered	  to	  still	  be	   in	  the	  replicative	  phase	  of	  
development,	   however,	   it	   is	   also	   the	   point	   at	   which	   asynchronous	   differentiation	  
from	   reticulate	   body	   to	   elementary	   body	   has	   begun	   [60].	   It	   is	   unlikely	   that	   this	  
process	  is	  occurring	  at	  the	  same	  rate	  in	  both	  strains	  at	  the	  mid-­‐replicative	  phase,	  and	  
of	   course	   some	   degree	   of	   variation	   in	   growth	   and	   replication	   is	   expected	   even	  
amongst	   separate	   inclusions	   of	   the	   same	   strain.	   The	   growth	   differential	   is	   clearly	  
demonstrated	  in	  the	  rate	  of	  production	  of	  infectious	  moieties	  in	  animal	  and	  human	  
strains	   in	   a	   study	   by	   Mitchell	   et	   al.	   (2009)	   [35]	   examining	   the	   developmental	  
differences	  between	  the	  koala	  LPCoLN	  strain	  and	  a	  human	  respiratory	  strain	  AR39.	  It	  
was	  shown	  that	  the	  number	  of	  LPCoLN	  genomes	  doubled	  at	  twice	  the	  rate	  of	  AR39,	  
and	  the	  average	  number	  of	  EBs	  detected	  at	   the	  72	  hour	  time	  point	   in	  LPCoLN	  was	  
three	   times	   that	  detected	   in	  AR39,	  This	   suggests	   that	  LPCoLN	  multiplies	  at	  a	  much	  
higher	  rate	  and	  completes	  its	  development	  cycle	  earlier	  than	  AR39.	  	  
	  
Confocal	   images	   taken	   at	   the	   48	   hour	   time	   point	   in	   our	   study	   clearly	   confirm	   a	  
difference	  in	  the	  number	  and	  size	  of	  the	  inclusions	  between	  A03	  and	  LPCoLN	  strains	  
(Figure	   2),	   as	   well	   as	   inclusion	   morphologies	   congruent	   with	   those	   observed	   in	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previous	  studies	  [35,	  37].	  With	  this	  in	  mind,	  the	  greater	  number	  of	  expressed	  genes	  
detected	   in	   the	   LPCoLN	   experiment	   is	   consistent	   with	   the	   production	   of	   higher	  
numbers	  of	  bacterial	  cells	  actively	  transcribing	  their	  genomes	  resulting	   in	  a	  greater	  
Chlamydia-­‐to-­‐host	  cell	  signal	  compared	  to	  A03.	  	  
	  
Using	  the	  data	  profile	  from	  the	  LPCoLN	  experiment,	  we	  sought	  to	  determine	  which	  
genes	  were	  represented	  at	  the	  48-­‐hour	  time	  point	   in	  the	  C.	  pneumoniae	   infectious	  
cycle.	  A	  number	  of	  gene	  families	  were	  highly	  expressed	   in	  this	  dataset	  at	   this	  mid-­‐
stage	  of	  the	  development	  cycle	  and	  were	  also	  detected	  in	  both	  the	  LPCoLN	  and	  A03	  
experiments.	  A	  number	  of	   genes	   that	  were	  detected	  only	   in	  either	   LPCoLN	  or	  A03	  
were	   also	   described,	   although,	   this	  may	   relate	   to	   the	   limitations	   of	   data	   set	   since	  
only	  16%	  and	  10%	  of	  the	  predicted	  possible	  transcriptome	  was	  detected	  for	  the	  two	  
strains.	  	  
	  	  
	  A	   significant	  percentage	  of	   expressed	  genes	   in	  both	   LPCoLN	  and	  A03	  experiments	  
are	  classified	  as	  IncA	  or	  putative	  IncA	  family	  genes.	  The	  Inclusion	  protein	  family	  is	  a	  
large	   gene	   family	   that	   has	   been	   well	   characterised	   in	   the	   Chlamydiae.	   In	   C.	  
trachomatis	   the	   Inc	   family	   encodes	   seven	   distinct	   orthologs	   (IncA	   through	   to	  
IncG)[72,	   73],	   however,	   C.	   pneumoniae	   genome	   encodes	   for	   only	   three	   inclusion	  
protein	  gene	  orthologs	  -­‐	  IncA,	  IncB	  and	  IncC.	  Of	  these	  three,	  the	  IncA	  gene	  family	  is	  
considerably	  expanded,	  with	  over	  100	  homologs	  predicted	  [61,	  62]	  by	  the	  presence	  
of	  a	  unique	  N-­‐terminal	  bilobed	  hydrophobic	  domain	   [74,	  75].	  21	   IncA	  and	  putative	  
IncA	  homologs	  were	  expressed	  in	  LPCoLN,	  one	  of	  which	  is	  strain-­‐specific	  to	  LPCoLN.	  
Human	  C.	  pneumoniae	  strains	  exhibit	  several	  instances	  where	  IncA	  homologs	  which	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are	   full-­‐length	   in	   LPCoLN	   are	   fragmented	   over	   two	   open	   reading	   frames	   [18],	  
effectively	   separating	   the	   N-­‐terminal	   bilobed	   IncA	   domain	   from	   the	   C-­‐terminal	  
domain	  -­‐	  commonly	  a	  DUF	  or	  a	  series	  of	  coiled-­‐coil	  motifs.	  It	  is	  not	  surprising	  that	  a	  
considerable	   number	   of	   IncA	   family	   genes	   are	   expressed	   in	   LPCoLN,	   which	  
demonstrates	  a	   fusogenic	   inclusion	  morphology.	   In	  addition	  to	   IncA	  being	   localised	  
to	  the	  inclusion	  membrane	  [76],	  the	  IncA	  gene	  family	  has	  been	  demonstrated	  to	  be	  
involved	   in	   fusion	  of	   chlamydial	   inclusions	   in	  C.	   trachomatis	   and	  C.	   caviae	   [77-­‐80].	  
Furthermore,	  genetic	  polymorphisms	  and	  the	  differential	  expression	  of	  IncA	  genes	  in	  
C.	   trachomatis	   have	   been	   demonstrated	   to	   correlate	   with	   tissue	   tropism	   [81]	   -­‐	  
whether	  a	   similar	  process	  occurs	   in	  C.	  pneumoniae	  with	   regards	   to	  host	   specificity	  
remains	  to	  be	  investigated.	  Whilst	  in	  vitro	  studies	  into	  the	  localisation	  and	  action	  of	  
IncA	   proteins	   in	   LPCoLN	   have	   not	   been	   undertaken,	   they	   may	   provide	   a	   starting	  
point	   to	  determine	  whether	   this	   gene	   family	  plays	  a	   role	   into	   the	  differing	  growth	  
and	  morphological	  characteristics	  of	  this	  strain.	  	  	  
	  
An	   unexpected	   finding	   for	   both	   strains	   investigated	   in	   this	   study	   was	   the	  
considerable	   levels	   of	   expression	   for	   genes	   within	   and	   adjacent	   to	   the	   plasticity	  
zone.	   The	   plasticity	   zone	   is	   a	   polymorphic	   region	   encompassing	   the	   terminus	   of	  
replication	  in	  Chlamydiae,	  which	  often	  codes	  for	  species-­‐	  and	  strain-­‐specific	  genes	  as	  
well	   as	   various	   virulence	   genes	   and	   immune	   modulation	   factors	   [82].	   The	   C.	  
pneumoniae	   plasticity	   zone	   is	  more	   compact	   in	   sequence	   length	  and	  gene	  content	  
compared	   to	   other	   chlamydial	   species	   [18,	   28,	   83].	   The	   plasticity	   zones	   between	  
human	  and	  animal	  C.	  pneumoniae	  strains	  differ	  in	  two	  major	  respects	  -­‐	  the	  presence	  
of	   a	   full-­‐length	   MACPF	   gene	   in	   animal	   strains	   which	   is	   5'	   truncated	   in	   human	   C.	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pneumoniae,	   and	   the	   presence	   of	   the	   guaB/A-­‐add	   purine	   biosynthetic	   genes	   in	  
human	   strains	   which	   are	   completely	   absent	   in	   koala	   and	   bandicoot	   strains	   of	   C.	  
pneumoniae.	   Upon	   further	   examination	   of	   the	   mapped	   transcriptome	   data,	   we	  
observed	  that	  numerous	  genes	  flanking	  the	  plasticity	  zone	  of	  both	  strains	  appeared	  
to	   be	   expressed	   as	   operons.	   The	   extended	   plasticity	   zone	   accounts	   for	   2%	   of	   the	  
total	  coding	  capacity	  of	  C.	  pneumoniae	  and	  in	  both	  strains,	  30%	  of	  genes	  within	  this	  
region	  were	   transcribed.	   For	   LPCoLN,	   this	   amounted	   to	  6%	  of	   the	   total	  number	  of	  
genes	   expressed,	   however,	   for	   A03	   this	   resulted	   in	   14%	   of	   the	   total	   number	   of	  
expressed	  genes	  being	  located	  in	  the	  extended	  plasticity	  zone.	  	  
	  
Two	  hypothetical	  proteins	  and	  an	  IncA	  gene	  shared	  expression	  in	  both	  strains	  within	  
this	   extended	  plasticity	   region.	   In	   our	   study,	  MACPF	  was	   expressed	   (full	   length)	   in	  
the	   LPCoLN	   strain.	   A	   previous	   study	   examining	   the	   functional	   characteristics	   of	  
MACPF	  in	  C.	  trachomatis	  found	  that	  the	  full	  length	  protein	  was	  expressed	  during	  the	  
mid-­‐phase	  of	   the	  development	   cycle	   and	   co-­‐localised	  with	   reticulate	  bodies	   at	   the	  
inclusion	  membrane	  [84],	  where	  it	  was	  shown	  to	  facilitate	  	  transport	  of	  lipid	  droplets	  
into	   the	   chlamydial	   inclusion.	   In	   the	  A03	   experiment,	   the	  guaB/A-­‐add	   operon	  was	  
expressed	   at	   the	   48-­‐hour	   time	   point.	   These	   genes	   are	   present	   in	   all	   human	   C.	  
pneumoniae	   strains,	   and	   also	   in	   the	   DC9	   frog	   C.	   pneumoniae	   strain	   [25].	   guaB	   is	  
fragmented	   in	   A03,	   and	   the	   larger	   3'	   fragment	   encoding	   for	   part	   of	   the	   IMPDH	  
domain	   is	  expressed.	  The	  guaA/GMP	  synthase	  gene	  has	  been	  demonstrated	   in	   the	  
production	  of	  cyclic	  GMP-­‐AMP	  in	  C.	  trachomatis,	  previously	  thought	  to	  be	  produced	  
only	   by	   gram-­‐positive	   bacteria,	  which	   functions	   as	   a	  DNA	   sensory	  molecule	   and	   is	  
involved	   in	   the	   induction	   of	   type-­‐I	   interferons	   during	  C.	   trachomatis	   infection	   [85-­‐
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87],	   whether	   a	   similar	   pathway	   is	   utilised	   in	   the	   A03	   strain	   could	   account	   for	   its	  
exquisite	   sensitivity	   to	   IFN-­‐γ	   [37].	   Interestingly,	   a	   study	   investigating	   the	   effect	   of	  
mutations	   in	   the	  Chlamydia	  muridarum	  plasticity	   zone	   found	   that	  guaA/B-­‐add	  was	  
expressed	   as	   an	   operon,	   and	   that	  mutations	   in	   these	   genes	   had	   little	   effect	   on	  C.	  
muridarum	  growth	  in	  vitro,	  but	  decreased	  virulence	  of	  the	  pathogen	  in	  vivo	  [88].	  This	  
presents	  an	  interesting	  avenue	  for	  future	  investigation	  in	  C.	  pneumoniae,	  due	  to	  the	  
genetic	  characterisation	  of	  several	  C.	  pneumoniae	  strains	  which	  code	  for	  full-­‐length	  
guaB,	   including	   the	   DC9	   frog	   strain	   which	   encodes	   an	   uninterrupted	   guaA/B-­‐add	  
operon	  [34].	  
	  
The	  plasticity	  zone	  and	  its	  flanking	  regions	  have	  been	  identified	  as	  a	  recombination	  
hotspot	   in	   C.	   pneumoniae	   [30]	   as	   well	   as	   other	   chlamydial	   species	   [82,	   89].	  
Transcription-­‐associated	   recombination	   is	   a	   common	   diversifying	   process	   in	   both	  
prokaryotes	   and	   eukaryotes	   alike	   [90,	   91],	   and	   the	   relatively	   heightened	   levels	   of	  
gene	  expression	  observed	  at	  the	  extended	  plasticity	  zone	  in	  LPCoLN,	  along	  with	  the	  
expression	   of	   recombinase	   genes	   (recJ,	   recR)	   [91-­‐94]	   suggest	   that	   transcription	  
associated	  recombination	  may	  be	  a	  driver	  of	  diversity	  at	  this	  locus.	  	  
	  
Of	   particular	   interest	   is	   the	   number	   of	   pseudogenes	   that	   were	   expressed	   in	   both	  
LPCoLN	  and	  A03	  strains	  in	  these	  experiments.	  	  Two	  pseudogenes	  were	  expressed	  in	  
LPCoLN	   (an	   IncA	   gene	   and	   pmpE/F4),	   whilst	   a	   single	   pseudogene,	   ispE,	   was	  
expressed	  in	  A03.	  Antigenic	  phase-­‐variation	  as	  the	  result	  of	  sequence	  polymorphism	  
in	   gene	   families	   such	   as	   IncA	   and	   pmp	   has	   been	   extensively	   reported	   in	   different	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chlamydial	   species	   [63,	   95,	   96],	   though	   this	   phenomenon	   has	   not	   yet	   been	  
investigated	  in	  C.	  pneumoniae.	  	  
The	  expression	  of	   the	   ispE	  pseudogene	   in	  A03	  presents	  an	   interesting	  case	   for	   the	  
effect	   of	   deletional	   bias	   ("use	   it	   or	   lose	   it")	   [97]	   in	  C.	   pneumoniae.	   ispE	   has	   been	  
associated	  with	  regulation	  of	  chromatin	  condensation	  in	  the	  transition	  of	  reticulate	  
to	  elementary	  bodies	  in	  C.	  trachomatis	  [98,	  99],	  and	  as	  such,	  the	  expression	  of	  this	  
gene	  in	  both	  LPCoLN	  and	  A03	  experiments	  is	  not	  unexpected	  at	  the	  mid-­‐replicative	  
time	   point	   during	   RB	   to	   EB	   differentiation.	   SMART	   analyses	   of	   the	   full-­‐length	  
translated	  homolog	  from	  LPCoLN	  and	  the	  truncated	  homolog	  from	  A03	  demonstrate	  
a	  single	  GHMP-­‐kinase	  domain	  spanning	  from	  position	  81	  to	  139	  in	  both	  strains,	  with	  
no	  other	  domains	  or	  motifs	  present.	  As	   the	   truncated	  homolog	   in	  A03	   is	  141AA	   in	  
length,	   it	   is	  entirely	  possible	   that	   this	  expressed	  pseudogene	   is	   functional	  and	   that	  
the	   3'	   end/C-­‐terminal	   is	   not	   functionally	   required.	   The	   full-­‐length	   gene	   is	   also	  
expressed	   in	   LPCoLN,	   however,	   the	   additional	   translated	   coding	   capacity	   at	   the	   C-­‐
terminal	   in	   LPCoLN	   contains	   no	   functional	   domains	   or	   secondary	   structures	  which	  
would	  have	  an	  effect	  on	  the	  tertiary	  structure	  or	  functionality	  of	  the	  mature	  protein.	  
In	  light	  of	  these	  findings,	  it	  may	  be	  possible	  that	  the	  C-­‐terminal	  end	  of	  the	  ispE	  gene	  
is	  not	  essential	  for	  functionality	  of	  this	  gene	  in	  human	  C.	  pneumoniae	  strains.	  
	  
In	   both	   strains,	   the	   majority	   of	   expressed	   genes	   are	   involved	   in	   replication	   and	  
transcription	   of	   the	   C.	   pneumoniae	   chromosome.	   	   Translated	   sequences	   of	  
expressed	   genes	   in	   LPCoLN	   were	   referenced	   against	   the	   STRING	   database	   to	  
determine	   co-­‐expressed	   genes	   and	   construct	   transcriptional	   pathways.	   Six	   genes	  
(topA,	   SNF2	   helicase,	   rpoB,	   atpB,	   gutQ	   sugar	   isomerase	   and	   pheT)	   were	   most	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commonly	   co-­‐expressed	   in	   STRINGdb	  pathways	   (Figure	   7).	   Four	   of	   these	   six	   genes	  
are	   involved	   in	   translation	   and	   replication	   of	   the	   chlamydial	   chromosome	  
(topoisomerase,	   helicase,	   RNA	   polymerase	   and	   phenylalanine	   tRNA	   ligase)	   whilst	  
atpB	   is	   involved	   in	  energy	  generation.	  Of	   these	   six	   genes,	  only	   rpoB	   is	   detected	   in	  
A03.	   A	   commonly	   co-­‐expressed	   gene	   in	   these	   pathways	   is	   gutQ/kpsF	   -­‐	   a	   sugar	  
isomerase	  gene	  that	  is	  believed	  to	  have	  originated	  from	  the	  mitochondria	  of	  plants	  
[100].	  In	  Eschericia	  coli,	  this	  gene	  is	  the	  last	  member	  of	  the	  glucitol	  operon	  and	  may	  
have	  a	  regulatory	  function	  [101].	  Its	  similarity	  to	  kdsD	  suggests	  that	  it	  may	  play	  a	  role	  
in	   the	   synthesis	   of	   chlamydial	   lipopolysaccharide	   [102-­‐104].	   Additionally,	   a	   2006	  
study	   by	  Mukhopadhyay	   identified	   a	   set	   of	   35	   proteins	   involved	   in	   the	   transition	  
from	  reticulate	  (24	  hour)	  to	  elementary	  (48	  hour)	  bodies	   in	  C.	  pneumoniae	  A03;	  as	  
expected	   the	  majority	   of	   proteins	   identified	   as	   upregulated	   over	   this	   time	   period	  
were	  involved	  in	  metabolic	  and	  cellular	  processes	  [105].	  At	  the	  48	  hour	  time	  point,	  
only	   seven	   of	   these	   genes	   had	   expression	   detected	   in	   LPCoLN	   (ompA,	   clpB,	   RpoA,	  
efp,	  rpiL,	  CPK_ORF01032	  and	  CPK_ORF00148)	  whilst	  only	  three	  were	  detected	  in	  our	  
A03	  study	  (tal,	  greA	  and	  RpoA).	  Whilst	  these	  studies	  are	  not	  directly	  comparable,	  it	  is	  
interesting	  that	  so	  few	  of	  the	  35	  upregulated	  proteins	  had	  gene	  expression	  detected	  
for	  either	  strain	  in	  this	  study.	  	  	  	  
	  
This	   study	   is	   the	   first	   to	   examine	   the	   transcriptome	   of	   an	   animal	   strain	   of	   C.	  
pneumoniae,	  and	  although	  similar	  highly	  expressed	  genes	  are	  detected	   in	  both	  the	  
human	   A03	   and	   animal	   LPCoLN	   strains,	   we	   note	   some	   interesting	   differences	  
apparent	   in	   the	  transcriptome	  of	  LPCoLN,	   in	   that	  a	  number	  of	  strain-­‐specific	  genes	  
and	  pseudogenes	  appear	  to	  be	  expressed	  at	  this	  point	   in	  the	  LPCoLN	  development	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cycle.	   We	   know	   that	   the	   LPCoLN	   strain	   (and	   the	   bandicoot	   B21	   strain)	   display	  
inherent	   differences	   in	   genome	   content	   [18,	   106],	   inclusion	   morphology	   and	  
replication	   characteristics	   [35]	   compared	   to	   human	   C.	   pneumoniae,	   as	   well	   as	  
differing	  susceptibility	  to	  tryptophan	  starvation	  as	  the	  result	  of	  IFN-­‐γ	  treatment	  [37,	  
107,	  108]	  and	  treatment	  with	  various	  antibiotics	  such	  as	  penicillin	  [36,	  109].	  Previous	  
studies	  have	  suggested	  a	  number	  of	  genetic	  determinants	  which	  may	  account	  for	  the	  
apparent	   differences	   in	   development	   and	   immune	   response	   between	   human	   and	  
animal	  C.	  pneumoniae	  strains	  [18,	  25,	  27,	  30,	  32,	  110],	  and	  our	  study	  has	  detected	  
some	  of	  these	  molecular	  markers	   in	  both	  LPCoLN	  and	  A03	  experiments.	   	  Given	  the	  
limitations	  of	  this	  study,	  it	  is	  impossible	  to	  determine	  whether	  any	  of	  these	  genes	  are	  
associated	   with	   the	   difference	   in	   growth,	   development	   and	   inclusion	   morphology	  
between	  koala	  and	  human	  C.	  pneumoniae	  strains.	  	  
	  
Interestingly,	   a	   study	   by	   Eickhoff	   et	   al.	   indicates	   that	   the	   host	   cell	   response	   to	   C.	  
pneumoniae	   infection	   in	   acute	   and	   IFN-­‐γ	   induced	   persistence	   models	   are	   similar,	  
though	   a	   number	   of	   genes	   involved	   in	   cell	   development	   and	   metabolism	   are	  
differentially	   regulated	   in	   both	   models,	   particularly	   those	   involved	   in	   lipid	   and	  
membrane	   synthesis,	   cytoskeletal	   organisation	   and	   apoptosis	   [111].	   It	   would	   be	  
interesting	   to	   investigate	  whether	   the	  differential	  expression	  of	  host	  genes	  plays	  a	  
role	  in	  modulating	  the	  growth	  and	  morphology	  of	  human	  and	  animal	  C.	  pneumoniae	  
strains	   in	  acute	  and	  persistent	   infections,	   in	  a	  study	  similar	  to	  that	  by	  Humphrys	  et	  
al.	  [55],	  where	  simultaneous	  host	  and	  chlamydial	  transcriptomes	  were	  obtained	  for	  
C.	   trachomatis	   at	   early	   and	  mid-­‐late	   time	   points	   in	   the	   development	   cycle.	   These	  
simultaneous	  comparisons	  allowed	  the	  authors	  to	  determine	  a	  number	  of	  chlamydial	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genes	   involved	   in	   early	   nutrient	   acquisition	   and	   a	   later	   gene	   response	   to	   reactive	  
oxygen	   species	   as	   an	   immune	   response	   by	   the	   host	   cell,	   as	   well	   as	   several	  
differentially	   modulated	   host	   genes	   involved	   in	   cytoskeletal	   arrangement	   and	  
inflammatory	  response	  to	   infection.	  Not	  surprisingly,	  several	  of	  the	  genes	  detected	  
at	  the	  mid-­‐late	  time	  point	   in	  the	  Humphrys	  study	  are	  also	  detected	   in	  our	  study	   in	  
both	   LPCoLN	   and	  A03	   strains,	  which	   suggests	   they	  may	   be	   essential	   for	   late-­‐stage	  
chlamydial	  development	  and	  differentiation.	  	  
	  
CONCLUSION	  
In	  this	  study,	  we	  used	  RNAseq	  to	  sequence	  and	  compare	  the	  transcriptomes	  of	  two	  
C.	  pneumoniae	  strains,	  LPCoLN	  from	  the	  koala	  and	  A03	  from	  human	  cardiac	  tissue,	  at	  
48	   hours	   post	   infection.	   Whilst	   both	   of	   our	   experiments	   failed	   to	   achieve	   the	  
minimum	  mapping	  depth	  for	  detection	  of	  the	  whole	  transcriptome,	  we	  were	  able	  to	  
detect	   some	   chlamydial	   reads	   at	   the	   absolute	   limit	   of	   detection,	   which	   we	  
considered	   to	   be	   highly	   expressed,	   amounting	   to	   approximately	   10%	   of	   the	   C.	  
pneumoniae	  genome.	  These	  highly	  expressed	  genes	  were	  predominantly	  associated	  
with	   the	   transcription	   and	   replication	   of	   the	  C.	   pneumoniae	   genome,	   as	  well	   as	   a	  
number	   of	   membrane	   associated	   genes,	   genes	   involved	   in	   metabolite	   synthesis,	  
active	   molecular	   transport	   and	   chaperone	   genes.	   Both	   strains	   demonstrated	  
expression	   for	   a	   large	   number	   of	   IncA	   family	   genes,	   involved	   in	   formation	   and	  
homotypic	   fusion	   of	   the	   chlamydial	   inclusion.	  We	   found	   that	   the	   region	   including	  
and	  directly	   flanking	   the	  plasticity	   zone	   in	  both	   strains	  was	  highly	   transcribed,	  and	  
several	   instances	  of	  strain-­‐specific	  genes	  were	  expressed	  within	  this	  region.	  In	  A03,	  
the	   extended	   plasticity	   zone	   accounted	   for	   13%	   of	   all	   transcripts	   detected,	   and	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several	   genes	   in	   this	   region	   were	   detected	   in	   all	   three	   replicates.	   A	   number	   of	  
pseudogenes	   were	   expressed	   in	   both	   LPCoLN	   and	   A03,	   suggesting	   that	   some	   of	  
these,	   such	  as	   IncA	   and	  pmpE/F4,	  may	  be	   involved	   in	   subverting	   the	  host	   immune	  
response,	   or	   in	   the	   case	   of	   ispE	   in	   A03	   -­‐	   likely	   functional	   but	   not	   requiring	   the	  
expression	  of	  the	  entire	  gene	  length.	  We	  were	  able	  to	  identify	  six	  genes	  which	  were	  
most	   commonly	   represented	   in	   string	   network	   analyses,	   predominantly	   associated	  
with	  transcription	  and	  replication	  of	  the	  C.	  pneumoniae	  chromosome,	  but	  given	  the	  
limited	   number	   of	   genes	   which	   were	   detected,	   entire	   pathways	   could	   not	   be	  
constructed.	  This	  study	   is	   the	   first	  attempt	   to	  characterise	   the	   transcriptome	  of	  an	  
animal	  C.	  pneumoniae	   strain,	  however	  we	  could	  not	  definitively	   identify	  any	  genes	  
which	  would	  account	   for	   its	  unique	  developmental	   and	  biological	  properties	  when	  
compared	  to	  human	  C.	  pneumoniae	  strains	  isolated	  from	  various	  pathologies.	  Whilst	  
these	   experiments	   were	   considered	   unsuccessful,	   our	   study	   did	   demonstrate	   a	  
number	   of	   similarities	   and	   differences	   in	   gene	   expression	   between	   animal	   and	  
human	   C.	   pneumoniae	   strains,	   with	   a	   number	   of	   putative	   targets	   identified	   for	  
further	  deep	  sequencing	  transcriptome	  studies.	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Chlamydia	  pneumoniae	  is	  an	  intriguing	  pathogen	  in	  that	  it	  appears	  to	  be	  ubiquitous	   3 
both	   in	   human	   and	   in	   animal	   populations,	   and	   whilst	   infection	   appears	   to	   be	   4 
predominantly	  asymptomatic,	   it	   is	  associated	  with	  a	  wide	   range	  of	   respiratory	  and	   5 
non-­‐respiratory	   diseases	   in	   these	   hosts.	   	   Given	   the	   breadth	   of	   human	   disease	   6 
pathologies	   and	   numerous	   animal	   hosts	   from	   which	   C.	   pneumoniae	   has	   been	   7 
isolated	   [1],	   a	   genetic	   basis	   to	   differentiate	   between	   strains	   has	   been	   theorised,	   8 
however	   previous	   studies	   seeking	   to	   segregate	   C.	   pneumoniae	   strains	   by	   host	   or	   9 
pathology,	  using	  target	  gene	  sequencing	  have	  met	  with	  mixed	  success.	  	  PCR	  studies	   10 
have	   described	   a	   genetically	   monomorphic	   pathogen,	   demonstrating	   highly	   11 
conserved	   gene	   order	   and	   nucleotide	   content,	   with	   a	   few	   notable	   differences	   12 
between	   animal	   and	   human	   strains	   and	   approximately	   300	   SNPs	   to	   distinguish	   13 
between	  different	  human	  strains	  [2,	  3].	  As	  next	  generation	  sequencing	  technologies	   14 
have	   advanced	   and	   become	   more	   accessible	   to	   researchers,	   whole	   genome	   15 
sequencing	   studies	   into	   human	   and	   animal	   C.	   pneumoniae	   strains	   have	   been	   16 
undertaken,	   however	   until	   recently,	   publicly	   available	   whole	   genome	   sequences	   17 
were	   restricted	   to	   four	   human	   C.	   pneumoniae	   strains	   and	   a	   single	   animal	   C.	   18 
pneumoniae	   strain,	   predominantly	   isolated	   from	   human	   respiratory	   samples	   [3-­‐5].	  	   19 
This	   made	   characterisation	   of	   molecular	   markers	   to	   distinguish	   between	   strains	   20 
isolated	  from	  various	  human	  pathologies	  unreliable,	  and	  provided	  no	  insight	  into	  the	   21 
level	   of	   genetic	   diversity	   present	   in	   animal	   strains.	   Additionally,	   in	   vitro	   studies	   of	   22 
human	   and	   animal	   C.	   pneumoniae	   strains	   demonstrated	   clear	   contrasts	   in	   23 
development	   and	   growth	   characteristics	   during	   acute	   infection	   [6]	   and	   also	   when	   24 
subjected	   to	   stressors	   such	   as	   IFN-­‐γ	   and	   antibiotic	   treatment	   [7-­‐9].	   The	   diverse	   25 
presentation	   of	   C.	   pneumoniae	   in	   human	   disease	   and	   its	   remarkable	   contrast	   in	   26 
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growth	  and	  development	  between	  human	  and	  animal	  strains	   led	  us	  to	  hypothesise	   27 
that	   there	   may	   be	   a	   genetic	   basis	   to	   C.	   pneumoniae	   tissue	   tropism	   and	   host	   28 
specificity.	  	  	   29 
	   30 
The	  current	  study	  aimed	  to	  address	  these	  knowledge	  gaps	  in	  two	  ways:	  (i)	  by	  whole	   31 
genome	   sequencing	  and	   comparative	   genomic	  analyses	  of	   a	   variety	  of	  human	  and	   32 
animal	   C.	   pneumoniae	   strains	   isolated	   from	   various	   disease	   pathologies	   and	   33 
geographic	   locations,	   and	   (ii)	   by	   comparative	  RNAseq	   transcriptome	   studies	  of	   the	   34 
koala	  LPCoLN	  and	  human	  atherosclerotic	  A03	  strains.	  	  	   35 
	   36 
C.	   pneumoniae	   has	   long	   been	   associated	   with	   cardiovascular	   diseases	   such	   as	   37 
atherosclerosis	   and	   myocardial	   infarction,	   and	   its	   identification	   in	   brain	   tissues	   38 
isolated	  from	  Alzheimer's	  patients	  in	  1998	  further	  expanded	  its	  presentation	  in	  non-­‐ 39 
respiratory	  pathologies	  [10-­‐13].	  	  Previous	  studies	  had	  attempted	  to	  characterise	  the	   40 
genetic	   diversity	   of	   human	  C.	   pneumoniae	   strains	   by	   PCR	   analysis	   of	   gene	   targets	   41 
including	   the	   16S	   ribosomal	   subunit	   (16S	   rRNA)	   [14,	   15],	   major	   outer	   membrane	   42 
protein	  (ompA)	  [16,	  17]	  and	  tyrosine	  permease	  (tyrP)	  [18].	  Furthermore,	  PCR	  analysis	   43 
of	  two	  respiratory	  strains	   isolated	  from	  Australian	   indigenous	   individuals	  suggested	   44 
that	   the	   genetic	   diversity	   of	   human	   C.	   pneumoniae	   strains	   could	   be	   even	   greater	   45 
than	   suggested	   from	   previous	   whole	   genome	   and	   PCR	   based	   studies	   [19].	   46 
Comparative	  genomic	  and	  phylogenetic	  analyses	  of	  a	  number	  of	  molecular	  markers	   47 
for	  both	  animal	  and	  human	  C.	  pneumoniae	  isolates	  demonstrated	  that	  the	  Australian	   48 
indigenous	  strains	  shared	  a	  number	  of	  distinct	  sequence	  polymorphisms	  in	  common	   49 
with	  animal	  C.	  pneumoniae	  strains.	  Shortly	  after	  the	  confirmation	  of	  C.	  pneumoniae	   50 
	  Chapter	  Seven:	  General	  Discussion	  and	  Future	  Directions	   247	  
as	  a	  human	  pathogen,	   the	   first	   animal	   strain	  of	  C.	  pneumoniae	  was	  described	   in	  a	   51 
horse	  with	  respiratory	  disease	  [20].	  The	  characterisation	  of	  C.	  pneumoniae	  in	  animals	   52 
as	  diverse	  as	  koalas,	   frogs,	   reptiles	  and	  dogs	   [21-­‐27]	   soon	   followed.	  Until	   recently,	   53 
only	   a	   single	   whole	   genome	   sequence	   for	   an	   animal	   C.	   pneumoniae	   strain	   was	   54 
available	   -­‐	   LPCoLN	   -­‐	   isolated	   from	   a	   koala	   with	   a	   respiratory	   tract	   infection	   [5].	   55 
Comparative	  studies	  between	  the	  koala	  and	  human	  strains	  of	  C.	  pneumoniae	  noted	   56 
that	  whilst	   human	  and	  animal	   strains	   shared	  a	  highly	   conserved	   core	   genome	  and	   57 
considerable	   nucleotide	   content,	   there	   were	   some	   significant	   differences	   in	   the	   58 
koala	  strain,	  suggesting	  that	  animal	  C.	  pneumoniae	  strains	  were	  ancestral	  to	  human	   59 
strains	   (Figure	  1).	   It	  was	   clear	   that	   that	  whole	   genome	   comparisons	  needed	   to	  be	   60 
expanded	   to	   include	   strains	   isolated	   from	   human	   non-­‐respiratory	   pathologies,	   as	   61 
well	  as	  obtained	  from	  hosts	  other	  than	  the	  koala,	  to	  further	  characterise	  the	  genetic	   62 
diversity	  of	  C.	  pneumoniae.	  	   63 
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64 
	   65 
Figure	  1	  -­‐	  The	  diversity	  of	  animal	  C.	  pneumoniae	  and	  model	  of	  possible	  pathways	  to	  human	  zoonosis.	  	   66 
C.	   pneumoniae	   has	   been	   characterised	   in	   a	   number	   of	   endo-­‐,	   ecto-­‐	   and	   poikilothermic	   animals.	   67 
Human	  C.	  pneumoniae	  strains	  are	  believed	  to	  have	  resulted	  from	  at	  least	  two	  zoonotic	  events	  in	  the	   68 
recent	  past.	  	  Figure	  from	  Roulis,	  Polkinghorne	  and	  Timms,	  2012	  [1].	   69 
	   70 
As	  part	  of	  the	  overarching	  study	  into	  the	  genetic	  diversity	  of	  human	  C.	  pneumoniae,	   71 
we	  investigated	  the	  genetic	  diversity	  of	  two	  non-­‐respiratory	  C.	  pneumoniae	  strains;	   72 
A03	  -­‐	  isolated	  from	  a	  patient	  undergoing	  carotid	  endarterectomy	  for	  atherosclerosis	   73 
and	  TOR-­‐1	  -­‐	  isolated	  from	  the	  post-­‐mortem	  brain	  of	  an	  Alzheimer's	  disease	  patient.	   74 
Recently	   after	   the	   submission	  of	   our	  manuscript	   [28],	   a	   study	  by	  Weinmaier	  et	   al.	   75 
[29]	   examined	   the	   genetic	   factors	   of	   respiratory	   and	   cardiovascular	   tropism	   in	   C.	   76 
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pneumoniae	   by	   whole	   genome	   sequencing	   and	   the	   comparison	   of	   19	   new	   C.	   77 
pneumoniae	  strains.	  Their	  study	  identified	  a	  number	  of	  SNPs	  and	  molecular	  markers	   78 
that	   appeared	   to	   clearly	   segregate	   respiratory	   and	   cardiovascular	   strains.	   Whilst	   79 
these	  sequences	  were	  not	  available	  to	  us	  at	  the	  time	  of	  manuscript	  submission,	  they	   80 
were	  further	  analysed	  as	  part	  of	  a	  further	  study	  where	  we	  characterised	  the	  genetic	   81 
diversity	  of	   three	  Australian	  human	  respiratory	  C.	  pneumoniae	   strains	   [30].	  Two	  of	   82 
the	  strains	  analysed	  (SH511	  and	  1979)	  were	  obtained	  from	  samples	  from	  Australian	   83 
indigenous	  patients	  in	  remote	  outback	  communities	  and	  previous	  studies	  suggested	   84 
that	   these	   strains	  phylogenetically	   clustered	  alternately	  with	  animal	   and	  human	  C.	   85 
pneumoniae	   strains	   dependent	   on	   the	   locus	   examined	   [19,	   31,	   32].	   In	   addition	   to	   86 
obtaining	  whole	   genome	   sequences	   for	   the	   two	   Australian	   indigenous	   strains,	   we	   87 
sequenced	   the	   genome	   of	   a	   clinical	   respiratory	   strain	   from	   a	   non-­‐indigenous	   88 
Australian	   patient	   (WA97001)	   [33],	   and	   performed	   comparative	   phylogenomic	   89 
investigations.	   	   Finally,	   we	   sequenced	   the	   chromosome	   and	   plasmid	   sequence	   of	   90 
strain	  B21	  isolated	  from	  a	  Western	  barred	  bandicoot	  (Perameles	  bougainville)	   [34].	   91 
Previous	  PCR	  studies	  examining	  a	  number	  of	  C.	  pneumoniae	   isolates	   from	  Western	   92 
barred	  bandicoots	  suggested	  that	  they	  were	  identical	  in	  nucleotide	  sequence	  to	  the	   93 
koala	   LPCoLN	   strain	   at	   several	   chromosomal	   and	   plasmid	   loci	   [19,	   35].	   	   Detailed	   94 
examination	  of	  the	  C.	  pneumoniae	  strains	  sequenced	  in	  these	  three	  studies	  builds	  an	   95 
interesting	  picture	  of	  C.	  pneumoniae	  disease	  association	  in	  humans	  and	  its	  evolution	   96 
in	   multiple	   hosts,	   attributing	   a	   much	   greater	   level	   of	   sequence	   diversity	   in	   C.	   97 
pneumoniae	  strains	  than	  was	  previously	  described.	   98 
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Overall,	  our	  studies	  have	  identified	  a	  number	  of	  differential	  phylogenetic	  groupings	   100 
in	   C.	   pneumoniae,	   which	   were	   strongly	   supported	   by	   comparative	   sequence	   101 
observations	   and	   recombination	   analyses.	   	   We	   identified	   four	   distinct	   clades	   and	   102 
sub-­‐clades	   within	   human	   C.	   pneumoniae,	   comprising	   the	   Australian	   indigenous	   103 
clade,	  the	  TW183	  clade	  and	  the	  main	  human	  C.	  pneumoniae	  clade	  which	  is	  divided	   104 
into	   the	  AR39	  and	  CWL029	  sub-­‐clades,	  with	  animal	  C.	  pneumoniae	   strains	  basal	  as	   105 
shown	  in	  figure	  2.	  	  	   106 
	   107 
	   108 
Figure	  2	  -­‐	  C.	  pneumoniae	  whole	  genome	  phylogeny	  constructed	  using	  MrBayes.	  Animal	  and	  human	  C.	   109 
pneumoniae	   strains	   form	   the	   two	   major	   clades,	   with	   four	   distinct	   clades	   within	   the	   human	   C.	   110 
pneumoniae	  tree.	  	  Figure	  from	  Roulis	  et	  al.	  2015	  [30]	   111 
	   112 
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A	   high	   level	   of	   sequence	   identity	   between	   different	   chlamydial	   strains	   is	   not	   113 
uncommon	   (between	  95	   to	  99.99%	  nucleotide	  pairwise	   identity)	   [2,	   28-­‐30,	   34,	   36,	   114 
37]	   and	   our	   comparative	   study	   of	   A03	   and	   TOR-­‐1,	   as	   well	   as	   the	   B21	   strain,	   115 
demonstrated	   that	   these	   observations	   can	   be	   extended	   to	   strains	   isolated	   from	   116 
differing	   anatomical	   sites	   and	   involved	   in	   different	   pathologies	   as	  well	   as	   isolated	   117 
from	  disparate	  hosts	  in	  considerably	  separated	  biogeographical	  areas.	  Our	  analyses	   118 
revealed	  an	  exceedingly	  small	  number	  of	  SNPs	  differentiating	  strains	  TW183	  and	  A03	   119 
(18	   SNPs),	   AR39	   from	   TOR-­‐1	   (34	   SNPs)	   and	   LPCoLN	   from	   B21	   (22	   SNPs),	   which	   120 
strongly	  supports	  their	  phylogenetic	  clustering.	  	   121 
	   122 
The	  case	  of	  TOR-­‐1	  clustering	  together	  with	  AR39	   in	  a	  subclade	  consisting	  purely	  of	   123 
respiratory	  derived	   strains	   is	   interesting.	   	   Like	  AR39,	   TOR-­‐1	  was	   found	   to	   code	   for	   124 
multiple	   copies	   of	   the	   tyrosine	   permease	   gene	   (tyrP)	   [12],	   which	   was	   previously	   125 
identified	   as	   a	   marker	   to	   distinguish	   vascular	   and	   respiratory	   strains	   of	   C.	   126 
pneumoniae	   [18].	   In	  this	  study,	  we	  confirmed	  the	  presence	  of	  three	  copies	  of	  tyrP,	   127 
identical	   in	   sequence	   to	   those	   of	   AR39,	   but	  were	   unable	   to	   determine	   their	   copy	   128 
order.	   The	   presence	   of	   triple-­‐copy	   tyrP	   strains	   in	   the	   human	   brain	   is	   particularly	   129 
interesting.	   C.	   pneumoniae	   demonstrates	   complete	   absence	   of	   a	   tryptophan	   130 
synthesis	   operon	   or	   tryptophan	   synthesis	   genes	   [38],	   and	   tyrP	   is	   believed	   to	   be	   131 
involved	   in	   tryptophan	   uptake	   and	   scavenging	   in	   C.	   pneumoniae	   [8].	   The	   A03	   132 
vascular	  strain,	  encoding	  for	  a	  single	  tyrP	  copy,	  was	  demonstrated	  to	  be	  particularly	   133 
sensitive	   to	   the	   effects	   of	   tryptophan	   depletion	   compared	   to	   AR39,	   a	   respiratory	   134 
strain	  with	  two	  tyrP	  copies.	  Chacko	  et	  al.	  hypothesised	  that	  the	  presence	  of	  two	  tyrP	   135 
copies	  allowed	  the	  respiratory	  strain	  to	  more	  efficiently	  scavenge	  minute	  quantities	   136 
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of	   tryptophan	   from	   the	  host	  during	   IFN-­‐γ-­‐mediated	   tryptophan	  depletion,	  delaying	   137 
the	  onset	  of	   persistence.	   Tryptophan	   is	   a	   precursor	  molecule	  used	   to	   synthesise	   a	   138 
number	   of	   important	   neurotransmitters	   in	   the	   brain,	   such	   as	   serotonin	   and	   139 
melatonin,	   with	   concentrations	   of	   tryptophan	   and	   its	   anabolites	   shown	   to	   be	   140 
depressed	  in	  Alzheimer's	  and	  related	  diseases	  [39,	  40],	  while	  studies	  examining	  the	   141 
effect	   of	   IFN-­‐γ	   in	   the	   brain	   have	   demonstrated	   conflicting	   neuroprotective	   and	   142 
degenerative	   roles	   [41,	   42]	   consistent	   with	   the	   development	   and	   progression	   of	   143 
Alzheimer's	  and	  other	  neurodegenerative	  pathologies.	  The	  induction	  of	  IFN-­‐γ	   in	  the	   144 
brain	   is	   significantly	   increased	   by	   C.	   pneumoniae	   infection	   [43-­‐46],	   which	   in	   turn	   145 
would	  decrease	  concentration	  of	  available	   tryptophan.	   If	   tyrP	   is	   indeed	   involved	   in	   146 
tryptophan	   uptake	   in	  C.	   pneumoniae,	   triple	   copy	   tyrP	   strains	  may	   be	   considerably	   147 
more	   efficient	   tryptophan	   transporters	   in	   the	   presence	   of	   minuscule	   tryptophan	   148 
concentrations	  and	  this	  could	  account	  for	  the	  presence	  of	  strains	  with	  an	  increased	   149 
number	  of	  tyrP	  copies	  in	  the	  Alzheimer's	  diseased	  brain.	  Another	  notable	  feature	  of	   150 
the	  TOR-­‐1	  strain	  was	   the	  presence	  of	  17	  SNPs	  spanning	  a	   locus	  of	  340	  nucleotides	   151 
homologous	   to	  hypothetical	  protein	  CP0543	   in	  AR39.	  The	  presence	  of	   such	  a	   large	   152 
number	   of	   divergent	   nucleotides	   at	   this	   locus	   for	   a	   strain	   so	   similar	   to	   AR39	   is	   153 
interesting:	  This	  locus	  is	  almost	  identical	  in	  all	  other	  human	  strains	  (with	  two	  SNPs	  in	   154 
strains	   SH511	   and	   1979,	   one	   of	   which	   is	   non-­‐synonymous),	   interrupted	   by	   an	   155 
additional	  920	  nucleotides	  in	  the	  koala	  and	  bandicoot	  strains,	  which	  encodes	  for	  an	   156 
integrated	   phage	   (prophage)	   remnant	   homologous	   to	   a	   minor	   capsid	   protein	   of	   157 
Chlamydiaphage	   [5,	  47].	  Whilst	  phage	  remnants	  have	  been	  previously	  described	  as	   158 
absent	  in	  human	  C.	  pneumoniae	  strains	  [5],	  we	  found	  that	  the	  5'	  region	  of	  this	  locus	   159 
in	   TOR-­‐1	   returned	   significant	   hits	   for	   similarity	   to	   Chlamydiaphage	   CPAR39.	   160 
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Prophages	  are	  common	  in	  bacteria	  [48,	  49]	  where	  they	  undergo	  sequence	  decay	  via	   161 
point	  mutations,	  sequence	  rearrangements	  and	  sequence	  deletions	  upon	  integration	   162 
to	  the	  bacterial	  genome.	  Prophages	  and	  prophage	  remnants	  can	  become	  fixed	  into	  a	   163 
bacterial	   chromosome	   when	   the	   prophage	   gene	   functionality	   is	   co-­‐opted	   by	   the	   164 
organism	   for	   development	   and	   virulence	   -­‐	   this	   is	   frequently	   demonstrated	   in	   165 
pathogenic	   bacteria,	   such	   as	   Clostridium	   botulinum	   and	   Vibrio	   cholerae,	   where	   166 
prophages	   encode	   for	   toxin	   genes	   which	   confer	   specific	   virulence	   traits	   [50].	   It	   is	   167 
interesting	   to	   note	   that	   the	   C.	   pneumoniae	   strain	   AR39,	   which	   shares	   the	   closest	   168 
sequence	   identity	   with	   TOR-­‐1,	   harbours	   the	   CPAR39	   Chlamydiaphage	   as	   an	   169 
extrachromosomal	   element	   [51,	   52],	   where	   it	   is	   has	   been	   demonstrated	   to	   170 
differentially	   suppress	   protein	   synthesis	   and	   secretion	   of	   polymorphic	   membrane	   171 
protein	   10	   (pmpG)	   and	   chlamydial	   protease-­‐like	   activity	   factor	   (CPAF),	   as	   well	   as	   172 
exhibiting	  a	  marked	  accumulation	  of	  IncA	  protein	  within	  the	  chlamydial	  inclusion	  and	   173 
failure	   to	   lyse	   [53].	  Horizontal	   gene	   transfer	   of	   CPAR39	  phage	   sequence	   to	   animal	   174 
strains,	  which	  are	  ancestral	  to	  human	  C.	  pneumoniae,	  has	  been	  speculated	  [54]	  and	   175 
it	   is	   likely	   that	   these	   prophage	   sequences	   have	   decayed	   considerably	   over	   the	   176 
evolution	  of	  human	  C.	  pneumoniae.	  	  	  In	  spite	  of	  these	  two	  major	  differences	  to	  the	   177 
AR39	  strain,	  TOR-­‐1	  tightly	  clusters	  in	  a	  sub-­‐clade	  consisting	  of	  solely	  of	  respiratory	  C.	   178 
pneumoniae	   strains.	  This	   suggests	   that	   the	  establishment	  of	  TOR-­‐1	   infection	   in	   the	   179 
patient	   was	   derived	   from	   an	   initial	   respiratory	   infection	   that	   disseminated	   to	   the	   180 
brain,	   and	   indicates	   a	   probable	   link	   between	   respiratory	   infection	   with	   C.	   181 
pneumoniae	  and	  central	  nervous	  system	  tropism.	  	   182 
	   183 
	   184 
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  A	   link	   between	   pathology	   and	   tissue	   tropism	   in	   TW183	   clade,	   containing	   strains	   185 
TW183,	   A03	   and	   UZG1,	   appears	   to	   be	   more	   complex.	   	   Strains	   in	   this	   clade	   are	   186 
derived	  from	  three	  different	  tissue	  sites:	  TW183	  is	  one	  of	  the	  original	  C.	  pneumoniae	   187 
type	   strains,	   and	   was	   isolated	   from	   the	   conjunctiva	   of	   a	   child	   in	   Taiwan	   during	   a	   188 
trachoma	  screening	  study	  [55],	  whilst	  A03	  was	  isolated	  from	  the	  carotid	  artery	  of	  a	   189 
patient	  undergoing	  endarterectomy	  for	  atherosclerosis	  [56]	  and	  UZG1,	  a	  respiratory	   190 
isolate	  from	  a	  patient	  in	  The	  Netherlands	  collected	  prior	  to	  1996	  [57].	  These	  strains	   191 
exhibit	   an	   exceedingly	   small	   number	   of	   SNPs	   between	   them	   (18	   SNPs	   between	   192 
TW183	   and	  A03,	   22	   SNPs	   between	   TW183	   and	  UZG1	   and	   30	   SNPs	   between	  UZG1	   193 
and	   A03),	   but	   greater	   than	   300	   divergent	   nucleotides	   when	   compared	   to	   other	   194 
human	   C.	   pneumoniae	   strains.	   This	   high	   level	   of	   sequence	   conservation	   validates	   195 
their	  inclusion	  into	  a	  well-­‐supported	  clade	  separate	  to	  that	  of	  the	  AR39	  and	  CWL029	   196 
clades.	   The	   most	   characteristic	   difference	   observed	   in	   these	   strains	   compared	   to	   197 
strains	  which	  cluster	  in	  the	  AR39	  and	  CWL029	  clades	  is	  that	  TW183,	  A03	  and	  UZG1	   198 
do	  not	  encode	  for	  homologs	  of	  the	  putative	   IncA	  genes	  CP0730	  and	  CP0729	  (AR39	   199 
locus	  numbering).	  In	  comparing	  interstrain	  polymorphisms	  between	  members	  of	  this	   200 
clade,	  we	  highly	  two	  differences.	  The	  first	  is	  the	  presence	  of	  two	  copies	  of	  tyrP	  in	  the	   201 
UZG1	   strain	   -­‐	   a	   respiratory	   strain	   [29],	   whilst	   both	   TW183	   and	   A03	   encode	   for	   a	   202 
single	  identical	  tyrP	  copy.	  In	  this	  case,	  both	  respiratory	  and	  cardiovascular	  strains	  in	   203 
this	  clade	  uphold	  the	  supposition	  of	  tyrP	  as	  a	  marker	  of	  tissue	  tropism	  put	  forward	   204 
by	  Gieffers	  et	  al	  [18].	  Taking	  the	  various	  pathologies	  and	  phylogenetic	  position	  of	  the	   205 
strains	   in	  the	  TW183	  clade	  into	  account,	  we	  consider	  these	  atypical	  C.	  pneumoniae	   206 
strains.	   	  As	  there	  are	  only	  three	  described	  strains	   in	  this	  clade,	   it	   is	  not	  possible	  to	   207 
deduce	   wether	   these	   strains	   and	   any	   undescribed	   strains	   similar	   to	   these,	   are	   208 
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respiratory	   in	   origin	   or	   have	   a	   transmission	   route	   other	   than	   by	   the	   respiratory	   209 
route,	   for	   example,	   an	   ocular	   route	   of	   transmission.	   Ocular	   transmission	   of	   C.	   210 
pneumoniae	   resulting	   in	   conjunctivitis	   with	   subsequent	   mild	   respiratory	   is	   not	   211 
unprecedented,	  with	   a	   case	  of	   infection	  of	   a	   laboratory	  worker	  with	   strain	   IOL207	   212 
previously	   documented	   [58].	   Interestingly,	   the	   TW183	   strains	   appear	   to	   be	   direct	   213 
descendants	  of	  the	  IOL207	  strain	  by	  Bayesian	  phylogeny	  in	  figure	  1.	  Dissemination	  of	   214 
ocular	   infection	   to	   other	   organs	   and	   systems	   has	   been	   described	   in	   Chlamydia	   215 
trachomatis,	  with	  the	  surprising	  discovery	  that	  ocular	  (trachoma)	  strains,	  and	  not	  the	   216 
more	   invasive	   urogenital	   or	   lymphogranuloma	   strains,	   were	   found	   in	   the	   synovial	   217 
tissues	  of	  patients	  with	  arthritis	  [59,	  60].	   218 
	  	  	  	   219 
A	  previous	  study	  by	  Mitchell	  et	  al.	  [19]	  examined	  the	  genetic	  diversity	  of	  a	  variety	  of	   220 
human	   and	   animal	   C.	   pneumoniae	   strains,	   two	   of	   which	   were	   isolated	   from	   221 
Australian	  indigenous	  patients	  in	  remote	  communities	  [31,	  32].	  We	  were	  interested	   222 
to	   investigate	   if	   the	   Australian	   indigenous	   strains	   coded	   for	   any	   additional,	   strain-­‐ 223 
specific	   polymorphic	   loci,	   and	   whether	   whole	   genome	   phylogenomic	   comparisons	   224 
would	   place	   their	   topology	   closer	   to	   animal	   or	   human	  C.	   pneumoniae	   strains.	  We	   225 
employed	  a	  comparative	  genomic	  approach	  as	  well	  as	  a	  variety	  of	  coalescent	  based	   226 
phylogenomic	  methods	  to	  characterise	  the	  evolutionary	  position	  of	  the	  Australian	  C.	   227 
pneumoniae	   strains,	   in	   the	   context	   of	   the	   now	   numerous	   C.	   pneumoniae	   whole	   228 
genome	  sequences	  available	  from	  previous	  studies	  [3-­‐5,	  28,	  29,	  34,	  38].	  Phylogenetic	   229 
analyses	   indicated	   that	   the	   two	   Australian	   indigenous	   strains	   formed	   a	   well-­‐ 230 
supported	  clade	  separate	   to	   the	   large	  non-­‐indigenous	  C.	  pneumoniae	  human	  clade	   231 
(consisting	   of	   respiratory	   and	   non-­‐respiratory	   strains)	   but	   were	   also	   considerably	   232 
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distant	   to	   the	   animal	   clade	   consisting	   of	   koala,	   bandicoot	   and	   frog	   strains.	   This	   233 
contrasts	   slightly	  with	   findings	   in	  Mitchell	  et	   al	   [19],	  which	   alternately	   place	   these	   234 
strains	   with	   human	   or	   animal	   C.	   pneumoniae	   clades	   depending	   on	   the	   molecular	   235 
target.	   We	   characterised	   additional	   polymorphic	   loci	   that	   further	   supported	   the	   236 
divergent	   branching	   of	   the	   Australian	   indigenous	   strains	   from	   the	  main	   human	   C.	   237 
pneumoniae	   clade,	   a	   number	   of	   which	   were	   quite	   unexpected.	  	   238 
The	   most	   surprising	   sequence	   polymorphism	   associated	   with	   the	   Australian	   239 
indigenous	  strains	  was	  the	  presence	  of	  an	  intact	  IncA	  gene	  previously	  only	  described	   240 
in	   koala	   and	   bandicoot	   C.	   pneumoniae	   strains	   [5,	   34].	   The	   koala	   and	   bandicoot	   241 
strains	   encode	   for	   four	   full-­‐length	   IncA	   genes	   at	   this	   locus,	   whilst	   human	   C.	   242 
pneumoniae	   strains	   encode	   for	   a	   variable	   number	   of	   intact	   and	   fragmented	   243 
homologs	  of	   these	   four	   IncA	   genes.	   The	  Australian	   indigenous	   strains	  were	  absent	   244 
for	  a	  CPK_ORF00547	  homolog,	  a	  genetic	   feature	   shared	  with	   strains	   in	   the	  TW813	   245 
clade	  and	  the	  DC9	  frog	  strain,	  but	   the	  only	  known	  human	  strains	   to	  encode	  for	  an	   246 
intact	  CPK_ORF00549	  homolog,	  as	  shown	  in	  Figure	  3.	  	   247 
248 
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   248 
Figure	  3	  -­‐	  IncA	  gene	  expansion	  locus	  in	  human	  and	  animal	  C.	  pneumoniae	  strains.	  Koala	  (LPCoLN)	  and	   249 
bandicoot	   (B21)	   strains	   encode	   for	   four	   intact	   IncA	   homologs	  whilst	   various	   numbers	   of	   intact	   and	   250 
fragmented	  copies	  are	  demonstrated	   in	  human	  C.	  pneumoniae	  and	  the	  frog	  (DC9)	  strain.	  Australian	   251 
indigenous	  strains	  SH511	  and	  1979	  are	  the	  only	  known	  human	  C.	  pneumoniae	  strains	  to	  encode	  for	  a	   252 
CPK_ORF00549	  homolog.	  Figure	  from	  Roulis	  et	  al.	  2015	  [30]	   253 
	   254 
Previous	  studies	  examining	  the	  guaA/B-­‐add	  operon	  in	  C.	  pneumoniae	  demonstrated	   255 
that	  this	   locus	  was	  absent	   in	  the	  koala	  and	  other	  marsupial	  C.	  pneumoniae	   strains,	   256 
but	   present	   to	   some	   extent	   in	   other	   animal	   strains	   and	   the	   indigenous	   Australian	   257 
strains	  [5,	  19].	  guaB,	  which	  encodes	  for	   inosine	  5'-­‐monophosphate	  dehydrogenase,	   258 
is	   encoded	   in	   all	   human	  C.	   pneumoniae	   strains,	   where	   it	   is	   annotated	   as	   either	   a	   259 
pseudogene	  or	  fragmented	  into	  two	  genes	  (guaB1	  and	  guaB2)	  due	  to	  the	  presence	   260 
of	  a	  premature	  stop	  codon.	  Whole	  genome	  analyses	  identified	  a	  T/C	  transition	  in	  the	   261 
Australian	  indigenous	  strains,	  as	  well	  as	  the	  DC9	  frog	  strain	  and	  IOL207,	  an	  atypical	   262 
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strain	  originally	  isolated	  from	  the	  eyes	  of	  an	  Iranian	  child	  in	  1967	  [58,	  61],	  resulting	   263 
in	  replacement	  of	  the	  stop	  codon	  with	  glutamine	  (Q)	  and	  encoding	  for	  an	  intact	  guaB	   264 
gene.	   The	   polymorphisms	   displayed	   across	   human	   C.	   pneumoniae	   strains	   at	   the	   265 
guaA/B-­‐add	  locus,	  and	  their	  complete	  absence	  in	  marsupial	  C.	  pneumoniae	  strains	  is	   266 
particularly	   interesting.	   The	   plasticity	   zone,	   a	   region	   that	   includes	   the	  guaA/B-­‐add	   267 
operon,	   encompasses	   the	   terminus	   of	   replication	   in	   Chlamydiae	   and	   is	   a	   268 
recombination	   hotspot	   [4,	   28,	   62].	   Transcriptional-­‐associated	   recombination	   is	   a	   269 
common	   diversifying	  mechanism	   in	   both	   prokaryotes	   and	   eukaryotes	   [63,	   64]	   and	   270 
horizontal	   gene	   transfer	   of	   this	   purine	   biosynthesis	   operon	   between	   different	   271 
chlamydial	  strains	  and	  different	  chlamydial	  species	  has	  been	  demonstrated	   in	  both	   272 
C.	  psittaci	  and	  C.	  caviae	   [65,	  66].	   	  A	  similar	  mechanism	   is	   likely	   responsible	   for	   the	   273 
presence	  of	   the	  guaA/B-­‐add	   operon	   in	   the	  DC9	   frog	   strain,	  whilst	   sequence	  decay	   274 
likely	   plays	   a	   part	   in	   the	   divergence	   between	   non-­‐indigenous	   and	   Australian	   275 
indigenous	  strains	  at	  this	  locus	  	   276 
	   277 
Even	  when	  the	  notable	  similarities	  to	  animal	  C.	  pneumoniae	  strains	  identified	  in	  this	   278 
and	  previous	  studies	  are	  taken	  into	  account,	  the	  average	  nucleotide	   identity	  of	  the	   279 
Australian	   indigenous	   strains	   SH511	   and	   1979	   is	   far	   more	   similar	   to	   that	   of	   the	   280 
strains	   which	   make	   up	   the	   major	   human	   C.	   pneumoniae	   clades	   than	   any	   of	   the	   281 
animal	  strains	  sequenced	  so	  far.	  Whilst	   it	   is	  possible	  that	  the	  Australian	   indigenous	   282 
strains	  evolved	   from	  C.	  pneumoniae	   strains	   similar	   in	   sequence	   to	   the	  LPCoLN	  and	   283 
B21	  marsupial	  strains,	  it	  is	  also	  possible,	  given	  the	  notable	  instances	  of	  gene	  decay,	   284 
presence	   of	   an	   intact	  guaB	   and	   part	   of	   the	  guaA	   gene,	   that	   these	   strains	   evolved	   285 
from	   an	   animal	   or	   human	   intermediate	   strain	  more	   similar	   to	   the	   DC9	   frog	   strain	   286 
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which	   encodes	   for	   the	   guaA/B-­‐add	   operon	   and	   is	   similarly	   lacking	   the	   287 
CPK_ORF00547	   gene,	   or	   through	   interstrain	   recombination	   from	   co-­‐infection	   with	   288 
different	   C.	   pneumoniae	   strains,	   which	   has	   been	   shown	   to	   be	   common	   in	   C.	   289 
trachomatis	  [67-­‐70].	   290 
	  	  	   291 
Previous	  PCR	  studies	  examined	  a	  diverse	  range	  of	  molecular	  targets	  from	  a	  number	   292 
of	   animal	   hosts,	   and	   found	   evidence	   for	   several	   animal	  C.	   pneumoniae	   genotypes	   293 
[17,	   19,	   71].	   These	   studies	   indicated	   that	   C.	   pneumoniae	   strains	   isolated	   from	   294 
Australian	   marsupials	   (koalas,	   bandicoots	   and	   potoroos)	   and	   an	   Australian	   295 
amphibian	   (giant	   barred	   frog)	   were	   identical	   [19],	   implying	   the	   existence	   of	   an	   296 
Australian	  -­‐	  possibly	  marsupial	   -­‐	  animal	  biovar.	   	   In	  order	  to	  determine	  whether	  the	   297 
considerable	  level	  of	  nucleotide	  identity	  demonstrated	  between	  marsupial	  strains	  of	   298 
C.	   pneumoniae	   was	   congruent	   with	   observations	   from	   targeted	   PCR	   studies,	   we	   299 
sequenced	  the	  B21	  strain	  from	  a	  western	  barred	  bandicoot	  and	  compared	  it	  to	  the	   300 
LPCoLN	   sequence.	   The	   strains	   from	   koala	   and	   western	   barred	   bandicoot	   were	   301 
essentially	  identical	  in	  sequence	  for	  both	  the	  chromosome	  and	  plasmid,	  with	  only	  22	   302 
SNPs	  on	  the	  chromosome	  and	  a	  single	  SNP	  detected	  on	  the	  plasmid	  [34].	  	  This	  raised	   303 
an	   interesting	   question	   as	   to	   the	   age	   and	   biogeography	   of	   these	   animal	   C.	   304 
pneumoniae	  strains:	  whilst	  koalas	  and	  the	  giant	  barred	  frog	  are	  considered	  to	  exist	   305 
sympatrically	   along	   the	   east	   coast	   of	  Australia,	   the	  Western	  barred	  bandicoot	   and	   306 
Gilberts	  potoroo	  are	  both	  found	  in	  Western	  Australia,	  but	  populations	  are	  located	  at	   307 
considerable	  distance	  from	  each	  other	  [72,	  73].	  At	  the	  time	  of	  European	  settlement,	   308 
the	  western	  barred	  bandicoot	  was	  considered	  common	  across	  the	  southern	  portion	   309 
of	  the	  continent	  -­‐	  in	  a	  wide	  arc	  stretching	  from	  Western	  Australia	  to	  the	  arid	  inland	   310 
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regions	  of	  New	  South	  Wales	  [74],	  whilst	  	  fossil	  evidence	  from	  the	  Pleistocene	  epoch	   311 
some	  40,000	  years	  ago	  suggests	  that	  the	  range	  of	  the	  western	  barred	  bandicoot	  was	   312 
much	  broader,	  to	  include	  south	  western	  Queensland	  [75].	  The	  presence	  of	  the	  koala	   313 
in	   south	   Western	   Australia	   has	   been	   demonstrated	   as	   recently	   as	   the	   late	   314 
pleistocene	  (approximately	  31-­‐81ka),	   from	  two	  caves	   in	  the	  Witchcliffe	  cave	  region	   315 
of	  Western	  Australia	  [76],	  whilst	  the	  fossil	   record	  of	  the	  Western	  barred	  bandicoot	   316 
has	  indicated	  that	  this	  species	  occurred	  sympatrically	  with	  the	  long	  nosed	  bandicoot	   317 
and	  southern	  brown	  bandicoot	  during	  the	  pleistocene	  epoch	  (40-­‐45ka)	  in	  the	  Darling	   318 
Downs	   region	   of	   Southern	   Queensland	   [75].	   	   Given	   that	   strains	   in	   the	   human	   C.	   319 
pneumoniae	   lineage	   were	   believed	   to	   have	   split	   from	   the	   animal	   lineage	   150,000	   320 
years	   ago	   [2],	   combined	   with	   the	   considerable	   geographical	   and	   chronological	   321 
distance	   between	   the	   two	   different	   host	   animals,	   the	   high	   level	   of	   nucleotide	   322 
sequence	  conservation	  between	  these	  two	  animal	  strains	  suggested	  the	  existence	  of	   323 
an	  ancient	  Australian	  animal	  C.	  pneumoniae	  lineage.	  	   324 
	  	  	   325 
Further	  support	  for	  this	  postulate	  came	  in	  the	  form	  of	  a	  third	  animal	  C.	  pneumoniae	   326 
whole	  genome	  sequence,	  DC9,	   isolated	   from	  an	  African	   clawed	   frog	   [29].	   Previous	   327 
studies	  examined	  SNPs	  between	  koala	  and	  frog	  C.	  pneumoniae	   isolates,	  particularly	   328 
those	   isolated	   from	  African	   clawed	   frogs.	   One	   study	   examined	   koala	   and	   the	   DC9	   329 
frog	  strain	  at	  over	  200	  loci	  and	  found	  only	  two	  SNPs	  between	  them	  [2]	  whilst	  other	   330 
studies	  compared	  another	  African	  clawed	  frog	  isolate,	  DE177	  with	  koala	  (and	  various	   331 
other	  animal	   isolates)	  and	  characterised	  numerous	  SNPs	   in	  a	  number	  of	  molecular	   332 
targets	  [19,	  77].	  We	  compared	  the	  frog	  DC9	  whole	  genome	  sequence	  to	  that	  of	  the	   333 
koala	   LPCoLN	   and	   bandicoot	   B21	   strains	   and	   found	   that	   the	   frog	   strain	   differed	   334 
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significantly	  from	  the	  marsupial	  strains	  at	  a	  number	  of	  loci	  considered	  to	  play	  a	  role	   335 
in	   chlamydial	   virulence.	   Oftentimes,	   the	   polymorphisms	   exhibited	   in	   the	   DC9	   frog	   336 
strain	  were	  identical	   in	  sequence	  to	  that	  of	  human	  C.	  pneumoniae	  strains.	  The	  DC9	   337 
strain	  coded	  for	  an	  almost	  intact	  guaA/B-­‐add	  operon,	  which	  is	  completely	  absent	  in	   338 
koala	  and	  bandicoot	  C.	  pneumoniae	  strains,	  and	  may	  only	  be	  partially	  present	  in	  the	   339 
DE177	  frog	  isolate.	  Furthermore,	  the	  DC9	  frog	  strain	  harbours	  deletions	  of	  the	  IncA	   340 
homologs	   CPK_ORF00547	   and	   CPK_00549,	   identical	   to	   that	   observed	   in	   non-­‐ 341 
indigenous	  human	  C.	  pneumoniae	  strains.	   	  The	  DC9	  homologs	  of	  CPK_ORF00341	  (a	   342 
putative	   IncA	   gene)	   and	   pmpE/F4	   are	   also	   almost	   identical	   to	   that	   of	   human	   C.	   343 
pneumoniae	   strains.	   A	   plasmid	   was	   not	   identified	   in	   the	   DC9	   strain,	   however	   the	   344 
authors	   caveat	   is	   that	   the	   sequencing	   and	   assembly	   methods	   used	   in	   their	   study	   345 
were	  not	  optimised	  for	  discovery	  of	  extrachromosomal	  elements	  [29].	  It	  is	  likely	  that	   346 
the	   DC9	   frog	   strain	   indeed	   harbours	   an	   extrachromosomal	   plasmid,	   as	   all	   C.	   347 
pneumoniae	   animal	   strains	   characterised	   to	   date	   have	   the	   presence	   of	   a	   plasmid	   348 
confirmed	  [19].	  	   349 
	   350 
Previous	   studies	   using	   targeted	   sequencing	   of	   SNPs	   and	   comparisons	   of	   C.	   351 
pneumoniae	  whole	   genomes	  described	   a	   highly	   homogenous	  population	  of	   strains	   352 
circulating	   in	   the	  human	  population,	  with	  only	  a	   few	  hundred	  SNPs	  between	  them	   353 
[2]	  and	  almost	  no	  difference	  in	  gene	  content	  or	  order	  [3,	  4,	  38],	  whilst	  comparisons	   354 
of	   human	   and	   koala	   C.	   pneumoniae	   demonstrated	   a	   number	   of	   gene	   family	   355 
expansions,	   additional	   nucleotide	   sequence	   and	   a	   large	   number	   of	   SNPs	   [5]	   .	   The	   356 
high	   level	   of	   nucleotide	   synteny	   between	   human	   strains	   in	   previous	   studies	   was	   357 
likely	   a	   result	   of	   sampling	   bias	   -­‐	   AR39,	   CWL029	   and	   J138	   are	   all	   respiratory	   C.	   358 
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pneumoniae	   strains,	   two	  of	  which	  were	   isolated	   from	  the	  United	  States.	  Our	   three	   359 
studies,	   in	   which	   we	   obtained	   whole	   genome	   sequences	   for	   a	   number	   of	   non-­‐ 360 
respiratory,	   Australian	   indigenous	   and	   animal	   C.	   pneumoniae	   strains	   [28,	   30,	   34],	   361 
combined	  with	  the	  large	  number	  of	  strains	  sequenced	  in	  the	  Weinmaier	  et	  al.	  study	   362 
[29]	  shows	  that	  both	  human	  and	  animal	  strains	  of	  C.	  pneumoniae	  are	  considerably	   363 
more	   genetically	   diverse	   than	   previous	   studies	   had	   described.	   Our	   studies	   364 
demonstrate	   that	   the	  diversity	  between	  strains	   isolated	   from	  different	  pathologies	   365 
and	   different	   hosts	   appear	   to	   primarily	   effect	   gene	   families	   involved	   in	   formation	   366 
and	  maintenance	  of	  the	  chlamydial	  inclusion	  as	  well	  as	  those	  involved	  with	  nutrient	   367 
acquisition	  and	  putative	  virulence	  factors.	  These	  targets	  have	  a	  higher	   likelihood	  of	   368 
interaction	   with	   the	   host	   cell	   and	   immune	   pressures,	   and	   this	   may	   be	   driving	   369 
nucleotide	  diversity	  at	  these	  loci	  as	  a	  mechanism	  to	  shield	  C.	  pneumoniae	  from	  the	   370 
host	  response	  to	  infection.	  	  	   371 
	   372 
In	   addition	   to	   our	   comparative	   genomic	   studies	   we	   employed	   a	   variety	   of	   373 
phylogenomic	   estimation	   methods	   to	   determine	   the	   evolutionary	   changes	   in	   C.	   374 
pneumoniae	   over	   time,	   and	   characterise	   the	   presence	   of	   homologous	   375 
recombination.	  Our	  studies	  found	  strong	  evidence	  of	  homologous	  recombination	  at	   376 
several	  loci	  that	  coincide	  with	  our	  descriptions	  of	  polymorphism	  and	  gene	  expansion	   377 
in	   human	   C.	   pneumoniae	   strains.	   	   In	   order	   to	   determine	   the	   evolutionary	   378 
relationships	   of	   human	  C.	   pneumoniae,	  we	   used	   a	   combination	   of	   BEAST	   [78]	   and	   379 
ClonalFrame	  [79]	  to	  determine	  the	  nucleotide	  substitution	  rates	  and	  the	  date	  of	  the	   380 
most	   recent	   common	   ancestor	   for	   the	   separate	   clades.	  We	   found	   that	   BEAST	   and	   381 
ClonalFrame	  predicted	  tree	  topologies	  identical	  to	  that	  of	  MrBayes	  and	  in	  agreement	   382 
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with	   the	   phylogenetic	   outputs	   generated	   in	   previous	   studies	   from	  whole	   genome	   383 
comparisons	  [29]	  and	  SNP	  comparisons	  [2],	  confirming	  our	  analysis	  parameters	  were	   384 
robust.	  	   385 
	   386 
In	   our	   study	   characterising	   the	   differences	   between	   respiratory,	   cardiac	   and	   387 
Alzheimer’s	  disease	  strains,	  we	  demonstrated	  a	  highly	  congruent	  mean	  substitution	   388 
rate	  of	  1.3x10-­‐6	   substitutions	  per	   site	  per	  year	  by	  BEAST	  and	  1.7x10-­‐6	   substitutions	   389 
per	  site	  per	  year	  with	  ClonalFrame.	   In	  our	  subsequent	  study,	   in	  which	  we	   included	   390 
the	   Australian	   indigenous	   and	   non-­‐indigenous	   C.	   pneumoniae	   strains,	   the	   strains	   391 
from	  the	  Weinmaier	  study	  [29]	  and	  both	  marsupial	  strains	  [5,	  34]	  we	  found	  that	  the	   392 
substitution	  rate	  determined	  by	  BEAST	  increased	  to	  4.64x10-­‐4	  substitutions	  per	  site	   393 
per	   year,	   whilst	   ClonalFrame	   predicted	   a	   rate	   of	   2.36x10-­‐5	   per	   site	   per	   year.	   The	   394 
apparent	  increase	  in	  the	  estimates	  can	  be	  accounted	  for	  not	  only	  by	  the	  inclusion	  of	   395 
more	   divergent	   human	   C.	   pneumoniae	   strains	   such	   as	   SH511	   and	   1979	   in	   the	   396 
analyses,	  but	  especially	  from	  the	  inclusion	  of	  three	  animal	  strains	  of	  C.	  pneumoniae,	   397 
which	   code	   for	   a	   significant	   number	   of	   polymorphisms	   (>6000	   SNPs)	   [5,	   47]	  when	   398 
compared	  to	  human	  C.	  pneumoniae	  strains.	  In	  spite	  of	  the	  inclusion	  of	  animal	  strains	   399 
in	  our	  analyses,	  we	  found	  that	  the	  substitution	  rate	  was	  still	  lower	  than	  described	  for	   400 
C.	  psittaci	  -­‐	  which	  has	  a	  predicted	  mean	  mutation	  rate	  of	  1.682x10-­‐4	  or	  1.74x10-­‐5	  by	   401 
BEAST	   and	   ClonalFrame	   analyses	   respectively	   [65].	   Whilst	   both	   analyses	   in	   C.	   402 
pneumoniae	   and	  C.	  psittaci	  were	  performed	  with	  a	  variety	  of	   strains	   isolated	   from	   403 
different	   hosts	   including	   humans,	   we	   believe	   that	   the	   marked	   difference	   in	   the	   404 
substitution	  rate	  of	  C.	  pneumoniae	  is	  due	  to	  either	  (i)	  a	  more	  recent	  expansion	  of	  C.	   405 
pneumoniae	   into	   the	   human	   host[5,	   19],	   therefore	   a	   shorter	   amount	   of	   time	   in	   406 
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which	   the	   strains	   have	   diversified	   and	   mutations	   become	   fixed,	   or	   (ii)	   that	   C.	   407 
pneumoniae	   is	   a	   considerably	   less	   virulent	   organism	   than	   C.	   psittaci	   [80,	   81]	   and	   408 
therefore	   less	   likely	  to	  be	  subject	  to	  host	   immune	  pressure,	  which	  drives	  sequence	   409 
diversification	  in	  an	  attempt	  to	  shield	  the	  organism	  from	  the	  host	  immune	  response.	  	   410 
	   411 
We	  estimated	  timelines	  for	  the	  most	  recent	  common	  ancestor	  (MRCA)	  for	  strains	  in	   412 
the	   AR39/CWL029	   (respiratory),	   TW183	   and	   Australian	   indigenous	   clades.	   	   Our	   413 
analyses	   suggest	   that	   the	  MRCA	   for	   the	   respiratory	   taxon	  was	  1151	  years,	  with	  an	   414 
MRCA	  for	  the	  TW183	  and	  Australian	   indigenous	  taxa	  at	  727	  and	  1028	  respectively.	   415 
ClonalFrame	   predictions	   for	   both	   studies	   place	   the	   MRCA	   at	   approximately	   1400	   416 
years.	   These	   findings	   present	   an	   interesting	   timeline	   for	   human	   C.	   pneumoniae	   417 
strains.	   	   Both	   algorithms	   predict	   that	   the	   Australian	   indigenous	   strains	   share	   a	   418 
common	   ancestor	   which	   is	   completely	   distinct	   from	   the	   non-­‐indigenous	   human	   419 
clade	  and	  which	  predates	   the	  exploration	  and	  settlement	  of	  Australia	  by	  European	   420 
explorers	  by	  several	  hundred	  years,	  whilst	  the	  MRCA	  of	  the	  TW183	  strains	  appear	  to	   421 
be	  basal	  to	  strains	   in	  the	  respiratory	  taxon	  where	  they	  shared	  a	  common	  ancestor.	  	   422 
MRCA	   dates	   for	   Australian	   indigenous	   and	   TW183	   nodes	   appear	   to	   be	   congruent	   423 
with	   estimates	   for	   the	   most	   recent	   clonal	   expansion	   of	   the	   major	   human	   C.	   424 
pneumoniae	   taxon,	   3300	   years	   ago	   [2]	   calculated	   using	   approximately	   200	   425 
synonymous	   SNPs.	   A	   timeline	   depicting	   the	   predicted	   clonal	   expansions	   and	   426 
calculated	  MRCA	  dates	  at	  clade	  nodes	  is	  outlined	  in	  figure	  4.	  Whilst	  MRCA	  estimates	   427 
differ	   between	   BEAST,	   ClonalFrame	   and	   the	   sSNP	   prediction	   methods,	   the	   clonal	   428 
expansion	   timeline	   of	   human	   C.	   pneumoniae	   strains	   is	   so	   close	   as	   to	   be	   almost	   429 
indistinguishable	   compared	   to	   the	   ancient	   C.	   pneumoniae	   animal	   lineage.	   430 
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431 
	   432 
	  Figure	  4	  -­‐	  	  Timeline	  of	  C.	  pneumoniae	  expansion	  in	  human	  and	  animal	  strains.	  Zoonotic	  transmission	   433 
of	   C.	   pneumoniae	   is	   believed	   to	   have	   occurred	   approximately	   150,000	   years	   ago,	   whilst	   the	   most	   434 
recent	   clonal	   expansion	   of	   the	   human	   clade	   has	   been	   predicted	   at	   3300	   years	   ago.	   Australian	   435 
indigenous	  strains	  form	  a	  distinct	  and	  separate	  lineage	  to	  the	  major	  human	  clade,	  whilst	  their	  MRCA	   436 
is	  similar	  to	  strains	  in	  the	  non-­‐indigenous	  human	  clade	  at	  C.	  1400.	  These	  estimates	  are	  supported	  by	   437 
the	  overall	  nucleotide	  synteny	  in	  comparing	  human	  C.	  pneumoniae	  strains.	  	   438 
	   439 
We	   used	   ClonalFrame	   to	   generate	   recombination	   profiles	   for	   all	   C.	   pneumoniae	   440 
strains	   based	   on	   whole	   genome	   alignments,	   and	   identified	   several	   shared	   loci	   of	   441 
recombination	   between	   human	  C.	   pneumoniae	   strains	  with	   two	   loci	   shared	   in	   the	   442 
frog	  strain	  DC9.	  The	  Australian	   indigenous	  strains	  SH511	  and	  1979	  demonstrated	  a	   443 
distinct	   and	   almost	   identical	   recombination	   profile,	   with	   a	   strong	   recombination	   444 
event	   shared	  with	   strains	  A03	  and	  WA97001	  encompassing	  a	   chromosomal	   region	   445 
coding	   for	   hypothetical	   and	   IncA	   genes.	   Additionally,	   strains	   A03,	   TW183	   and	   446 
WA97001	   share	   a	   strong	   recombination	   signal,	  which	   again	   encompasses	   a	   region	   447 
coding	   for	   putative	   IncA	   genes.	   No	   recombination	   events	   were	   detected	   in	   the	   448 
CWL029	  clade,	   indicating	  that	  strains	   in	  this	  clade	  are	  the	  result	  of	  a	  monophyletic	   449 
expansion	  and	  suggesting	  that	  the	  cardiovascular	  strains	  that	  appear	  to	  be	  the	  most	   450 
recent	  members	  of	  this	  clade	  are	  directly	  descended	  from	  respiratory	  C.	  pneumoniae	   451 
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strains.	  Recombination	  and	  mutation	  profiles	  for	  all	  C.	  pneumoniae	  strains	  are	  shown	   452 
in	  Figure	  5.	  	   453 
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   454 
Figure	   5	   -­‐	   Recombination	  profiles	   for	   all	   30	   sequenced	  C.	   pneumoniae	   strains.	   	   Red	  bars	   indicate	   detected	   recombination	   signals	  whilst	   green	   ticks	   are	   nucleotide	  mutations.	   455 
Recombination	   events	   are	   rare	   in	   the	   non-­‐indigenous	   C.	   pneumoniae	   clade,	   whilst	   recombination	   signals	   in	   Australian	   indigenous	   strains	   are	   distinct	   and	   are	   predominantly	   456 
identified	  at	  loci	  encoding	  for	  IncA	  and	  putative	  IncA	  genes.	  No	  recombination	  signals	  are	  detected	  in	  the	  Australian	  marsupial	  strains	  (LPCoLN	  and	  B21)	  nor	  in	  strains	  within	  the	   457 
CWL029	  clade,	  which	  contain	  both	  respiratory	  and	  vascular	  C.	  pneumoniae	  strains.	  Figure	  from	  Roulis	  et	  al.	  2015	  [30].	   458 
	  Chapter	  Seven:	  General	  Discussion	  and	  Future	  Directions	   268	  
Instances	  of	  recombination	  in	  C.	  pneumoniae	  appear	  to	  predominantly	  affect	  genes	   459 
in	   the	   IncA	   family,	  as	  well	  as	   the	   region	   flanking	   the	  plasticity	  zone.	  The	   IncA	  gene	   460 
family	  is	  considerably	  expanded	  in	  C.	  pneumoniae,	  with	  over	  100	  characterised	  and	   461 
putative	   IncA	   genes	   identified	   by	   the	   presence	   of	   a	   characteristic	   5'	   bi-­‐lobed	   462 
hydrophobic	  domain	  [82,	  83].	  Sequence	  identity	  between	  genes	  at	  this	  locus	  is	  high,	   463 
which	   satisfies	   the	   requirement	   of	   identical	   nucleotides	   at	   one	   or	   both	   ends	   of	   a	   464 
recombining	   locus	   to	   initiate	   recombination	   [84],	   and	   suggests	   that	   sequence	   465 
diversity	   within	   this	   locus	   in	   both	   human	   and	   animal	   strains	   is	   driven	   by	   a	   466 
combination	   of	   gene	   decay	   and	   gene	   expansion	   due	   to	   recombination.	   Sequence	   467 
diversity	  as	  a	  result	  of	  recombination	  in	  the	  inclusion	  gene	  family	  is	  not	  uncommon,	   468 
with	  evidence	  that	  polymorphisms	  within	  these	  genes	  segregate	  for	  different	  tissue	   469 
tropisms	  in	  C.	  trachomatis	  [85-­‐87].	  A	  similar	  mechanism	  is	  likely	  responsible	  for	  the	   470 
presence	  of	   the	  guaA/B-­‐add	   operon	   in	   the	  DC9	   frog	   strain,	  whilst	   sequence	  decay	   471 
may	   play	   a	   part	   in	   the	   divergence	   between	   non-­‐indigenous	   and	   Australian	   472 
indigenous	  strains	  at	  this	  locus.	  	  Indeed,	  it	  has	  been	  shown	  that	  the	  plasticity	  zone,	  a	   473 
region	   that	   includes	   the	   guaA/B-­‐add	   operon	   as	   well	   as	   a	   number	   of	   IncA	   genes,	   474 
encompasses	   the	   terminus	   of	   replication	   in	   Chlamydiae	   and	   is	   a	   recombination	   475 
hotspot	   [4,	   28,	   62].	   Additionally,	   we	   have	   shown	   in	   our	   RNAseq	   studies	   that	   the	   476 
plasticity	   zone	   is	   highly	   transcriptionally	   active	   in	   both	   animal	   and	   human	   strains	   477 
during	  mid-­‐phase	  of	  the	  development	  cycle.	  	   478 
	   479 
The	   overall	   genetic	   similarity	   between	   animal	   and	   human	   C.	   pneumoniae	   strains	   480 
brings	  into	  question	  the	  choice	  of	  out-­‐group	  in	  whole	  genome	  phylogenetic	  analyses.	   481 
We	  chose	  to	  designate	  the	  koala	  LPCoLN	  strain	  as	  an	  out-­‐group	  in	  our	  phylogenetic	   482 
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studies,	   as	   opposed	   to	   using	   a	   related	   chlamydial	   species,	   such	   as	   Chlamydia	   483 
pecorum	   [88,	   89].	   The	   reasoning	   behind	   this	   is	   two-­‐fold.	   Firstly,	   the	   inclusion	   of	   a	   484 
more	   genetically	   distant	   out-­‐group	   would	   speciate	   the	   tree	   but	   not	   necessarily	   485 
change	   the	   phylogenetic	   order	   of	   C.	   pneumoniae	   strains	   in	   the	   tree,	   resulting	   in	   486 
human	  and	  animal	  C.	  pneumoniae	   clades	   forming	   separate	  polytomies.	   This	  would	   487 
show	  that	  whilst	  animal	  and	  human	  C.	  pneumoniae	  strains	  are	  directly	  and	  closely	   488 
related,	   the	   evolutionary	   topology	   between	   the	   different	   strains	   would	   remain	   489 
unresolved	  [90,	  91].	  Secondly,	  the	  inclusion	  of	  a	  more	  genetically	  distant	  out-­‐group	   490 
would	   skew	   estimations	   of	   substitution	   rate	   and	   recombination	   ratio.	   	   Our	   491 
phylogenomic	   analyses	   appear	   robust	   and	   agree	   with	   phylogenetic	   inferences	   of	   492 
diversity	  and	  evolution	  of	  C.	  pneumoniae	  from	  previous	  studies	  [2,	  5,	  29],	  therefore	   493 
the	   use	   of	   programs	   such	   as	   BEAST	   and	   ClonalFrame,	   which	   were	   designed	   to	   494 
estimate	   rates	   of	   mutation	   and	   recombination	   in	   much	   larger	   and	   often	   more	   495 
divergent	   datasets	   [92-­‐94]	   as	   well	   as	   highly	   conserved	   viral	   genome	   and	   bacterial	   496 
MLST	   datasets	   	   [78,	   79,	   95]	   are	   entirely	   practical	   for	   the	   analysis	   of	   such	   closely	   497 
related	  strains	  as	  C.	  pneumoniae.	  	  	  	   498 
	   499 
In	   chapter	   six,	   we	   sought	   to	   investigate	   the	   differences	   in	   gene	   expression	   in	   an	   500 
acute	   infection	  of	  BEAS-­‐2B	  cells	  with	  human	  cardiac	  C.	  pneumoniae	   strain	  A03	  and	   501 
the	  koala	  respiratory	  C.	  pneumoniae	   strain	  LPCoLN.	  Previous	  studies	  had	  described	   502 
significant	   differences	   in	   growth	   characteristics	   between	   human	   and	   animal	   C.	   503 
pneumoniae	   strains,	   particularly	   in	   the	   development	   of	   the	   chlamydial	   inclusion,	   504 
chromosome	  replication	  and	  morphological	  characteristics	  of	  the	  inclusion	  [6],	  with	   505 
the	  koala	  LPCoLN	  strain	  exhibiting	  more	  aggressive	  replication	  and	  large,	  amorphous	   506 
	  Chapter	  Seven:	  General	  Discussion	  and	  Future	  Directions	   270	  
fusogenic	  inclusions	  compared	  to	  AR39	  under	  the	  same	  growth	  conditions.	  A	  recent	   507 
study	  by	  Chacko	  et	  al.	  [8]	  expanded	  on	  these	  intital	  observations	  by	  investigating	  the	   508 
growth	  characteristics	  of	   four	  C.	  pneumoniae	   strains	   (LPCoLN,	  B21,	  AR39	  and	  A03)	   509 
when	   subjected	   to	   IFN-­‐γ	   induced	   tryptophan	   starvation	   (a	   possible	  mechanism	   of	   510 
immune-­‐mediated	  persistence)	  and	  subsequent	  rescue	  with	  exogenous	  tryptophan.	   511 
This	   study	   found	   that	   A03,	   a	   cardiac	   human	   strain,	   readily	   entered	   an	   aberrant	   512 
persistent	  state,	  at	  much	   lower	   IFN-­‐γ	   concentrations	  than	  required	  for	  either	  AR39	   513 
or	  the	  animal	  strains.	  Surprisingly,	  it	  was	  also	  the	  strain	  that	  most	  readily	  recovered	   514 
from	   the	   induction	   of	   persistence	   by	   addition	   of	   exogenous	   tryptophan.	   Both	   the	   515 
LPCoLN	   and	   B21	   animal	   strains	   did	   not	   appear	   to	   be	   readily	   affected	   by	   IFN-­‐γ	   516 
mediated	  induction	  of	  persistence	  and	  subsequent	  rescue	  had	  little	  effect.	  	   517 
Myers	   et	   al.	   [5]	   described	   significant	   genetic	   differences	   between	   the	   koala	   and	   518 
human	  strains	  of	  C.	  pneumoniae,	  whilst	  we	  reported	  only	  minimal	  difference	  in	  the	   519 
genomes	  between	  koala	  and	  bandicoot	  strains	  [34].	  Furthermore,	  we	  reported	  some	   520 
notable	   genetic	   differences	   between	   the	   human	   cardiac	   A03	   strain	   and	   the	   521 
respiratory	  AR39	   strain	   [28].	  With	   these	   characteristic	   genetic	   differences	   in	  mind,	   522 
we	  sought	  to	  determine	  the	  transcriptomic	  profiles	  of	  strains	  LPCoLN	  and	  A03,	  and	   523 
determine	  if	  there	  was	  any	  evidence	  for	  expression	  of	  genes	  that	  had	  been	  noted	  as	   524 
being	   genetically	   divergent	   between	   human/human	   and	   human/animal	   strains,	   or	   525 
evidence	  for	  divergent	  expression	  of	  genes	  involved	  in	  nutrient	  acquisition,	  virulence	   526 
or	  immune	  response.	  	   527 
	   528 
Previous	   transcriptome	   studies	   in	   Chlamydiae	   sought	   to	   overcome	   the	   marked	   529 
difference	   between	   the	   level	   of	   host	   transcript	   and	   chlamydial	   transcript	   by	   530 
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increasing	   the	   multiplicity	   of	   infection	   (MOI)	   to	   levels	   far	   in	   excess	   of	   a	   531 
physiologically	   relevant	   infection	   [96-­‐100],	   however	   there	   have	   also	   been	   studies	   532 
successfully	   accomplished	   at	  more	   physiologically	   relevant	  MOIs	   [101-­‐103].	   As	  we	   533 
sought	   to	   put	   our	   transcriptome	   study	   in	   the	   context	   of	   the	   work	   carried	   out	   in	   534 
Chacko	  et	  al.	   [8],	  we	  used	  an	  MOI	  of	  1	   for	  both	  animal	  and	  human	  C.	  pneumoniae	   535 
strains	   in	   this	   study.	   Previous	   studies	   determined	   the	   optimal	   sequencing	   and	   536 
mapping	  depth	   to	   detect	   the	  majority	   of	   prokaryotic	   transcripts	   at	   5	   to	   10	  million	   537 
non-­‐rRNA	  reads	  [101,	  104]	  and	  whilst	  we	  performed	  prokaryotic	  mRNA	  enrichment	   538 
steps	   resulting	   in	   an	   adequate	   final	   RNA	   yield,	   we	   were	   unable	   to	   achieve	   the	   539 
minimum	  required	  mapping	  depth	  for	  either	  A03	  or	  LPCoLN	  experiments.	  Mapping	   540 
of	   the	   transcriptomic	   data	   confirmed	   that	   the	  mRNA	   enrichment	   steps	   were	   only	   541 
partially	   successful	   and	   host	   transcript	   was	   predominant.	   In	   spite	   of	   this	   major	   542 
limitation,	   we	   successfully	   mapped	   transcript	   to	   over	   100	   genes	   in	   both	   A03	   and	   543 
LPCoLN	  experiments	  (Figure	  6).	   544 
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   545 
Figure	  6	  -­‐	  BLAST	  ring	  image	  diagrams	  denoting	  expressed	  genes	  and	  their	  location	  on	  the	  C.	  pneumoniae	  chromosome	  for	  strains	  LPCoLN	  (A)	  and	  A03	  (B).	  185	  genes	  had	   546 
transcript	  mapped	  in	  LPCoLN	  whilst	  A03	  had	  110	  genes	  mapped.	  Images	  were	  generated	  using	  BRIG	  0.95	  [105].	   547 
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One	   of	   the	  major	   limitations	   in	   comparing	   datasets	   between	   the	   two	   strains	   was	   the	  
substantial	  disparity	   in	   the	  depth	  of	  mapped	  data	  between	  A03	  and	  LPCoLN	  strains,	  as	  
well	   as	   the	   number	   of	   successful	   experimental	   replicates	   between	   the	   strains.	   A03	  
mapped	   significantly	   less	   reads	   than	   LPCoLN	   and	   detected	   approximately	   half	   the	  
number	  of	  expressed	  genes.	  Furthermore,	   the	  majority	  of	  genes	  were	  only	  detected	   in	  
one	  out	  of	  three	  experimental	  replicates.	   In	  contrast,	  the	  mapping	  depth	  was	  higher	   in	  
LPCoLN,	   with	   twice	   the	   number	   of	   expressed	   genes,	   and	   almost	   a	   quarter	   of	   these	  
detected	   in	   both	   experimental	   replicates.	   Given	   the	  mapping	   depth	   for	   both	   A03	   and	  
LPCoLN	  was	  considerably	  lower	  than	  expected	  in	  comparison	  to	  similar	  studies	  [96,	  101],	  
with	  signal	   inundated	  by	  host	  transcript,	  we	  designated	  the	  genes	  for	  which	  signal	  was	  
detected	  to	  be	  highly	   to	  very	  highly	  expressed.	   	  Direct	  comparison	  of	   the	  two	  datasets	  
was	   not	   possible	   due	   to	   the	   discrepancy	   in	   the	   number	   of	   experimental	   replicates	   for	  
each	   strain	   -­‐	   therefore,	   we	   used	   the	   data	   from	   this	   study	   to	   infer	   trends	   in	   gene	  
expression	  for	  the	  two	  strains.	  	  
	  
At	  the	  48	  hour	  time	  point,	  C.	  pneumoniae	  is	  considered	  to	  be	  in	  the	  mid-­‐replicative	  phase	  
of	   development,	   where	   asynchronous	   differentiation	   of	   the	   reticulate	   body	   to	  
elementary	  body	  has	  been	  shown	  to	  occur	  [106].	  This	  process	  is	  unlikely	  to	  be	  occurring	  
at	  the	  same	  rate	  in	  our	  experiments,	  as	  a	  comparison	  of	  chlamydial	  development	  in	  the	  
koala	   LPCoLN	   strain	   and	   human	   respiratory	   strain	   AR39	   suggested	   that	   the	   LPCoLN	  
produced	  three	  times	  the	  number	  of	  infectious	  moieties	  and	  completed	  its	  development	  
cycle	  at	  a	  faster	  rate	  than	  AR39	  [6].	  As	  such,	  we	  expected	  to	  see	  the	  expression	  of	  genes	  
involved	  in	  the	  transition	  from	  reticulate	  body	  (RB)	  to	  elementary	  body	  (EB)	  forms	  [107,	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108],	   however	   only	   a	   few	   of	   these	   genes	   were	   detected	   in	   the	   LPCoLN	   and	   A03	  
experiments.	  We	   found	   that	  genes	   involved	   in	   transcriptional	   regulation,	   chromosomal	  
replication,	   synthesis	   of	   membrane	   precursors,	   metabolism	   and	   maintenance	   of	   the	  
chlamydial	   inclusion	  were	   expressed	   in	   both	   LPCoLN	   and	  A03.	   A	   large	   number	   of	   IncA	  
family	  genes	  were	  expressed	  in	  both	  LPCoLN	  and	  A03,	  and	  four	  of	  these	  were	  commonly	  
expressed	  between	  the	  two	  strains.	  The	   IncA	  gene	  family	   is	  considerably	  expanded	  and	  
genetically	  abundant	  in	  C.	  pneumoniae	  compared	  to	  other	  Chlamydiae	  [82,	  83],	  even	  so,	  
the	  expression	  of	  a	  large	  number	  of	  these	  genes	  was	  unexpected.	  Previous	  transcriptome	  
studies	  in	  C.	  pneumoniae	  detected	  far	  fewer	  expressed	  IncA	  genes	  [98]	  or	  characterised	  
their	  expression	  at	  different	  time	  points	  [96].	  IncA	  is	  a	  type	  III	  secretion	  effector,	  involved	  
in	  maintenance	  and	  homotypic	  fusion	  of	  the	  chlamydial	  inclusion	  [109-­‐111].	  	  It	  is	  possible	  
that	   the	   large	   number	   of	   IncA	   genes	   expressed	   in	   the	   LPCoLN	   strain	   contributes	   to	   its	  
amorphous,	  fusogenic	  phenotype	  compared	  to	  human	  C.	  pneumoniae	  strains	  [6].	  	  
	  
The	   pmp	   gene	   family	   is	   also	   significantly	   expanded	   in	   C.	   pneumoniae	   compared	   to	   C.	  
trachomatis	  [38],	  however	  we	  found	  that	  the	  pmp	  gene	  family	  was	  little	  represented	  in	  
these	  experiments,	  with	  only	  one	  pmp	  gene	  detected	  in	  A03,	  and	  two	  in	  LPCoLN,	  one	  of	  
which	   is	   a	   pseudogene.	   It	   is	   interesting	   that	   two	   pseudogenes	   were	   expressed	   in	   the	  
LPCoLN	  strain	  -­‐	  pmpE/F4	  and	  an	   IncA	   -­‐	  both	  of	  which	  are	  considered	  putative	  virulence	  
targets.	  The	  expression	  of	  pmp	  and	  Inc	  pseudogenes	  in	  Chlamydiae	  has	  previously	  been	  
described	   as	   a	   possible	   host	   immune	  evasion	  mechanism	   through	   antigenic	   shift	   [112-­‐
114].	   The	   expression	   of	   these	   genes	   in	   LPCoLN	   is	   the	   first	   description	   of	   virulence	  
pseudogene	   expression	   in	   C.	   pneumoniae,	   though	   whether	   this	   phenomenon	   differs	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between	  human	  and	  animal	  strains	  cannot	  be	  determined	  from	  our	  data.	  	  Interestingly,	  a	  
pseudogene	  encoding	  for	  a	  truncated	  homolog	  of	  ispE	  is	  expressed	  to	  the	  stop	  codon	  in	  
the	   A03	   experiment.	   ispE	   has	   been	   shown	   to	   be	   involved	   in	   the	   condensation	   of	  
chromatin	   during	   the	   transition	   of	   RB	   to	   EB	   forms	   in	  C.	   trachomatis	   [115,	   116],	   so	   its	  
expression	   in	   both	   LPCoLN	   and	   A03	   strains	   at	   this	   time	   point	   was	   expected.	   SMART	  
domain	   architecture	   analyses	   of	   the	   full	   length	   and	   truncated	   homologs	   of	   this	   gene	  
indicate	  that	  no	  predicted	  domains	  or	  secondary	  protein	  structure	  is	  coded	  past	  the	  stop	  
codon,	  suggesting	  that	  whilst	  this	  gene	  is	  expressed	  in	  both	  LPCoLN	  and	  A03	  strains,	  the	  
C-­‐terminus	   of	   this	   gene	   may	   not	   be	   functionally	   required	   in	   human	   C.	   pneumoniae	  
strains.	  	  	  
	  	  	  
A	  large	  number	  of	  genes	  were	  expressed	  encompassing	  the	  region	  including	  and	  directly	  
flanking	   the	  plasticity	   zone.	  This	  was	  particularly	  pronounced	   in	  A03	  where	  14%	  of	   the	  
genes	  detected	  were	  encoded	  in	  this	  region,	  as	  well	  as	  three	  genes	  being	  expressed	  in	  all	  
three	  replicates	  from	  this	  region.	  There	  are	  notable	  genetic	  differences	   in	  the	  plasticity	  
zones	   between	   the	   two	   strains,	   in	   particular	   with	   the	   presence	   of	   the	   guaB/A-­‐add	  
operon,	   which	   all	   three	   genes	   are	   expressed	   in	   A03,	   and	   the	   MACPF	   gene	   which	   is	  
expressed	  in	  LPCoLN.	  In	  C.	  trachomatis	  the	  full	  length	  MACPF	  protein	  is	  expressed	  during	  
the	   mid-­‐phase	   of	   the	   development	   cycle,	   co-­‐localising	   with	   reticulate	   bodies	   and	  
facilitating	   lipid	   droplets	   into	   the	   chlamydial	   inclusion	   [117].	   An	   interesting	   biological	  
feature	   of	   the	   A03	   strain	   is	   its	   exquisite	   sensitivity	   to	   IFN-­‐γ	   as	   a	   means	   to	   induce	  
persistence	   [8]	   and	   the	   expression	   of	   guaA	   in	   A03	  may	   be	   intricately	   linked	  with	   this	  
sensitivity	   -­‐	   guaA	   is	   involved	   in	   the	   production	   of	   cyclic	   GMP-­‐AMP	   in	   C.	   trachomatis,	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functioning	  as	  a	  DNA	  sensory	  molecule	  and	   inducing	  type-­‐I	   interferons	  during	   infection	  
[118-­‐120].	   	   The	   high	   number	   of	   genes	   expressed	   in	   the	   plasticity	   zone	   of	   both	   strains	  
could	  also	  account	  for	  the	  divergence	  in	  nucleotide	  sequence	  and	  gene	  content	  between	  
the	   strains.	  Recombination	  at	   the	  plasticity	   zone	  has	  been	   identified	   in	  C.	  pneumoniae	  
and	   other	   chlamydial	   species	   [4,	   28,	   62]	   and	   the	   relatively	   heightened	   levels	   of	   gene	  
expression	   observed	   at	   the	   plasticity	   zone	   in	   both	   experiments,	   along	   with	   the	  
expression	  of	  recombinase	  genes	  (recJ,	  recR)	  [64,	  121-­‐123],	  could	  be	  a	  driver	  of	  diversity	  
at	  this	  locus.	  	  
	  
Genes	  involved	  in	  transcription	  and	  replication	  of	  the	  C.	  pneumoniae	  chromosome	  made	  
up	   the	   majority	   of	   transcribed	   genes	   in	   both	   experiments.	   We	   referenced	   translated	  
sequences	   for	   expressed	   genes	   against	   the	   STRING10	   database	   [124]	   and	   KEGG	  
PATHWAY	   [125]	   in	   order	   to	   determine	   gene	   co-­‐expression/co-­‐occurrence	   and	   to	  
investigate	   which	   genes	   were	   expressed	   on	   different	   biological	   pathways.	   Whilst	   we	  
could	  not	   construct	  any	   complete	  pathways	   from	  genes	  expressed	   in	  either	   LPCoLN	  or	  
A03	  experiments,	  we	  did	  find	  that	  six	  genes	  were	  commonly	  co-­‐expressed	  in	  STRING10	  
analyses.	  These	  genes	  were	  topA,	  SNF2	  helicase,	  rpoB,	  atpB,	  gutQ	  sugar	   isomerase	  and	  
pheT	  -­‐	  four	  of	  which	  (topA,	  SNF2	  helicase,	  rpoB	  and	  pheT)	  are	  are	  directly	  involved	  with	  
transcription	  and	  replication	  of	  the	  bacterial	  chromosome,	  however	  only	  one	  of	  these	  six	  
genes,	  rpoB,	  was	  detected	  in	  A03.	  	  
	  
In	   undertaking	   this	   study,	  we	   sought	   to	   determine	  whether	   transcriptional	   differences	  
were	   apparent	   in	   a	   comparison	   of	   two	   C.	   pneumoniae	   strains,	   A03,	   a	   human	   cardiac	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strain	   isolated	   from	   a	   patient	   with	   atherosclerosis	   [56],	   and	   LPCoLN,	   an	   animal	   strain	  
isolated	   from	   a	   koala	   with	   respiratory	   disease	   [5].	   Whilst	   both	   the	   LPCoLN	   and	   A03	  
RNAseq	   experiments	   were	   not	   entirely	   successful,	   we	   were	   able	   to	   detect	   and	  
characterise	  a	  number	  of	  genes	  in	  both	  C.	  pneumoniae	  strains	  that	  we	  considered	  to	  be	  
highly	  expressed	  at	  the	  mid-­‐replicative	  phase	  of	  the	  C.	  pneumoniae	  development	  cycle.	  
Additionally,	   this	   is	   the	   first	   study	   investigating	   the	   transcriptome	   of	   an	   animal	   C.	  
pneumoniae	   strain.	   Given	   the	   disparity	   in	   the	   number	   of	   experimental	   replicates,	  
mapping	  depth	  and	  number	  of	  genes	  detected	  in	  both	  experiments,	  we	  were	  unable	  to	  
determine	   if	   the	   expression	   of	   any	   particular	   genes	   or	   pathways	   would	   explain	   the	  
characteristic	  development	  and	  morphological	  differences	  between	  the	  two	  strains.	  	  
	  	  
CONCLUSIONS	  
In	   summary,	   we	   sequenced	   a	   number	   of	   human	   and	   animal	   C.	   pneumoniae	   strains	  
isolated	  from	  pathologically	  and	  geographically	  distinct	  sites	  and	  characterised	  a	  number	  
of	  distinct	  molecular	  markers	  which	  appear	  to	  be	  specific	  to	  different	  strains.	  Whilst	  the	  
overall	   nucleotide	   content	   and	   gene	   order	   of	   both	   human	   and	   animal	   C.	   pneumoniae	  
strains	  is	  highly	  conserved,	  a	  number	  of	  minor	  polymorphisms	  were	  identified	  that	  may	  
account	   for	   the	   presence	   and	   biological	   fitness	   of	   particular	   C.	   pneumoniae	   strains	   in	  
different	   disease	   niches.	   These	   polymorphic	   genes	   were	   predominantly	   involved	   in	  
development	   and	   formation	   of	   the	   chlamydial	   inclusion	   (IncA),	   membrane	  
autotransporters	   (pmpG	   and	   pmpE/F4),	   purine	   biosynthesis	   (guaB)	   and	   an	   integrated	  
phage	   fragment	   in	   strain	   TOR-­‐1.	   We	   were	   able	   to	   categorise	   human	   C.	   pneumoniae	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strains	  into	  four	  defined	  clades,	  with	  each	  of	  these	  clades	  exhibiting	  conserved	  sequence	  
polymorphisms	   supporting	   their	   differential	   phylogenetic	   groupings.	   The	   first	   of	   these	  
clades	   was	   populated	   by	   the	   genetically	   distinct	   Australian	   indigenous	   strains	   which	  
formed	   a	   separate	   branch	   to	   the	   main	   non-­‐indigenous	   human	   clade.	   The	   three	   non-­‐
indigenous	   clades	   consisted	   of	   the	   TW183	   clade	   containing	   three	   atypical	   strains	  
including	   the	   A03	   atherosclerosis	   strain,	   with	   no	   definitive	   pathology,	   the	   AR39	   clade	  
which	   consists	   of	   respiratory	   strains	   and	   the	   single	   TOR-­‐1	   Alzheimer's	   strain,	   and	   the	  
CWL029	  clade	  populated	  by	  respiratory	  and	  cardiovascular	  strains.	  Using	  phylogenomic	  
analysis	   methods,	   we	   demonstrated	   that	   the	   Australian	   indigenous	   clade	   had	   a	   most	  
recent	  common	  ancestor	  that	  predated	  the	  exploration	  and	  settlement	  of	  the	  continent	  
by	  several	  hundred	  years,	  and	  a	  distinct	  recombination	  profile	  with	  only	  a	  few	  instances	  
of	  recombination	  shared	  with	  other	  human	  C.	  pneumoniae	  strains.	  
We	   sequenced	   an	   animal	  C.	   pneumoniae	   strain	   isolated	   from	   the	   endangered	  western	  
barred	   bandicoot	   (B21)	   and	   compared	   it	   to	   the	   koala	   LPCoLN	   and	  African	   clawed	   frog	  
DC9	  strains.	  22	  SNPs	  differentiated	  the	  B21	  and	  LPCoLN	  strains	  with	  a	  single	  SNP	  on	  the	  
plasmid.	  The	  high	  level	  of	  sequence	  identity	  along	  with	  PCR	  sequencing	  findings	  from	  a	  
number	  of	  other	  Australian	  animals	  from	  Mitchell	  et	  al.	  [19]	  suggests	  the	  existence	  of	  an	  
Australia	   animal	   biovar.	   In	   comparing	   the	   DC9	   strain	   to	   LPCoLN	   and	   B21,	   we	  
demonstrated	   that	   this	   strain	   exhibited	   greater	   nucleotide	   diversity	   with	   several	   loci	  
almost	   identical	   in	   sequence	   to	   human	   C.	   pneumoniae	   strains,	   as	   well	   as	   evidence	   of	  
shared	  recombination	  between	  DC9	  and	  human	  C.	  pneumoniae.	  These	  findings	  indicate	  
that	  an	  amphibian	  strain	  similar	  in	  sequence	  to	  DC9,	  or	  a	  similar	  intermediate	  strain,	  was	  
likely	  the	  progenitor	  strain	  to	  human	  C.	  pneumoniae.	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In	   order	   to	   determine	   whether	   sequence	   polymorphisms	   correlated	   to	   transcriptional	  
differences	   in	   human	   and	   animal	  C.	   pneumoniae	   acute	   infections,	  we	   used	   RNAseq	   to	  
compare	   the	   transcriptomes	  of	   the	   LPCoLN	  and	  A03	   strains	  at	   the	  48-­‐hour	   time	  point.	  
Additionally,	  this	  was	  the	  first	  attempt	  to	  characterise	  the	  transcriptome	  of	  an	  animal	  C.	  
pneumoniae	   strain.	  Whilst	   our	   study	  was	   not	   entirely	   successful	   in	   that	   the	  minimum	  
required	  mapping	   depth	  was	   not	   achieved	   for	   either	   experiment	   [101,	   104],	   we	  were	  
able	  map	  transcripts	  to	  over	  100	  genes	  in	  both	  experiments,	  corresponding	  to	  the	  most	  
highly	   expressed	   genes	   for	   each	   strain	   at	   this	   time	   point.	   Genes	   involved	   in	  
replication/transcription,	   lipid	   and	   nutrient	   metabolism,	   membrane	   synthesis	   and	   a	  
number	   of	   hypothetical	   protein	   genes	   were	   detected.	   The	   plasticity	   zone	   was	  
considerably	  transcriptionally	  active	  in	  both	  strains,	  as	  were	  genes	  belonging	  to	  the	  IncA	  
family	  of	  inclusion	  proteins.	  	  We	  detected	  the	  expression	  of	  pseudogenes	  in	  both	  strains,	  
with	  particular	  note	  that	  the	   ispE	  pseudogene	  was	  expressed	  to	  the	  stop	  codon	  in	  A03.	  
Whilst	   we	   were	   unable	   to	   definitively	   identify	   any	   genes	   in	   either	   LPCoLN	   or	   A03	  
experiments	  that	  would	  account	  for	  their	  divergent	  developmental	  phenotypes,	  we	  were	  
able	  to	  identify	  a	  number	  of	  commonly	  expressed	  genes,	  as	  well	  as	  several	  differences	  in	  
gene	  expression,	  between	  the	  two	  strains	  that	  provide	  targets	  for	  further	  investigation	  in	  
deep	  sequencing	  C.	  pneumoniae	  transcriptome	  studies.	  	  
	  
FUTURE	  DIRECTIONS	  	  
Despite	   its	   association	   with	   numerous	   non-­‐respiratory	   human	   pathologies,	   C.	  
pneumoniae	   is	   not	   routinely	   tested	   for	   in	   clinical	   or	   post-­‐mortem	   settings.	   Atypical	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strains	   such	   as	   TW183	   (isolated	   from	  an	  ocular	   swab	  during	   trachoma	   screening),	   A03	  
(isolated	   from	   a	   patient	   undergoing	   carotid	   endarterectomy	   for	   atherosclerosis)	   and	  
UZG1	   (a	  clinical	   respiratory	   strain)	  do	  not	  appear	   to	  be	  as	  prevalent	  as	   those	   from	  the	  
CWL029	   and	   AR39	   strain	   groups	   -­‐	   this	   may	   be	   due	   to	   them	   being	   uncommon	   in	   the	  
human	  population,	  or	  present	  in	  atypical	  samples	  which	  are	  not	  routinely	  tested	  for	  the	  
presence	  of	  C.	  pneumoniae.	   	  Very	  few	  post-­‐mortem	  brain	  samples	  have	  been	  screened	  
for	   C.	   pneumoniae.	   Further	   characterisation	   of	   strains	   from	   Alzheimer's	   and	   other	  
neurological	  diseases	  may	  uncover	  novel	  C.	  pneumoniae	  strains,	  or	  strains	  very	  similar	  to	  
TOR-­‐1.	   Further	   characterisation	   of	  C.	   pneumoniae	   strains	   from	   atypical	   samples	  would	  
allow	   researchers	   to	   identify	   further	  molecular	  markers	   to	  discriminate	  C.	  pneumoniae	  
pathotypes	   in	   human	   disease	   and	   determine	   their	   developmental	   characteristics	   in	  
physiologically	  relevant	  in	  vitro	  studies.	  	  
	  
The	  majority	  of	  human	  C.	  pneumoniae	   strains	  are	   isolated	   from	  patients	   in	  developed,	  
westernised	   countries	   and	   populous	   urbanised	   centres.	   Our	   description	   of	   an	  
evolutionarily	   distinct	   lineage	   of	   C.	   pneumoniae	   isolated	   from	   Australian	   indigenous	  
individuals	   from	   remote	   communities	   indicates	   that	   a	  wider	   range	   of	   strains	   are	   likely	  
circulating	  in	  the	  greater	  human	  population	  than	  previous	  comparative	  studies	  suggest.	  
Whether	   a	   biogeographical	   determinant	   is	   involved	   in	   the	   evolution	   of	   human	   C.	  
pneumoniae	  strains	  is	  currently	  unclear,	  however	  wider	  screening	  of	  individuals	  from	  less	  
populous	   and	   remote	   geographical	   areas	  may	  uncover	   strains	   similar	   to	   the	  Australian	  
indigenous	  strains	  or	  completely	  novel	  strains	  which	  have	  evolved	  in	  isolation	  just	  as	  the	  
Australian	  indigenous	  strains	  have.	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  The	  phylogenomic	  position	  and	  evolution	  of	  animal	  C.	  pneumoniae	  strains	  with	  respect	  
to	  host	   specificity	   is	   still	  unclear.	  Comparative	  analyses	  of	   the	   three	  currently	  available	  
animal	   C.	   pneumoniae	   whole	   genomes,	   as	   well	   as	   the	   molecular	   targets	   described	   in	  
Mitchell	  et	  al.	  [19]	  suggest	  that	  the	  genetic	  diversity	  of	  animal	  C.	  pneumoniae	  is	  greater	  
than	  previously	  identified	  and	  is	  likely	  to	  be	  just	  as	  diverse	  as	  the	  human	  C.	  pneumoniae	  
strains.	  The	  possibility	  of	  an	  Australian	  marsupial	  biovar	  may	  also	  become	  apparent.	  To	  
date,	  comparative	  studies	  using	  strains	  N16	  (horse	  -­‐	  [20]),	  GBF	  (giant	  barred	  frog	  -­‐	  [23]),	  
iguana,	   turtle	   and	   Burmese	   python	   [22]	   are	   being	   undertaken	   and	   are	   expected	   to	  
further	  discriminate	  the	  phylogenetic	  positions	  of	  these	  animal	  strains	  in	  C.	  pneumoniae.	  	  
	  
We	   have	   identified	   four	   strains	   (AR39,	   TOR-­‐1,	   A03	   and	   UZG1),	   which	   differ	   in	   gene	  
content	   at	   two	   specific	   loci	   (IncA	   and	   tyrP),	   isolated	   from	   three	   different	   disease	  
pathologies	   (respiratory,	   Alzheimer's	   and	   cardiovascular).	   The	   developmental	  
characteristics	   of	   strains	   AR39	   and	   A03	   during	   acute	   infection,	   IFN-­‐γ	   treatment	   and	  
response	   to	   exogenous	   tryptophan	   have	   been	   compared	   and	   described	   [8].	   The	  
developmental	   characteristics	   of	   strains	   TOR-­‐1	   (which	   differs	   from	   AR39	   in	   that	   it	  
encodes	  for	  three	  tyrP	  copies	  instead	  of	  two)	  and	  UZG1	  (which	  differs	  from	  A03	  in	  that	  it	  
encodes	  for	  two	  tyrP	  copies	  instead	  of	  a	  single	  copy)	  have	  not	  yet	  been	  investigated.	  A	  
comparative	  developmental	  study	  examining	  all	  four	  strains	  under	  identical	  growth	  and	  
treatment	  conditions	  would	  further	  illuminate	  the	  role	  of	  tyrP	  in	  tryptophan	  uptake	  and	  
its	   relevance	   in	   the	   C.	   pneumoniae	   response	   to	   IFN-­‐γ.	   Furthermore,	   should	   the	  
respiratory	   strains	   AR39	   and	   UZG1,	   which	   differ	   by	   the	   absence	   of	   an	   IncA	   homolog,	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display	   divergent	   developmental	   characteristics	   then	   this	   particular	   IncA	   homolog	  may	  
play	  a	  role	  in	  the	  development	  and	  tropism	  of	  different	  C.	  pneumoniae	  strains.	  	  
	  
Further	  optimisation	  of	  the	  growth,	  harvest	  and	  enrichment	  methods	  for	  C.	  pneumoniae	  
must	   be	   undertaken	   to	   in	   order	   to	   obtain	   a	   reliable	   experiment	   with	   enough	   depth	  
(minimum	   2	   million	   reads)	   to	   construct	   a	   whole	   RNAseq	   transcriptome.	   This	   will	  
obviously	   vary	   between	   animal	   and	   human	   strains.	   Once	   a	   reliable	   transcriptome	   has	  
been	  obtained,	  discrimination	  of	  human	  and	  animal	  gene	  expression	  of	  low	  to	  very	  high	  
expressed	   genes	   and	   pathways	   can	   be	   elucidated,	   which	   should	   identify	   a	   number	   of	  
molecular	   targets	   which	   may	   be	   responsible	   for	   the	   difference	   in	   growth	   and	  
morphological	  characteristics	  between	  animal	  and	  human	  C.	  pneumoniae	  strains.	  Further	  
studies	  can	  then	  be	  undertaken	  using	  the	  same	  conditions	  described	  in	  Chacko	  et	  al.	  [7,	  
8]	  to	  determine	  variations	  in	  gene	  expression	  during	  immune-­‐modulated	  persistence	  and	  
rescue	  at	  different	   time	  points.	  This	  will	  hopefully	  give	  a	  more	  complete	  picture	  of	   the	  
transcriptional	   landscape	   of	   human	   and	   animal	   C.	   pneumoniae,	   and	   should	   also	  
illuminate	  which	  genes	  account	  for	  the	  dramatic	  difference	  in	  IFN-­‐γ	  induced	  persistence	  
and	  tryptophan	  rescue	  between	  the	  LPCoLN,	  AR39	  and	  A03	  strains.	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Draft Genome and Plasmid Sequences of Chlamydia pneumoniae
Strain B21 from an Australian Endangered Marsupial, the Western
Barred Bandicoot
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Chlamydia pneumoniae is a ubiquitous intracellular pathogen, first associated with human respiratory disease and subsequently
detected in a range of mammals, amphibians, and reptiles. Here we report the draft genome sequence for strain B21 of C. pneu-
moniae, isolated from the endangered Australian marsupial the western barred bandicoot.
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Chlamydia pneumoniae is an obligate intracellular bacteriumassociated with community-acquired pneumonia and de-
tected in cold- and warm-blooded hosts such as amphibians, rep-
tiles, marsupials, and humans (1–3). Although minor genetic dif-
ferences suggest that human strains are a result of several zoonotic
events in this pathogen’s history, both human and koala strains of
C. pneumoniae are highly conserved in their gene content and
organization (4). Interestingly, a previous study examining se-
lectedmolecular targets inmarsupialC. pneumoniae isolates dem-
onstrated identical sequences for all isolates tested (5).With this in
mind, we sequenced the chromosome and plasmid of B21, an
isolate from the western barred bandicoot (Perameles bougain-
ville), an endangered Western Australian marsupial.
The C. pneumoniae B21 chromosome and plasmid were se-
quenced in duplicate using the Ion Torrent platform P1 chip with
200-bp chemistry, resulting in over 120 million reads. Read qual-
ity analyses were performedusing FASTQCversion 0.10.1 (Babra-
ham Bioinformatics group [http://www.bioinformatics.bbsrc.ac
.uk/projects/fastqc]), with average Phred scores of 24. CLC
Genomics Workbench (version 6.0.2; CLC bio, Denmark) was
used to trim sequences as well as perform de novo assembly and
readmapping, with read coverages exceeding 5,000. The de novo
assembly consists of 164 chromosomal contig sequences and a
single contig for the plasmid. The predicted length of the C. pneu-
moniae B21 chromosome is 1,241,009 bp, with GC content of
40.5%. The B21 plasmid is 7,529 nucleotides (nt) in length, with a
GC content of 33.0%. Automatic annotationwas performed using
RAST (6) and manually curated using Artemis (7).
The draft B21 chromosome and plasmid were pairwise aligned
to all available C. pneumoniae genome and plasmid sequences (4,
8–11) by use ofMultiple Alignment using Fast Fourier Transform
(MAFFT) (12). The B21 chromosome contains 1,308 predicted
coding sequences (CDS) with 37 tRNAs and a single rRNA
operon, while the B21 plasmid has eight predicted CDS. Nucleo-
tide variants were predicted by mapping the reads of C. pneu-
moniae B21 to the complete genome ofC. pneumoniae LPCoLN, a
koala strain. Twenty-six variants were predicted, of which 15 are
within homopolymeric tracts of various lengths. Four variants are
predicted within intergenic regions. PCR and sequencing analysis
of four variants has demonstrated identical sequences to those of
LPCoLN. The B21 chromosome is 99.99% identical to that of
LPCoLN and 96.9% identical to human strains. Two open reading
frames (ORFs) are predicted for the pmp18 (pmpE/F) B21 ho-
molog, which are full length in human strains and a pseudogene in
LPCoLN. The B21 plasmid has 99.99% nucleotide identity to the
LPCoLN plasmid and 96.3% identity to the horse C. pneumoniae
N16 plasmid isolate (13). A single nucleotide deletion is noted at
the 3= end of locus X556p_1186 in the B21 plasmid within a ho-
mopolymeric tract, resulting in the truncation of X556p_1186 in
B21 by 8 amino acids. X556p_1186 is predicted to encode
pGP3-D, a putative virulence factor associated with growth of
Chlamydia in mammalian cells (14).
Nucleotide sequence accessionnumbers.Thiswhole-genome
shotgun project has been deposited at DDBJ/EMBL/GenBank un-
der the accession number AZNB00000000. The version described
in this paper is version AZNB01000000.
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Phylogenetic analysis of human Chlamydia
pneumoniae strains reveals a distinct
Australian indigenous clade that predates
European exploration of the continent
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Abstract
Background: The obligate intracellular bacterium Chlamydia pneumoniae is a common respiratory pathogen, which
has been found in a range of hosts including humans, marsupials and amphibians. Whole genome comparisons of
human C. pneumoniae have previously highlighted a highly conserved nucleotide sequence, with minor but key
polymorphisms and additional coding capacity when human and animal strains are compared.
Results: In this study, we sequenced three Australian human C. pneumoniae strains, two of which were isolated from
patients in remote indigenous communities, and compared them to all available C. pneumoniae genomes. Our study
demonstrated a phylogenetically distinct human C. pneumoniae clade containing the two indigenous Australian strains,
with estimates that the most recent common ancestor of these strains predates the arrival of European settlers to
Australia. We describe several polymorphisms characteristic to these strains, some of which are similar in sequence to
animal C. pneumoniae strains, as well as evidence to suggest that several recombination events have shaped these
distinct strains.
Conclusions: Our study reveals a greater sequence diversity amongst both human and animal C. pneumoniae strains,
and suggests that a wider range of strains may be circulating in the human population than current sampling indicates.
Keywords: Chlamydia pneumoniae, Whole genome sequencing, Phylogenomics, Polymorphisms, Inclusion proteins,
Polymorphic membrane protein, Inosine-monophosphate dehydrogenase, Recombination, Infection
Background
Chlamydia pneumoniae is an obligate intracellular
bacterium and member of the Chlamydiaceae, a family
of pathogens of higher eukaryotes with a distinct
biphasic development cycle [1]. Whilst C. pneumoniae
is primarily recognised as an aetiological agent of
community acquired pneumonia and other respiratory
diseases in humans [2], it has a broad host range
encompassing both warm [3–5] and cold blooded
animals [6, 7]. Members of the Chlamydiaceae are
characterised by their compact genomes and highly
conserved gene content [8]. C. pneumoniae has the great-
est coding capacity of the Chlamydiaceae, with animal
strains of C. pneumoniae having between 20Kbp (animal
versus human C. pneumoniae) to almost 200Kbp (animal
C. pneumoniae versus C. trachomatis serovar D) [9, 10] of
extra nucleotide sequence. The additional coding capacity
of C. pneumoniae is predominantly accounted for by the
expansion of the polymorphic membrane protein (pmp)
and inclusion membrane protein (inc) gene families
[10–12], both of which are involved in the formation
and maintenance of the chlamydial inclusion body,
modulation of the host cell response [12, 13], as well as
a large number of species-specific metabolic and hypo-
thetical protein genes [9, 10, 14].
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In addition to its description as a cause of human
respiratory disease, C. pneumoniae has been implicated in
a variety of human pathologies, including cardiovascular
disease, Alzheimer’s disease, ischaemic stroke, asthma and
lung cancer [15–18]. Until recently, the majority of fully se-
quenced C. pneumoniae whole genomes were from strains
that were isolated from respiratory pathologies [10, 19, 20],
and demonstrated highly conserved nucleotide sequence
content and gene order. Recently, several genomes from
respiratory and cardiovascular strains were reported, as
were whole genome sequences from atherosclerotic and
Alzheimer’s C. pneumoniae strains, which allowed for
comparison of strains isolated from different diseases, and
demonstrated that only minor genetic differences were
found between these strains [9, 21, 22].
A previous study examining the genetic diversity be-
tween human and animal C. pneumoniae suggested that a
genetically distinct strain of human C. pneumoniae was
present and circulating within Australian indigenous com-
munities [23]. PCR analysis of a small number of selected
target genes was performed on two respiratory strains
isolated from Indigenous Australian patients in geograph-
ically separate regions [24, 25] and these were shown to
have nucleotide sequence, that in some instances, placed
these strains phylogenetically closer to animal strains of C.
pneumoniae than those circulating in human populations
in Australia and worldwide [23].
To further explore the genetic diversity of Australian
human C. pneumoniae strains, we genome sequenced and
performed comparative genomic and phylogenetic ana-
lyses of two human Australian indigenous C. pneumoniae
strains and a third strain from an Australian Caucasian pa-
tient. In doing so, we (i) demonstrate that the indigenous
Australian human strains form a separate clade branching
earlier than other human C. pneumoniae strains; (ii) iden-
tify genetic markers unique to Australian indigenous and
non-indigenous strains; and (iii) reveal evidence of limited
recombination within C. pneumoniae strains from the
greater human C. pneumoniae clade.
Results
Phylogenetic relationships in human C. pneumoniae
reveal a distinct Australian indigenous clade predating
European exploration of the continent
C. pneumoniae strains SH511, 1979 [24, 25] and
WA97001 [26] were sequenced following capture of C.
pneumoniae DNA using a set of species-specific SureSe-
lectXT RNA probes [27–29]. Sequencing reads of C. pneu-
moniae WA97001, SH511 and 1797 were mapped to the
reference genome, C. pneumoniae AR39, to check the effi-
cacy of the SureSelectXT DNA captures. The genome of
SH511 had the highest mean read depth of 1944×, followed
by 1979, which had an average read depth of 1887×. The
SH511 and 1979 assembled into 10 contigs and 31 contigs,
respectively. In contrast, C. pneumoniae WA97001 genome
had a significantly lower read depth of 15× and assembled
into 104 contigs.
In order to determine the evolutionary and phylogenetic
relationships between the Australian C. pneumoniae strains
and those previously published, Bayesian and coalescent
estimation methods were used to construct phylogenetic
trees based on whole genome alignments of all human C.
pneumoniae strains and the three published animal C.
pneumoniae strains.
Percentage pairwise identities between indigenous and
non-indigenous strains ranged from 98.4 to 98.8 %,
whilst non-indigenous strains were 99.0 % or greater.
Percentage identities of all strains used in the MrBayes
analysis are outlined in Table 1. The resulting phylogen-
etic tree as represented in Fig. 1, demonstrates a clear
demarcation of animal and human clades. The majority
of non-indigenous human strains cluster into two clades:
a large single clade that contains the AR39 and CWL029
subclades, and the smaller TW183 clade [22]. Interest-
ingly, the two Australian indigenous C. pneumoniae
strains, SH511 and 1979, formed their own clade which
branched deepest from the main human C. pneumoniae
grouping, but was also considerably distant to the animal
C. pneumoniae clade. The Australian caucasian strain
WA97001 and IOL207 (a strain isolated from a case of
acute conjunctivitis) [30] formed their own separate
branches in the main human C. pneumoniae clade.
To investigate the evolutionary relationships of these
deep-branching Australian indigenous human strains fur-
ther, we determined the date of the most recent common
ancestor (MRCA) of the indigenous Australian C. pneu-
moniae strains by using BEAST [31] and ClonalFrame
[32] coalescent estimation methods. BEAST analysis of
indigenous and non-indigenous C. pneumoniae strains
reveals an MRCA for indigenous strains at 1028, with a
95 % credibility interval between 996 and 1062 years. The
mean substitution rate was determined to be 4.64 × 10−4
substitutions per site, per year. ClonalFrame analysis of
indigenous and non-indigenous C. pneumoniae strains
reveals a MRCA of 1425 for the indigenous strains, with a
mean substitution rate of 2.36 × 10−5 per site per year.
Though there are minor differences in the predicted
MRCA and substitution rates between the two programs,
which can be accounted for by the difference in their
calculation methods [33], their estimates support similar
evolutionary timelines and dates.
Identification of genetic markers that distinguish
Australian indigenous strains from non-indigenous and
animal C. pneumoniae strains
Using a PCR-based sequencing approach, we previously
identified a series of potential genetic markers that could
be used to distinguish Caucasian C. pneumoniae strains
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Table 1 Percentage nucleotide pairwise identities of all C. pneumoniae strains
CM1 GiD TOR-1 AR39 YK41 J138 CV14 PB2 PB1 CWL011 Wien3 CWL029 U1271 CV15 Wien1
CM1 100 100 100 99.9 99.7 99.7 99.7 99.7 99.8 99.8 99.6 99.8 99.7 99.7
GiD 100 100 100 99.9 99.7 99.7 99.7 99.7 99.8 99.8 99.6 99.8 99.7 99.7
TOR-1 100 100 100 99.9 99.7 99.7 99.7 99.7 99.8 99.8 99.6 99.8 99.7 99.7
AR39 100 100 100 99.9 99.7 99.7 99.7 99.7 99.8 99.8 99.6 99.8 99.7 99.7
YK41 99.9 99.9 99.9 99.9 99.6 99.7 99.7 99.7 99.7 99.7 99.6 99.7 99.7 99.7
J138 99.7 99.7 99.7 99.7 99.6 99.7 99.7 99.7 99.7 99.7 99.6 99.7 99.7 99.7
CV14 99.7 99.7 99.7 99.7 99.7 99.7 100 100 100 100 99.8 100 100 100
PB2 99.7 99.7 99.7 99.7 99.7 99.7 100 100 100 100 99.8 100 100 100
PB1 99.7 99.7 99.7 99.7 99.7 99.7 100 100 100 100 99.8 100 100 100
CWL011 99.8 99.8 99.8 99.8 99.7 99.7 100 100 100 100 99.9 100 100 100
Wein3 99.8 99.8 99.8 99.8 99.7 99.7 100 100 100 100 99.9 100 100 100
CWL029 99.6 99.6 99.6 99.6 99.6 99.6 99.8 99.8 99.8 99.9 99.9 99.9 99.8 99.8
U1271 99.8 99.8 99.8 99.8 99.7 99.7 100 100 100 100 100 99.9 100 100
CV15 99.7 99.7 99.7 99.7 99.7 99.7 100 100 100 100 100 99.8 100 100
Wein1 99.7 99.7 99.7 99.7 99.7 99.7 100 100 100 100 100 99.8 100 100
K7 99.8 99.8 99.8 99.8 99.7 99.7 100 99.9 100 100 100 99.9 100 100 100
Wein2 99.8 99.8 99.8 99.8 99.7 99.7 100 99.9 100 100 100 99.9 100 100 100
MUL2216 99.8 99.8 99.8 99.8 99.7 99.7 100 99.9 100 100 100 99.9 100 100 100
Panola 99.8 99.8 99.8 99.8 99.7 99.7 100 99.9 99.9 100 100 99.9 100 100 100
H12 99.4 99.4 99.4 99.4 99.4 99.4 99.6 99.6 99.6 99.7 99.7 99.5 99.7 99.6 99.6
UZG1 99.6 99.6 99.6 99.6 99.5 99.5 99.7 99.7 99.7 99.7 99.7 99.6 99.7 99.7 99.7
TW183 99.6 99.6 99.6 99.6 99.5 99.5 99.7 99.7 99.7 99.7 99.7 99.6 99.7 99.7 99.7
A03 99.5 99.5 99.5 99.5 99.5 99.5 99.6 99.6 99.6 99.6 99.6 99.8 99.6 99.6 99.6
WA97001 99.7 99.7 99.7 99.7 99.7 99.5 99.5 99.5 99.5 99.5 99.5 99.4 99.5 99.5 99.5
1979 98.6 98.6 98.6 98.6 98.6 98.7 98.7 98.7 98.7 98.7 98.7 98.9 98.7 98.7 98.7
SH511 98.7 98.7 98.7 98.7 98.6 98.7 98.7 98.7 98.7 98.8 98.8 98.9 98.8 98.7 98.7
IOL207 99.2 99.2 99.2 99.2 99.2 99.2 99.4 99.4 99.4 99.4 99.4 99.3 99.4 99.4 99.4
DC9 97.9 97.9 97.9 97.9 97.9 97.9 98 98 98 98 98 97.9 98 98 98
LPCoLN 94.6 94.6 94.6 94.6 94.6 94.8 94.7 94.7 94.7 94.7 94.7 94.6 94.7 94.7 94.7













Table 1 Percentage nucleotide pairwise identities of all C. pneumoniae strains (Continued)
K7 Wien2 MUL2216 Panola H12 UZG1 TW183 A03 WA97001 1979 SH511 IOL207 DC9 LPCoLN B21
CM1 99.8 99.8 99.8 99.8 99.4 99.6 99.6 99.5 99.7 98.6 98.7 99.2 97.9 94.6 94.6
GiD 99.8 99.8 99.8 99.8 99.4 99.6 99.6 99.5 99.7 98.6 98.7 99.2 97.9 94.6 94.6
TOR-1 99.8 99.8 99.8 99.8 99.4 99.6 99.6 99.5 99.7 98.6 98.7 99.2 97.9 94.6 94.6
AR39 99.8 99.8 99.8 99.8 99.4 99.6 99.6 99.5 99.7 98.6 98.7 99.2 97.9 94.6 94.6
YK41 99.7 99.7 99.7 99.7 99.4 99.5 99.5 99.5 99.7 98.6 98.6 99.2 97.9 94.6 94.6
J138 99.7 99.7 99.7 99.7 99.4 99.5 99.5 99.5 99.5 98.7 98.7 99.2 97.9 94.8 94.8
CV14 100 100 100 100 99.6 99.7 99.7 99.6 99.5 98.7 98.7 99.4 98 94.7 94.7
PB2 99.9 99.9 99.9 99.9 99.6 99.7 99.7 99.6 99.5 98.7 98.7 99.4 98 94.7 94.7
PB1 100 100 100 99.9 99.6 99.7 99.7 99.6 99.5 98.7 98.7 99.4 98 94.7 94.7
CWL011 100 100 100 100 99.7 99.7 99.7 99.6 99.5 98.7 98.8 99.4 98 94.7 94.7
Wein3 100 100 100 100 99.7 99.7 99.7 99.6 99.5 98.7 98.8 99.4 98 94.7 94.7
CWL029 99.9 99.9 99.9 99.9 99.5 99.6 99.6 99.8 99.4 98.9 98.9 99.3 97.9 94.6 94.6
U1271 100 100 100 100 99.7 99.7 99.7 99.6 99.5 98.7 98.8 99.4 98 94.7 94.7
CV15 100 100 100 100 99.6 99.7 99.7 99.6 99.5 98.7 98.7 99.4 98 94.7 94.7
Wein1 100 100 100 100 99.6 99.7 99.7 99.6 99.5 98.7 98.7 99.4 98 94.7 94.7
K7 100 100 100 99.7 99.7 99.7 99.6 99.5 98.7 98.8 99.4 98 94.7 94.7
Wein2 100 100 100 99.7 99.7 99.7 99.6 99.5 98.7 98.8 99.4 98 94.7 94.7
MUL2216 100 100 100 99.7 99.7 99.7 99.6 99.5 98.7 98.8 99.4 98 94.7 94.7
Panola 100 100 100 99.7 99.7 99.7 99.6 99.5 98.7 98.8 99.4 98 94.7 94.7
H12 99.7 99.7 99.7 99.7 99.4 99.4 99.3 99.2 98.4 98.4 99.1 97.8 94.4 94.4
UZG1 99.7 99.7 99.7 99.7 99.4 100 99.6 99.3 98.8 98.8 99.2 98.2 94.5 94.5
TW183 99.7 99.7 99.7 99.7 99.4 100 99.6 99.3 98.8 98.8 99.2 98.2 94.5 94.5
A03 99.6 99.6 99.6 99.6 99.3 99.6 99.6 99.3 98.9 98.9 99.1 97.9 94.5 94.4
WA97001 99.5 99.5 99.5 99.5 99.2 99.3 99.3 99.3 98.8 98.8 99 97.8 94.5 94.5
1979 98.7 98.7 98.7 98.7 98.4 98.8 98.8 98.9 98.8 99.7 98.4 97.5 94.2 94.2
SH511 98.8 98.8 98.8 98.8 98.4 98.8 98.8 98.9 98.8 99.7 98.4 97.5 94.3 94.3
IOL207 99.4 99.4 99.4 99.4 99.1 99.2 99.2 99.1 99 98.4 98.4 97.6 94.3 94.3
DC9 98 98 98 98 97.8 98.2 98.2 97.9 97.8 97.5 97.5 97.6 93.6 93.6
LPCoLN 94.7 94.7 94.7 94.7 94.4 94.5 94.5 94.5 94.5 94.2 94.3 94.3 93.6 100













of different origins [23]. In the current study, fine-
detailed genomic comparisons identified a series of novel
genetic markers unique to the Australian indigenous
strains, as well as unexpected sequence diversity in the
DC9, WA97001 and IOL207 strains, which support their
distinct phylogenetic positions in the C. pneumoniae
tree.
One of the most significant regions of genetic variation
identified is located around four full-length IncA genes
annotated in koala strain LPCoLN (CPK_ORF00546 to
CPKORF00549 [9]); the differences of which support our
phylogenetic results. The most notable finding in this
region for the three Australian strains was the observation
that the Australian indigenous strains contain a full-length
homolog of CPK_ORF00549 sharing 99.4 % nucleotide
pairwise identity to the koala homolog (Fig. 2). The
presence of this gene in strains SH511 and 1979, and its
significant sequence identity to the koala/bandicoot
homolog supports the branching of the Australian
indigenous clade earliest in the greater human C. pneumo-
niae phylogeny. Conversely, the Australian indigenous
strains do not have a copy of CPK_ORF00547. This locus
is also absent in the frog (DC9) strain and all strains
within the TW183 clade, but is found in fragmented forms
in all other human strains. Gene copy numbers and frag-
mentation with respect to the koala LPCoLN strain is rep-
resented in Fig. 2.
Another genetic marker unique to the Australian indi-
genous C. pneumoniae strains SH511 and 1979, was the
presence of a 159 bp insertion in the gene homologous
to koala CPK_ORF0341 (585 bp insertion compared to
the AR39 homolog). Translation of the open reading
frame suggests that this is a putative IncA gene which is
full length in the koala strain. However, this gene is
slightly truncated by 84 amino acids in indigenous
strains (354 amino acids in length) and is only 154
amino acids in length in all other strains, including frog
DC9 - due to a single nucleotide insertion 3’ which
Fig. 1 Chlamydia pneumoniae whole genome phylogeny constructed using MrBayes. Posterior probabilities >0.75 shown. Animal and human C.
pneumoniae strains form the two major clades, with four distinct clades within the human C. pneumoniae tree
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results in a frame shift (Fig. 3). Again, the large, strain-
specific insertion and its sequence similarity to the koala
homolog, supports the earliest branching of the Australian
indigenous strains in the major human C. pneumoniae
clade.
Sequence polymorphism has been described in the
guaB/A-add operon in human and animal C. pneumo-
niae strains, with previous studies detailing that human
C. pneumoniae strains encode fragmented inosine-5-
monophosphate dehydrogenase (guaB) genes [9]. In
this study, we found that like the DC9 frog strain, the
Australian indigenous strains and strain IOL207 encode
for a full length, intact guaB gene. By comparison, all other
human strains have a T/C transition at nucleotide position
262, which results in a stop codon (Fig. 4). Varied levels of
sequence decay are evident in the Australian strains for
GMP synthase (guaA) and adenosine deaminase (add). De-
letions in both the guaA and add homologs of WA97001
Fig. 2 The IncA gene expansion and recombination locus spanning homologs of CPK_ORF546 through 549 (LPCoLN locus numbering). Human
and frog C. pneumoniae strains encode for either two or three copies with various levels of fragmentation between strains. Different clades within
human C. pneumoniae encode for identical sequence length across this locus. The Australian indigenous strains are the only known human C.
pneumoniae strains to encode for a CPK_ORF00549 homolog
Fig. 3 A large sequence insertion is specific to indigenous strains SH511 and 1979, within a putative IncA gene homologous to CPK_ORF341. This
insertion encodes an almost full-length IncA homolog similar to that in the koala and bandicoot strains. Sequences at this locus for SH511 and
1979 are identical, and are shown compared to human strain AR39 and koala strain LPCoLN
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result in truncations of these genes with loss of functional
domains, whilst the Australian indigenous strains exhibit
extensive sequence decay at this locus, resulting in the ab-
sence of guaA-add and the downstream hypothetical pro-
tein. Interestingly, whilst the entire guaA/B-add operon is
absent in both koala and bandicoot strains, these genes are
present in the frog strain DC9.
Various sequence polymorphisms are evident in the
Australian C. pneumoniae strains for the pmpE/F4 gene.
Both indigenous Australian strains 1979 and SH511 are
truncated as the result of several deletions, whilst a single
nucleotide insertion in WA97001 results in a frameshift
causing truncation of this gene. This results in the loss of
the C-terminal autotransporter domain for all three strains
- however the mid-gene region encoding for nine FXXN
and eight GGA(I,L,V) amino acid motifs are highly con-
served across all the human C. pneumoniae strains (Fig. 5).
Additionally, whilst both the koala and bandicoot homologs
of this gene display extensive sequence polymorphism, the
DC9 frog homolog is highly similar in sequence to the
non-indigenous human pmpE/F4 and encodes for the full-
length protein.
Fig. 4 A single nucleotide transition in strains SH511, 1979, DC9 and IOL207 results in a full-length guaB gene, compared to fragmented genes in other
human C. pneumoniae represented by AR39. The amino acid residue change at position 88 in strains IOL207, 1979, SH511 and DC9 is highlighted in the
pink box, whilst the black arrow below the AR39 sequence indicates the guaB stop codon which is present in all other human C. pneumoniae strains. The
IOL207 homolog is N-terminal truncated by 23 amino acids
Fig. 5 pmpE/F4 displays significant sequence polymorphism and decay in Australian C. pneumoniae strains SH511, 1979 and WA97001, resulting in
truncated homologs of this protein. The frog DC9 homolog is similar in sequence to human C. pnuemoniae strains, unlike the koala and bandicoot
strains which are highly polymorphic at this locus. The GGA(I,L,V) - FXXN amino acid repeat motifs characteristic to the polymorphic membrane protein
gene family are highlighted, whilst sequence for the C-terminal autotransporter domain is clearly absent in SH511, 1979, WA97001 and LPCoLN strains
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Australian indigenous strains demonstrate characteristic
recombination profiles with only a few instances shared
with non-indigenous strains
In addition to estimation of the MRCA and mean substi-
tution rate, ClonalFrame was used to determine the
recombination profiles and any shared recombination loci
in C. pneumoniae. Our study found that the Australian
indigenous strains SH511 and 1979 had a distinct and
almost identical recombination and nucleotide substitu-
tion profile, with only a single difference in recombination
locus between the two: SH511 between 296,000 and
298,000 bp and 1979 between 310,000 and 316,000 bp.
Additionally, SH511 and 1979 share a strongly sup-
ported recombination event with the atherosclerosis
strain A03 and to a lesser extent with Australian non-
indigenous strain WA97001 between 778,000 and
784,000, which encompasses hypothetical protein and
putative IncA genes. In comparing recombination pro-
files across the non-indigenous C. pneumoniae strains,
the Australian WA97001 strain shares a single strong
recombination event with A03 and TW183 between
823,600 and 827,100 bp, which encompasses putative
IncA genes. Several nucleotide substitution events are
shared amongst the various C. pneumoniae strains,
though the highest number of nucleotide substitutions
occur in strains J138, IOL207 and DC9 (Fig. 6). A Phi
test for recombination was performed on the C. pneu-
moniae whole genome alignment using SplitsTree4
[34], which found a total of 16,329 informative sites
and statistically significant evidence of recombination
(p = 5.538 × 10−4).
Discussion
C. pneumoniae has been described as an ancient patho-
gen, with the broadest host range of any member of the
Chlamydiaceae [35]. Comparative whole genome studies
examining the differences between human respiratory
[20], non-respiratory [9, 21, 22, 36] and animal C. pneu-
moniae strains [9] all demonstrate a highly conserved core
genome with subtle strain-specific differences. We previ-
ously characterized some of these subtle differences using
a PCR/sequencing approach and revealed that the two
human Australian indigenous human strains sequenced in
this study shared genetic markers with the koala LPCoLN
strain [9] for some genes and away from other human
non-Australian indigenous strains [23]. To further explore
the relationship of Australian indigenous and non-
indigenous human strains, in the current study, we
obtained whole genome sequences for three Australian
respiratory strains (SH511, 1979 and WA97001) and
Fig. 6 Whole genome recombination mappings as predicted by ClonalFrame coalescent methods. Red bars represent recombination events and green
ticks represent mutations. Strains SH511 and 1979 share almost identical recombination profiles, with non-indigenous human C. pneumoniae and the
DC9 frog strain sharing recombination events at discrete loci. The predicted whole genome phylogeny based on recombination and mutation events is
consistent with the groupings demonstrated using BEAST and MrBayes prediction methods
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performed comparative analyses to further understand
their relationship to other previously characterized hu-
man and animal C. pneumoniae strains.
Using a variety of phylogenomic tools, our analysis sug-
gests that the Australian C. pneumoniae indigenous
strains form a phylogenetically distinct clade away from all
other human C. pneumoniae strains sequenced to date.
This is substantiated by unique sequence polymorphisms
and recombination profiles associated with the Australian
indigenous strains. In contrast to previous phylogenies
constructed using sequenced PCR fragments, which
alternately placed the Australian indigenous strains within
either the human or animal branches of the tree [23], the
use of whole genome sequences gives a more accurate
description of the position of these strains within the
greater C. pneumoniae evolutionary tree. Fine-detailed
genomic comparisons also revealed several novel genetic
markers in Australian indigenous human C. pneumoniae
strains, beyond those previously identified in previous
PCR-based studies [23].
The Australian indigenous strains demonstrate a copy
number incongruity within the CPK_ORF00546 to
CPK_ORF00549 IncA gene family. This gene family expan-
sion was first described in the koala LPCoLN strain [9]
with human C. pneumoniae strains exhibiting variable
levels of gene fragmentation and gene loss at this locus.
The Australian indigenous strains are unique in that they
specifically encode a homolog to CPK_ORF00549: to date,
SH511 and 1979 are the only human C. pnuemoniae
strains that encode for this homolog. Previous studies have
shown that C. pneumoniae encodes a far larger number of
IncA and putative IncA proteins compared to other Chla-
mydiae [11, 12], many of which are species-specific. Strong
recombination signals were also detected within several
human C. pneumoniae strains at loci encoding IncA pro-
teins, which suggests that recombination may account for
the expanded number of IncA proteins in C. pneumoniae.
One of the more subtle genetic differences observed be-
tween the strains analysed was the maintenance of a partial
purine biosynthesis pathway encoded by guaA/B-add [10].
Previous studies demonstrated that the guaB gene is frag-
mented in human C. pneumoniae strains [14], however in
this study we demonstrate that strains DC9, SH511 and
1979 encode for an intact guaB gene. Given that the
Australian indigenous strains do not encode guaA-add, it
is likely that the sequence for guaB was a recent acquisi-
tion from a strain most similar to DC9. Interestingly, in
contrast to the koala and bandicoot strains where the
entire guaA/B-add operon is absent [9, 37], the frog DC9
strain encodes guaA/B-add genes, with >99.5 % nucleotide
pairwise identity to all human C. pneumoniae strains, with
the exception of the three Australian strains. Studies in
both C. psittaci and Chlamydia caviae have found evi-
dence for horizontal gene transfer of the guaA/B-add
operon between different chlamydial strains and species
[33, 38], lending further support for the recent acquisition
of guaB by the Australian indigenous strains. Whilst it is
unclear what effect the presence or absence of guaA/B-
add has on the growth and virulence of human and animal
C. pneumoniae strains, a previous study examining the
effect of mutations in the Chlamydia muridarum plasticity
zone suggest that 5’ point mutations of guaB and add
result in attenuated virulence in vivo, whilst guaA/B-add
mutations do not affect the growth characteristics of these
strains in vitro [39]. These observations are similar to those
reported for the growth and virulence of Borrelia burgdor-
feri and Francisella tularensis guaA/B +/− strains in vitro
and in vivo [40, 41].
In order to further explore the evolutionary relation-
ships of the Australian indigenous C. pneumoniae strains,
BEAST and ClonalFrame analyses predicted that these
strains had an MRCA of 1028 and 1425, respectively. Both
of these estimations pre-date the known colonization of
the Australian continent by Europeans by several hundred
years, but are virtually identical to the previously esti-
mated MRCA for strains within the non-indigenous clade
at 1151 +/− 20 years [21].
Given this new evidence and our previous data suggest-
ing that C. pneumoniae strains in humans likely originated
from a zoonotic event(s) [9, 23], it is interesting to specu-
late on the origin of these indigenous human C. pneumo-
niae strains. Two possible evolutionary hypotheses to
explain the deep-branching of these strains are proposed:
(A), the Australian indigenous strains have evolved from a
separate zoonotic transmission event, or alternate inter-
mediate strain, to that of the other human C. pneumoniae
strains. These ancestral strains were subsequently endemic
on the Australian continent and continued to evolve in
isolation to the non-indigenous C. pneumoniae strains.
Alternatively (B), all human C. pneumoniae strains dis-
seminated from a common intermediate strain, resultant
from a single zoonotic event several thousand years ago,
and evolved separately in response to their different
ecological niches (Fig. 7). Our findings provide support for
both hypotheses.
With respect to hypothesis (A), estimations from both
BEAST and ClonalFrame analyses indicate an MRCA for
the indigenous strains several hundred years prior to the
first reported visitation of the Australian continent by
Dutch or British explorers [42, 43]. This suggests the
possibility that an endemic strain similar to our strains
may have been circulating within the indigenous popula-
tion prior to the arrival of European colonisation. Given
the sequence similarity of the indigenous strains to the
koala and bandicoot C. pneumoniae strains at several
key loci (the absence of guaA-add, polymorphisms in
pmpE/F4 and the IncA gene expansion), as well as those
previously described [23], it is possible that a strain
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similar to these animal strains was zoonotically transmit-
ted to humans on the Australian continent. Hunter-
gatherer communities lived in close proximity and inter-
acted with wild animals throughout human history,
which would facilitate the transmission of a pathogen to
humans. Serological studies examining the prevalence of
chlamydial infection in remote indigenous communities
have reported levels of almost 60 % adult female
seroprevalence to C. pneumoniae [24]. Several species of
native Australian marsupials [9, 23, 37, 44] as well as an
amphibian [7, 23] have been demonstrated to have gen-
etic sequence similar to that of the koala LPCoLN strain.
Studies have shown that koala and bandicoot C. pneu-
moniae strains readily infect various human-derived cell
lines [3, 45, 46], and evidence for human carotid artery
and PBMC strains which are genotypically similar to the
koala strain at the ompA and yge-urk intergenic spacer
loci have been reported [47]. If the distinct phylogenetic
clustering of SH511 and 1979 is a result of a separate
zoonotic event to that of the main human C. pneumo-
niae lineage, then it is likely that the animal strain that
they have evolved from is still unknown, and probably
more similar to the frog DC9 strain in sequence and nu-
cleotide content.
The alternate hypothesis (B), is that all human C. pneu-
moniae strains disseminated from a single zoonotic event
(presumably in Americas or Europe) and then differenti-
ated along separate evolutionary paths, dependent on their
geographical and disease niche. The estimated MRCA for
indigenous and non-indigenous human strains differs by
less than 200 years, whilst their phylogenetic distance is
significantly closer, compared to the animal strains. The
overall nucleotide pairwise identity of the Australian indi-
genous strains is more similar to other human strains of
C. pneumoniae, even when significant similarities to ani-
mal strains at discrete loci are included. There are two
Fig. 7 Evolutionary hypothesis model describing two alternate hypotheses for the characteristic deep-branching of the Australian indigenous strains
SH511 and 1979. In hypothesis A, Australian indigenous strains evolved from a separate zoonotic (or intermediate) transmission event, and continued
to evolve in isolation from non-indigenous human C. pneumoniae strains. In hypothesis B, all human C. pneumoniae strains disseminated from a single
zoonotic (or intermediate) transmission event and evolved separately in response to differing ecological functions
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possible mechanisms to explain the dissemination of these
particular strains: Firstly - various strains of C. pneumo-
niae were circulating in the worldwide human population
approximately 40 thousand years ago, which is well prior
to the colonisation of the Australian continent [48], and
that one or some of these strains came to the continent
with the arrival of the indigenous peoples. This would
account for the characteristic sequence polymorphisms
present in the SH511 and 1979 but not in other human C.
pneumoniae strains. Alternately - the worldwide variation
in human C. pneumoniae is far greater than has yet been
determined, and several strain types were introduced to
the Australian continent with European colonisation. This
in turn accounts for the overall sequence similarity of the
SH511 and 1979 strains to non-indigenous human C.
pneumoniae strains, in particular WA97001, with which it
shares a considerable number of SNPs, as opposed to the
Australian marsupial strains, LPCoLN and B21. In both
cases, genetically distinct subpopulations of C. pneumoniae
could have spread throughout, and evolved in isolation
within the indigenous Australian population. Genotypic
variation amongst concurrent populations of monomorphic
bacteria resulting from selective sweeps is well documented
in both Chlamydia [49, 50] and other bacterial species [51].
The differentiation of the main human C. pneumoniae
lineage from both the indigenous and animal lineages could
be explained by adaptation of these strains to selective and
antigenic pressure as a result of extensive antibiotic treat-
ment regimes [52].
Whilst our study provides evidence for a phylogenetically
and genetically distinct branch of human C. pneumoniae,
these inferences are made on a relatively small sample size,
taken from two individuals from remote communities in
the same state, over two decades ago. It is highly unlikely
that sampling from the same remote communities and
wider ranging communities will uncover the same strains
as documented in this study; given the increased inter-
action between members of remote indigenous communi-
ties and neighbouring townships, as well as expanded
antibiotic treatment regimes for a range of bacterial infec-
tions, including Chlamydia, within these communities. It is
also possible that greater sampling for C. pneumoniae in
countries outside Australia would uncover a wider range of
strains, some of which may be similar to those described in
this study.
Conclusion
In summary, we used a combination of comparative
genomic and phylogenetic methods to determine the evolu-
tionary position of three Australian human C. pneumoniae
strains within the greater C. pneumoniae tree. Our study
demonstrated a phylogenetically distinct human C. pneu-
moniae clade consisting of two Australian indigenous
strains, that branched earlier in the human C. pneumoniae
evolutionary tree with an estimated MRCA predating the
exploration and colonisation of the continent by European
settlers by several hundred years. Our findings indicate that
a unique strain of C. pneumoniae evolved in isolation
within the Australian indigenous population, as evidenced
by the unique recombination profiles and distinct sequence
polymorphisms in these strains. This suggests that a far
greater level of sequence diversity is present amongst hu-
man and animal C. pneumoniae strains than previously sur-
mised, and that further sampling of C. pneumoniae isolates
from wider geographical regions may uncover strains which
have evolved similarly to this unique C. pneumoniae clade.
Methods
Description of Chlamydia pneumoniae strains, cell
culturing and DNA purification
Three Australian C. pneumoniae cultured isolates
(WA97001, SH511 and 1979) were used for comparative
analyses in this study. The non-indigenous isolate
WA97001 is a clinical nasopharyngeal isolate fromWestern
Australia [26] whilst isolates SH511 and 1979 are indigen-
ous Australian isolates from two separate patients in
remote Northern Territory communities [24, 25].
Isolate WA97001 was propagated on McCoy cells in T75
flasks for five passages, based on a previously described
method [46]. Infected cells were pooled and semi-purified
using a sonication and centrifugation method prior to pas-
sage. The final semi-purified product was stored in an
equal volume of SPG media [53]. 500 μl of this semi-
purified material was used for DNA extraction. Isolates
SH511 and 1979 were extracted from non-viable archival
culture material [23]; 500 μl of each isolate was used for
DNA extraction.
DNA extraction was performed using phenol:chlorofor-
m:IAA, based on a well described method [54], with the
addition of 2 μl of glycogen prior to ethanol precipitation
at −20 °C overnight. Precipitated DNA was dissolved in
50 μl of TE buffer. 500 ng of extracted DNA was used to
perform pan-Chlamydiales 16S rRNA [55] and C. pneu-
moniae specific RpoB [56] PCR to confirm the presence of
C. pneumoniae DNA, and 500 ng of stock DNA was elec-
trophoresed on a 0.8 % TBE agarose gel to confirm high
molecular weight DNA. Each DNA extraction yielded
greater than 2 μg of high molecular weight genomic DNA,
which was used for sequence capture and Illumina HiSeq
2500 whole genome sequencing at the Institute for
Genome Sciences, Baltimore, Maryland.
Sequence capture, whole genome sequencing and
assembly
Sequence capture was performed on total DNA extracted
from WA97001, SH511 and 1979 with Agilent SureSe-
lectXT DNA capture probes designed to C. pneumoniae
reference strain AR39, using a hybridisation capture and
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amplification process [27–29]. Captured and amplified
products were sequenced using the Illumina HiSeq 2500
platform, resulting in paired-end 100 base pair reads. Read
quality was checked with FastQC (http://www.bioinforma-
tics.bbsrc.ac.uk/projects/fastqc/) and genomes were assem-
bled de novo using SPAdes 3.0.0 with SPAdes 3.0.0 with k-
mer values set to of 15, 21, 33, 51 and 71 [57]. All assem-
bled contigs were aligned to the reference C. pneumoniae
AR39 genome using BLASTn to remove non-chlamydial
contigs. Concatenated genome contigs were annotated
using the RAST pipeline [58] and manually curated using
ARTEMIS [59]. Total read depth of WA97001, SH511 and
1979 was calculated by mapping the raw reads to complete
genome of C. pneumoniae AR39 using the BWA-backtrack
algorithm with BWA aligner [60]. Raw reads were also
mapped to the complete genome of C. pneumoniae
LPCoLN for comparison. The BWA parameters used
include the number of differences allowed between the
reference and query set at 0.04 and the number of differ-
ences allowed in the seed was 2. The maximum number of
gaps allowed in the alignment was 1 and the gap penalty
was set at 11.
Phylogenetic and recombination analyses
De novo assemblies and readmapped assembled consen-
sus sequences for WA97001, SH511 and 1979 were
aligned to the existing human C. pneumoniae whole
genome sequences [10, 19–22, 61] and animal C. pneu-
moniae strains LPCoLN, B21 and DC9 [9, 22, 37] in
Geneious 6.1.8 [62] using the MAFFT plugin implemen-
tation [63]. Coverage analyses for readmapped assem-
blies and manual curation of annotated genomes was
performed using ARTEMIS [59].
Phylogenetic analyses were performed on whole genome
alignments, with the LPCoLN koala [9] C. pneumoniae
strain indicated as an outlier. Whole genome alignments
were also filtered for poorly aligned and gap regions using
Gblocks 0.91b [64]. Mid-point rooted trees were
constructed with the MrBayes plugin [65] in Geneious,
utilising a Jukes-Cantor substitution model with with four
Markov Chain Monte Carlo (MCMC) chains and 1.1
million cycles, sampled every 1000 generations and the first
10,000 trees discarded as burn-in. Estimates of strain
evolution over time were performed on whole genome
alignments using the BEAST package [31]. Indigenous,
non-indigenous and animal isolates were defined in separ-
ate taxon sets and a GTR nucleotide substitution model
was employed. MRCA priors were set at a normal distribu-
tion with a mean of 95.2 +/− 7.4 [66]. MCMC chain length
was set to 5 × 107 to ensure effective sample sizes were
sufficient for strong posterior distribution statistics. Clonal-
Frame [67] was used to determine homologous recombin-
ation within C. pneumoniae genomes, and progressive
MAUVE [68] was used to generate the input alignments.
Three successive runs of ClonalFrame were performed on
the whole genome alignment, each with 20,000 iterations
and 10,000 of these discarded as burn-in. The three runs
were checked for convergence and their trees combined
for analysis. An additional Phi test for recombination was
performed in SplitsTree4 [34] using the whole genome
alignment generated by MAFFT in Geneious.
The accession numbers for the C. pneumoniae whole
genome sequences used in the comparative analyses and
phylogenies are outlined in Table 2.
Description of polymorphic hotspots in C. pneumoniae
whole genome alignments
De novo and readmapping assemblies were used to con-
struct whole genome alignments with previously described
Table 2 C. pneumoniae strain designations and accession
numbers
Strain designation Accession number Reference/s



















SH511 SRP061961 [25] This study









1979 SRP062031 [25] This study
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human and animal C. pneumoniae whole genomes in
MAFFT [63] in Geneious [62]. Single nucleotide polymor-
phisms (SNPs) and insertions/deletions were detected
using the Variations/SNPs tool in Geneious, and larger
scale differences were detected via manual scanning of the
genome alignment. Sequence for genes which appeared to
have significant deletions or insertions were manually ex-
tracted and sequence run against the BLAST [69] database
to determine closest homologs. Sequences were translated
and searched against the SMART database [70] to predict
any changes in functional domains or protein motifs.
Availabilty of supporting data
The WA97001, SH511 and 1979 whole genome se-
quencing projects can be found on National Center for
Biotechnology Information (NCBI) BioProject under
accession numbers [Bioproject:PRJNA291806, Biopro-
ject:PRJNA291802 and Bioproject:PRJNA291805] with
reads deposited in the Short Reads Archive under ac-
cession numbers [SRA:SRR2144962, SRA:SRR2144961
and SRA:SRR2144960] respectively.
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